id	sid	tid	token	lemma	pos
dpc-1099	1	1	dermatology	dermatology	NOUN
dpc-1099	1	2	:	:	PUNCT
dpc-1099	1	3	practical	practical	ADJ
dpc-1099	1	4	and	and	CCONJ
dpc-1099	1	5	conceptual	conceptual	ADJ
dpc-1099	1	6	review	review	NOUN
dpc-1099	1	7	|	|	ADV
dpc-1099	1	8	dermatol	dermatol	ADJ
dpc-1099	1	9	pract	pract	NOUN
dpc-1099	1	10	concept	concept	NOUN
dpc-1099	1	11	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	1	12	1	1	NUM
dpc-1099	1	13	dermatology	dermatology	NOUN
dpc-1099	1	14	practical	practical	ADJ
dpc-1099	1	15	&	&	CCONJ
dpc-1099	1	16	conceptual	conceptual	ADJ
dpc-1099	1	17	introduction	introduction	NOUN
dpc-1099	1	18	autoimmune	autoimmune	ADJ
dpc-1099	1	19	bullous	bullous	ADJ
dpc-1099	1	20	disorders	disorder	NOUN
dpc-1099	1	21	(	(	PUNCT
dpc-1099	1	22	abds	abds	NOUN
dpc-1099	1	23	)	)	PUNCT
dpc-1099	1	24	encompass	encompass	VERB
dpc-1099	1	25	a	a	DET
dpc-1099	1	26	number	number	NOUN
dpc-1099	1	27	of	of	ADP
dpc-1099	1	28	heterogeneous	heterogeneous	ADJ
dpc-1099	1	29	conditions	condition	NOUN
dpc-1099	1	30	linked	link	VERB
dpc-1099	1	31	by	by	ADP
dpc-1099	1	32	the	the	DET
dpc-1099	1	33	loss	loss	NOUN
dpc-1099	1	34	of	of	ADP
dpc-1099	1	35	tolerance	tolerance	NOUN
dpc-1099	1	36	to	to	ADP
dpc-1099	1	37	structural	structural	ADJ
dpc-1099	1	38	proteins	protein	NOUN
dpc-1099	1	39	of	of	ADP
dpc-1099	1	40	the	the	DET
dpc-1099	1	41	skin	skin	NOUN
dpc-1099	1	42	.	.	PUNCT
dpc-1099	2	1	as	as	ADP
dpc-1099	2	2	a	a	DET
dpc-1099	2	3	consequence	consequence	NOUN
dpc-1099	2	4	of	of	ADP
dpc-1099	2	5	breakdown	breakdown	NOUN
dpc-1099	2	6	of	of	ADP
dpc-1099	2	7	tolerance	tolerance	NOUN
dpc-1099	2	8	,	,	PUNCT
dpc-1099	2	9	autoantibodies	autoantibody	NOUN
dpc-1099	2	10	targeting	target	VERB
dpc-1099	2	11	epidermal	epidermal	ADJ
dpc-1099	2	12	or	or	CCONJ
dpc-1099	2	13	subepidermal	subepidermal	NOUN
dpc-1099	2	14	adhesion	adhesion	NOUN
dpc-1099	2	15	proteins	protein	NOUN
dpc-1099	2	16	are	be	AUX
dpc-1099	2	17	produced	produce	VERB
dpc-1099	2	18	.	.	PUNCT
dpc-1099	3	1	the	the	DET
dpc-1099	3	2	loss	loss	NOUN
dpc-1099	3	3	of	of	ADP
dpc-1099	3	4	adhesion	adhesion	NOUN
dpc-1099	3	5	between	between	ADP
dpc-1099	3	6	keratinocytes	keratinocyte	NOUN
dpc-1099	3	7	or	or	CCONJ
dpc-1099	3	8	between	between	ADP
dpc-1099	3	9	basal	basal	ADJ
dpc-1099	3	10	keratinocytes	keratinocyte	NOUN
dpc-1099	3	11	and	and	CCONJ
dpc-1099	3	12	the	the	DET
dpc-1099	3	13	underlying	underlie	VERB
dpc-1099	3	14	epidermal	epidermal	ADJ
dpc-1099	3	15	basement	basement	NOUN
dpc-1099	3	16	membrane	membrane	NOUN
dpc-1099	3	17	leads	lead	VERB
dpc-1099	3	18	to	to	ADP
dpc-1099	3	19	an	an	DET
dpc-1099	3	20	impaired	impaired	ADJ
dpc-1099	3	21	resilience	resilience	NOUN
dpc-1099	3	22	of	of	ADP
dpc-1099	3	23	the	the	DET
dpc-1099	3	24	epidermis	epidermis	NOUN
dpc-1099	3	25	resulting	result	VERB
dpc-1099	3	26	in	in	ADP
dpc-1099	3	27	intraepithelial	intraepithelial	ADJ
dpc-1099	3	28	or	or	CCONJ
dpc-1099	3	29	subepithelial	subepithelial	ADJ
dpc-1099	3	30	blisters	blister	NOUN
dpc-1099	3	31	and	and	CCONJ
dpc-1099	3	32	erosions	erosion	NOUN
dpc-1099	3	33	of	of	ADP
dpc-1099	3	34	the	the	DET
dpc-1099	3	35	skin	skin	NOUN
dpc-1099	3	36	and	and	CCONJ
dpc-1099	3	37	mucous	mucous	ADJ
dpc-1099	3	38	membranes	membrane	NOUN
dpc-1099	3	39	.	.	PUNCT
dpc-1099	4	1	abds	abds	PROPN
dpc-1099	4	2	pemphigus	pemphigus	PROPN
dpc-1099	4	3	vulgaris	vulgaris	NOUN
dpc-1099	4	4	and	and	CCONJ
dpc-1099	4	5	bullous	bullous	ADJ
dpc-1099	4	6	pemphigoid	pemphigoid	NOUN
dpc-1099	4	7	:	:	PUNCT
dpc-1099	4	8	update	update	NOUN
dpc-1099	4	9	on	on	ADP
dpc-1099	4	10	diagnosis	diagnosis	NOUN
dpc-1099	4	11	and	and	CCONJ
dpc-1099	4	12	treatment	treatment	NOUN
dpc-1099	4	13	vito	vito	PROPN
dpc-1099	4	14	di	di	PROPN
dpc-1099	4	15	lernia,1	lernia,1	PROPN
dpc-1099	4	16	dahiana	dahiana	PROPN
dpc-1099	4	17	m.	m.	PROPN
dpc-1099	4	18	casanova,1	casanova,1	NOUN
dpc-1099	4	19	mohamad	mohamad	PROPN
dpc-1099	4	20	goldust,2	goldust,2	NOUN
dpc-1099	4	21	cinzia	cinzia	PROPN
dpc-1099	4	22	ricci1	ricci1	PROPN
dpc-1099	4	23	1	1	NUM
dpc-1099	4	24	dermatology	dermatology	NOUN
dpc-1099	4	25	unit	unit	NOUN
dpc-1099	4	26	,	,	PUNCT
dpc-1099	4	27	arcispedale	arcispedale	PROPN
dpc-1099	4	28	santa	santa	PROPN
dpc-1099	4	29	maria	maria	PROPN
dpc-1099	4	30	nuova	nuova	PROPN
dpc-1099	4	31	,	,	PUNCT
dpc-1099	4	32	azienda	azienda	PROPN
dpc-1099	4	33	usl	usl	PROPN
dpc-1099	4	34	-	-	PUNCT
dpc-1099	4	35	irccs	irccs	NOUN
dpc-1099	4	36	di	di	PROPN
dpc-1099	4	37	reggio	reggio	PROPN
dpc-1099	4	38	emilia	emilia	PROPN
dpc-1099	4	39	,	,	PUNCT
dpc-1099	4	40	italy	italy	PROPN
dpc-1099	4	41	2	2	NUM
dpc-1099	4	42	university	university	PROPN
dpc-1099	4	43	guglielmo	guglielmo	PROPN
dpc-1099	4	44	marconi	marconi	PROPN
dpc-1099	4	45	,	,	PUNCT
dpc-1099	4	46	rome	rome	PROPN
dpc-1099	4	47	,	,	PUNCT
dpc-1099	4	48	italy	italy	PROPN
dpc-1099	4	49	&	&	CCONJ
dpc-1099	4	50	department	department	PROPN
dpc-1099	4	51	of	of	ADP
dpc-1099	4	52	dermatology	dermatology	NOUN
dpc-1099	4	53	,	,	PUNCT
dpc-1099	4	54	university	university	NOUN
dpc-1099	4	55	hospital	hospital	NOUN
dpc-1099	4	56	,	,	PUNCT
dpc-1099	4	57	basel	basel	PROPN
dpc-1099	4	58	,	,	PUNCT
dpc-1099	4	59	switzerland	switzerland	PROPN
dpc-1099	4	60	key	key	ADJ
dpc-1099	4	61	words	word	NOUN
dpc-1099	4	62	:	:	PUNCT
dpc-1099	4	63	pemphigus	pemphigus	NOUN
dpc-1099	4	64	,	,	PUNCT
dpc-1099	4	65	pemphigoid	pemphigoid	ADJ
dpc-1099	4	66	,	,	PUNCT
dpc-1099	4	67	autoimmune	autoimmune	ADJ
dpc-1099	4	68	,	,	PUNCT
dpc-1099	4	69	bullous	bullous	ADJ
dpc-1099	4	70	,	,	PUNCT
dpc-1099	4	71	disorder	disorder	NOUN
dpc-1099	4	72	citation	citation	NOUN
dpc-1099	4	73	:	:	PUNCT
dpc-1099	4	74	di	di	PROPN
dpc-1099	4	75	lernia	lernia	PROPN
dpc-1099	4	76	v	v	PROPN
dpc-1099	4	77	,	,	PUNCT
dpc-1099	4	78	casanova	casanova	X
dpc-1099	4	79	dm	dm	PROPN
dpc-1099	4	80	,	,	PUNCT
dpc-1099	4	81	goldust	goldust	PROPN
dpc-1099	4	82	m	m	PROPN
dpc-1099	4	83	,	,	PUNCT
dpc-1099	4	84	ricci	ricci	PROPN
dpc-1099	4	85	c.	c.	PROPN
dpc-1099	4	86	pemphigus	pemphigus	PROPN
dpc-1099	4	87	vulgaris	vulgaris	PROPN
dpc-1099	4	88	and	and	CCONJ
dpc-1099	4	89	bullous	bullous	ADJ
dpc-1099	4	90	pemphigoid	pemphigoid	NOUN
dpc-1099	4	91	:	:	PUNCT
dpc-1099	4	92	update	update	NOUN
dpc-1099	4	93	on	on	ADP
dpc-1099	4	94	diagnosis	diagnosis	NOUN
dpc-1099	4	95	and	and	CCONJ
dpc-1099	4	96	treatment	treatment	NOUN
dpc-1099	4	97	.	.	PUNCT
dpc-1099	5	1	dermatol	dermatol	NOUN
dpc-1099	5	2	pract	pract	PROPN
dpc-1099	5	3	concept	concept	NOUN
dpc-1099	5	4	.	.	PUNCT
dpc-1099	6	1	2020;10(3):e2020050	2020;10(3):e2020050	X
dpc-1099	6	2	.	.	PUNCT
dpc-1099	7	1	doi	doi	NOUN
dpc-1099	7	2	:	:	PUNCT
dpc-1099	7	3	https://doi.org/10.5826/dpc.1003a50	https://doi.org/10.5826/dpc.1003a50	ADJ
dpc-1099	7	4	accepted	accept	VERB
dpc-1099	7	5	:	:	PUNCT
dpc-1099	7	6	march	march	PROPN
dpc-1099	7	7	5	5	NUM
dpc-1099	7	8	,	,	PUNCT
dpc-1099	7	9	2020	2020	NUM
dpc-1099	7	10	;	;	PUNCT
dpc-1099	7	11	published	publish	VERB
dpc-1099	7	12	:	:	PUNCT
dpc-1099	7	13	june	june	PROPN
dpc-1099	7	14	29	29	NUM
dpc-1099	7	15	,	,	PUNCT
dpc-1099	7	16	2020	2020	NUM
dpc-1099	7	17	copyright	copyright	NOUN
dpc-1099	7	18	:	:	PUNCT
dpc-1099	7	19	©	©	PROPN
dpc-1099	7	20	2020	2020	NUM
dpc-1099	7	21	di	di	X
dpc-1099	7	22	lernia	lernia	PROPN
dpc-1099	7	23	et	et	PROPN
dpc-1099	7	24	al	al	PROPN
dpc-1099	7	25	.	.	PUNCT
dpc-1099	8	1	this	this	PRON
dpc-1099	8	2	is	be	AUX
dpc-1099	8	3	an	an	DET
dpc-1099	8	4	open	open	ADJ
dpc-1099	8	5	-	-	PUNCT
dpc-1099	8	6	access	access	NOUN
dpc-1099	8	7	article	article	NOUN
dpc-1099	8	8	distributed	distribute	VERB
dpc-1099	8	9	under	under	ADP
dpc-1099	8	10	the	the	DET
dpc-1099	8	11	terms	term	NOUN
dpc-1099	8	12	of	of	ADP
dpc-1099	8	13	the	the	DET
dpc-1099	8	14	creative	creative	ADJ
dpc-1099	8	15	commons	common	NOUN
dpc-1099	8	16	attribution	attribution	NOUN
dpc-1099	8	17	license	license	NOUN
dpc-1099	8	18	,	,	PUNCT
dpc-1099	8	19	which	which	PRON
dpc-1099	8	20	permits	permit	VERB
dpc-1099	8	21	unrestricted	unrestricted	ADJ
dpc-1099	8	22	use	use	NOUN
dpc-1099	8	23	,	,	PUNCT
dpc-1099	8	24	distribution	distribution	NOUN
dpc-1099	8	25	,	,	PUNCT
dpc-1099	8	26	and	and	CCONJ
dpc-1099	8	27	reproduction	reproduction	NOUN
dpc-1099	8	28	in	in	ADP
dpc-1099	8	29	any	any	DET
dpc-1099	8	30	medium	medium	NOUN
dpc-1099	8	31	,	,	PUNCT
dpc-1099	8	32	provided	provide	VERB
dpc-1099	8	33	the	the	DET
dpc-1099	8	34	original	original	ADJ
dpc-1099	8	35	author	author	NOUN
dpc-1099	8	36	and	and	CCONJ
dpc-1099	8	37	source	source	NOUN
dpc-1099	8	38	are	be	AUX
dpc-1099	8	39	credited	credit	VERB
dpc-1099	8	40	.	.	PUNCT
dpc-1099	9	1	funding	funding	NOUN
dpc-1099	9	2	:	:	PUNCT
dpc-1099	9	3	none	none	NOUN
dpc-1099	9	4	.	.	PUNCT
dpc-1099	10	1	competing	compete	VERB
dpc-1099	10	2	interests	interest	NOUN
dpc-1099	10	3	:	:	PUNCT
dpc-1099	10	4	the	the	DET
dpc-1099	10	5	authors	author	NOUN
dpc-1099	10	6	have	have	VERB
dpc-1099	10	7	no	no	DET
dpc-1099	10	8	conflicts	conflict	NOUN
dpc-1099	10	9	of	of	ADP
dpc-1099	10	10	interest	interest	NOUN
dpc-1099	10	11	to	to	PART
dpc-1099	10	12	disclose	disclose	VERB
dpc-1099	10	13	.	.	PUNCT
dpc-1099	11	1	authorship	authorship	NOUN
dpc-1099	11	2	:	:	PUNCT
dpc-1099	11	3	all	all	DET
dpc-1099	11	4	authors	author	NOUN
dpc-1099	11	5	have	have	AUX
dpc-1099	11	6	contributed	contribute	VERB
dpc-1099	11	7	significantly	significantly	ADV
dpc-1099	11	8	to	to	ADP
dpc-1099	11	9	this	this	DET
dpc-1099	11	10	publication	publication	NOUN
dpc-1099	11	11	.	.	PUNCT
dpc-1099	12	1	corresponding	correspond	VERB
dpc-1099	12	2	author	author	NOUN
dpc-1099	12	3	:	:	PUNCT
dpc-1099	12	4	vito	vito	PROPN
dpc-1099	12	5	di	di	PROPN
dpc-1099	12	6	lernia	lernia	PROPN
dpc-1099	12	7	,	,	PUNCT
dpc-1099	12	8	md	md	PROPN
dpc-1099	12	9	,	,	PUNCT
dpc-1099	12	10	dermatology	dermatology	NOUN
dpc-1099	12	11	unit	unit	NOUN
dpc-1099	12	12	,	,	PUNCT
dpc-1099	12	13	arcispedale	arcispedale	PROPN
dpc-1099	12	14	santa	santa	PROPN
dpc-1099	12	15	maria	maria	PROPN
dpc-1099	12	16	nuova	nuova	PROPN
dpc-1099	12	17	,	,	PUNCT
dpc-1099	12	18	viale	viale	PROPN
dpc-1099	12	19	risorgimento	risorgimento	PROPN
dpc-1099	12	20	80	80	NUM
dpc-1099	12	21	,	,	PUNCT
dpc-1099	12	22	42123	42123	NUM
dpc-1099	12	23	reggio	reggio	PROPN
dpc-1099	12	24	emilia	emilia	PROPN
dpc-1099	12	25	,	,	PUNCT
dpc-1099	12	26	italy	italy	PROPN
dpc-1099	12	27	.	.	PUNCT
dpc-1099	13	1	email	email	NOUN
dpc-1099	13	2	:	:	PUNCT
dpc-1099	13	3	vito.dilernia@ausl.re.it	vito.dilernia@ausl.re.it	PUNCT
dpc-1099	13	4	autoimmune	autoimmune	ADJ
dpc-1099	13	5	bullous	bullous	ADJ
dpc-1099	13	6	disorders	disorder	NOUN
dpc-1099	13	7	are	be	AUX
dpc-1099	13	8	a	a	DET
dpc-1099	13	9	heterogeneous	heterogeneous	ADJ
dpc-1099	13	10	spectrum	spectrum	NOUN
dpc-1099	13	11	of	of	ADP
dpc-1099	13	12	skin	skin	NOUN
dpc-1099	13	13	disorders	disorder	NOUN
dpc-1099	13	14	characterized	characterize	VERB
dpc-1099	13	15	by	by	ADP
dpc-1099	13	16	the	the	DET
dpc-1099	13	17	production	production	NOUN
dpc-1099	13	18	of	of	ADP
dpc-1099	13	19	autoantibodies	autoantibody	NOUN
dpc-1099	13	20	against	against	ADP
dpc-1099	13	21	adhesion	adhesion	NOUN
dpc-1099	13	22	molecules	molecule	NOUN
dpc-1099	13	23	of	of	ADP
dpc-1099	13	24	the	the	DET
dpc-1099	13	25	skin	skin	NOUN
dpc-1099	13	26	.	.	PUNCT
dpc-1099	14	1	the	the	DET
dpc-1099	14	2	2	2	NUM
dpc-1099	14	3	major	major	ADJ
dpc-1099	14	4	groups	group	NOUN
dpc-1099	14	5	of	of	ADP
dpc-1099	14	6	diseases	disease	NOUN
dpc-1099	14	7	are	be	AUX
dpc-1099	14	8	“	"	PUNCT
dpc-1099	14	9	pemphigus	pemphigus	NOUN
dpc-1099	14	10	diseases	disease	NOUN
dpc-1099	14	11	”	"	PUNCT
dpc-1099	14	12	and	and	CCONJ
dpc-1099	14	13	“	"	PUNCT
dpc-1099	14	14	autoimmune	autoimmune	ADJ
dpc-1099	14	15	bullous	bullous	ADJ
dpc-1099	14	16	diseases	disease	NOUN
dpc-1099	14	17	of	of	ADP
dpc-1099	14	18	the	the	DET
dpc-1099	14	19	pemphigoid	pemphigoid	ADJ
dpc-1099	14	20	type	type	NOUN
dpc-1099	14	21	.	.	PUNCT
dpc-1099	14	22	”	"	PUNCT
dpc-1099	15	1	pemphigus	pemphigus	NOUN
dpc-1099	15	2	diseases	disease	NOUN
dpc-1099	15	3	are	be	AUX
dpc-1099	15	4	a	a	DET
dpc-1099	15	5	group	group	NOUN
dpc-1099	15	6	of	of	ADP
dpc-1099	15	7	autoimmune	autoimmune	ADJ
dpc-1099	15	8	blistering	blister	VERB
dpc-1099	15	9	diseases	disease	NOUN
dpc-1099	15	10	of	of	ADP
dpc-1099	15	11	the	the	DET
dpc-1099	15	12	skin	skin	NOUN
dpc-1099	15	13	and	and	CCONJ
dpc-1099	15	14	mucous	mucous	ADJ
dpc-1099	15	15	membranes	membrane	NOUN
dpc-1099	15	16	characterized	characterize	VERB
dpc-1099	15	17	by	by	ADP
dpc-1099	15	18	intraepithelial	intraepithelial	ADJ
dpc-1099	15	19	cleft	cleft	NOUN
dpc-1099	15	20	and	and	CCONJ
dpc-1099	15	21	acantholysis	acantholysis	NOUN
dpc-1099	15	22	.	.	PUNCT
dpc-1099	16	1	the	the	DET
dpc-1099	16	2	main	main	ADJ
dpc-1099	16	3	subtypes	subtype	NOUN
dpc-1099	16	4	of	of	ADP
dpc-1099	16	5	pemphigus	pemphigus	NOUN
dpc-1099	16	6	include	include	VERB
dpc-1099	16	7	pemphigus	pemphigus	NOUN
dpc-1099	16	8	vulgaris	vulgaris	NOUN
dpc-1099	16	9	,	,	PUNCT
dpc-1099	16	10	pemphigus	pemphigus	PROPN
dpc-1099	16	11	foliaceus	foliaceus	NOUN
dpc-1099	16	12	,	,	PUNCT
dpc-1099	16	13	and	and	CCONJ
dpc-1099	16	14	paraneoplastic	paraneoplastic	ADJ
dpc-1099	16	15	pemphigus	pemphigus	NOUN
dpc-1099	16	16	.	.	PUNCT
dpc-1099	17	1	diagnosis	diagnosis	NOUN
dpc-1099	17	2	is	be	AUX
dpc-1099	17	3	based	base	VERB
dpc-1099	17	4	on	on	ADP
dpc-1099	17	5	clinical	clinical	ADJ
dpc-1099	17	6	manifestations	manifestation	NOUN
dpc-1099	17	7	and	and	CCONJ
dpc-1099	17	8	confirmed	confirm	VERB
dpc-1099	17	9	with	with	ADP
dpc-1099	17	10	histological	histological	ADJ
dpc-1099	17	11	,	,	PUNCT
dpc-1099	17	12	immunofluorescence	immunofluorescence	NOUN
dpc-1099	17	13	,	,	PUNCT
dpc-1099	17	14	and	and	CCONJ
dpc-1099	17	15	serological	serological	ADJ
dpc-1099	17	16	testing	testing	NOUN
dpc-1099	17	17	.	.	PUNCT
dpc-1099	18	1	recently	recently	ADV
dpc-1099	18	2	multivariant	multivariant	NOUN
dpc-1099	18	3	enzyme‐linked	enzyme‐linke	VERB
dpc-1099	18	4	immunosorbent	immunosorbent	VERB
dpc-1099	18	5	assay	assay	NOUN
dpc-1099	18	6	systems	system	NOUN
dpc-1099	18	7	have	have	AUX
dpc-1099	18	8	been	be	AUX
dpc-1099	18	9	developed	develop	VERB
dpc-1099	18	10	as	as	ADP
dpc-1099	18	11	practical	practical	ADJ
dpc-1099	18	12	screening	screening	NOUN
dpc-1099	18	13	tools	tool	NOUN
dpc-1099	18	14	for	for	ADP
dpc-1099	18	15	patients	patient	NOUN
dpc-1099	18	16	with	with	ADP
dpc-1099	18	17	suspected	suspect	VERB
dpc-1099	18	18	autoimmune	autoimmune	ADJ
dpc-1099	18	19	bullous	bullous	ADJ
dpc-1099	18	20	dermatoses	dermatosis	NOUN
dpc-1099	18	21	.	.	PUNCT
dpc-1099	19	1	the	the	DET
dpc-1099	19	2	current	current	ADJ
dpc-1099	19	3	first	first	ADJ
dpc-1099	19	4	-	-	PUNCT
dpc-1099	19	5	line	line	NOUN
dpc-1099	19	6	treatment	treatment	NOUN
dpc-1099	19	7	of	of	ADP
dpc-1099	19	8	pemphigus	pemphigus	NOUN
dpc-1099	19	9	is	be	AUX
dpc-1099	19	10	based	base	VERB
dpc-1099	19	11	on	on	ADP
dpc-1099	19	12	systemic	systemic	ADJ
dpc-1099	19	13	corticosteroids	corticosteroid	NOUN
dpc-1099	19	14	that	that	PRON
dpc-1099	19	15	are	be	AUX
dpc-1099	19	16	often	often	ADV
dpc-1099	19	17	combined	combine	VERB
dpc-1099	19	18	with	with	ADP
dpc-1099	19	19	immunosuppressive	immunosuppressive	ADJ
dpc-1099	19	20	adjuvants	adjuvant	NOUN
dpc-1099	19	21	,	,	PUNCT
dpc-1099	19	22	such	such	ADJ
dpc-1099	19	23	as	as	ADP
dpc-1099	19	24	azathioprine	azathioprine	NOUN
dpc-1099	19	25	,	,	PUNCT
dpc-1099	19	26	mycophenolate	mycophenolate	PROPN
dpc-1099	19	27	mofetil	mofetil	PROPN
dpc-1099	19	28	,	,	PUNCT
dpc-1099	19	29	and	and	CCONJ
dpc-1099	19	30	the	the	DET
dpc-1099	19	31	anti	anti	ADJ
dpc-1099	19	32	-	-	ADJ
dpc-1099	19	33	cd20	cd20	ADJ
dpc-1099	19	34	monoclonal	monoclonal	NOUN
dpc-1099	19	35	antibody	antibody	NOUN
dpc-1099	19	36	rituximab	rituximab	NOUN
dpc-1099	19	37	,	,	PUNCT
dpc-1099	19	38	usually	usually	ADV
dpc-1099	19	39	at	at	ADP
dpc-1099	19	40	initiation	initiation	NOUN
dpc-1099	19	41	of	of	ADP
dpc-1099	19	42	treatment	treatment	NOUN
dpc-1099	19	43	.	.	PUNCT
dpc-1099	20	1	rituximab	rituximab	NOUN
dpc-1099	20	2	efficacy	efficacy	NOUN
dpc-1099	20	3	is	be	AUX
dpc-1099	20	4	higher	high	ADJ
dpc-1099	20	5	when	when	SCONJ
dpc-1099	20	6	it	it	PRON
dpc-1099	20	7	is	be	AUX
dpc-1099	20	8	administered	administer	VERB
dpc-1099	20	9	early	early	ADV
dpc-1099	20	10	in	in	ADP
dpc-1099	20	11	the	the	DET
dpc-1099	20	12	course	course	NOUN
dpc-1099	20	13	of	of	ADP
dpc-1099	20	14	the	the	DET
dpc-1099	20	15	disease	disease	NOUN
dpc-1099	20	16	.	.	PUNCT
dpc-1099	21	1	therefore	therefore	ADV
dpc-1099	21	2	,	,	PUNCT
dpc-1099	21	3	it	it	PRON
dpc-1099	21	4	should	should	AUX
dpc-1099	21	5	be	be	AUX
dpc-1099	21	6	used	use	VERB
dpc-1099	21	7	as	as	ADP
dpc-1099	21	8	first	first	ADJ
dpc-1099	21	9	-	-	PUNCT
dpc-1099	21	10	line	line	NOUN
dpc-1099	21	11	treatment	treatment	NOUN
dpc-1099	21	12	to	to	PART
dpc-1099	21	13	improve	improve	VERB
dpc-1099	21	14	efficacy	efficacy	NOUN
dpc-1099	21	15	and	and	CCONJ
dpc-1099	21	16	reduce	reduce	VERB
dpc-1099	21	17	cumulative	cumulative	ADJ
dpc-1099	21	18	doses	dose	NOUN
dpc-1099	21	19	of	of	ADP
dpc-1099	21	20	corticosteroids	corticosteroid	NOUN
dpc-1099	21	21	and	and	CCONJ
dpc-1099	21	22	their	their	PRON
dpc-1099	21	23	side	side	NOUN
dpc-1099	21	24	effects	effect	NOUN
dpc-1099	21	25	.	.	PUNCT
dpc-1099	22	1	treatment	treatment	NOUN
dpc-1099	22	2	of	of	ADP
dpc-1099	22	3	bullous	bullous	ADJ
dpc-1099	22	4	pemphigoid	pemphigoid	NOUN
dpc-1099	22	5	is	be	AUX
dpc-1099	22	6	based	base	VERB
dpc-1099	22	7	on	on	ADP
dpc-1099	22	8	disease	disease	NOUN
dpc-1099	22	9	extension	extension	NOUN
dpc-1099	22	10	.	.	PUNCT
dpc-1099	23	1	localized	localized	ADJ
dpc-1099	23	2	and	and	CCONJ
dpc-1099	23	3	mild	mild	ADJ
dpc-1099	23	4	forms	form	NOUN
dpc-1099	23	5	can	can	AUX
dpc-1099	23	6	be	be	AUX
dpc-1099	23	7	treated	treat	VERB
dpc-1099	23	8	with	with	ADP
dpc-1099	23	9	superpotent	superpotent	NOUN
dpc-1099	23	10	topical	topical	ADJ
dpc-1099	23	11	corticosteroids	corticosteroid	NOUN
dpc-1099	23	12	or	or	CCONJ
dpc-1099	23	13	with	with	ADP
dpc-1099	23	14	nonimmunosuppressive	nonimmunosuppressive	ADJ
dpc-1099	23	15	agents	agent	NOUN
dpc-1099	23	16	.	.	PUNCT
dpc-1099	24	1	in	in	ADP
dpc-1099	24	2	patients	patient	NOUN
dpc-1099	24	3	with	with	ADP
dpc-1099	24	4	generalized	generalized	ADJ
dpc-1099	24	5	disease	disease	NOUN
dpc-1099	24	6	or	or	CCONJ
dpc-1099	24	7	whose	whose	DET
dpc-1099	24	8	disease	disease	NOUN
dpc-1099	24	9	is	be	AUX
dpc-1099	24	10	resistant	resistant	ADJ
dpc-1099	24	11	to	to	ADP
dpc-1099	24	12	the	the	DET
dpc-1099	24	13	treatments	treatment	NOUN
dpc-1099	24	14	described	describe	VERB
dpc-1099	24	15	above	above	ADV
dpc-1099	24	16	,	,	PUNCT
dpc-1099	24	17	systemic	systemic	ADJ
dpc-1099	24	18	corticosteroids	corticosteroid	NOUN
dpc-1099	24	19	are	be	AUX
dpc-1099	24	20	preferred	preferred	ADJ
dpc-1099	24	21	and	and	CCONJ
dpc-1099	24	22	effective	effective	ADJ
dpc-1099	24	23	.	.	PUNCT
dpc-1099	25	1	adjuvant	adjuvant	ADJ
dpc-1099	25	2	immunosuppressants	immunosuppressant	NOUN
dpc-1099	25	3	are	be	AUX
dpc-1099	25	4	often	often	ADV
dpc-1099	25	5	combined	combine	VERB
dpc-1099	25	6	with	with	ADP
dpc-1099	25	7	steroids	steroid	NOUN
dpc-1099	25	8	for	for	ADP
dpc-1099	25	9	their	their	PRON
dpc-1099	25	10	steroid	steroid	NOUN
dpc-1099	25	11	-	-	PUNCT
dpc-1099	25	12	sparing	spare	VERB
dpc-1099	25	13	effect	effect	NOUN
dpc-1099	25	14	.	.	PUNCT
dpc-1099	25	15	  	  	SPACE
dpc-1099	26	1	abstract	abstract	ADJ
dpc-1099	26	2	https://doi.org/10.5826/dpc.1003a50	https://doi.org/10.5826/dpc.1003a50	ADJ
dpc-1099	26	3	mailto:vito.dilernia@ausl.re.it	mailto:vito.dilernia@ausl.re.it	NUM
dpc-1099	26	4	2	2	NUM
dpc-1099	26	5	review	review	NOUN
dpc-1099	26	6	|	|	ADV
dpc-1099	26	7	dermatol	dermatol	ADJ
dpc-1099	26	8	pract	pract	NOUN
dpc-1099	26	9	concept	concept	NOUN
dpc-1099	26	10	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	26	11	tic	tic	ADJ
dpc-1099	26	12	pemphigus	pemphigus	NOUN
dpc-1099	26	13	(	(	PUNCT
dpc-1099	26	14	table	table	NOUN
dpc-1099	26	15	1	1	NUM
dpc-1099	26	16	)	)	PUNCT
dpc-1099	26	17	.	.	PUNCT
dpc-1099	27	1	pemphigus	pemphigus	PROPN
dpc-1099	27	2	is	be	AUX
dpc-1099	27	3	driven	drive	VERB
dpc-1099	27	4	by	by	ADP
dpc-1099	27	5	pathogenic	pathogenic	ADJ
dpc-1099	27	6	antibodies	antibody	NOUN
dpc-1099	27	7	to	to	ADP
dpc-1099	27	8	both	both	PRON
dpc-1099	27	9	desmoglein	desmoglein	PROPN
dpc-1099	27	10	(	(	PUNCT
dpc-1099	27	11	dsg	dsg	PROPN
dpc-1099	27	12	)	)	PUNCT
dpc-1099	27	13	1	1	NUM
dpc-1099	27	14	and	and	CCONJ
dpc-1099	27	15	3	3	NUM
dpc-1099	27	16	(	(	PUNCT
dpc-1099	27	17	pv	pv	INTJ
dpc-1099	27	18	,	,	PUNCT
dpc-1099	27	19	mucocutaneous	mucocutaneous	ADJ
dpc-1099	27	20	type	type	NOUN
dpc-1099	27	21	)	)	PUNCT
dpc-1099	27	22	,	,	PUNCT
dpc-1099	27	23	or	or	CCONJ
dpc-1099	27	24	dsg3	dsg3	PROPN
dpc-1099	27	25	(	(	PUNCT
dpc-1099	27	26	pv	pv	INTJ
dpc-1099	27	27	,	,	PUNCT
dpc-1099	27	28	mucosal	mucosal	ADJ
dpc-1099	27	29	dominant	dominant	NOUN
dpc-1099	27	30	-	-	PUNCT
dpc-1099	27	31	type	type	NOUN
dpc-1099	27	32	)	)	PUNCT
dpc-1099	27	33	,	,	PUNCT
dpc-1099	27	34	or	or	CCONJ
dpc-1099	27	35	dsg1	dsg1	NOUN
dpc-1099	27	36	(	(	PUNCT
dpc-1099	27	37	pf	pf	NOUN
dpc-1099	27	38	)	)	PUNCT
dpc-1099	27	39	.	.	PUNCT
dpc-1099	28	1	numerous	numerous	ADJ
dpc-1099	28	2	antigens	antigen	NOUN
dpc-1099	28	3	are	be	AUX
dpc-1099	28	4	involved	involve	VERB
dpc-1099	28	5	in	in	ADP
dpc-1099	28	6	paraneoplastic	paraneoplastic	ADJ
dpc-1099	28	7	pemphigus	pemphigus	NOUN
dpc-1099	28	8	(	(	PUNCT
dpc-1099	28	9	table	table	NOUN
dpc-1099	28	10	2	2	NUM
dpc-1099	28	11	)	)	PUNCT
dpc-1099	28	12	.	.	PUNCT
dpc-1099	29	1	abds	abds	NOUN
dpc-1099	29	2	of	of	ADP
dpc-1099	29	3	the	the	DET
dpc-1099	29	4	pemphigoid	pemphigoid	ADJ
dpc-1099	29	5	type	type	NOUN
dpc-1099	29	6	or	or	CCONJ
dpc-1099	29	7	autoimmune	autoimmune	ADJ
dpc-1099	29	8	subepidermal	subepidermal	NOUN
dpc-1099	29	9	blistering	blister	VERB
dpc-1099	29	10	diseases	disease	NOUN
dpc-1099	29	11	of	of	ADP
dpc-1099	29	12	the	the	DET
dpc-1099	29	13	skin	skin	NOUN
dpc-1099	29	14	and	and	CCONJ
dpc-1099	29	15	mucosae	mucosa	NOUN
dpc-1099	29	16	constitute	constitute	VERB
dpc-1099	29	17	a	a	DET
dpc-1099	29	18	large	large	ADJ
dpc-1099	29	19	group	group	NOUN
dpc-1099	29	20	of	of	ADP
dpc-1099	29	21	diseases	disease	NOUN
dpc-1099	29	22	characterized	characterize	VERB
dpc-1099	29	23	by	by	ADP
dpc-1099	29	24	the	the	DET
dpc-1099	29	25	production	production	NOUN
dpc-1099	29	26	of	of	ADP
dpc-1099	29	27	circulating	circulate	VERB
dpc-1099	29	28	autoantibodies	autoantibody	NOUN
dpc-1099	29	29	against	against	ADP
dpc-1099	29	30	several	several	ADJ
dpc-1099	29	31	structural	structural	ADJ
dpc-1099	29	32	proteins	protein	NOUN
dpc-1099	29	33	of	of	ADP
dpc-1099	29	34	the	the	DET
dpc-1099	29	35	basement	basement	NOUN
dpc-1099	29	36	membrane	membrane	NOUN
dpc-1099	29	37	zone	zone	NOUN
dpc-1099	29	38	,	,	PUNCT
dpc-1099	29	39	leading	lead	VERB
dpc-1099	29	40	histologically	histologically	ADV
dpc-1099	29	41	to	to	ADP
dpc-1099	29	42	subepidermal	subepidermal	NOUN
dpc-1099	29	43	blistering	blister	VERB
dpc-1099	29	44	.	.	PUNCT
dpc-1099	30	1	the	the	DET
dpc-1099	30	2	main	main	ADJ
dpc-1099	30	3	disorders	disorder	NOUN
dpc-1099	30	4	include	include	VERB
dpc-1099	30	5	bp	bp	PROPN
dpc-1099	30	6	,	,	PUNCT
dpc-1099	30	7	pemphigoid	pemphigoid	PROPN
dpc-1099	30	8	gestationis	gestationis	PROPN
dpc-1099	30	9	,	,	PUNCT
dpc-1099	30	10	mucous	mucous	ADJ
dpc-1099	30	11	membrane	membrane	NOUN
dpc-1099	30	12	pemphigoid	pemphigoid	NOUN
dpc-1099	30	13	,	,	PUNCT
dpc-1099	30	14	epidermolysis	epidermolysis	NOUN
dpc-1099	30	15	bullosa	bullosa	PROPN
dpc-1099	30	16	acquisita	acquisita	PROPN
dpc-1099	30	17	,	,	PUNCT
dpc-1099	30	18	and	and	CCONJ
dpc-1099	30	19	anti	anti	ADJ
dpc-1099	30	20	-	-	ADJ
dpc-1099	30	21	p200	p200	ADJ
dpc-1099	30	22	pemphigoid	pemphigoid	NOUN
dpc-1099	30	23	[	[	X
dpc-1099	30	24	2	2	NUM
dpc-1099	30	25	]	]	PUNCT
dpc-1099	30	26	(	(	PUNCT
dpc-1099	30	27	table	table	NOUN
dpc-1099	30	28	3	3	NUM
dpc-1099	30	29	)	)	PUNCT
dpc-1099	30	30	.	.	PUNCT
dpc-1099	31	1	bp	bp	PROPN
dpc-1099	31	2	is	be	AUX
dpc-1099	31	3	characterized	characterize	VERB
dpc-1099	31	4	by	by	ADP
dpc-1099	31	5	the	the	DET
dpc-1099	31	6	generation	generation	NOUN
dpc-1099	31	7	of	of	ADP
dpc-1099	31	8	autoantibodies	autoantibody	NOUN
dpc-1099	31	9	directed	direct	VERB
dpc-1099	31	10	in	in	ADP
dpc-1099	31	11	particular	particular	ADJ
dpc-1099	31	12	against	against	ADP
dpc-1099	31	13	bp180	bp180	PROPN
dpc-1099	31	14	/	/	SYM
dpc-1099	31	15	collagen	collagen	NOUN
dpc-1099	31	16	xvii	xvii	VERB
dpc-1099	31	17	and	and	CCONJ
dpc-1099	31	18	bp230	bp230	VERB
dpc-1099	31	19	/	/	SYM
dpc-1099	31	20	dystonin	dystonin	NOUN
dpc-1099	31	21	.	.	PUNCT
dpc-1099	32	1	epidemiology	epidemiology	NOUN
dpc-1099	32	2	prospective	prospective	ADJ
dpc-1099	32	3	studies	study	NOUN
dpc-1099	32	4	suggest	suggest	VERB
dpc-1099	32	5	the	the	DET
dpc-1099	32	6	incidence	incidence	NOUN
dpc-1099	32	7	rates	rate	NOUN
dpc-1099	32	8	of	of	ADP
dpc-1099	32	9	abds	abds	NOUN
dpc-1099	32	10	are	be	AUX
dpc-1099	32	11	in	in	ADP
dpc-1099	32	12	the	the	DET
dpc-1099	32	13	range	range	NOUN
dpc-1099	32	14	of	of	ADP
dpc-1099	32	15	14.5	14.5	NUM
dpc-1099	32	16	-	-	SYM
dpc-1099	32	17	20.4	20.4	NUM
dpc-1099	32	18	/	/	SYM
dpc-1099	32	19	million	million	NUM
dpc-1099	33	1	[	[	X
dpc-1099	33	2	3	3	NUM
dpc-1099	33	3	-	-	SYM
dpc-1099	33	4	5	5	NUM
dpc-1099	33	5	]	]	PUNCT
dpc-1099	33	6	.	.	PUNCT
dpc-1099	34	1	most	most	ADJ
dpc-1099	34	2	of	of	ADP
dpc-1099	34	3	the	the	DET
dpc-1099	34	4	available	available	ADJ
dpc-1099	34	5	epidemiological	epidemiological	ADJ
dpc-1099	34	6	data	datum	NOUN
dpc-1099	34	7	derive	derive	ADJ
dpc-1099	34	8	from	from	ADP
dpc-1099	34	9	pv	pv	PROPN
dpc-1099	34	10	,	,	PUNCT
dpc-1099	34	11	the	the	DET
dpc-1099	34	12	most	most	ADV
dpc-1099	34	13	frequently	frequently	ADV
dpc-1099	34	14	reported	report	VERB
dpc-1099	34	15	disorder	disorder	NOUN
dpc-1099	34	16	among	among	ADP
dpc-1099	34	17	the	the	DET
dpc-1099	34	18	pds	pds	NOUN
dpc-1099	34	19	,	,	PUNCT
dpc-1099	34	20	and	and	CCONJ
dpc-1099	34	21	bp	bp	PROPN
dpc-1099	35	1	[	[	X
dpc-1099	35	2	3	3	NUM
dpc-1099	35	3	]	]	PUNCT
dpc-1099	35	4	.	.	PUNCT
dpc-1099	36	1	pv	pv	ADJ
dpc-1099	36	2	incidence	incidence	NOUN
dpc-1099	36	3	appears	appear	VERB
dpc-1099	36	4	to	to	PART
dpc-1099	36	5	be	be	AUX
dpc-1099	36	6	highly	highly	ADV
dpc-1099	36	7	variable	variable	ADJ
dpc-1099	36	8	according	accord	VERB
dpc-1099	36	9	to	to	ADP
dpc-1099	36	10	geographic	geographic	ADJ
dpc-1099	36	11	regions	region	NOUN
dpc-1099	36	12	and	and	CCONJ
dpc-1099	36	13	ethnic	ethnic	ADJ
dpc-1099	36	14	groups	group	NOUN
dpc-1099	36	15	.	.	PUNCT
dpc-1099	37	1	the	the	DET
dpc-1099	37	2	incidence	incidence	NOUN
dpc-1099	37	3	rates	rate	NOUN
dpc-1099	37	4	reported	report	VERB
dpc-1099	37	5	in	in	ADP
dpc-1099	37	6	european	european	ADJ
dpc-1099	37	7	prospective	prospective	ADJ
dpc-1099	37	8	studies	study	NOUN
dpc-1099	37	9	range	range	VERB
dpc-1099	37	10	between	between	ADP
dpc-1099	37	11	0.5	0.5	NUM
dpc-1099	37	12	and	and	CCONJ
dpc-1099	37	13	4.0	4.0	NUM
dpc-1099	37	14	/	/	SYM
dpc-1099	37	15	million	million	NUM
dpc-1099	37	16	[	[	X
dpc-1099	37	17	5,6	5,6	NUM
dpc-1099	37	18	]	]	X
dpc-1099	37	19	.	.	PUNCT
dpc-1099	38	1	higher	high	ADJ
dpc-1099	38	2	rates	rate	NOUN
dpc-1099	38	3	,	,	PUNCT
dpc-1099	38	4	up	up	ADP
dpc-1099	38	5	to	to	ADP
dpc-1099	38	6	16.1	16.1	NUM
dpc-1099	38	7	/	/	SYM
dpc-1099	38	8	million	million	NUM
dpc-1099	38	9	/	/	SYM
dpc-1099	38	10	year	year	NOUN
dpc-1099	38	11	,	,	PUNCT
dpc-1099	38	12	have	have	AUX
dpc-1099	38	13	been	be	AUX
dpc-1099	38	14	observed	observe	VERB
dpc-1099	38	15	in	in	ADP
dpc-1099	38	16	subjects	subject	NOUN
dpc-1099	38	17	from	from	ADP
dpc-1099	38	18	israel	israel	PROPN
dpc-1099	38	19	and	and	CCONJ
dpc-1099	38	20	iran	iran	PROPN
dpc-1099	39	1	[	[	X
dpc-1099	39	2	7,8	7,8	NUM
dpc-1099	39	3	]	]	PUNCT
dpc-1099	39	4	.	.	PUNCT
dpc-1099	40	1	in	in	ADP
dpc-1099	40	2	fact	fact	NOUN
dpc-1099	40	3	,	,	PUNCT
dpc-1099	40	4	the	the	DET
dpc-1099	40	5	disease	disease	NOUN
dpc-1099	40	6	is	be	AUX
dpc-1099	40	7	more	more	ADV
dpc-1099	40	8	common	common	ADJ
dpc-1099	40	9	among	among	ADP
dpc-1099	40	10	individuals	individual	NOUN
dpc-1099	40	11	of	of	ADP
dpc-1099	40	12	ashkenazi	ashkenazi	ADJ
dpc-1099	40	13	origin	origin	NOUN
dpc-1099	40	14	,	,	PUNCT
dpc-1099	40	15	but	but	CCONJ
dpc-1099	40	16	also	also	ADV
dpc-1099	40	17	in	in	ADP
dpc-1099	40	18	ethnic	ethnic	ADJ
dpc-1099	40	19	groups	group	NOUN
dpc-1099	40	20	from	from	ADP
dpc-1099	40	21	iraq	iraq	PROPN
dpc-1099	40	22	and	and	CCONJ
dpc-1099	40	23	iran	iran	PROPN
dpc-1099	40	24	.	.	PUNCT
dpc-1099	41	1	therefore	therefore	ADV
dpc-1099	41	2	,	,	PUNCT
dpc-1099	41	3	ethnic	ethnic	ADJ
dpc-1099	41	4	differences	difference	NOUN
dpc-1099	41	5	should	should	AUX
dpc-1099	41	6	be	be	AUX
dpc-1099	41	7	taken	take	VERB
dpc-1099	41	8	into	into	ADP
dpc-1099	41	9	account	account	NOUN
dpc-1099	41	10	when	when	SCONJ
dpc-1099	41	11	comparing	compare	VERB
dpc-1099	41	12	incidence	incidence	NOUN
dpc-1099	41	13	rates	rate	NOUN
dpc-1099	41	14	in	in	ADP
dpc-1099	41	15	countries	country	NOUN
dpc-1099	41	16	with	with	ADP
dpc-1099	41	17	populations	population	NOUN
dpc-1099	41	18	of	of	ADP
dpc-1099	41	19	jewish	jewish	ADJ
dpc-1099	41	20	heritage	heritage	NOUN
dpc-1099	41	21	[	[	X
dpc-1099	41	22	3,9	3,9	NUM
dpc-1099	41	23	]	]	PUNCT
dpc-1099	41	24	.	.	PUNCT
dpc-1099	42	1	pemphigus	pemphigus	PROPN
dpc-1099	42	2	is	be	AUX
dpc-1099	42	3	most	most	ADV
dpc-1099	42	4	frequently	frequently	ADV
dpc-1099	42	5	diagnosed	diagnose	VERB
dpc-1099	42	6	between	between	ADP
dpc-1099	42	7	ages	age	NOUN
dpc-1099	42	8	50	50	NUM
dpc-1099	42	9	and	and	CCONJ
dpc-1099	42	10	60	60	NUM
dpc-1099	42	11	in	in	ADP
dpc-1099	42	12	european	european	ADJ
dpc-1099	42	13	countries	country	NOUN
dpc-1099	42	14	,	,	PUNCT
dpc-1099	42	15	but	but	CCONJ
dpc-1099	42	16	it	it	PRON
dpc-1099	42	17	can	can	AUX
dpc-1099	42	18	be	be	AUX
dpc-1099	42	19	seen	see	VERB
dpc-1099	42	20	earlier	early	ADV
dpc-1099	42	21	outside	outside	ADV
dpc-1099	42	22	of	of	ADP
dpc-1099	42	23	europe	europe	PROPN
dpc-1099	42	24	.	.	PUNCT
dpc-1099	43	1	are	be	AUX
dpc-1099	43	2	a	a	DET
dpc-1099	43	3	major	major	ADJ
dpc-1099	43	4	cause	cause	NOUN
dpc-1099	43	5	of	of	ADP
dpc-1099	43	6	severe	severe	ADJ
dpc-1099	43	7	morbidity	morbidity	NOUN
dpc-1099	43	8	and	and	CCONJ
dpc-1099	43	9	considerable	considerable	ADJ
dpc-1099	43	10	mortality	mortality	NOUN
dpc-1099	43	11	[	[	X
dpc-1099	43	12	1	1	NUM
dpc-1099	43	13	]	]	PUNCT
dpc-1099	43	14	.	.	PUNCT
dpc-1099	44	1	based	base	VERB
dpc-1099	44	2	on	on	ADP
dpc-1099	44	3	the	the	DET
dpc-1099	44	4	available	available	ADJ
dpc-1099	44	5	literature	literature	PROPN
dpc-1099	44	6	data	datum	NOUN
dpc-1099	44	7	,	,	PUNCT
dpc-1099	44	8	this	this	DET
dpc-1099	44	9	paper	paper	NOUN
dpc-1099	44	10	aims	aim	VERB
dpc-1099	44	11	to	to	PART
dpc-1099	44	12	provide	provide	VERB
dpc-1099	44	13	an	an	DET
dpc-1099	44	14	up	up	ADP
dpc-1099	44	15	-	-	PUNCT
dpc-1099	44	16	to	to	ADP
dpc-1099	44	17	-	-	PUNCT
dpc-1099	44	18	date	date	NOUN
dpc-1099	44	19	overview	overview	NOUN
dpc-1099	44	20	on	on	ADP
dpc-1099	44	21	diagnosis	diagnosis	NOUN
dpc-1099	44	22	and	and	CCONJ
dpc-1099	44	23	therapy	therapy	NOUN
dpc-1099	44	24	of	of	ADP
dpc-1099	44	25	pemphigus	pemphigus	NOUN
dpc-1099	44	26	vulgaris	vulgaris	NOUN
dpc-1099	44	27	(	(	PUNCT
dpc-1099	44	28	pv	pv	NOUN
dpc-1099	44	29	)	)	PUNCT
dpc-1099	44	30	and	and	CCONJ
dpc-1099	44	31	bullous	bullous	ADJ
dpc-1099	44	32	pemphigoid	pemphigoid	NOUN
dpc-1099	44	33	(	(	PUNCT
dpc-1099	44	34	bp	bp	PROPN
dpc-1099	44	35	)	)	PUNCT
dpc-1099	44	36	,	,	PUNCT
dpc-1099	44	37	which	which	PRON
dpc-1099	44	38	represent	represent	VERB
dpc-1099	44	39	the	the	DET
dpc-1099	44	40	2	2	NUM
dpc-1099	44	41	major	major	ADJ
dpc-1099	44	42	diseases	disease	NOUN
dpc-1099	44	43	in	in	ADP
dpc-1099	44	44	the	the	DET
dpc-1099	44	45	heterogeneous	heterogeneous	ADJ
dpc-1099	44	46	clinical	clinical	ADJ
dpc-1099	44	47	spectrum	spectrum	NOUN
dpc-1099	44	48	of	of	ADP
dpc-1099	44	49	abds	abds	NOUN
dpc-1099	44	50	.	.	PUNCT
dpc-1099	45	1	classification	classification	VERB
dpc-1099	45	2	the	the	DET
dpc-1099	45	3	classification	classification	NOUN
dpc-1099	45	4	of	of	ADP
dpc-1099	45	5	an	an	DET
dpc-1099	45	6	abd	abd	NOUN
dpc-1099	45	7	relies	rely	VERB
dpc-1099	45	8	on	on	ADP
dpc-1099	45	9	the	the	DET
dpc-1099	45	10	level	level	NOUN
dpc-1099	45	11	of	of	ADP
dpc-1099	45	12	blistering	blister	VERB
dpc-1099	45	13	and	and	CCONJ
dpc-1099	45	14	considers	consider	VERB
dpc-1099	45	15	2	2	NUM
dpc-1099	45	16	major	major	ADJ
dpc-1099	45	17	groups	group	NOUN
dpc-1099	45	18	of	of	ADP
dpc-1099	45	19	diseases	disease	NOUN
dpc-1099	45	20	,	,	PUNCT
dpc-1099	45	21	namely	namely	ADV
dpc-1099	45	22	“	"	PUNCT
dpc-1099	45	23	pemphigus	pemphigus	NOUN
dpc-1099	45	24	diseases”(pds	diseases”(pds	NOUN
dpc-1099	45	25	)	)	PUNCT
dpc-1099	45	26	and	and	CCONJ
dpc-1099	45	27	“	"	PUNCT
dpc-1099	45	28	abds	abds	NOUN
dpc-1099	45	29	of	of	ADP
dpc-1099	45	30	the	the	DET
dpc-1099	45	31	pemphigoid	pemphigoid	ADJ
dpc-1099	45	32	type	type	NOUN
dpc-1099	45	33	.	.	PUNCT
dpc-1099	45	34	”	"	PUNCT
dpc-1099	46	1	pds	pds	NOUN
dpc-1099	46	2	are	be	AUX
dpc-1099	46	3	characterized	characterize	VERB
dpc-1099	46	4	by	by	ADP
dpc-1099	46	5	the	the	DET
dpc-1099	46	6	production	production	NOUN
dpc-1099	46	7	of	of	ADP
dpc-1099	46	8	pathogenic	pathogenic	ADJ
dpc-1099	46	9	autoantibodies	autoantibody	NOUN
dpc-1099	46	10	directed	direct	VERB
dpc-1099	46	11	against	against	ADP
dpc-1099	46	12	different	different	ADJ
dpc-1099	46	13	proteins	protein	NOUN
dpc-1099	46	14	of	of	ADP
dpc-1099	46	15	the	the	DET
dpc-1099	46	16	desmosome	desmosome	ADJ
dpc-1099	46	17	,	,	PUNCT
dpc-1099	46	18	leading	lead	VERB
dpc-1099	46	19	histologically	histologically	ADV
dpc-1099	46	20	to	to	ADP
dpc-1099	46	21	intraepithelial	intraepithelial	ADJ
dpc-1099	46	22	blistering	blistering	NOUN
dpc-1099	46	23	.	.	PUNCT
dpc-1099	47	1	there	there	PRON
dpc-1099	47	2	are	be	VERB
dpc-1099	47	3	several	several	ADJ
dpc-1099	47	4	variants	variant	NOUN
dpc-1099	47	5	of	of	ADP
dpc-1099	47	6	pemphigus	pemphigus	NOUN
dpc-1099	47	7	,	,	PUNCT
dpc-1099	47	8	but	but	CCONJ
dpc-1099	47	9	the	the	DET
dpc-1099	47	10	3	3	NUM
dpc-1099	47	11	major	major	ADJ
dpc-1099	47	12	forms	form	NOUN
dpc-1099	47	13	include	include	VERB
dpc-1099	47	14	pv	pv	INTJ
dpc-1099	47	15	,	,	PUNCT
dpc-1099	47	16	pemphigus	pemphigus	NOUN
dpc-1099	47	17	foliaceus	foliaceus	NOUN
dpc-1099	47	18	(	(	PUNCT
dpc-1099	47	19	pf	pf	NOUN
dpc-1099	47	20	)	)	PUNCT
dpc-1099	47	21	,	,	PUNCT
dpc-1099	47	22	and	and	CCONJ
dpc-1099	47	23	paraneoplastable	paraneoplastable	ADJ
dpc-1099	47	24	2	2	NUM
dpc-1099	47	25	.	.	PUNCT
dpc-1099	47	26	classification	classification	NOUN
dpc-1099	47	27	and	and	CCONJ
dpc-1099	47	28	autoantigens	autoantigen	NOUN
dpc-1099	47	29	in	in	ADP
dpc-1099	47	30	pemphigus	pemphigus	PROPN
dpc-1099	47	31	group	group	NOUN
dpc-1099	47	32	diseases	disease	NOUN
dpc-1099	47	33	diseases	disease	VERB
dpc-1099	47	34	ig	ig	PRON
dpc-1099	47	35	antigen	antigen	ADV
dpc-1099	47	36	pemphigus	pemphigus	NOUN
dpc-1099	47	37	vulgaris	vulgaris	NOUN
dpc-1099	47	38	,	,	PUNCT
dpc-1099	47	39	mucosal	mucosal	ADJ
dpc-1099	47	40	dominant	dominant	ADJ
dpc-1099	47	41	type	type	NOUN
dpc-1099	47	42	pemphigus	pemphigus	NOUN
dpc-1099	47	43	vulgaris	vulgaris	NOUN
dpc-1099	47	44	,	,	PUNCT
dpc-1099	47	45	mucocutaneous	mucocutaneous	ADJ
dpc-1099	47	46	type	type	NOUN
dpc-1099	47	47	igg	igg	PROPN
dpc-1099	47	48	igg	igg	PROPN
dpc-1099	47	49	dsg3	dsg3	PROPN
dpc-1099	47	50	dsg3	dsg3	PROPN
dpc-1099	48	1	+	+	CCONJ
dpc-1099	48	2	dsg1	dsg1	VERB
dpc-1099	48	3	pemphigus	pemphigus	PROPN
dpc-1099	48	4	vegetans	vegetan	NOUN
dpc-1099	48	5	igg	igg	PROPN
dpc-1099	48	6	dsg3	dsg3	PROPN
dpc-1099	48	7	,	,	PUNCT
dpc-1099	48	8	dsg1	dsg1	NOUN
dpc-1099	48	9	,	,	PUNCT
dpc-1099	48	10	dsc3	dsc3	PROPN
dpc-1099	48	11	pemphigus	pemphigus	PROPN
dpc-1099	48	12	herpetiformis	herpetiformis	PROPN
dpc-1099	48	13	igg	igg	PROPN
dpc-1099	48	14	dsg1	dsg1	PROPN
dpc-1099	48	15	,	,	PUNCT
dpc-1099	48	16	(	(	PUNCT
dpc-1099	48	17	dsg3	dsg3	PROPN
dpc-1099	48	18	)	)	PUNCT
dpc-1099	48	19	,	,	PUNCT
dpc-1099	48	20	dscs	dscs	ADJ
dpc-1099	48	21	pemphigus	pemphigus	PROPN
dpc-1099	48	22	foliaceus	foliaceus	PROPN
dpc-1099	48	23	igg	igg	PROPN
dpc-1099	48	24	dsg1	dsg1	PROPN
dpc-1099	48	25	pemphigus	pemphigus	PROPN
dpc-1099	48	26	erythematosus	erythematosus	PROPN
dpc-1099	48	27	igg	igg	PROPN
dpc-1099	48	28	dsg1	dsg1	VERB
dpc-1099	48	29	paraneoplastic	paraneoplastic	ADJ
dpc-1099	48	30	pemphigus	pemphigus	PROPN
dpc-1099	48	31	igg	igg	PROPN
dpc-1099	48	32	plectin	plectin	PROPN
dpc-1099	48	33	,	,	PUNCT
dpc-1099	48	34	epiplakin	epiplakin	ADV
dpc-1099	48	35	,	,	PUNCT
dpc-1099	48	36	desmoplakin	desmoplakin	PROPN
dpc-1099	48	37	i	i	PROPN
dpc-1099	48	38	/	/	SYM
dpc-1099	48	39	ii	ii	PROPN
dpc-1099	48	40	,	,	PUNCT
dpc-1099	48	41	bp230	bp230	VERB
dpc-1099	48	42	,	,	PUNCT
dpc-1099	48	43	envoplakin	envoplakin	ADJ
dpc-1099	48	44	,	,	PUNCT
dpc-1099	48	45	periplakin	periplakin	X
dpc-1099	48	46	,	,	PUNCT
dpc-1099	48	47	dsg3	dsg3	PROPN
dpc-1099	48	48	,	,	PUNCT
dpc-1099	48	49	dsg1	dsg1	NOUN
dpc-1099	48	50	,	,	PUNCT
dpc-1099	48	51	dscs	dscs	ADJ
dpc-1099	48	52	,	,	PUNCT
dpc-1099	48	53	α-2	α-2	NOUN
dpc-1099	48	54	-	-	PUNCT
dpc-1099	48	55	macroglobulin	macroglobulin	PROPN
dpc-1099	48	56	-	-	PUNCT
dpc-1099	48	57	like-1	like-1	PROPN
dpc-1099	48	58	iga	iga	PROPN
dpc-1099	48	59	pemphigus	pemphigus	NOUN
dpc-1099	48	60	,	,	PUNCT
dpc-1099	48	61	subcorneal	subcorneal	ADJ
dpc-1099	48	62	pustular	pustular	ADJ
dpc-1099	48	63	dermatosis	dermatosis	NOUN
dpc-1099	48	64	type	type	NOUN
dpc-1099	48	65	iga	iga	PROPN
dpc-1099	48	66	pemphigus	pemphigus	NOUN
dpc-1099	48	67	,	,	PUNCT
dpc-1099	48	68	intraepidermal	intraepidermal	ADJ
dpc-1099	48	69	neutrophilic	neutrophilic	ADJ
dpc-1099	48	70	type	type	NOUN
dpc-1099	48	71	iga	iga	PROPN
dpc-1099	48	72	dermatosis	dermatosis	NOUN
dpc-1099	48	73	iga	iga	PROPN
dpc-1099	48	74	iga	iga	PROPN
dpc-1099	48	75	dsc1	dsc1	PROPN
dpc-1099	48	76	unknown	unknown	ADJ
dpc-1099	48	77	bp	bp	PROPN
dpc-1099	48	78	=	=	PUNCT
dpc-1099	48	79	bullous	bullous	ADJ
dpc-1099	48	80	pemphigoid	pemphigoid	ADV
dpc-1099	48	81	;	;	PUNCT
dpc-1099	48	82	dsc	dsc	NOUN
dpc-1099	48	83	=	=	PUNCT
dpc-1099	48	84	desmocollin	desmocollin	PROPN
dpc-1099	48	85	;	;	PUNCT
dpc-1099	48	86	dsg	dsg	PROPN
dpc-1099	48	87	=	=	SYM
dpc-1099	48	88	desmoglein	desmoglein	PROPN
dpc-1099	48	89	;	;	PUNCT
dpc-1099	48	90	ig	ig	PROPN
dpc-1099	48	91	=	=	NOUN
dpc-1099	48	92	immunoglobulin	immunoglobulin	NOUN
dpc-1099	48	93	.	.	PUNCT
dpc-1099	49	1	table	table	NOUN
dpc-1099	49	2	1	1	NUM
dpc-1099	49	3	.	.	PUNCT
dpc-1099	50	1	classification	classification	NOUN
dpc-1099	50	2	of	of	ADP
dpc-1099	50	3	pemphigus	pemphigus	NOUN
dpc-1099	50	4	type	type	NOUN
dpc-1099	50	5	variants	variant	NOUN
dpc-1099	50	6	pemphigus	pemphigus	ADJ
dpc-1099	50	7	vulgaris	vulgaris	PROPN
dpc-1099	50	8	pemphigus	pemphigus	PROPN
dpc-1099	50	9	vegetans	vegetan	NOUN
dpc-1099	50	10	pemphigus	pemphigus	PROPN
dpc-1099	50	11	herpetiformis	herpetiformis	ADV
dpc-1099	50	12	pemphigus	pemphigus	PROPN
dpc-1099	50	13	foliaceus	foliaceus	PROPN
dpc-1099	50	14	fogo	fogo	PROPN
dpc-1099	50	15	selvagem	selvagem	PROPN
dpc-1099	50	16	(	(	PUNCT
dpc-1099	50	17	pemphigus	pemphigus	NOUN
dpc-1099	50	18	brasiliensis	brasiliensis	NOUN
dpc-1099	50	19	)	)	PUNCT
dpc-1099	50	20	pemphigus	pemphigus	NOUN
dpc-1099	50	21	erythematosus	erythematosus	PROPN
dpc-1099	50	22	paraneoplastic	paraneoplastic	PROPN
dpc-1099	50	23	pemphigus	pemphigus	PROPN
dpc-1099	50	24	atypical	atypical	ADJ
dpc-1099	50	25	pemphigus	pemphigus	NOUN
dpc-1099	50	26	“	"	PUNCT
dpc-1099	50	27	drug	drug	NOUN
dpc-1099	50	28	-	-	PUNCT
dpc-1099	50	29	induced	induce	VERB
dpc-1099	50	30	”	"	PUNCT
dpc-1099	50	31	pemphigus	pemphigus	PROPN
dpc-1099	50	32	iga	iga	PROPN
dpc-1099	50	33	pemphigus	pemphigus	PROPN
dpc-1099	50	34	ig	ig	PROPN
dpc-1099	50	35	=	=	NOUN
dpc-1099	50	36	immunoglobulin	immunoglobulin	NOUN
dpc-1099	50	37	.	.	PUNCT
dpc-1099	51	1	review	review	VERB
dpc-1099	51	2	|	|	ADV
dpc-1099	51	3	dermatol	dermatol	ADJ
dpc-1099	51	4	pract	pract	NOUN
dpc-1099	51	5	concept	concept	NOUN
dpc-1099	51	6	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	51	7	3	3	NUM
dpc-1099	51	8	cadherins	cadherin	VERB
dpc-1099	51	9	dsg1	dsg1	NOUN
dpc-1099	51	10	and	and	CCONJ
dpc-1099	51	11	dsg3	dsg3	PROPN
dpc-1099	51	12	,	,	PUNCT
dpc-1099	51	13	causes	cause	VERB
dpc-1099	51	14	loss	loss	NOUN
dpc-1099	51	15	of	of	ADP
dpc-1099	51	16	epidermal	epidermal	ADJ
dpc-1099	51	17	keratinocyte	keratinocyte	NOUN
dpc-1099	51	18	adhesion	adhesion	NOUN
dpc-1099	51	19	.	.	PUNCT
dpc-1099	52	1	dsg3	dsg3	ADJ
dpc-1099	52	2	-	-	PUNCT
dpc-1099	52	3	specific	specific	ADJ
dpc-1099	52	4	autoreactive	autoreactive	ADJ
dpc-1099	52	5	t	t	NOUN
dpc-1099	52	6	cells	cell	NOUN
dpc-1099	52	7	are	be	AUX
dpc-1099	52	8	deleted	delete	VERB
dpc-1099	52	9	in	in	ADP
dpc-1099	52	10	periphery	periphery	NOUN
dpc-1099	52	11	,	,	PUNCT
dpc-1099	52	12	and	and	CCONJ
dpc-1099	52	13	regulatory	regulatory	ADJ
dpc-1099	52	14	t	t	NOUN
dpc-1099	52	15	cells	cell	NOUN
dpc-1099	52	16	(	(	PUNCT
dpc-1099	52	17	tregs	treg	NOUN
dpc-1099	52	18	)	)	PUNCT
dpc-1099	52	19	play	play	VERB
dpc-1099	52	20	an	an	DET
dpc-1099	52	21	important	important	ADJ
dpc-1099	52	22	role	role	NOUN
dpc-1099	52	23	in	in	ADP
dpc-1099	52	24	such	such	ADJ
dpc-1099	52	25	peripheral	peripheral	ADJ
dpc-1099	52	26	tolerance	tolerance	NOUN
dpc-1099	52	27	[	[	X
dpc-1099	52	28	17	17	NUM
dpc-1099	52	29	]	]	PUNCT
dpc-1099	52	30	.	.	PUNCT
dpc-1099	53	1	environmental	environmental	ADJ
dpc-1099	53	2	factors	factor	NOUN
dpc-1099	53	3	,	,	PUNCT
dpc-1099	53	4	in	in	ADP
dpc-1099	53	5	particular	particular	ADJ
dpc-1099	53	6	pathogens	pathogen	NOUN
dpc-1099	53	7	,	,	PUNCT
dpc-1099	53	8	have	have	AUX
dpc-1099	53	9	been	be	AUX
dpc-1099	53	10	hypothesized	hypothesize	VERB
dpc-1099	53	11	as	as	ADP
dpc-1099	53	12	causes	cause	NOUN
dpc-1099	53	13	of	of	ADP
dpc-1099	53	14	reverting	revert	VERB
dpc-1099	53	15	immunological	immunological	ADJ
dpc-1099	53	16	tolerance	tolerance	NOUN
dpc-1099	53	17	with	with	ADP
dpc-1099	53	18	resulting	result	VERB
dpc-1099	53	19	autoantibody	autoantibody	ADJ
dpc-1099	53	20	production	production	NOUN
dpc-1099	53	21	[	[	X
dpc-1099	53	22	18	18	NUM
dpc-1099	53	23	]	]	PUNCT
dpc-1099	53	24	.	.	PUNCT
dpc-1099	54	1	a	a	DET
dpc-1099	54	2	possible	possible	ADJ
dpc-1099	54	3	link	link	NOUN
dpc-1099	54	4	with	with	ADP
dpc-1099	54	5	rotavirus	rotavirus	NOUN
dpc-1099	54	6	infection	infection	NOUN
dpc-1099	54	7	has	have	AUX
dpc-1099	54	8	been	be	AUX
dpc-1099	54	9	suggested	suggest	VERB
dpc-1099	54	10	because	because	SCONJ
dpc-1099	54	11	of	of	ADP
dpc-1099	54	12	cross	cross	ADJ
dpc-1099	54	13	-	-	ADJ
dpc-1099	54	14	reactive	reactive	ADJ
dpc-1099	54	15	vh1	vh1	PROPN
dpc-1099	54	16	-	-	PUNCT
dpc-1099	54	17	46	46	NUM
dpc-1099	54	18	antibodies	antibodie	VERB
dpc-1099	54	19	,	,	PUNCT
dpc-1099	54	20	which	which	PRON
dpc-1099	54	21	are	be	AUX
dpc-1099	54	22	able	able	ADJ
dpc-1099	54	23	both	both	PRON
dpc-1099	54	24	to	to	PART
dpc-1099	54	25	disrupt	disrupt	VERB
dpc-1099	54	26	keratinocyte	keratinocyte	NOUN
dpc-1099	54	27	adhesion	adhesion	NOUN
dpc-1099	54	28	and	and	CCONJ
dpc-1099	54	29	inhibit	inhibit	VERB
dpc-1099	54	30	rotavirus	rotavirus	NOUN
dpc-1099	54	31	replication	replication	NOUN
dpc-1099	54	32	[	[	X
dpc-1099	54	33	19	19	NUM
dpc-1099	54	34	]	]	PUNCT
dpc-1099	54	35	.	.	PUNCT
dpc-1099	55	1	an	an	DET
dpc-1099	55	2	additional	additional	ADJ
dpc-1099	55	3	relationship	relationship	NOUN
dpc-1099	55	4	between	between	ADP
dpc-1099	55	5	the	the	DET
dpc-1099	55	6	exposure	exposure	NOUN
dpc-1099	55	7	to	to	ADP
dpc-1099	55	8	a	a	DET
dpc-1099	55	9	noninfectious	noninfectious	ADJ
dpc-1099	55	10	environmental	environmental	ADJ
dpc-1099	55	11	antigen	antigen	NOUN
dpc-1099	55	12	and	and	CCONJ
dpc-1099	55	13	the	the	DET
dpc-1099	55	14	development	development	NOUN
dpc-1099	55	15	of	of	ADP
dpc-1099	55	16	an	an	DET
dpc-1099	55	17	autoimmune	autoimmune	ADJ
dpc-1099	55	18	response	response	NOUN
dpc-1099	55	19	to	to	ADP
dpc-1099	55	20	self	self	NOUN
dpc-1099	55	21	-	-	PUNCT
dpc-1099	55	22	antigen	antigen	NOUN
dpc-1099	55	23	has	have	AUX
dpc-1099	55	24	been	be	AUX
dpc-1099	55	25	documented	document	VERB
dpc-1099	55	26	in	in	ADP
dpc-1099	55	27	fogo	fogo	PROPN
dpc-1099	55	28	selvagem	selvagem	PROPN
dpc-1099	55	29	,	,	PUNCT
dpc-1099	55	30	the	the	DET
dpc-1099	55	31	endemic	endemic	ADJ
dpc-1099	55	32	form	form	NOUN
dpc-1099	55	33	of	of	ADP
dpc-1099	55	34	pf	pf	PROPN
dpc-1099	55	35	.	.	PUNCT
dpc-1099	56	1	in	in	ADP
dpc-1099	56	2	this	this	DET
dpc-1099	56	3	condition	condition	NOUN
dpc-1099	56	4	,	,	PUNCT
dpc-1099	56	5	cross	cross	ADJ
dpc-1099	56	6	-	-	ADJ
dpc-1099	56	7	reactive	reactive	ADJ
dpc-1099	56	8	epitopes	epitope	NOUN
dpc-1099	56	9	on	on	ADP
dpc-1099	56	10	dsg1	dsg1	NOUN
dpc-1099	56	11	and	and	CCONJ
dpc-1099	56	12	ljm11	ljm11	PROPN
dpc-1099	56	13	sand	sand	NOUN
dpc-1099	56	14	fly	fly	VERB
dpc-1099	56	15	salivary	salivary	ADJ
dpc-1099	56	16	gland	gland	NOUN
dpc-1099	56	17	antigen	antigen	NOUN
dpc-1099	56	18	could	could	AUX
dpc-1099	56	19	drive	drive	VERB
dpc-1099	56	20	the	the	DET
dpc-1099	56	21	production	production	NOUN
dpc-1099	56	22	of	of	ADP
dpc-1099	56	23	pathogenic	pathogenic	ADJ
dpc-1099	56	24	igg4	igg4	NOUN
dpc-1099	56	25	autoantibodies	autoantibody	NOUN
dpc-1099	56	26	anti	anti	ADJ
dpc-1099	56	27	-	-	NOUN
dpc-1099	56	28	dsg1	dsg1	ADJ
dpc-1099	56	29	[	[	X
dpc-1099	56	30	20	20	NUM
dpc-1099	56	31	]	]	PUNCT
dpc-1099	56	32	.	.	PUNCT
dpc-1099	57	1	although	although	SCONJ
dpc-1099	57	2	antibody	antibody	NOUN
dpc-1099	57	3	-	-	PUNCT
dpc-1099	57	4	mediated	mediate	VERB
dpc-1099	57	5	disease	disease	NOUN
dpc-1099	57	6	mechanisms	mechanism	NOUN
dpc-1099	57	7	in	in	ADV
dpc-1099	57	8	pv	pv	NOUN
dpc-1099	57	9	are	be	AUX
dpc-1099	57	10	widely	widely	ADV
dpc-1099	57	11	characterized	characterize	VERB
dpc-1099	57	12	,	,	PUNCT
dpc-1099	57	13	the	the	DET
dpc-1099	57	14	t	t	NOUN
dpc-1099	57	15	cell	cell	NOUN
dpc-1099	57	16	implication	implication	NOUN
dpc-1099	57	17	has	have	VERB
dpc-1099	57	18	to	to	PART
dpc-1099	57	19	be	be	AUX
dpc-1099	57	20	better	well	ADV
dpc-1099	57	21	clarified	clarify	VERB
dpc-1099	57	22	.	.	PUNCT
dpc-1099	58	1	autoreactive	autoreactive	PROPN
dpc-1099	58	2	cd4	cd4	PROPN
dpc-1099	58	3	+	+	PROPN
dpc-1099	58	4	t	t	PROPN
dpc-1099	58	5	lymphocytes	lymphocyte	NOUN
dpc-1099	58	6	have	have	AUX
dpc-1099	58	7	been	be	AUX
dpc-1099	58	8	implicated	implicate	VERB
dpc-1099	58	9	in	in	ADP
dpc-1099	58	10	the	the	DET
dpc-1099	58	11	regulation	regulation	NOUN
dpc-1099	58	12	of	of	ADP
dpc-1099	58	13	the	the	DET
dpc-1099	58	14	production	production	NOUN
dpc-1099	58	15	of	of	ADP
dpc-1099	58	16	pathogenic	pathogenic	ADJ
dpc-1099	58	17	anti	anti	ADJ
dpc-1099	58	18	-	-	ADJ
dpc-1099	58	19	dsg3	dsg3	ADJ
dpc-1099	58	20	autoantibodies	autoantibody	NOUN
dpc-1099	58	21	by	by	ADP
dpc-1099	58	22	b	b	NOUN
dpc-1099	58	23	cells	cell	NOUN
dpc-1099	58	24	[	[	X
dpc-1099	58	25	21	21	NUM
dpc-1099	58	26	]	]	PUNCT
dpc-1099	58	27	.	.	PUNCT
dpc-1099	59	1	there	there	PRON
dpc-1099	59	2	is	be	VERB
dpc-1099	59	3	a	a	DET
dpc-1099	59	4	strong	strong	ADJ
dpc-1099	59	5	association	association	NOUN
dpc-1099	59	6	between	between	ADP
dpc-1099	59	7	pv	pv	NOUN
dpc-1099	59	8	and	and	CCONJ
dpc-1099	59	9	distinct	distinct	VERB
dpc-1099	59	10	major	major	ADJ
dpc-1099	59	11	histocompatibility	histocompatibility	NOUN
dpc-1099	59	12	complex	complex	ADJ
dpc-1099	59	13	class	class	NOUN
dpc-1099	59	14	ii	ii	NOUN
dpc-1099	59	15	haplotypes	haplotype	NOUN
dpc-1099	59	16	,	,	PUNCT
dpc-1099	59	17	which	which	PRON
dpc-1099	59	18	are	be	AUX
dpc-1099	59	19	considered	consider	VERB
dpc-1099	59	20	essential	essential	ADJ
dpc-1099	59	21	for	for	ADP
dpc-1099	59	22	the	the	DET
dpc-1099	59	23	presentation	presentation	NOUN
dpc-1099	59	24	of	of	ADP
dpc-1099	59	25	specific	specific	ADJ
dpc-1099	59	26	dsg3	dsg3	ADJ
dpc-1099	59	27	peptides	peptide	NOUN
dpc-1099	59	28	to	to	PART
dpc-1099	59	29	autoreactive	autoreactive	VERB
dpc-1099	59	30	cd4	cd4	PROPN
dpc-1099	59	31	+	+	PROPN
dpc-1099	59	32	helper	helper	NOUN
dpc-1099	59	33	t	t	PROPN
dpc-1099	59	34	cells	cell	NOUN
dpc-1099	59	35	[	[	X
dpc-1099	59	36	18,22	18,22	X
dpc-1099	59	37	]	]	X
dpc-1099	59	38	.	.	PUNCT
dpc-1099	60	1	the	the	DET
dpc-1099	60	2	causes	cause	NOUN
dpc-1099	60	3	of	of	ADP
dpc-1099	60	4	loss	loss	NOUN
dpc-1099	60	5	of	of	ADP
dpc-1099	60	6	tolerance	tolerance	NOUN
dpc-1099	60	7	leading	lead	VERB
dpc-1099	60	8	to	to	ADP
dpc-1099	60	9	the	the	DET
dpc-1099	60	10	production	production	NOUN
dpc-1099	60	11	of	of	ADP
dpc-1099	60	12	antibodies	antibody	NOUN
dpc-1099	60	13	anti	anti	ADJ
dpc-1099	60	14	-	-	ADJ
dpc-1099	60	15	bp180	bp180	ADJ
dpc-1099	60	16	/	/	SYM
dpc-1099	60	17	collagen	collagen	NOUN
dpc-1099	60	18	xvii	xvii	VERB
dpc-1099	60	19	and	and	CCONJ
dpc-1099	60	20	bp230	bp230	VERB
dpc-1099	60	21	/	/	SYM
dpc-1099	60	22	dystonin	dystonin	NOUN
dpc-1099	60	23	,	,	PUNCT
dpc-1099	60	24	and	and	CCONJ
dpc-1099	60	25	less	less	ADV
dpc-1099	60	26	frequently	frequently	ADV
dpc-1099	60	27	also	also	ADV
dpc-1099	60	28	against	against	ADP
dpc-1099	60	29	other	other	ADJ
dpc-1099	60	30	antigens	antigen	NOUN
dpc-1099	60	31	in	in	ADP
dpc-1099	60	32	bp	bp	PROPN
dpc-1099	60	33	,	,	PUNCT
dpc-1099	60	34	are	be	AUX
dpc-1099	60	35	not	not	PART
dpc-1099	60	36	known	know	VERB
dpc-1099	60	37	.	.	PUNCT
dpc-1099	61	1	bp	bp	PROPN
dpc-1099	61	2	has	have	AUX
dpc-1099	61	3	been	be	AUX
dpc-1099	61	4	linked	link	VERB
dpc-1099	61	5	to	to	ADP
dpc-1099	61	6	environmental	environmental	ADJ
dpc-1099	61	7	factors	factor	NOUN
dpc-1099	61	8	as	as	ADP
dpc-1099	61	9	physical	physical	ADJ
dpc-1099	61	10	agents	agent	NOUN
dpc-1099	61	11	,	,	PUNCT
dpc-1099	61	12	such	such	ADJ
dpc-1099	61	13	as	as	ADP
dpc-1099	61	14	radiation	radiation	NOUN
dpc-1099	61	15	therapy	therapy	NOUN
dpc-1099	61	16	,	,	PUNCT
dpc-1099	61	17	ultraviolet	ultraviolet	ADJ
dpc-1099	61	18	radiation	radiation	NOUN
dpc-1099	61	19	[	[	X
dpc-1099	61	20	23	23	NUM
dpc-1099	61	21	]	]	X
dpc-1099	61	22	trauma	trauma	NOUN
dpc-1099	61	23	,	,	PUNCT
dpc-1099	61	24	neurodegeneration	neurodegeneration	NOUN
dpc-1099	61	25	or	or	CCONJ
dpc-1099	61	26	neuroinflammation	neuroinflammation	NOUN
dpc-1099	61	27	[	[	X
dpc-1099	61	28	24	24	NUM
dpc-1099	61	29	]	]	PUNCT
dpc-1099	61	30	and	and	CCONJ
dpc-1099	61	31	drugs	drug	NOUN
dpc-1099	61	32	,	,	PUNCT
dpc-1099	61	33	in	in	ADP
dpc-1099	61	34	particular	particular	ADJ
dpc-1099	61	35	gliptins	gliptin	NOUN
dpc-1099	61	36	[	[	X
dpc-1099	61	37	25	25	NUM
dpc-1099	61	38	]	]	PUNCT
dpc-1099	61	39	.	.	PUNCT
dpc-1099	62	1	muramatsu	muramatsu	PROPN
dpc-1099	62	2	et	et	PROPN
dpc-1099	62	3	al	al	PROPN
dpc-1099	62	4	demonstrated	demonstrate	VERB
dpc-1099	62	5	that	that	SCONJ
dpc-1099	62	6	tregs	treg	NOUN
dpc-1099	62	7	are	be	AUX
dpc-1099	62	8	essential	essential	ADJ
dpc-1099	62	9	in	in	ADP
dpc-1099	62	10	preventing	prevent	VERB
dpc-1099	62	11	the	the	DET
dpc-1099	62	12	spontaneous	spontaneous	ADJ
dpc-1099	62	13	production	production	NOUN
dpc-1099	62	14	of	of	ADP
dpc-1099	62	15	bp	bp	PROPN
dpc-1099	62	16	autoantibodies	autoantibody	NOUN
dpc-1099	62	17	as	as	ADV
dpc-1099	62	18	well	well	ADV
dpc-1099	62	19	[	[	X
dpc-1099	62	20	26	26	NUM
dpc-1099	62	21	]	]	PUNCT
dpc-1099	62	22	.	.	PUNCT
dpc-1099	63	1	an	an	DET
dpc-1099	63	2	imbalance	imbalance	NOUN
dpc-1099	63	3	between	between	ADP
dpc-1099	63	4	autoreactive	autoreactive	ADJ
dpc-1099	63	5	helper	helper	NOUN
dpc-1099	63	6	t	t	PROPN
dpc-1099	63	7	cells	cell	NOUN
dpc-1099	63	8	and	and	CCONJ
dpc-1099	63	9	tregs	treg	NOUN
dpc-1099	63	10	and	and	CCONJ
dpc-1099	63	11	a	a	DET
dpc-1099	63	12	t	t	NOUN
dpc-1099	63	13	cell	cell	NOUN
dpc-1099	63	14	-	-	PUNCT
dpc-1099	63	15	independent	independent	ADJ
dpc-1099	63	16	activation	activation	NOUN
dpc-1099	63	17	of	of	ADP
dpc-1099	63	18	a	a	DET
dpc-1099	63	19	toll	toll	NOUN
dpc-1099	63	20	-	-	PUNCT
dpc-1099	63	21	like	like	ADJ
dpc-1099	63	22	receptor	receptor	NOUN
dpc-1099	63	23	the	the	DET
dpc-1099	63	24	yearly	yearly	ADJ
dpc-1099	63	25	incidence	incidence	NOUN
dpc-1099	63	26	of	of	ADP
dpc-1099	63	27	bp	bp	PROPN
dpc-1099	63	28	reported	report	VERB
dpc-1099	63	29	in	in	ADP
dpc-1099	63	30	european	european	ADJ
dpc-1099	63	31	prospective	prospective	ADJ
dpc-1099	63	32	studies	study	NOUN
dpc-1099	63	33	varies	vary	VERB
dpc-1099	63	34	between	between	ADP
dpc-1099	63	35	2.5	2.5	NUM
dpc-1099	63	36	and	and	CCONJ
dpc-1099	63	37	13	13	NUM
dpc-1099	63	38	/	/	SYM
dpc-1099	63	39	million	million	NUM
dpc-1099	63	40	[	[	X
dpc-1099	63	41	5,6	5,6	NUM
dpc-1099	63	42	]	]	X
dpc-1099	63	43	.	.	PUNCT
dpc-1099	64	1	the	the	DET
dpc-1099	64	2	largest	large	ADJ
dpc-1099	64	3	series	series	NOUN
dpc-1099	64	4	of	of	ADP
dpc-1099	64	5	patients	patient	NOUN
dpc-1099	64	6	(	(	PUNCT
dpc-1099	64	7	n	n	NOUN
dpc-1099	64	8	=	=	SYM
dpc-1099	64	9	869	869	NUM
dpc-1099	64	10	)	)	PUNCT
dpc-1099	64	11	collected	collect	VERB
dpc-1099	64	12	in	in	ADP
dpc-1099	64	13	a	a	DET
dpc-1099	64	14	retrospective	retrospective	ADJ
dpc-1099	64	15	historical	historical	ADJ
dpc-1099	64	16	cohort	cohort	NOUN
dpc-1099	64	17	from	from	ADP
dpc-1099	64	18	the	the	DET
dpc-1099	64	19	uk	uk	PROPN
dpc-1099	64	20	showed	show	VERB
dpc-1099	64	21	higher	high	ADJ
dpc-1099	64	22	incidence	incidence	NOUN
dpc-1099	64	23	rates	rate	NOUN
dpc-1099	64	24	of	of	ADP
dpc-1099	64	25	42.8	42.8	NUM
dpc-1099	64	26	/	/	SYM
dpc-1099	64	27	million	million	NUM
dpc-1099	65	1	[	[	X
dpc-1099	65	2	10	10	NUM
dpc-1099	65	3	]	]	PUNCT
dpc-1099	65	4	.	.	PUNCT
dpc-1099	66	1	rising	rise	VERB
dpc-1099	66	2	incidence	incidence	NOUN
dpc-1099	66	3	rates	rate	NOUN
dpc-1099	66	4	of	of	ADP
dpc-1099	66	5	bp	bp	PROPN
dpc-1099	66	6	in	in	ADP
dpc-1099	66	7	europe	europe	PROPN
dpc-1099	66	8	have	have	AUX
dpc-1099	66	9	been	be	AUX
dpc-1099	66	10	linked	link	VERB
dpc-1099	66	11	to	to	ADP
dpc-1099	66	12	risk	risk	NOUN
dpc-1099	66	13	factors	factor	NOUN
dpc-1099	66	14	,	,	PUNCT
dpc-1099	66	15	including	include	VERB
dpc-1099	66	16	population	population	NOUN
dpc-1099	66	17	aging	aging	NOUN
dpc-1099	66	18	;	;	PUNCT
dpc-1099	66	19	drugs	drug	NOUN
dpc-1099	66	20	,	,	PUNCT
dpc-1099	66	21	in	in	ADP
dpc-1099	66	22	particular	particular	ADJ
dpc-1099	66	23	antidiabetics	antidiabetic	NOUN
dpc-1099	66	24	;	;	PUNCT
dpc-1099	66	25	diuretics	diuretic	NOUN
dpc-1099	66	26	;	;	PUNCT
dpc-1099	66	27	phenothiazines	phenothiazine	NOUN
dpc-1099	66	28	;	;	PUNCT
dpc-1099	66	29	major	major	ADJ
dpc-1099	66	30	cognitive	cognitive	ADJ
dpc-1099	66	31	impairment	impairment	NOUN
dpc-1099	66	32	;	;	PUNCT
dpc-1099	66	33	and	and	CCONJ
dpc-1099	66	34	disabling	disable	VERB
dpc-1099	66	35	neurological	neurological	ADJ
dpc-1099	66	36	disorders	disorder	NOUN
dpc-1099	66	37	[	[	X
dpc-1099	66	38	3,11	3,11	NOUN
dpc-1099	66	39	]	]	X
dpc-1099	66	40	.	.	PUNCT
dpc-1099	67	1	bp	bp	PROPN
dpc-1099	67	2	affects	affect	VERB
dpc-1099	67	3	mostly	mostly	ADV
dpc-1099	67	4	the	the	DET
dpc-1099	67	5	elderly	elderly	ADJ
dpc-1099	67	6	:	:	PUNCT
dpc-1099	67	7	it	it	PRON
dpc-1099	67	8	is	be	AUX
dpc-1099	67	9	generally	generally	ADV
dpc-1099	67	10	seen	see	VERB
dpc-1099	67	11	in	in	ADP
dpc-1099	67	12	individuals	individual	NOUN
dpc-1099	67	13	older	old	ADJ
dpc-1099	67	14	than	than	ADP
dpc-1099	67	15	70	70	NUM
dpc-1099	67	16	years	year	NOUN
dpc-1099	67	17	.	.	PUNCT
dpc-1099	68	1	overall	overall	ADJ
dpc-1099	68	2	incidence	incidence	NOUN
dpc-1099	68	3	is	be	AUX
dpc-1099	68	4	higher	high	ADJ
dpc-1099	68	5	in	in	ADP
dpc-1099	68	6	females	female	NOUN
dpc-1099	68	7	[	[	X
dpc-1099	68	8	3	3	NUM
dpc-1099	68	9	]	]	PUNCT
dpc-1099	68	10	.	.	PUNCT
dpc-1099	69	1	genetics	genetic	NOUN
dpc-1099	69	2	there	there	PRON
dpc-1099	69	3	is	be	VERB
dpc-1099	69	4	evidence	evidence	NOUN
dpc-1099	69	5	that	that	SCONJ
dpc-1099	69	6	genetics	genetic	NOUN
dpc-1099	69	7	plays	play	VERB
dpc-1099	69	8	a	a	DET
dpc-1099	69	9	critical	critical	ADJ
dpc-1099	69	10	role	role	NOUN
dpc-1099	69	11	in	in	ADP
dpc-1099	69	12	pv	pv	PROPN
dpc-1099	69	13	development	development	NOUN
dpc-1099	69	14	,	,	PUNCT
dpc-1099	69	15	severity	severity	NOUN
dpc-1099	69	16	,	,	PUNCT
dpc-1099	69	17	and	and	CCONJ
dpc-1099	69	18	prognosis	prognosis	NOUN
dpc-1099	69	19	.	.	PUNCT
dpc-1099	70	1	an	an	DET
dpc-1099	70	2	increased	increase	VERB
dpc-1099	70	3	frequency	frequency	NOUN
dpc-1099	70	4	of	of	ADP
dpc-1099	70	5	hla	hla	PROPN
dpc-1099	70	6	-	-	PUNCT
dpc-1099	70	7	drb1	drb1	PROPN
dpc-1099	70	8	*	*	NOUN
dpc-1099	70	9	04:02	04:02	NUM
dpc-1099	70	10	haplotypes	haplotype	NOUN
dpc-1099	70	11	in	in	ADP
dpc-1099	70	12	ashkenazi	ashkenazi	ADJ
dpc-1099	70	13	jewish	jewish	ADJ
dpc-1099	70	14	patients	patient	NOUN
dpc-1099	70	15	[	[	X
dpc-1099	70	16	12	12	NUM
dpc-1099	70	17	]	]	PUNCT
dpc-1099	70	18	and	and	CCONJ
dpc-1099	70	19	dqb1	dqb1	PROPN
dpc-1099	70	20	*	*	SYM
dpc-1099	70	21	05:03	05:03	NUM
dpc-1099	70	22	in	in	ADP
dpc-1099	70	23	non	non	ADJ
dpc-1099	70	24	-	-	ADJ
dpc-1099	70	25	jewish	jewish	ADJ
dpc-1099	70	26	caucasian	caucasian	ADJ
dpc-1099	70	27	populations	population	NOUN
dpc-1099	70	28	[	[	X
dpc-1099	70	29	13	13	NUM
dpc-1099	70	30	]	]	PUNCT
dpc-1099	70	31	has	have	AUX
dpc-1099	70	32	been	be	AUX
dpc-1099	70	33	observed	observe	VERB
dpc-1099	70	34	.	.	PUNCT
dpc-1099	71	1	the	the	DET
dpc-1099	71	2	coexistence	coexistence	NOUN
dpc-1099	71	3	of	of	ADP
dpc-1099	71	4	alleles	allele	NOUN
dpc-1099	71	5	of	of	ADP
dpc-1099	71	6	drb1	drb1	NOUN
dpc-1099	71	7	*	*	PROPN
dpc-1099	71	8	14	14	NUM
dpc-1099	71	9	/	/	SYM
dpc-1099	71	10	dqb1	dqb1	ADJ
dpc-1099	71	11	*	*	NUM
dpc-1099	71	12	05	05	NUM
dpc-1099	71	13	and	and	CCONJ
dpc-1099	71	14	a*11	a*11	PROPN
dpc-1099	71	15	/	/	SYM
dpc-1099	71	16	dqb1	dqb1	PROPN
dpc-1099	71	17	*	*	ADJ
dpc-1099	71	18	05	05	PRON
dpc-1099	71	19	would	would	AUX
dpc-1099	71	20	be	be	AUX
dpc-1099	71	21	strongly	strongly	ADV
dpc-1099	71	22	influential	influential	ADJ
dpc-1099	71	23	for	for	ADP
dpc-1099	71	24	the	the	DET
dpc-1099	71	25	predisposition	predisposition	NOUN
dpc-1099	71	26	to	to	ADP
dpc-1099	71	27	the	the	DET
dpc-1099	71	28	disease	disease	NOUN
dpc-1099	71	29	,	,	PUNCT
dpc-1099	71	30	while	while	SCONJ
dpc-1099	71	31	that	that	PRON
dpc-1099	71	32	of	of	ADP
dpc-1099	71	33	hla	hla	PROPN
dpc-1099	71	34	-	-	PUNCT
dpc-1099	71	35	b*50	b*50	NOUN
dpc-1099	71	36	/	/	SYM
dpc-1099	71	37	dqb1	dqb1	ADJ
dpc-1099	71	38	*	*	NUM
dpc-1099	71	39	02	02	NUM
dpc-1099	71	40	could	could	AUX
dpc-1099	71	41	play	play	VERB
dpc-1099	71	42	a	a	DET
dpc-1099	71	43	protective	protective	ADJ
dpc-1099	71	44	role	role	NOUN
dpc-1099	71	45	[	[	X
dpc-1099	71	46	14	14	NUM
dpc-1099	71	47	]	]	PUNCT
dpc-1099	71	48	.	.	PUNCT
dpc-1099	72	1	in	in	ADP
dpc-1099	72	2	addition	addition	NOUN
dpc-1099	72	3	,	,	PUNCT
dpc-1099	72	4	multiple	multiple	ADJ
dpc-1099	72	5	single	single	ADJ
dpc-1099	72	6	nucleotide	nucleotide	ADJ
dpc-1099	72	7	polymorphisms	polymorphism	NOUN
dpc-1099	72	8	within	within	ADP
dpc-1099	72	9	different	different	ADJ
dpc-1099	72	10	genes	gene	NOUN
dpc-1099	72	11	may	may	AUX
dpc-1099	72	12	confer	confer	VERB
dpc-1099	72	13	susceptibility	susceptibility	NOUN
dpc-1099	72	14	to	to	ADP
dpc-1099	72	15	the	the	DET
dpc-1099	72	16	diseases	disease	NOUN
dpc-1099	72	17	,	,	PUNCT
dpc-1099	72	18	probably	probably	ADV
dpc-1099	72	19	in	in	ADP
dpc-1099	72	20	a	a	DET
dpc-1099	72	21	population‐specific	population‐specific	ADJ
dpc-1099	72	22	way	way	NOUN
dpc-1099	72	23	[	[	X
dpc-1099	72	24	15	15	NUM
dpc-1099	72	25	]	]	PUNCT
dpc-1099	72	26	.	.	PUNCT
dpc-1099	73	1	serological	serological	ADJ
dpc-1099	73	2	typing	typing	NOUN
dpc-1099	73	3	for	for	ADP
dpc-1099	73	4	hla	hla	PROPN
dpc-1099	73	5	class	class	PROPN
dpc-1099	73	6	ii	ii	PROPN
dpc-1099	73	7	antigens	antigen	NOUN
dpc-1099	73	8	in	in	ADP
dpc-1099	73	9	patients	patient	NOUN
dpc-1099	73	10	with	with	ADP
dpc-1099	73	11	abd	abd	PROPN
dpc-1099	73	12	of	of	ADP
dpc-1099	73	13	the	the	DET
dpc-1099	73	14	pemphigoid	pemphigoid	ADJ
dpc-1099	73	15	type	type	NOUN
dpc-1099	73	16	revealed	reveal	VERB
dpc-1099	73	17	a	a	DET
dpc-1099	73	18	highly	highly	ADV
dpc-1099	73	19	significant	significant	ADJ
dpc-1099	73	20	association	association	NOUN
dpc-1099	73	21	with	with	ADP
dpc-1099	73	22	hla	hla	PROPN
dpc-1099	73	23	-	-	PUNCT
dpc-1099	73	24	dqβ1	dqβ1	NOUN
dpc-1099	73	25	*	*	NOUN
dpc-1099	73	26	0301	0301	NUM
dpc-1099	74	1	[	[	X
dpc-1099	74	2	16	16	NUM
dpc-1099	74	3	]	]	PUNCT
dpc-1099	74	4	.	.	PUNCT
dpc-1099	75	1	pathophysiology	pathophysiology	NOUN
dpc-1099	75	2	pv	pv	NOUN
dpc-1099	75	3	and	and	CCONJ
dpc-1099	75	4	bp	bp	PROPN
dpc-1099	75	5	are	be	AUX
dpc-1099	75	6	characterized	characterize	VERB
dpc-1099	75	7	by	by	ADP
dpc-1099	75	8	the	the	DET
dpc-1099	75	9	loss	loss	NOUN
dpc-1099	75	10	of	of	ADP
dpc-1099	75	11	tolerance	tolerance	NOUN
dpc-1099	75	12	to	to	ADP
dpc-1099	75	13	autoantigens	autoantigen	NOUN
dpc-1099	75	14	expressed	express	VERB
dpc-1099	75	15	primarily	primarily	ADV
dpc-1099	75	16	in	in	ADP
dpc-1099	75	17	the	the	DET
dpc-1099	75	18	skin	skin	NOUN
dpc-1099	75	19	,	,	PUNCT
dpc-1099	75	20	in	in	ADP
dpc-1099	75	21	particular	particular	ADJ
dpc-1099	75	22	desmosomal	desmosomal	ADJ
dpc-1099	75	23	proteins	protein	NOUN
dpc-1099	75	24	in	in	ADP
dpc-1099	75	25	pv	pv	NOUN
dpc-1099	75	26	and	and	CCONJ
dpc-1099	75	27	components	component	NOUN
dpc-1099	75	28	of	of	ADP
dpc-1099	75	29	the	the	DET
dpc-1099	75	30	hemidesmosomes	hemidesmosome	NOUN
dpc-1099	75	31	in	in	ADP
dpc-1099	75	32	bp	bp	PROPN
dpc-1099	75	33	.	.	PUNCT
dpc-1099	76	1	in	in	ADP
dpc-1099	76	2	pds	pds	NOUN
dpc-1099	76	3	,	,	PUNCT
dpc-1099	76	4	the	the	DET
dpc-1099	76	5	production	production	NOUN
dpc-1099	76	6	of	of	ADP
dpc-1099	76	7	pathogenic	pathogenic	ADJ
dpc-1099	76	8	immunoglobulin	immunoglobulin	NOUN
dpc-1099	76	9	g	g	PROPN
dpc-1099	76	10	(	(	PUNCT
dpc-1099	76	11	igg	igg	PROPN
dpc-1099	76	12	)	)	PUNCT
dpc-1099	76	13	autoantibodies	autoantibody	NOUN
dpc-1099	76	14	,	,	PUNCT
dpc-1099	76	15	mainly	mainly	ADV
dpc-1099	76	16	igg4	igg4	NOUN
dpc-1099	76	17	,	,	PUNCT
dpc-1099	76	18	against	against	ADP
dpc-1099	76	19	the	the	DET
dpc-1099	76	20	desmosomal	desmosomal	ADJ
dpc-1099	76	21	table	table	NOUN
dpc-1099	76	22	3	3	NUM
dpc-1099	76	23	.	.	PUNCT
dpc-1099	76	24	classification	classification	NOUN
dpc-1099	76	25	and	and	CCONJ
dpc-1099	76	26	autoantigens	autoantigen	NOUN
dpc-1099	76	27	in	in	ADP
dpc-1099	76	28	autoimmune	autoimmune	ADJ
dpc-1099	76	29	bullous	bullous	ADJ
dpc-1099	76	30	disorders	disorder	NOUN
dpc-1099	76	31	of	of	ADP
dpc-1099	76	32	the	the	DET
dpc-1099	76	33	pemphigoid	pemphigoid	ADJ
dpc-1099	76	34	type	type	NOUN
dpc-1099	76	35	diseases	disease	NOUN
dpc-1099	76	36	ig	ig	PRON
dpc-1099	76	37	antigen	antigen	VERB
dpc-1099	76	38	bullous	bullous	ADJ
dpc-1099	76	39	pemphigoid	pemphigoid	VERB
dpc-1099	76	40	ig	ig	PROPN
dpc-1099	76	41	bp180	bp180	PROPN
dpc-1099	76	42	,	,	PUNCT
dpc-1099	76	43	bp230	bp230	PROPN
dpc-1099	76	44	pemphigoid	pemphigoid	PROPN
dpc-1099	76	45	gestationis	gestationis	PROPN
dpc-1099	76	46	ig	ig	PROPN
dpc-1099	76	47	bp180	bp180	PROPN
dpc-1099	76	48	,	,	PUNCT
dpc-1099	76	49	bp230	bp230	PROPN
dpc-1099	76	50	linear	linear	PROPN
dpc-1099	76	51	iga	iga	PROPN
dpc-1099	76	52	dermatosis	dermatosis	NOUN
dpc-1099	76	53	iga	iga	PROPN
dpc-1099	76	54	bp180	bp180	ADJ
dpc-1099	76	55	mucous	mucous	ADJ
dpc-1099	76	56	membrane	membrane	NOUN
dpc-1099	76	57	pemphigoid	pemphigoid	ADJ
dpc-1099	76	58	igg	igg	PROPN
dpc-1099	76	59	/	/	SYM
dpc-1099	76	60	iga	iga	PROPN
dpc-1099	76	61	bp180	bp180	PROPN
dpc-1099	76	62	,	,	PUNCT
dpc-1099	76	63	bp230	bp230	PROPN
dpc-1099	76	64	,	,	PUNCT
dpc-1099	76	65	laminin	laminin	VERB
dpc-1099	76	66	332	332	NUM
dpc-1099	76	67	,	,	PUNCT
dpc-1099	76	68	α6β4	α6β4	X
dpc-1099	76	69	integrin	integrin	NOUN
dpc-1099	76	70	anti	anti	ADJ
dpc-1099	76	71	-	-	ADJ
dpc-1099	76	72	laminin	laminin	ADJ
dpc-1099	76	73	γ-1	γ-1	NOUN
dpc-1099	76	74	pemphigoid	pemphigoid	PROPN
dpc-1099	76	75	igg	igg	PROPN
dpc-1099	76	76	laminin	laminin	PROPN
dpc-1099	76	77	γ-1(p200	γ-1(p200	PROPN
dpc-1099	76	78	)	)	PUNCT
dpc-1099	77	1	lichen	lichen	NOUN
dpc-1099	77	2	planus	planu	VERB
dpc-1099	77	3	pemphigoid	pemphigoid	PROPN
dpc-1099	77	4	igg	igg	PROPN
dpc-1099	77	5	bp180	bp180	PROPN
dpc-1099	77	6	,	,	PUNCT
dpc-1099	77	7	bp230	bp230	VERB
dpc-1099	77	8	epidermolysis	epidermolysis	NOUN
dpc-1099	77	9	bullosa	bullosa	PROPN
dpc-1099	77	10	acquisita	acquisita	PROPN
dpc-1099	77	11	igg	igg	PROPN
dpc-1099	77	12	type	type	PROPN
dpc-1099	77	13	vii	vii	PROPN
dpc-1099	77	14	collagen	collagen	PROPN
dpc-1099	77	15	dermatitis	dermatitis	PROPN
dpc-1099	77	16	herpetiformis	herpetiformis	PROPN
dpc-1099	77	17	iga	iga	PROPN
dpc-1099	77	18	(	(	PUNCT
dpc-1099	77	19	igg	igg	PROPN
dpc-1099	77	20	)	)	PUNCT
dpc-1099	77	21	epidermal	epidermal	ADJ
dpc-1099	77	22	transglutaminase	transglutaminase	NOUN
dpc-1099	77	23	,	,	PUNCT
dpc-1099	77	24	tissue	tissue	NOUN
dpc-1099	77	25	transglutaminase	transglutaminase	NOUN
dpc-1099	77	26	,	,	PUNCT
dpc-1099	77	27	deamidated	deamidate	VERB
dpc-1099	77	28	gliadin	gliadin	VERB
dpc-1099	77	29	bp	bp	PROPN
dpc-1099	77	30	=	=	PUNCT
dpc-1099	77	31	bullous	bullous	ADJ
dpc-1099	77	32	pemphigoid	pemphigoid	ADV
dpc-1099	77	33	;	;	PUNCT
dpc-1099	77	34	ig	ig	PROPN
dpc-1099	77	35	=	=	PUNCT
dpc-1099	77	36	immunoglobulin	immunoglobulin	NOUN
dpc-1099	77	37	.	.	PUNCT
dpc-1099	78	1	4	4	NUM
dpc-1099	78	2	review	review	NOUN
dpc-1099	78	3	|	|	ADV
dpc-1099	78	4	dermatol	dermatol	ADJ
dpc-1099	78	5	pract	pract	NOUN
dpc-1099	78	6	concept	concept	NOUN
dpc-1099	78	7	2020;10(3):e2020050	2020;10(3):e2020050	PROPN
dpc-1099	78	8	(	(	PUNCT
dpc-1099	78	9	figures	figure	NOUN
dpc-1099	78	10	4	4	NUM
dpc-1099	78	11	and	and	CCONJ
dpc-1099	78	12	5	5	NUM
dpc-1099	78	13	)	)	PUNCT
dpc-1099	78	14	.	.	PUNCT
dpc-1099	79	1	pruritus	pruritus	PROPN
dpc-1099	79	2	is	be	AUX
dpc-1099	79	3	common	common	ADJ
dpc-1099	79	4	and	and	CCONJ
dpc-1099	79	5	often	often	ADV
dpc-1099	79	6	severe	severe	ADJ
dpc-1099	79	7	.	.	PUNCT
dpc-1099	80	1	after	after	ADP
dpc-1099	80	2	rupture	rupture	NOUN
dpc-1099	80	3	,	,	PUNCT
dpc-1099	80	4	bullae	bullae	PROPN
dpc-1099	80	5	leave	leave	VERB
dpc-1099	80	6	moist	moist	ADJ
dpc-1099	80	7	erosions	erosion	NOUN
dpc-1099	80	8	and	and	CCONJ
dpc-1099	80	9	crusts	crust	NOUN
dpc-1099	80	10	that	that	PRON
dpc-1099	80	11	resolve	resolve	VERB
dpc-1099	80	12	without	without	ADP
dpc-1099	80	13	scarring	scar	VERB
dpc-1099	80	14	.	.	PUNCT
dpc-1099	81	1	mucosal	mucosal	ADJ
dpc-1099	81	2	involvement	involvement	NOUN
dpc-1099	81	3	may	may	AUX
dpc-1099	81	4	be	be	AUX
dpc-1099	81	5	observed	observe	VERB
dpc-1099	81	6	in	in	ADP
dpc-1099	81	7	10	10	NUM
dpc-1099	81	8	%	%	NOUN
dpc-1099	81	9	to	to	PART
dpc-1099	81	10	30	30	NUM
dpc-1099	81	11	%	%	NOUN
dpc-1099	81	12	of	of	ADP
dpc-1099	81	13	the	the	DET
dpc-1099	81	14	cases	case	NOUN
dpc-1099	81	15	with	with	ADP
dpc-1099	81	16	oral	oral	ADJ
dpc-1099	81	17	,	,	PUNCT
dpc-1099	81	18	esophageal	esophageal	ADJ
dpc-1099	81	19	,	,	PUNCT
dpc-1099	81	20	and	and	CCONJ
dpc-1099	81	21	genital	genital	ADJ
dpc-1099	81	22	involvement	involvement	NOUN
dpc-1099	81	23	.	.	PUNCT
dpc-1099	82	1	two	two	NUM
dpc-1099	82	2	disease	disease	NOUN
dpc-1099	82	3	scores	score	NOUN
dpc-1099	82	4	,	,	PUNCT
dpc-1099	82	5	the	the	DET
dpc-1099	82	6	bp	bp	PROPN
dpc-1099	82	7	disease	disease	PROPN
dpc-1099	82	8	area	area	NOUN
dpc-1099	82	9	index	index	NOUN
dpc-1099	82	10	and	and	CCONJ
dpc-1099	82	11	the	the	DET
dpc-1099	82	12	autoimmune	autoimmune	ADJ
dpc-1099	82	13	bullous	bullous	ADJ
dpc-1099	82	14	skin	skin	NOUN
dpc-1099	82	15	disorder	disorder	NOUN
dpc-1099	82	16	intensity	intensity	NOUN
dpc-1099	82	17	score	score	NOUN
dpc-1099	82	18	,	,	PUNCT
dpc-1099	82	19	have	have	AUX
dpc-1099	82	20	shown	show	VERB
dpc-1099	82	21	significant	significant	ADJ
dpc-1099	82	22	reliability	reliability	NOUN
dpc-1099	82	23	,	,	PUNCT
dpc-1099	82	24	validity	validity	NOUN
dpc-1099	82	25	,	,	PUNCT
dpc-1099	82	26	and	and	CCONJ
dpc-1099	82	27	responsiveness	responsiveness	NOUN
dpc-1099	82	28	[	[	X
dpc-1099	82	29	29	29	NUM
dpc-1099	82	30	-	-	SYM
dpc-1099	82	31	31	31	NUM
dpc-1099	82	32	]	]	PUNCT
dpc-1099	82	33	.	.	PUNCT
dpc-1099	83	1	bp	bp	PROPN
dpc-1099	83	2	shows	show	VERB
dpc-1099	83	3	a	a	DET
dpc-1099	83	4	different	different	ADJ
dpc-1099	83	5	clinical	clinical	ADJ
dpc-1099	83	6	course	course	NOUN
dpc-1099	83	7	in	in	ADP
dpc-1099	83	8	infants	infant	NOUN
dpc-1099	83	9	and	and	CCONJ
dpc-1099	83	10	system	system	NOUN
dpc-1099	83	11	could	could	AUX
dpc-1099	83	12	underlie	underlie	VERB
dpc-1099	83	13	a	a	DET
dpc-1099	83	14	b	b	NOUN
dpc-1099	83	15	cell	cell	NOUN
dpc-1099	83	16	stimulation	stimulation	NOUN
dpc-1099	83	17	,	,	PUNCT
dpc-1099	83	18	with	with	ADP
dpc-1099	83	19	resulting	result	VERB
dpc-1099	83	20	bp	bp	PROPN
dpc-1099	83	21	autoantibody	autoantibody	VERB
dpc-1099	83	22	production	production	NOUN
dpc-1099	83	23	[	[	X
dpc-1099	83	24	24	24	NUM
dpc-1099	83	25	]	]	PUNCT
dpc-1099	83	26	.	.	PUNCT
dpc-1099	84	1	clinical	clinical	ADJ
dpc-1099	84	2	presentation	presentation	NOUN
dpc-1099	84	3	pv	pv	INTJ
dpc-1099	84	4	,	,	PUNCT
dpc-1099	84	5	the	the	DET
dpc-1099	84	6	most	most	ADV
dpc-1099	84	7	frequent	frequent	ADJ
dpc-1099	84	8	and	and	CCONJ
dpc-1099	84	9	severe	severe	ADJ
dpc-1099	84	10	form	form	NOUN
dpc-1099	84	11	of	of	ADP
dpc-1099	84	12	pemphigus	pemphigus	NOUN
dpc-1099	84	13	,	,	PUNCT
dpc-1099	84	14	affects	affect	VERB
dpc-1099	84	15	both	both	DET
dpc-1099	84	16	skin	skin	NOUN
dpc-1099	84	17	and	and	CCONJ
dpc-1099	84	18	mucosal	mucosal	NOUN
dpc-1099	84	19	surfaces	surface	NOUN
dpc-1099	84	20	.	.	PUNCT
dpc-1099	85	1	the	the	DET
dpc-1099	85	2	disease	disease	NOUN
dpc-1099	85	3	often	often	ADV
dpc-1099	85	4	begins	begin	VERB
dpc-1099	85	5	in	in	ADP
dpc-1099	85	6	the	the	DET
dpc-1099	85	7	oral	oral	ADJ
dpc-1099	85	8	mucosa	mucosa	NOUN
dpc-1099	85	9	with	with	ADP
dpc-1099	85	10	superficial	superficial	ADJ
dpc-1099	85	11	,	,	PUNCT
dpc-1099	85	12	flaccid	flaccid	ADJ
dpc-1099	85	13	blisters	blister	NOUN
dpc-1099	85	14	that	that	PRON
dpc-1099	85	15	rapidly	rapidly	ADV
dpc-1099	85	16	rupture	rupture	VERB
dpc-1099	85	17	,	,	PUNCT
dpc-1099	85	18	leaving	leave	VERB
dpc-1099	85	19	slow	slow	ADJ
dpc-1099	85	20	-	-	PUNCT
dpc-1099	85	21	healing	healing	NOUN
dpc-1099	85	22	,	,	PUNCT
dpc-1099	85	23	painful	painful	ADJ
dpc-1099	85	24	,	,	PUNCT
dpc-1099	85	25	moist	moist	ADJ
dpc-1099	85	26	erosions	erosion	NOUN
dpc-1099	85	27	that	that	PRON
dpc-1099	85	28	may	may	AUX
dpc-1099	85	29	make	make	VERB
dpc-1099	85	30	oral	oral	ADJ
dpc-1099	85	31	intake	intake	NOUN
dpc-1099	85	32	difficult	difficult	ADJ
dpc-1099	85	33	and	and	CCONJ
dpc-1099	85	34	cause	cause	VERB
dpc-1099	85	35	pain	pain	NOUN
dpc-1099	85	36	and	and	CCONJ
dpc-1099	85	37	fetor	fetor	NOUN
dpc-1099	85	38	as	as	ADV
dpc-1099	85	39	well	well	ADV
dpc-1099	85	40	.	.	PUNCT
dpc-1099	86	1	accompanying	accompany	VERB
dpc-1099	86	2	symptoms	symptom	NOUN
dpc-1099	86	3	are	be	AUX
dpc-1099	86	4	sialorrhea	sialorrhea	ADJ
dpc-1099	86	5	and	and	CCONJ
dpc-1099	86	6	bloody	bloody	ADJ
dpc-1099	86	7	saliva	saliva	NOUN
dpc-1099	86	8	.	.	PUNCT
dpc-1099	87	1	involvement	involvement	NOUN
dpc-1099	87	2	of	of	ADP
dpc-1099	87	3	other	other	ADJ
dpc-1099	87	4	skin	skin	NOUN
dpc-1099	87	5	areas	area	NOUN
dpc-1099	87	6	may	may	AUX
dpc-1099	87	7	occur	occur	VERB
dpc-1099	87	8	from	from	ADP
dpc-1099	87	9	weeks	week	NOUN
dpc-1099	87	10	to	to	ADP
dpc-1099	87	11	months	month	NOUN
dpc-1099	87	12	later	later	ADV
dpc-1099	87	13	.	.	PUNCT
dpc-1099	88	1	in	in	ADP
dpc-1099	88	2	addition	addition	NOUN
dpc-1099	88	3	to	to	ADP
dpc-1099	88	4	the	the	DET
dpc-1099	88	5	cutaneous	cutaneous	ADJ
dpc-1099	88	6	and	and	CCONJ
dpc-1099	88	7	mucosal	mucosal	NOUN
dpc-1099	88	8	surfaces	surface	NOUN
dpc-1099	88	9	of	of	ADP
dpc-1099	88	10	the	the	DET
dpc-1099	88	11	mouth	mouth	NOUN
dpc-1099	88	12	(	(	PUNCT
dpc-1099	88	13	figure	figure	NOUN
dpc-1099	88	14	1	1	NUM
dpc-1099	88	15	)	)	PUNCT
dpc-1099	88	16	,	,	PUNCT
dpc-1099	88	17	the	the	DET
dpc-1099	88	18	pharynx	pharynx	NOUN
dpc-1099	88	19	,	,	PUNCT
dpc-1099	88	20	vocal	vocal	ADJ
dpc-1099	88	21	folds	fold	NOUN
dpc-1099	88	22	,	,	PUNCT
dpc-1099	88	23	and	and	CCONJ
dpc-1099	88	24	anogenital	anogenital	ADJ
dpc-1099	88	25	mucosa	mucosa	NOUN
dpc-1099	88	26	may	may	AUX
dpc-1099	88	27	also	also	ADV
dpc-1099	88	28	be	be	AUX
dpc-1099	88	29	affected	affect	VERB
dpc-1099	88	30	.	.	PUNCT
dpc-1099	89	1	scalp	scalp	NOUN
dpc-1099	89	2	involvement	involvement	NOUN
dpc-1099	89	3	is	be	AUX
dpc-1099	89	4	observed	observe	VERB
dpc-1099	89	5	in	in	ADP
dpc-1099	89	6	up	up	ADP
dpc-1099	89	7	to	to	PART
dpc-1099	89	8	60	60	NUM
dpc-1099	89	9	%	%	NOUN
dpc-1099	89	10	of	of	ADP
dpc-1099	89	11	patients	patient	NOUN
dpc-1099	89	12	(	(	PUNCT
dpc-1099	89	13	figure	figure	NOUN
dpc-1099	89	14	2	2	NUM
dpc-1099	89	15	)	)	PUNCT
dpc-1099	89	16	.	.	PUNCT
dpc-1099	90	1	clinical	clinical	ADJ
dpc-1099	90	2	variants	variant	NOUN
dpc-1099	90	3	include	include	VERB
dpc-1099	90	4	mucosal	mucosal	NOUN
dpc-1099	90	5	-	-	PUNCT
dpc-1099	90	6	only	only	ADJ
dpc-1099	90	7	disease	disease	NOUN
dpc-1099	90	8	(	(	PUNCT
dpc-1099	90	9	which	which	PRON
dpc-1099	90	10	correlates	correlate	VERB
dpc-1099	90	11	with	with	ADP
dpc-1099	90	12	circulating	circulate	VERB
dpc-1099	90	13	anti	anti	ADJ
dpc-1099	90	14	-	-	ADJ
dpc-1099	90	15	dsg3	dsg3	ADJ
dpc-1099	90	16	autoantibodies	autoantibody	NOUN
dpc-1099	90	17	)	)	PUNCT
dpc-1099	90	18	,	,	PUNCT
dpc-1099	90	19	cutaneous	cutaneous	ADJ
dpc-1099	90	20	-	-	PUNCT
dpc-1099	90	21	only	only	ADJ
dpc-1099	90	22	disease	disease	NOUN
dpc-1099	90	23	(	(	PUNCT
dpc-1099	90	24	anti	anti	ADJ
dpc-1099	90	25	-	-	ADJ
dpc-1099	90	26	dsg1	dsg1	ADJ
dpc-1099	90	27	antibody	antibody	NOUN
dpc-1099	90	28	predominant	predominant	ADJ
dpc-1099	90	29	)	)	PUNCT
dpc-1099	90	30	,	,	PUNCT
dpc-1099	90	31	or	or	CCONJ
dpc-1099	90	32	more	more	ADV
dpc-1099	90	33	frequently	frequently	ADV
dpc-1099	90	34	,	,	PUNCT
dpc-1099	90	35	mucocutaneous	mucocutaneous	ADJ
dpc-1099	90	36	involvement	involvement	NOUN
dpc-1099	90	37	(	(	PUNCT
dpc-1099	90	38	presence	presence	NOUN
dpc-1099	90	39	of	of	ADP
dpc-1099	90	40	both	both	PRON
dpc-1099	90	41	anti	anti	ADJ
dpc-1099	90	42	-	-	ADJ
dpc-1099	90	43	dsg1	dsg1	NOUN
dpc-1099	90	44	and	and	CCONJ
dpc-1099	90	45	anti	anti	ADJ
dpc-1099	90	46	-	-	ADJ
dpc-1099	90	47	dsg3	dsg3	ADJ
dpc-1099	90	48	antibodies	antibody	NOUN
dpc-1099	90	49	)	)	PUNCT
dpc-1099	90	50	.	.	PUNCT
dpc-1099	91	1	recently	recently	ADV
dpc-1099	91	2	,	,	PUNCT
dpc-1099	91	3	clinical	clinical	ADJ
dpc-1099	91	4	scores	score	NOUN
dpc-1099	91	5	of	of	ADP
dpc-1099	91	6	disease	disease	NOUN
dpc-1099	91	7	severity	severity	NOUN
dpc-1099	91	8	have	have	AUX
dpc-1099	91	9	been	be	AUX
dpc-1099	91	10	implemented	implement	VERB
dpc-1099	91	11	.	.	PUNCT
dpc-1099	92	1	the	the	DET
dpc-1099	92	2	pemphigus	pemphigus	PROPN
dpc-1099	92	3	disease	disease	PROPN
dpc-1099	92	4	area	area	NOUN
dpc-1099	92	5	index	index	NOUN
dpc-1099	92	6	and	and	CCONJ
dpc-1099	92	7	autoimmune	autoimmune	ADJ
dpc-1099	92	8	bullous	bullous	ADJ
dpc-1099	92	9	skin	skin	NOUN
dpc-1099	92	10	disorder	disorder	NOUN
dpc-1099	92	11	intensity	intensity	NOUN
dpc-1099	92	12	score	score	NOUN
dpc-1099	92	13	have	have	AUX
dpc-1099	92	14	been	be	AUX
dpc-1099	92	15	recognized	recognize	VERB
dpc-1099	92	16	as	as	ADP
dpc-1099	92	17	robust	robust	ADJ
dpc-1099	92	18	tools	tool	NOUN
dpc-1099	92	19	to	to	PART
dpc-1099	92	20	correctly	correctly	ADV
dpc-1099	92	21	assess	assess	VERB
dpc-1099	92	22	disease	disease	NOUN
dpc-1099	92	23	activity	activity	NOUN
dpc-1099	92	24	[	[	X
dpc-1099	92	25	27	27	NUM
dpc-1099	92	26	]	]	PUNCT
dpc-1099	92	27	.	.	PUNCT
dpc-1099	93	1	classic	classic	ADJ
dpc-1099	93	2	bp	bp	PROPN
dpc-1099	93	3	affects	affect	VERB
dpc-1099	93	4	elderly	elderly	ADJ
dpc-1099	93	5	individuals	individual	NOUN
dpc-1099	93	6	,	,	PUNCT
dpc-1099	93	7	usually	usually	ADV
dpc-1099	93	8	above	above	ADP
dpc-1099	93	9	age	age	NOUN
dpc-1099	93	10	70	70	NUM
dpc-1099	93	11	years	year	NOUN
dpc-1099	93	12	.	.	PUNCT
dpc-1099	94	1	the	the	DET
dpc-1099	94	2	spectrum	spectrum	NOUN
dpc-1099	94	3	of	of	ADP
dpc-1099	94	4	clinical	clinical	ADJ
dpc-1099	94	5	presentation	presentation	NOUN
dpc-1099	94	6	is	be	AUX
dpc-1099	94	7	highly	highly	ADV
dpc-1099	94	8	variable	variable	ADJ
dpc-1099	94	9	.	.	PUNCT
dpc-1099	95	1	in	in	ADP
dpc-1099	95	2	a	a	DET
dpc-1099	95	3	consistent	consistent	ADJ
dpc-1099	95	4	proportion	proportion	NOUN
dpc-1099	95	5	of	of	ADP
dpc-1099	95	6	patients	patient	NOUN
dpc-1099	95	7	,	,	PUNCT
dpc-1099	95	8	the	the	DET
dpc-1099	95	9	blistering	blister	VERB
dpc-1099	95	10	eruption	eruption	NOUN
dpc-1099	95	11	is	be	AUX
dpc-1099	95	12	preceded	precede	VERB
dpc-1099	95	13	by	by	ADP
dpc-1099	95	14	a	a	DET
dpc-1099	95	15	prodromal	prodromal	ADJ
dpc-1099	95	16	nonbullous	nonbullous	ADJ
dpc-1099	95	17	phase	phase	NOUN
dpc-1099	95	18	,	,	PUNCT
dpc-1099	95	19	usually	usually	ADV
dpc-1099	95	20	lasting	last	VERB
dpc-1099	95	21	weeks	week	NOUN
dpc-1099	95	22	to	to	ADP
dpc-1099	95	23	months	month	NOUN
dpc-1099	95	24	and	and	CCONJ
dpc-1099	95	25	even	even	ADV
dpc-1099	95	26	,	,	PUNCT
dpc-1099	95	27	in	in	ADP
dpc-1099	95	28	rare	rare	ADJ
dpc-1099	95	29	cases	case	NOUN
dpc-1099	95	30	,	,	PUNCT
dpc-1099	95	31	remaining	remain	VERB
dpc-1099	95	32	the	the	DET
dpc-1099	95	33	only	only	ADJ
dpc-1099	95	34	manifestation	manifestation	NOUN
dpc-1099	95	35	of	of	ADP
dpc-1099	95	36	the	the	DET
dpc-1099	95	37	disease	disease	NOUN
dpc-1099	95	38	[	[	X
dpc-1099	95	39	28	28	NUM
dpc-1099	95	40	]	]	PUNCT
dpc-1099	95	41	.	.	PUNCT
dpc-1099	96	1	during	during	ADP
dpc-1099	96	2	the	the	DET
dpc-1099	96	3	nonbullous	nonbullous	ADJ
dpc-1099	96	4	phase	phase	NOUN
dpc-1099	96	5	,	,	PUNCT
dpc-1099	96	6	pruritic	pruritic	NOUN
dpc-1099	96	7	,	,	PUNCT
dpc-1099	96	8	erythematous	erythematous	ADJ
dpc-1099	96	9	,	,	PUNCT
dpc-1099	96	10	or	or	CCONJ
dpc-1099	96	11	urticarial	urticarial	ADJ
dpc-1099	96	12	patches	patch	NOUN
dpc-1099	96	13	and	and	CCONJ
dpc-1099	96	14	plaques	plaque	NOUN
dpc-1099	96	15	occur	occur	VERB
dpc-1099	96	16	.	.	PUNCT
dpc-1099	97	1	also	also	ADV
dpc-1099	97	2	eczematous	eczematous	ADJ
dpc-1099	97	3	,	,	PUNCT
dpc-1099	97	4	polycyclic	polycyclic	NOUN
dpc-1099	97	5	,	,	PUNCT
dpc-1099	97	6	targetoid	targetoid	ADJ
dpc-1099	97	7	,	,	PUNCT
dpc-1099	97	8	nodular	nodular	ADJ
dpc-1099	97	9	,	,	PUNCT
dpc-1099	97	10	or	or	CCONJ
dpc-1099	97	11	lichenoid	lichenoid	NOUN
dpc-1099	97	12	lesions	lesion	NOUN
dpc-1099	97	13	may	may	AUX
dpc-1099	97	14	be	be	AUX
dpc-1099	97	15	observed	observe	VERB
dpc-1099	97	16	(	(	PUNCT
dpc-1099	97	17	figure	figure	NOUN
dpc-1099	97	18	3	3	NUM
dpc-1099	97	19	)	)	PUNCT
dpc-1099	97	20	.	.	PUNCT
dpc-1099	98	1	the	the	DET
dpc-1099	98	2	bullous	bullous	ADJ
dpc-1099	98	3	phase	phase	NOUN
dpc-1099	98	4	is	be	AUX
dpc-1099	98	5	characterized	characterize	VERB
dpc-1099	98	6	by	by	ADP
dpc-1099	98	7	tense	tense	ADJ
dpc-1099	98	8	bullae	bullae	NOUN
dpc-1099	98	9	on	on	ADP
dpc-1099	98	10	an	an	DET
dpc-1099	98	11	erythematous	erythematous	ADJ
dpc-1099	98	12	,	,	PUNCT
dpc-1099	98	13	urticarial	urticarial	ADJ
dpc-1099	98	14	base	base	NOUN
dpc-1099	98	15	,	,	PUNCT
dpc-1099	98	16	localized	localized	ADJ
dpc-1099	98	17	or	or	CCONJ
dpc-1099	98	18	widespread	widespread	ADJ
dpc-1099	98	19	figure	figure	NOUN
dpc-1099	98	20	1	1	NUM
dpc-1099	98	21	.	.	PUNCT
dpc-1099	98	22	solitary	solitary	ADJ
dpc-1099	98	23	lip	lip	NOUN
dpc-1099	98	24	ulcerations	ulceration	NOUN
dpc-1099	98	25	as	as	ADP
dpc-1099	98	26	highly	highly	ADV
dpc-1099	98	27	unusual	unusual	ADJ
dpc-1099	98	28	manifestations	manifestation	NOUN
dpc-1099	98	29	of	of	ADP
dpc-1099	98	30	pemphigus	pemphigus	PROPN
dpc-1099	98	31	.	.	PUNCT
dpc-1099	99	1	figure	figure	NOUN
dpc-1099	99	2	2	2	NUM
dpc-1099	99	3	.	.	PUNCT
dpc-1099	100	1	erosions	erosion	NOUN
dpc-1099	100	2	,	,	PUNCT
dpc-1099	100	3	crusted	crust	VERB
dpc-1099	100	4	and	and	CCONJ
dpc-1099	100	5	scaly	scaly	NOUN
dpc-1099	100	6	plaques	plaque	NOUN
dpc-1099	100	7	in	in	ADP
dpc-1099	100	8	a	a	DET
dpc-1099	100	9	case	case	NOUN
dpc-1099	100	10	of	of	ADP
dpc-1099	100	11	pemphigus	pemphigus	NOUN
dpc-1099	100	12	of	of	ADP
dpc-1099	100	13	the	the	DET
dpc-1099	100	14	scalp	scalp	NOUN
dpc-1099	100	15	.	.	PUNCT
dpc-1099	101	1	the	the	DET
dpc-1099	101	2	scalp	scalp	NOUN
dpc-1099	101	3	shows	show	VERB
dpc-1099	101	4	an	an	DET
dpc-1099	101	5	abundance	abundance	NOUN
dpc-1099	101	6	of	of	ADP
dpc-1099	101	7	desmogleins	desmoglein	NOUN
dpc-1099	101	8	in	in	ADP
dpc-1099	101	9	hair	hair	NOUN
dpc-1099	101	10	follicles	follicle	NOUN
dpc-1099	101	11	and	and	CCONJ
dpc-1099	101	12	may	may	AUX
dpc-1099	101	13	be	be	AUX
dpc-1099	101	14	the	the	DET
dpc-1099	101	15	first	first	ADJ
dpc-1099	101	16	location	location	NOUN
dpc-1099	101	17	of	of	ADP
dpc-1099	101	18	the	the	DET
dpc-1099	101	19	disease	disease	NOUN
dpc-1099	101	20	.	.	PUNCT
dpc-1099	102	1	figure	figure	VERB
dpc-1099	102	2	3	3	NUM
dpc-1099	102	3	.	.	PUNCT
dpc-1099	102	4	numerous	numerous	ADJ
dpc-1099	102	5	polycyclic	polycyclic	NOUN
dpc-1099	102	6	and	and	CCONJ
dpc-1099	102	7	targetoid	targetoid	NOUN
dpc-1099	102	8	lesions	lesion	NOUN
dpc-1099	102	9	during	during	ADP
dpc-1099	102	10	the	the	DET
dpc-1099	102	11	nonbullous	nonbullous	ADJ
dpc-1099	102	12	phase	phase	NOUN
dpc-1099	102	13	of	of	ADP
dpc-1099	102	14	bullous	bullous	ADJ
dpc-1099	102	15	pemphigoid	pemphigoid	NOUN
dpc-1099	102	16	.	.	PUNCT
dpc-1099	103	1	review	review	VERB
dpc-1099	103	2	|	|	ADV
dpc-1099	103	3	dermatol	dermatol	ADJ
dpc-1099	103	4	pract	pract	NOUN
dpc-1099	103	5	concept	concept	NOUN
dpc-1099	103	6	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	103	7	5	5	NUM
dpc-1099	103	8	intraepidermal	intraepidermal	ADJ
dpc-1099	103	9	blister	blister	NOUN
dpc-1099	103	10	caused	cause	VERB
dpc-1099	103	11	by	by	ADP
dpc-1099	103	12	acantholysis	acantholysis	NOUN
dpc-1099	103	13	,	,	PUNCT
dpc-1099	103	14	which	which	PRON
dpc-1099	103	15	consists	consist	VERB
dpc-1099	103	16	of	of	ADP
dpc-1099	103	17	the	the	DET
dpc-1099	103	18	separation	separation	NOUN
dpc-1099	103	19	of	of	ADP
dpc-1099	103	20	keratinocytes	keratinocyte	NOUN
dpc-1099	103	21	just	just	ADV
dpc-1099	103	22	above	above	ADP
dpc-1099	103	23	the	the	DET
dpc-1099	103	24	basal	basal	ADJ
dpc-1099	103	25	cell	cell	NOUN
dpc-1099	103	26	layer	layer	NOUN
dpc-1099	103	27	due	due	ADP
dpc-1099	103	28	to	to	ADP
dpc-1099	103	29	a	a	DET
dpc-1099	103	30	loss	loss	NOUN
dpc-1099	103	31	of	of	ADP
dpc-1099	103	32	the	the	DET
dpc-1099	103	33	normal	normal	ADJ
dpc-1099	103	34	cell	cell	NOUN
dpc-1099	103	35	attachment	attachment	NOUN
dpc-1099	103	36	.	.	PUNCT
dpc-1099	104	1	in	in	ADP
dpc-1099	104	2	the	the	DET
dpc-1099	104	3	cavity	cavity	NOUN
dpc-1099	104	4	of	of	ADP
dpc-1099	104	5	the	the	DET
dpc-1099	104	6	blister	blister	NOUN
dpc-1099	104	7	,	,	PUNCT
dpc-1099	104	8	a	a	DET
dpc-1099	104	9	few	few	ADJ
dpc-1099	104	10	inflammatory	inflammatory	ADJ
dpc-1099	104	11	cells	cell	NOUN
dpc-1099	104	12	,	,	PUNCT
dpc-1099	104	13	in	in	ADP
dpc-1099	104	14	particular	particular	ADJ
dpc-1099	104	15	eosinophils	eosinophil	NOUN
dpc-1099	104	16	,	,	PUNCT
dpc-1099	104	17	may	may	AUX
dpc-1099	104	18	be	be	AUX
dpc-1099	104	19	observed	observe	VERB
dpc-1099	104	20	.	.	PUNCT
dpc-1099	105	1	the	the	DET
dpc-1099	105	2	surrounding	surround	VERB
dpc-1099	105	3	inflammation	inflammation	NOUN
dpc-1099	105	4	is	be	AUX
dpc-1099	105	5	minimal	minimal	ADJ
dpc-1099	105	6	[	[	PUNCT
dpc-1099	105	7	22	22	NUM
dpc-1099	105	8	]	]	PUNCT
dpc-1099	105	9	.	.	PUNCT
dpc-1099	106	1	eosinophilic	eosinophilic	ADJ
dpc-1099	106	2	spongiosis	spongiosis	NOUN
dpc-1099	106	3	may	may	AUX
dpc-1099	106	4	be	be	AUX
dpc-1099	106	5	the	the	DET
dpc-1099	106	6	only	only	ADJ
dpc-1099	106	7	histological	histological	ADJ
dpc-1099	106	8	feature	feature	NOUN
dpc-1099	106	9	of	of	ADP
dpc-1099	106	10	pemphigus	pemphigus	NOUN
dpc-1099	106	11	in	in	ADP
dpc-1099	106	12	the	the	DET
dpc-1099	106	13	initial	initial	ADJ
dpc-1099	106	14	stages	stage	NOUN
dpc-1099	106	15	.	.	PUNCT
dpc-1099	107	1	in	in	ADP
dpc-1099	107	2	such	such	ADJ
dpc-1099	107	3	cases	case	NOUN
dpc-1099	107	4	eosinophils	eosinophil	NOUN
dpc-1099	107	5	invade	invade	VERB
dpc-1099	107	6	a	a	DET
dpc-1099	107	7	spongiotic	spongiotic	ADJ
dpc-1099	107	8	epidermis	epidermis	NOUN
dpc-1099	107	9	without	without	ADP
dpc-1099	107	10	evidence	evidence	NOUN
dpc-1099	107	11	of	of	ADP
dpc-1099	107	12	acantholysis	acantholysis	NOUN
dpc-1099	107	13	.	.	PUNCT
dpc-1099	108	1	single	single	ADJ
dpc-1099	108	2	or	or	CCONJ
dpc-1099	108	3	grouped	group	VERB
dpc-1099	108	4	acantholytic	acantholytic	ADJ
dpc-1099	108	5	cells	cell	NOUN
dpc-1099	108	6	can	can	AUX
dpc-1099	108	7	be	be	AUX
dpc-1099	108	8	quickly	quickly	ADV
dpc-1099	108	9	documented	document	VERB
dpc-1099	108	10	by	by	ADP
dpc-1099	108	11	cytological	cytological	ADJ
dpc-1099	108	12	examination	examination	NOUN
dpc-1099	108	13	(	(	PUNCT
dpc-1099	108	14	tzanck	tzanck	ADP
dpc-1099	108	15	cytodiagnostic	cytodiagnostic	ADJ
dpc-1099	108	16	test	test	NOUN
dpc-1099	108	17	)	)	PUNCT
dpc-1099	108	18	.	.	PUNCT
dpc-1099	109	1	after	after	ADP
dpc-1099	109	2	opening	opening	NOUN
dpc-1099	109	3	of	of	ADP
dpc-1099	109	4	an	an	DET
dpc-1099	109	5	intact	intact	ADJ
dpc-1099	109	6	roof	roof	NOUN
dpc-1099	109	7	of	of	ADP
dpc-1099	109	8	a	a	DET
dpc-1099	109	9	blister	blister	NOUN
dpc-1099	109	10	,	,	PUNCT
dpc-1099	109	11	material	material	NOUN
dpc-1099	109	12	has	have	VERB
dpc-1099	109	13	to	to	PART
dpc-1099	109	14	be	be	AUX
dpc-1099	109	15	scraped	scrape	VERB
dpc-1099	109	16	from	from	ADP
dpc-1099	109	17	the	the	DET
dpc-1099	109	18	base	base	NOUN
dpc-1099	109	19	of	of	ADP
dpc-1099	109	20	a	a	DET
dpc-1099	109	21	vesicle	vesicle	NOUN
dpc-1099	109	22	or	or	CCONJ
dpc-1099	109	23	blister	blister	NOUN
dpc-1099	109	24	and	and	CCONJ
dpc-1099	109	25	smeared	smear	VERB
dpc-1099	109	26	onto	onto	ADP
dpc-1099	109	27	a	a	DET
dpc-1099	109	28	microscopic	microscopic	ADJ
dpc-1099	109	29	slide	slide	NOUN
dpc-1099	109	30	.	.	PUNCT
dpc-1099	110	1	after	after	ADP
dpc-1099	110	2	air	air	NOUN
dpc-1099	110	3	-	-	PUNCT
dpc-1099	110	4	drying	dry	VERB
dpc-1099	110	5	,	,	PUNCT
dpc-1099	110	6	samples	sample	NOUN
dpc-1099	110	7	are	be	AUX
dpc-1099	110	8	commonly	commonly	ADV
dpc-1099	110	9	stained	stain	VERB
dpc-1099	110	10	with	with	ADP
dpc-1099	110	11	may	may	PROPN
dpc-1099	110	12	-	-	PUNCT
dpc-1099	110	13	grünwald	grünwald	NOUN
dpc-1099	110	14	-	-	PUNCT
dpc-1099	110	15	giemsa	giemsa	NOUN
dpc-1099	110	16	and	and	CCONJ
dpc-1099	110	17	evaluated	evaluated	ADJ
dpc-1099	110	18	.	.	PUNCT
dpc-1099	111	1	this	this	DET
dpc-1099	111	2	test	test	NOUN
dpc-1099	111	3	does	do	AUX
dpc-1099	111	4	not	not	PART
dpc-1099	111	5	replace	replace	VERB
dpc-1099	111	6	histological	histological	ADJ
dpc-1099	111	7	examination	examination	NOUN
dpc-1099	111	8	,	,	PUNCT
dpc-1099	111	9	since	since	SCONJ
dpc-1099	111	10	acantholytic	acantholytic	ADJ
dpc-1099	111	11	keratinocytes	keratinocyte	NOUN
dpc-1099	111	12	may	may	AUX
dpc-1099	111	13	also	also	ADV
dpc-1099	111	14	be	be	AUX
dpc-1099	111	15	observed	observe	VERB
dpc-1099	111	16	in	in	ADP
dpc-1099	111	17	other	other	ADJ
dpc-1099	111	18	dermatoses	dermatosis	NOUN
dpc-1099	111	19	as	as	ADP
dpc-1099	111	20	a	a	DET
dpc-1099	111	21	secondary	secondary	ADJ
dpc-1099	111	22	phenomenon	phenomenon	NOUN
dpc-1099	111	23	to	to	ADP
dpc-1099	111	24	inflammation	inflammation	NOUN
dpc-1099	111	25	or	or	CCONJ
dpc-1099	111	26	ballooning	ballooning	NOUN
dpc-1099	111	27	degeneration	degeneration	NOUN
dpc-1099	111	28	.	.	PUNCT
dpc-1099	112	1	bullous	bullous	ADJ
dpc-1099	112	2	pemphigoid	pemphigoid	ADV
dpc-1099	112	3	the	the	DET
dpc-1099	112	4	histopathological	histopathological	ADJ
dpc-1099	112	5	assessment	assessment	NOUN
dpc-1099	112	6	of	of	ADP
dpc-1099	112	7	an	an	DET
dpc-1099	112	8	early	early	ADJ
dpc-1099	112	9	bulla	bulla	NOUN
dpc-1099	112	10	shows	show	VERB
dpc-1099	112	11	a	a	DET
dpc-1099	112	12	subepidermal	subepidermal	NOUN
dpc-1099	112	13	blister	blister	NOUN
dpc-1099	112	14	containing	contain	VERB
dpc-1099	112	15	a	a	DET
dpc-1099	112	16	net	net	NOUN
dpc-1099	112	17	of	of	ADP
dpc-1099	112	18	fibrin	fibrin	NOUN
dpc-1099	112	19	with	with	ADP
dpc-1099	112	20	a	a	DET
dpc-1099	112	21	variable	variable	ADJ
dpc-1099	112	22	number	number	NOUN
dpc-1099	112	23	of	of	ADP
dpc-1099	112	24	eosinophils	eosinophil	NOUN
dpc-1099	112	25	and/or	and/or	CCONJ
dpc-1099	112	26	neutrophils	neutrophil	NOUN
dpc-1099	112	27	accompanied	accompany	VERB
dpc-1099	112	28	by	by	ADP
dpc-1099	112	29	a	a	DET
dpc-1099	112	30	dermal	dermal	ADJ
dpc-1099	112	31	inflammatory	inflammatory	NOUN
dpc-1099	112	32	infiltrate	infiltrate	NOUN
dpc-1099	112	33	mainly	mainly	ADV
dpc-1099	112	34	consisting	consist	VERB
dpc-1099	112	35	of	of	ADP
dpc-1099	112	36	eosinophils	eosinophil	NOUN
dpc-1099	112	37	and	and	CCONJ
dpc-1099	112	38	neutrophils	neutrophil	NOUN
dpc-1099	112	39	[	[	X
dpc-1099	112	40	3,33	3,33	X
dpc-1099	112	41	]	]	X
dpc-1099	112	42	.	.	PUNCT
dpc-1099	113	1	in	in	ADP
dpc-1099	113	2	the	the	DET
dpc-1099	113	3	nonbullous	nonbullous	ADJ
dpc-1099	113	4	phase	phase	NOUN
dpc-1099	113	5	,	,	PUNCT
dpc-1099	113	6	histopathological	histopathological	ADJ
dpc-1099	113	7	findings	finding	NOUN
dpc-1099	113	8	may	may	AUX
dpc-1099	113	9	be	be	AUX
dpc-1099	113	10	nonspecific	nonspecific	ADJ
dpc-1099	113	11	,	,	PUNCT
dpc-1099	113	12	since	since	SCONJ
dpc-1099	113	13	only	only	ADV
dpc-1099	113	14	subepidermal	subepidermal	ADJ
dpc-1099	113	15	clefts	cleft	NOUN
dpc-1099	113	16	and	and	CCONJ
dpc-1099	113	17	eosinophilic	eosinophilic	ADJ
dpc-1099	113	18	spongiosis	spongiosis	NOUN
dpc-1099	113	19	may	may	AUX
dpc-1099	113	20	be	be	AUX
dpc-1099	113	21	observed	observe	VERB
dpc-1099	113	22	[	[	PUNCT
dpc-1099	113	23	34	34	NUM
dpc-1099	113	24	]	]	PUNCT
dpc-1099	113	25	.	.	PUNCT
dpc-1099	114	1	direct	direct	ADJ
dpc-1099	114	2	immunofluorescence	immunofluorescence	NOUN
dpc-1099	114	3	dif	dif	ADV
dpc-1099	114	4	is	be	AUX
dpc-1099	114	5	the	the	DET
dpc-1099	114	6	most	most	ADV
dpc-1099	114	7	reliable	reliable	ADJ
dpc-1099	114	8	and	and	CCONJ
dpc-1099	114	9	sensitive	sensitive	ADJ
dpc-1099	114	10	diagnostic	diagnostic	ADJ
dpc-1099	114	11	test	test	NOUN
dpc-1099	114	12	for	for	ADP
dpc-1099	114	13	abds	abds	NOUN
dpc-1099	114	14	for	for	ADP
dpc-1099	114	15	the	the	DET
dpc-1099	114	16	most	most	ADJ
dpc-1099	114	17	part	part	NOUN
dpc-1099	114	18	.	.	PUNCT
dpc-1099	115	1	however	however	ADV
dpc-1099	115	2	,	,	PUNCT
dpc-1099	115	3	nonspecific	nonspecific	ADJ
dpc-1099	115	4	staining	stain	VERB
dpc-1099	115	5	may	may	AUX
dpc-1099	115	6	occasionally	occasionally	ADV
dpc-1099	115	7	be	be	AUX
dpc-1099	115	8	seen	see	VERB
dpc-1099	115	9	in	in	ADP
dpc-1099	115	10	other	other	ADJ
dpc-1099	115	11	cutaneous	cutaneous	ADJ
dpc-1099	115	12	disorders	disorder	NOUN
dpc-1099	115	13	with	with	ADP
dpc-1099	115	14	occasional	occasional	ADJ
dpc-1099	115	15	false	false	ADJ
dpc-1099	115	16	-	-	PUNCT
dpc-1099	115	17	positive	positive	ADJ
dpc-1099	115	18	findings	finding	NOUN
dpc-1099	115	19	[	[	X
dpc-1099	115	20	35,36	35,36	NUM
dpc-1099	115	21	]	]	PUNCT
dpc-1099	115	22	.	.	PUNCT
dpc-1099	116	1	dif	dif	PROPN
dpc-1099	116	2	investigates	investigate	VERB
dpc-1099	116	3	the	the	DET
dpc-1099	116	4	skin	skin	NOUN
dpc-1099	116	5	or	or	CCONJ
dpc-1099	116	6	children	child	NOUN
dpc-1099	116	7	.	.	PUNCT
dpc-1099	117	1	acral	acral	ADJ
dpc-1099	117	2	involvement	involvement	PROPN
dpc-1099	117	3	is	be	AUX
dpc-1099	117	4	common	common	ADJ
dpc-1099	117	5	,	,	PUNCT
dpc-1099	117	6	especially	especially	ADV
dpc-1099	117	7	on	on	ADP
dpc-1099	117	8	the	the	DET
dpc-1099	117	9	face	face	NOUN
dpc-1099	117	10	(	(	PUNCT
dpc-1099	117	11	62	62	NUM
dpc-1099	117	12	%	%	NOUN
dpc-1099	117	13	)	)	PUNCT
dpc-1099	117	14	,	,	PUNCT
dpc-1099	117	15	palms	palm	NOUN
dpc-1099	117	16	and	and	CCONJ
dpc-1099	117	17	soles	sol	NOUN
dpc-1099	117	18	(	(	PUNCT
dpc-1099	117	19	79	79	NUM
dpc-1099	117	20	%	%	NOUN
dpc-1099	117	21	)	)	PUNCT
dpc-1099	117	22	;	;	PUNCT
dpc-1099	117	23	localized	localized	ADJ
dpc-1099	117	24	lesions	lesion	NOUN
dpc-1099	117	25	on	on	ADP
dpc-1099	117	26	the	the	DET
dpc-1099	117	27	genital	genital	ADJ
dpc-1099	117	28	area	area	NOUN
dpc-1099	117	29	may	may	AUX
dpc-1099	117	30	be	be	AUX
dpc-1099	117	31	observed	observe	VERB
dpc-1099	117	32	in	in	ADP
dpc-1099	117	33	17	17	NUM
dpc-1099	117	34	%	%	NOUN
dpc-1099	117	35	of	of	ADP
dpc-1099	117	36	cases	case	NOUN
dpc-1099	117	37	[	[	X
dpc-1099	117	38	32	32	NUM
dpc-1099	117	39	]	]	PUNCT
dpc-1099	117	40	.	.	PUNCT
dpc-1099	118	1	diagnosis	diagnosis	NOUN
dpc-1099	118	2	clinical	clinical	ADJ
dpc-1099	118	3	presentations	presentation	NOUN
dpc-1099	118	4	of	of	ADP
dpc-1099	118	5	abds	abds	NOUN
dpc-1099	118	6	often	often	ADV
dpc-1099	118	7	overlap	overlap	VERB
dpc-1099	118	8	,	,	PUNCT
dpc-1099	118	9	and	and	CCONJ
dpc-1099	118	10	diagnosis	diagnosis	NOUN
dpc-1099	118	11	may	may	AUX
dpc-1099	118	12	not	not	PART
dpc-1099	118	13	be	be	AUX
dpc-1099	118	14	easily	easily	ADV
dpc-1099	118	15	made	make	VERB
dpc-1099	118	16	on	on	ADP
dpc-1099	118	17	the	the	DET
dpc-1099	118	18	basis	basis	NOUN
dpc-1099	118	19	of	of	ADP
dpc-1099	118	20	clinical	clinical	ADJ
dpc-1099	118	21	features	feature	NOUN
dpc-1099	118	22	alone	alone	ADV
dpc-1099	118	23	.	.	PUNCT
dpc-1099	119	1	therefore	therefore	ADV
dpc-1099	119	2	,	,	PUNCT
dpc-1099	119	3	abds	abds	NOUN
dpc-1099	119	4	are	be	AUX
dpc-1099	119	5	usually	usually	ADV
dpc-1099	119	6	diagnosed	diagnose	VERB
dpc-1099	119	7	using	use	VERB
dpc-1099	119	8	3	3	NUM
dpc-1099	119	9	criteria	criterion	NOUN
dpc-1099	119	10	:	:	PUNCT
dpc-1099	119	11	(	(	PUNCT
dpc-1099	119	12	1	1	X
dpc-1099	119	13	)	)	PUNCT
dpc-1099	119	14	the	the	DET
dpc-1099	119	15	overall	overall	ADJ
dpc-1099	119	16	clinical	clinical	ADJ
dpc-1099	119	17	picture	picture	NOUN
dpc-1099	119	18	,	,	PUNCT
dpc-1099	119	19	including	include	VERB
dpc-1099	119	20	patient	patient	NOUN
dpc-1099	119	21	history	history	NOUN
dpc-1099	119	22	and	and	CCONJ
dpc-1099	119	23	physical	physical	ADJ
dpc-1099	119	24	examination	examination	NOUN
dpc-1099	119	25	;	;	PUNCT
dpc-1099	119	26	(	(	PUNCT
dpc-1099	119	27	2	2	X
dpc-1099	119	28	)	)	PUNCT
dpc-1099	119	29	histopathology	histopathology	NOUN
dpc-1099	119	30	;	;	PUNCT
dpc-1099	119	31	and	and	CCONJ
dpc-1099	119	32	(	(	PUNCT
dpc-1099	119	33	3	3	X
dpc-1099	119	34	)	)	PUNCT
dpc-1099	119	35	a	a	DET
dpc-1099	119	36	positive	positive	ADJ
dpc-1099	119	37	direct	direct	ADJ
dpc-1099	119	38	immunofluorescence	immunofluorescence	NOUN
dpc-1099	119	39	(	(	PUNCT
dpc-1099	119	40	dif	dif	X
dpc-1099	119	41	)	)	PUNCT
dpc-1099	119	42	microscopy	microscopy	NOUN
dpc-1099	119	43	,	,	PUNCT
dpc-1099	119	44	usually	usually	ADV
dpc-1099	119	45	performed	perform	VERB
dpc-1099	119	46	on	on	ADP
dpc-1099	119	47	perilesional	perilesional	ADJ
dpc-1099	119	48	skin	skin	NOUN
dpc-1099	119	49	,	,	PUNCT
dpc-1099	119	50	or	or	CCONJ
dpc-1099	119	51	serological	serological	ADJ
dpc-1099	119	52	detection	detection	NOUN
dpc-1099	119	53	of	of	ADP
dpc-1099	119	54	autoantibodies	autoantibody	NOUN
dpc-1099	119	55	against	against	ADP
dpc-1099	119	56	the	the	DET
dpc-1099	119	57	involved	involved	ADJ
dpc-1099	119	58	epithelial	epithelial	ADJ
dpc-1099	119	59	antigens	antigen	NOUN
dpc-1099	119	60	[	[	X
dpc-1099	119	61	22	22	NUM
dpc-1099	119	62	]	]	PUNCT
dpc-1099	119	63	.	.	PUNCT
dpc-1099	120	1	immunodiagnostic	immunodiagnostic	ADJ
dpc-1099	120	2	tests	test	NOUN
dpc-1099	120	3	are	be	AUX
dpc-1099	120	4	particularly	particularly	ADV
dpc-1099	120	5	useful	useful	ADJ
dpc-1099	120	6	to	to	PART
dpc-1099	120	7	differentiate	differentiate	VERB
dpc-1099	120	8	the	the	DET
dpc-1099	120	9	various	various	ADJ
dpc-1099	120	10	diseases	disease	NOUN
dpc-1099	120	11	.	.	PUNCT
dpc-1099	121	1	histopathology	histopathology	NOUN
dpc-1099	121	2	pemphigus	pemphigus	PROPN
dpc-1099	121	3	vulgaris	vulgaris	PROPN
dpc-1099	121	4	biopsy	biopsy	NOUN
dpc-1099	121	5	should	should	AUX
dpc-1099	121	6	be	be	AUX
dpc-1099	121	7	taken	take	VERB
dpc-1099	121	8	in	in	ADP
dpc-1099	121	9	an	an	DET
dpc-1099	121	10	early	early	ADJ
dpc-1099	121	11	intact	intact	ADJ
dpc-1099	121	12	blister	blister	NOUN
dpc-1099	121	13	.	.	PUNCT
dpc-1099	122	1	when	when	SCONJ
dpc-1099	122	2	only	only	ADJ
dpc-1099	122	3	erosions	erosion	NOUN
dpc-1099	122	4	are	be	AUX
dpc-1099	122	5	present	present	ADJ
dpc-1099	122	6	,	,	PUNCT
dpc-1099	122	7	as	as	SCONJ
dpc-1099	122	8	usually	usually	ADV
dpc-1099	122	9	happens	happen	VERB
dpc-1099	122	10	in	in	ADP
dpc-1099	122	11	the	the	DET
dpc-1099	122	12	oral	oral	ADJ
dpc-1099	122	13	area	area	NOUN
dpc-1099	122	14	,	,	PUNCT
dpc-1099	122	15	a	a	DET
dpc-1099	122	16	biopsy	biopsy	NOUN
dpc-1099	122	17	should	should	AUX
dpc-1099	122	18	be	be	AUX
dpc-1099	122	19	obtained	obtain	VERB
dpc-1099	122	20	from	from	ADP
dpc-1099	122	21	the	the	DET
dpc-1099	122	22	active	active	ADJ
dpc-1099	122	23	border	border	NOUN
dpc-1099	122	24	of	of	ADP
dpc-1099	122	25	a	a	DET
dpc-1099	122	26	denuded	denuded	ADJ
dpc-1099	122	27	area	area	NOUN
dpc-1099	122	28	.	.	PUNCT
dpc-1099	123	1	the	the	DET
dpc-1099	123	2	characteristic	characteristic	ADJ
dpc-1099	123	3	histological	histological	ADJ
dpc-1099	123	4	finding	finding	NOUN
dpc-1099	123	5	is	be	AUX
dpc-1099	123	6	an	an	DET
dpc-1099	123	7	figure	figure	NOUN
dpc-1099	123	8	4	4	NUM
dpc-1099	123	9	.	.	PUNCT
dpc-1099	123	10	urticarial	urticarial	ADJ
dpc-1099	123	11	and	and	CCONJ
dpc-1099	123	12	polycyclic	polycyclic	ADJ
dpc-1099	123	13	lesions	lesion	NOUN
dpc-1099	123	14	of	of	ADP
dpc-1099	123	15	the	the	DET
dpc-1099	123	16	nonbullous	nonbullous	ADJ
dpc-1099	123	17	phase	phase	NOUN
dpc-1099	123	18	of	of	ADP
dpc-1099	123	19	bullous	bullous	ADJ
dpc-1099	123	20	pemphigoid	pemphigoid	NOUN
dpc-1099	123	21	associated	associate	VERB
dpc-1099	123	22	with	with	ADP
dpc-1099	123	23	a	a	DET
dpc-1099	123	24	tense	tense	ADJ
dpc-1099	123	25	bulla	bulla	NOUN
dpc-1099	123	26	on	on	ADP
dpc-1099	123	27	the	the	DET
dpc-1099	123	28	flexor	flexor	ADJ
dpc-1099	123	29	surface	surface	NOUN
dpc-1099	123	30	of	of	ADP
dpc-1099	123	31	a	a	DET
dpc-1099	123	32	forearm	forearm	NOUN
dpc-1099	123	33	.	.	PUNCT
dpc-1099	124	1	figure	figure	NOUN
dpc-1099	124	2	5	5	NUM
dpc-1099	124	3	.	.	PUNCT
dpc-1099	124	4	typical	typical	ADJ
dpc-1099	124	5	tense	tense	ADJ
dpc-1099	124	6	bullae	bullae	NOUN
dpc-1099	124	7	on	on	ADP
dpc-1099	124	8	an	an	DET
dpc-1099	124	9	erythematous	erythematous	ADJ
dpc-1099	124	10	base	base	NOUN
dpc-1099	124	11	in	in	ADP
dpc-1099	124	12	a	a	DET
dpc-1099	124	13	patient	patient	NOUN
dpc-1099	124	14	with	with	ADP
dpc-1099	124	15	bullous	bullous	ADJ
dpc-1099	124	16	pemphigoid	pemphigoid	NOUN
dpc-1099	124	17	.	.	PUNCT
dpc-1099	125	1	6	6	NUM
dpc-1099	125	2	review	review	NOUN
dpc-1099	125	3	|	|	ADV
dpc-1099	125	4	dermatol	dermatol	ADJ
dpc-1099	125	5	pract	pract	NOUN
dpc-1099	125	6	concept	concept	NOUN
dpc-1099	125	7	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	125	8	dsg1	dsg1	NOUN
dpc-1099	125	9	and	and	CCONJ
dpc-1099	125	10	dsg3	dsg3	PROPN
dpc-1099	125	11	generally	generally	ADV
dpc-1099	125	12	correlate	correlate	VERB
dpc-1099	125	13	with	with	ADP
dpc-1099	125	14	the	the	DET
dpc-1099	125	15	extent	extent	NOUN
dpc-1099	125	16	and	and	CCONJ
dpc-1099	125	17	clinical	clinical	ADJ
dpc-1099	125	18	activity	activity	NOUN
dpc-1099	125	19	of	of	ADP
dpc-1099	125	20	disease	disease	NOUN
dpc-1099	125	21	,	,	PUNCT
dpc-1099	125	22	and	and	CCONJ
dpc-1099	125	23	high	high	ADJ
dpc-1099	125	24	levels	level	NOUN
dpc-1099	125	25	of	of	ADP
dpc-1099	125	26	anti	anti	NOUN
dpc-1099	125	27	-	-	NOUN
dpc-1099	125	28	dsg1	dsg1	NOUN
dpc-1099	125	29	by	by	ADP
dpc-1099	125	30	elisa	elisa	PROPN
dpc-1099	125	31	has	have	VERB
dpc-1099	125	32	a	a	DET
dpc-1099	125	33	positive	positive	ADJ
dpc-1099	125	34	predictive	predictive	ADJ
dpc-1099	125	35	value	value	NOUN
dpc-1099	125	36	for	for	ADP
dpc-1099	125	37	skin	skin	NOUN
dpc-1099	125	38	relapses	relapse	NOUN
dpc-1099	125	39	[	[	X
dpc-1099	125	40	37	37	NUM
dpc-1099	125	41	]	]	PUNCT
dpc-1099	125	42	.	.	PUNCT
dpc-1099	126	1	therefore	therefore	ADV
dpc-1099	126	2	,	,	PUNCT
dpc-1099	126	3	elisa	elisa	PROPN
dpc-1099	126	4	may	may	AUX
dpc-1099	126	5	represent	represent	VERB
dpc-1099	126	6	a	a	DET
dpc-1099	126	7	good	good	ADJ
dpc-1099	126	8	serological	serological	ADJ
dpc-1099	126	9	marker	marker	NOUN
dpc-1099	126	10	of	of	ADP
dpc-1099	126	11	disease	disease	NOUN
dpc-1099	126	12	activity	activity	NOUN
dpc-1099	126	13	,	,	PUNCT
dpc-1099	126	14	although	although	SCONJ
dpc-1099	126	15	evidence	evidence	NOUN
dpc-1099	126	16	about	about	ADP
dpc-1099	126	17	its	its	PRON
dpc-1099	126	18	predictive	predictive	ADJ
dpc-1099	126	19	value	value	NOUN
dpc-1099	126	20	from	from	ADP
dpc-1099	126	21	large	large	ADJ
dpc-1099	126	22	prospective	prospective	ADJ
dpc-1099	126	23	cohort	cohort	NOUN
dpc-1099	126	24	studies	study	NOUN
dpc-1099	126	25	is	be	AUX
dpc-1099	126	26	lacking	lack	VERB
dpc-1099	126	27	[	[	X
dpc-1099	126	28	37	37	NUM
dpc-1099	126	29	]	]	PUNCT
dpc-1099	126	30	.	.	PUNCT
dpc-1099	127	1	one	one	PRON
dpc-1099	127	2	must	must	AUX
dpc-1099	127	3	keep	keep	VERB
dpc-1099	127	4	in	in	ADP
dpc-1099	127	5	mind	mind	NOUN
dpc-1099	127	6	that	that	SCONJ
dpc-1099	127	7	anti‐dsg	anti‐dsg	PROPN
dpc-1099	127	8	antibodies	antibody	NOUN
dpc-1099	127	9	have	have	AUX
dpc-1099	127	10	been	be	AUX
dpc-1099	127	11	occasionally	occasionally	ADV
dpc-1099	127	12	discovered	discover	VERB
dpc-1099	127	13	in	in	ADP
dpc-1099	127	14	sera	sera	NOUN
dpc-1099	127	15	of	of	ADP
dpc-1099	127	16	normal	normal	ADJ
dpc-1099	127	17	patients	patient	NOUN
dpc-1099	127	18	and	and	CCONJ
dpc-1099	127	19	those	those	PRON
dpc-1099	127	20	affected	affect	VERB
dpc-1099	127	21	with	with	ADP
dpc-1099	127	22	other	other	ADJ
dpc-1099	127	23	bullous	bullous	ADJ
dpc-1099	127	24	diseases	disease	NOUN
dpc-1099	127	25	[	[	X
dpc-1099	127	26	41	41	NUM
dpc-1099	127	27	]	]	PUNCT
dpc-1099	127	28	.	.	PUNCT
dpc-1099	128	1	in	in	ADP
dpc-1099	128	2	addition	addition	NOUN
dpc-1099	128	3	,	,	PUNCT
dpc-1099	128	4	a	a	DET
dpc-1099	128	5	small	small	ADJ
dpc-1099	128	6	number	number	NOUN
dpc-1099	128	7	of	of	ADP
dpc-1099	128	8	pemphigus	pemphigus	NOUN
dpc-1099	128	9	patients	patient	NOUN
dpc-1099	128	10	may	may	AUX
dpc-1099	128	11	not	not	PART
dpc-1099	128	12	show	show	VERB
dpc-1099	128	13	the	the	DET
dpc-1099	128	14	pv	pv	NOUN
dpc-1099	128	15	phenotype	phenotype	NOUN
dpc-1099	128	16	expected	expect	VERB
dpc-1099	128	17	by	by	ADP
dpc-1099	128	18	their	their	PRON
dpc-1099	128	19	dsg	dsg	PROPN
dpc-1099	128	20	autoantibody	autoantibody	VERB
dpc-1099	128	21	serum	serum	NOUN
dpc-1099	128	22	profile	profile	NOUN
dpc-1099	128	23	[	[	X
dpc-1099	128	24	42	42	NUM
dpc-1099	128	25	]	]	PUNCT
dpc-1099	128	26	.	.	PUNCT
dpc-1099	129	1	bullous	bullous	ADJ
dpc-1099	129	2	pemphigoid	pemphigoid	PROPN
dpc-1099	129	3	iif	iif	PROPN
dpc-1099	129	4	may	may	AUX
dpc-1099	129	5	demonstrate	demonstrate	VERB
dpc-1099	129	6	circulating	circulate	VERB
dpc-1099	129	7	igg	igg	PROPN
dpc-1099	129	8	antibodies	antibody	NOUN
dpc-1099	129	9	binding	bind	VERB
dpc-1099	129	10	to	to	ADP
dpc-1099	129	11	the	the	DET
dpc-1099	129	12	basal	basal	ADJ
dpc-1099	129	13	membrane	membrane	NOUN
dpc-1099	129	14	.	.	PUNCT
dpc-1099	130	1	the	the	DET
dpc-1099	130	2	most	most	ADV
dpc-1099	130	3	specific	specific	ADJ
dpc-1099	130	4	test	test	NOUN
dpc-1099	130	5	substrate	substrate	NOUN
dpc-1099	130	6	for	for	ADP
dpc-1099	130	7	bp	bp	PROPN
dpc-1099	130	8	is	be	AUX
dpc-1099	130	9	salt	salt	NOUN
dpc-1099	130	10	-	-	PUNCT
dpc-1099	130	11	split	split	NOUN
dpc-1099	130	12	skin	skin	NOUN
dpc-1099	130	13	,	,	PUNCT
dpc-1099	130	14	which	which	PRON
dpc-1099	130	15	is	be	AUX
dpc-1099	130	16	healthy	healthy	ADJ
dpc-1099	130	17	human	human	ADJ
dpc-1099	130	18	skin	skin	NOUN
dpc-1099	130	19	in	in	ADP
dpc-1099	130	20	which	which	PRON
dpc-1099	130	21	subepidermal	subepidermal	NOUN
dpc-1099	130	22	splitting	splitting	NOUN
dpc-1099	130	23	was	be	AUX
dpc-1099	130	24	induced	induce	VERB
dpc-1099	130	25	by	by	ADP
dpc-1099	130	26	1	1	NUM
dpc-1099	130	27	mol	mol	ADP
dpc-1099	130	28	/	/	SYM
dpc-1099	130	29	l	l	NOUN
dpc-1099	130	30	sodium	sodium	NOUN
dpc-1099	130	31	chloride	chloride	NOUN
dpc-1099	130	32	solution	solution	NOUN
dpc-1099	130	33	[	[	X
dpc-1099	130	34	43	43	NUM
dpc-1099	130	35	]	]	PUNCT
dpc-1099	130	36	.	.	PUNCT
dpc-1099	131	1	other	other	ADJ
dpc-1099	131	2	substrates	substrate	NOUN
dpc-1099	131	3	include	include	VERB
dpc-1099	131	4	monkey	monkey	NOUN
dpc-1099	131	5	or	or	CCONJ
dpc-1099	131	6	rabbit	rabbit	NOUN
dpc-1099	131	7	esophagus	esophagus	NOUN
dpc-1099	131	8	,	,	PUNCT
dpc-1099	131	9	with	with	ADP
dpc-1099	131	10	possible	possible	ADJ
dpc-1099	131	11	lower	low	ADJ
dpc-1099	131	12	sensitivity	sensitivity	NOUN
dpc-1099	131	13	[	[	X
dpc-1099	131	14	38	38	NUM
dpc-1099	131	15	]	]	PUNCT
dpc-1099	131	16	.	.	PUNCT
dpc-1099	132	1	elisa	elisa	PROPN
dpc-1099	132	2	test	test	NOUN
dpc-1099	132	3	may	may	AUX
dpc-1099	132	4	show	show	VERB
dpc-1099	132	5	anti	anti	ADJ
dpc-1099	132	6	-	-	ADJ
dpc-1099	132	7	bp180	bp180	ADJ
dpc-1099	132	8	and	and	CCONJ
dpc-1099	132	9	anti	anti	ADJ
dpc-1099	132	10	-	-	ADJ
dpc-1099	132	11	bp230	bp230	ADJ
dpc-1099	132	12	igg	igg	PROPN
dpc-1099	132	13	antibodies	antibodie	VERB
dpc-1099	132	14	.	.	PUNCT
dpc-1099	133	1	the	the	DET
dpc-1099	133	2	serum	serum	NOUN
dpc-1099	133	3	level	level	NOUN
dpc-1099	133	4	of	of	ADP
dpc-1099	133	5	anti	anti	ADJ
dpc-1099	133	6	-	-	ADJ
dpc-1099	133	7	bp180	bp180	ADJ
dpc-1099	133	8	antibodies	antibody	NOUN
dpc-1099	133	9	may	may	AUX
dpc-1099	133	10	be	be	AUX
dpc-1099	133	11	monitored	monitor	VERB
dpc-1099	133	12	during	during	ADP
dpc-1099	133	13	the	the	DET
dpc-1099	133	14	course	course	NOUN
dpc-1099	133	15	of	of	ADP
dpc-1099	133	16	the	the	DET
dpc-1099	133	17	disease	disease	NOUN
dpc-1099	133	18	.	.	PUNCT
dpc-1099	134	1	high	high	ADJ
dpc-1099	134	2	titers	titer	NOUN
dpc-1099	134	3	of	of	ADP
dpc-1099	134	4	anti	anti	ADJ
dpc-1099	134	5	-	-	ADJ
dpc-1099	134	6	bp180	bp180	ADJ
dpc-1099	134	7	nc16a	nc16a	NOUN
dpc-1099	134	8	igg	igg	PROPN
dpc-1099	134	9	after	after	ADP
dpc-1099	134	10	therapy	therapy	NOUN
dpc-1099	134	11	cessation	cessation	NOUN
dpc-1099	134	12	are	be	AUX
dpc-1099	134	13	considered	consider	VERB
dpc-1099	134	14	a	a	DET
dpc-1099	134	15	predictor	predictor	NOUN
dpc-1099	134	16	of	of	ADP
dpc-1099	134	17	risk	risk	NOUN
dpc-1099	134	18	of	of	ADP
dpc-1099	134	19	relapse	relapse	NOUN
dpc-1099	134	20	.	.	PUNCT
dpc-1099	135	1	even	even	ADV
dpc-1099	135	2	then	then	ADV
dpc-1099	135	3	,	,	PUNCT
dpc-1099	135	4	the	the	DET
dpc-1099	135	5	test	test	NOUN
dpc-1099	135	6	result	result	NOUN
dpc-1099	135	7	may	may	AUX
dpc-1099	135	8	be	be	AUX
dpc-1099	135	9	positive	positive	ADJ
dpc-1099	135	10	in	in	ADP
dpc-1099	135	11	healthy	healthy	ADJ
dpc-1099	135	12	individuals	individual	NOUN
dpc-1099	135	13	or	or	CCONJ
dpc-1099	135	14	in	in	ADP
dpc-1099	135	15	individuals	individual	NOUN
dpc-1099	135	16	with	with	ADP
dpc-1099	135	17	other	other	ADJ
dpc-1099	135	18	pruritic	pruritic	NOUN
dpc-1099	135	19	,	,	PUNCT
dpc-1099	135	20	inflammatory	inflammatory	ADJ
dpc-1099	135	21	skin	skin	NOUN
dpc-1099	135	22	disorders	disorder	NOUN
dpc-1099	135	23	[	[	X
dpc-1099	135	24	38	38	NUM
dpc-1099	135	25	]	]	PUNCT
dpc-1099	135	26	.	.	PUNCT
dpc-1099	136	1	therapeutic	therapeutic	ADJ
dpc-1099	136	2	management	management	NOUN
dpc-1099	136	3	because	because	SCONJ
dpc-1099	136	4	of	of	ADP
dpc-1099	136	5	their	their	PRON
dpc-1099	136	6	chronic	chronic	ADJ
dpc-1099	136	7	nature	nature	NOUN
dpc-1099	136	8	,	,	PUNCT
dpc-1099	136	9	abds	abds	PROPN
dpc-1099	136	10	may	may	AUX
dpc-1099	136	11	last	last	VERB
dpc-1099	136	12	for	for	ADP
dpc-1099	136	13	a	a	DET
dpc-1099	136	14	lifetime	lifetime	NOUN
dpc-1099	136	15	or	or	CCONJ
dpc-1099	136	16	for	for	ADP
dpc-1099	136	17	several	several	ADJ
dpc-1099	136	18	years	year	NOUN
dpc-1099	136	19	with	with	ADP
dpc-1099	136	20	a	a	DET
dpc-1099	136	21	high	high	ADJ
dpc-1099	136	22	tendency	tendency	NOUN
dpc-1099	136	23	to	to	PART
dpc-1099	136	24	relapse	relapse	VERB
dpc-1099	136	25	.	.	PUNCT
dpc-1099	137	1	pv	pv	PROPN
dpc-1099	137	2	is	be	AUX
dpc-1099	137	3	a	a	DET
dpc-1099	137	4	potentially	potentially	ADV
dpc-1099	137	5	life	life	NOUN
dpc-1099	137	6	-	-	PUNCT
dpc-1099	137	7	threatening	threaten	VERB
dpc-1099	137	8	skin	skin	NOUN
dpc-1099	137	9	disorder	disorder	NOUN
dpc-1099	137	10	that	that	PRON
dpc-1099	137	11	requires	require	VERB
dpc-1099	137	12	early	early	ADJ
dpc-1099	137	13	recognition	recognition	NOUN
dpc-1099	137	14	and	and	CCONJ
dpc-1099	137	15	prompt	prompt	ADJ
dpc-1099	137	16	treatment	treatment	NOUN
dpc-1099	137	17	.	.	PUNCT
dpc-1099	138	1	bp	bp	PROPN
dpc-1099	138	2	is	be	AUX
dpc-1099	138	3	highly	highly	ADV
dpc-1099	138	4	associated	associate	VERB
dpc-1099	138	5	with	with	ADP
dpc-1099	138	6	old	old	ADJ
dpc-1099	138	7	age	age	NOUN
dpc-1099	138	8	,	,	PUNCT
dpc-1099	138	9	distinct	distinct	ADJ
dpc-1099	138	10	drugs	drug	NOUN
dpc-1099	138	11	,	,	PUNCT
dpc-1099	138	12	and	and	CCONJ
dpc-1099	138	13	neurological	neurological	ADJ
dpc-1099	138	14	and	and	CCONJ
dpc-1099	138	15	psychiatric	psychiatric	ADJ
dpc-1099	138	16	diseases	disease	NOUN
dpc-1099	138	17	.	.	PUNCT
dpc-1099	139	1	treatment	treatment	NOUN
dpc-1099	139	2	depends	depend	VERB
dpc-1099	139	3	on	on	ADP
dpc-1099	139	4	the	the	DET
dpc-1099	139	5	extent	extent	NOUN
dpc-1099	139	6	and	and	CCONJ
dpc-1099	139	7	severity	severity	NOUN
dpc-1099	139	8	of	of	ADP
dpc-1099	139	9	disease	disease	NOUN
dpc-1099	139	10	.	.	PUNCT
dpc-1099	140	1	in	in	ADP
dpc-1099	140	2	both	both	DET
dpc-1099	140	3	conditions	condition	NOUN
dpc-1099	140	4	the	the	DET
dpc-1099	140	5	primary	primary	ADJ
dpc-1099	140	6	objective	objective	NOUN
dpc-1099	140	7	is	be	AUX
dpc-1099	140	8	to	to	PART
dpc-1099	140	9	promote	promote	VERB
dpc-1099	140	10	healing	healing	NOUN
dpc-1099	140	11	of	of	ADP
dpc-1099	140	12	the	the	DET
dpc-1099	140	13	bullous	bullous	ADJ
dpc-1099	140	14	and	and	CCONJ
dpc-1099	140	15	erosive	erosive	VERB
dpc-1099	140	16	cutaneous	cutaneous	ADJ
dpc-1099	140	17	and/or	and/or	CCONJ
dpc-1099	140	18	mucous	mucous	ADJ
dpc-1099	140	19	lesions	lesion	NOUN
dpc-1099	140	20	.	.	PUNCT
dpc-1099	141	1	additional	additional	ADJ
dpc-1099	141	2	goals	goal	NOUN
dpc-1099	141	3	are	be	AUX
dpc-1099	141	4	to	to	PART
dpc-1099	141	5	reduce	reduce	VERB
dpc-1099	141	6	itch	itch	NOUN
dpc-1099	141	7	,	,	PUNCT
dpc-1099	141	8	prevent	prevent	VERB
dpc-1099	141	9	or	or	CCONJ
dpc-1099	141	10	reduce	reduce	VERB
dpc-1099	141	11	the	the	DET
dpc-1099	141	12	recurrences	recurrence	NOUN
dpc-1099	141	13	of	of	ADP
dpc-1099	141	14	the	the	DET
dpc-1099	141	15	blistering	blister	VERB
dpc-1099	141	16	eruptions	eruption	NOUN
dpc-1099	141	17	,	,	PUNCT
dpc-1099	141	18	improve	improve	VERB
dpc-1099	141	19	the	the	DET
dpc-1099	141	20	quality	quality	NOUN
dpc-1099	141	21	of	of	ADP
dpc-1099	141	22	life	life	NOUN
dpc-1099	141	23	of	of	ADP
dpc-1099	141	24	patients	patient	NOUN
dpc-1099	141	25	,	,	PUNCT
dpc-1099	141	26	and	and	CCONJ
dpc-1099	141	27	minimize	minimize	VERB
dpc-1099	141	28	and	and	CCONJ
dpc-1099	141	29	identify	identify	VERB
dpc-1099	141	30	as	as	ADV
dpc-1099	141	31	quickly	quickly	ADV
dpc-1099	141	32	as	as	ADP
dpc-1099	141	33	possible	possible	ADJ
dpc-1099	141	34	serious	serious	ADJ
dpc-1099	141	35	side	side	NOUN
dpc-1099	141	36	effects	effect	NOUN
dpc-1099	141	37	associated	associate	VERB
dpc-1099	141	38	with	with	ADP
dpc-1099	141	39	long	long	ADJ
dpc-1099	141	40	-	-	PUNCT
dpc-1099	141	41	term	term	NOUN
dpc-1099	141	42	treatment	treatment	NOUN
dpc-1099	141	43	,	,	PUNCT
dpc-1099	141	44	particularly	particularly	ADV
dpc-1099	141	45	in	in	ADP
dpc-1099	141	46	the	the	DET
dpc-1099	141	47	elderly	elderly	ADJ
dpc-1099	141	48	[	[	X
dpc-1099	141	49	37,38	37,38	NOUN
dpc-1099	141	50	]	]	PUNCT
dpc-1099	141	51	.	.	PUNCT
dpc-1099	142	1	a	a	DET
dpc-1099	142	2	complete	complete	ADJ
dpc-1099	142	3	medical	medical	ADJ
dpc-1099	142	4	history	history	NOUN
dpc-1099	142	5	focusing	focus	VERB
dpc-1099	142	6	on	on	ADP
dpc-1099	142	7	drug	drug	NOUN
dpc-1099	142	8	history	history	NOUN
dpc-1099	142	9	and	and	CCONJ
dpc-1099	142	10	comorbid	comorbid	NOUN
dpc-1099	142	11	diseases	disease	NOUN
dpc-1099	142	12	that	that	PRON
dpc-1099	142	13	may	may	AUX
dpc-1099	142	14	affect	affect	VERB
dpc-1099	142	15	treatment	treatment	NOUN
dpc-1099	142	16	decisions	decision	NOUN
dpc-1099	142	17	is	be	AUX
dpc-1099	142	18	mandatory	mandatory	ADJ
dpc-1099	142	19	.	.	PUNCT
dpc-1099	143	1	a	a	DET
dpc-1099	143	2	complete	complete	ADJ
dpc-1099	143	3	biochemistry	biochemistry	NOUN
dpc-1099	143	4	screening	screening	NOUN
dpc-1099	143	5	should	should	AUX
dpc-1099	143	6	be	be	AUX
dpc-1099	143	7	conducted	conduct	VERB
dpc-1099	143	8	and	and	CCONJ
dpc-1099	143	9	should	should	AUX
dpc-1099	143	10	include	include	VERB
dpc-1099	143	11	liver	liver	NOUN
dpc-1099	143	12	and	and	CCONJ
dpc-1099	143	13	renal	renal	ADJ
dpc-1099	143	14	function	function	NOUN
dpc-1099	143	15	tests	test	NOUN
dpc-1099	143	16	.	.	PUNCT
dpc-1099	144	1	treatment	treatment	NOUN
dpc-1099	144	2	pemphigus	pemphigus	NOUN
dpc-1099	144	3	vulgaris	vulgaris	NOUN
dpc-1099	144	4	the	the	DET
dpc-1099	144	5	morbidity	morbidity	NOUN
dpc-1099	144	6	and	and	CCONJ
dpc-1099	144	7	mortality	mortality	NOUN
dpc-1099	144	8	of	of	ADP
dpc-1099	144	9	pv	pv	INTJ
dpc-1099	144	10	have	have	AUX
dpc-1099	144	11	remained	remain	VERB
dpc-1099	144	12	high	high	ADJ
dpc-1099	144	13	owing	owe	VERB
dpc-1099	144	14	to	to	ADP
dpc-1099	144	15	complications	complication	NOUN
dpc-1099	144	16	of	of	ADP
dpc-1099	144	17	therapy	therapy	NOUN
dpc-1099	144	18	,	,	PUNCT
dpc-1099	144	19	such	such	ADJ
dpc-1099	144	20	as	as	ADP
dpc-1099	144	21	pneumonia	pneumonia	NOUN
dpc-1099	144	22	,	,	PUNCT
dpc-1099	144	23	septicemia	septicemia	NOUN
dpc-1099	144	24	,	,	PUNCT
dpc-1099	144	25	mucous	mucous	ADJ
dpc-1099	144	26	membrane	membrane	NOUN
dpc-1099	144	27	and	and	CCONJ
dpc-1099	144	28	shows	show	VERB
dpc-1099	144	29	antibody	antibody	NOUN
dpc-1099	144	30	deposition	deposition	NOUN
dpc-1099	144	31	on	on	ADP
dpc-1099	144	32	the	the	DET
dpc-1099	144	33	keratinocyte	keratinocyte	NOUN
dpc-1099	144	34	cell	cell	NOUN
dpc-1099	144	35	surface	surface	NOUN
dpc-1099	144	36	(	(	PUNCT
dpc-1099	144	37	in	in	ADP
dpc-1099	144	38	pds	pds	NOUN
dpc-1099	144	39	)	)	PUNCT
dpc-1099	144	40	or	or	CCONJ
dpc-1099	144	41	along	along	ADP
dpc-1099	144	42	the	the	DET
dpc-1099	144	43	basement	basement	NOUN
dpc-1099	144	44	cell	cell	NOUN
dpc-1099	144	45	membrane	membrane	NOUN
dpc-1099	144	46	(	(	PUNCT
dpc-1099	144	47	in	in	ADP
dpc-1099	144	48	bp	bp	PROPN
dpc-1099	144	49	)	)	PUNCT
dpc-1099	144	50	.	.	PUNCT
dpc-1099	145	1	pemphigus	pemphigus	PROPN
dpc-1099	145	2	vulgaris	vulgaris	PROPN
dpc-1099	145	3	biopsy	biopsy	NOUN
dpc-1099	145	4	of	of	ADP
dpc-1099	145	5	perilesional	perilesional	ADJ
dpc-1099	145	6	skin	skin	NOUN
dpc-1099	145	7	or	or	CCONJ
dpc-1099	145	8	mucosa	mucosa	NOUN
dpc-1099	145	9	shows	show	VERB
dpc-1099	145	10	deposits	deposit	NOUN
dpc-1099	145	11	of	of	ADP
dpc-1099	145	12	igg	igg	PROPN
dpc-1099	145	13	at	at	ADP
dpc-1099	145	14	the	the	DET
dpc-1099	145	15	keratinocyte	keratinocyte	NOUN
dpc-1099	145	16	cell	cell	NOUN
dpc-1099	145	17	membrane	membrane	NOUN
dpc-1099	146	1	[	[	X
dpc-1099	146	2	22,37	22,37	NOUN
dpc-1099	146	3	]	]	X
dpc-1099	146	4	.	.	PUNCT
dpc-1099	147	1	igg	igg	PROPN
dpc-1099	147	2	deposition	deposition	NOUN
dpc-1099	147	3	is	be	AUX
dpc-1099	147	4	seen	see	VERB
dpc-1099	147	5	in	in	ADP
dpc-1099	147	6	up	up	ADP
dpc-1099	147	7	to	to	PART
dpc-1099	147	8	100	100	NUM
dpc-1099	147	9	%	%	NOUN
dpc-1099	147	10	of	of	ADP
dpc-1099	147	11	patients	patient	NOUN
dpc-1099	147	12	with	with	ADP
dpc-1099	147	13	active	active	ADJ
dpc-1099	147	14	disease	disease	NOUN
dpc-1099	147	15	.	.	PUNCT
dpc-1099	148	1	complement	complement	NOUN
dpc-1099	148	2	(	(	PUNCT
dpc-1099	148	3	c3	c3	NOUN
dpc-1099	148	4	)	)	PUNCT
dpc-1099	148	5	deposition	deposition	NOUN
dpc-1099	148	6	may	may	AUX
dpc-1099	148	7	not	not	PART
dpc-1099	148	8	be	be	AUX
dpc-1099	148	9	observed	observe	VERB
dpc-1099	148	10	,	,	PUNCT
dpc-1099	148	11	since	since	SCONJ
dpc-1099	148	12	igg4	igg4	PROPN
dpc-1099	148	13	,	,	PUNCT
dpc-1099	148	14	the	the	DET
dpc-1099	148	15	dominant	dominant	ADJ
dpc-1099	148	16	subclass	subclass	NOUN
dpc-1099	148	17	of	of	ADP
dpc-1099	148	18	igg	igg	PROPN
dpc-1099	148	19	involved	involve	VERB
dpc-1099	148	20	in	in	ADP
dpc-1099	148	21	pv	pv	ADV
dpc-1099	148	22	,	,	PUNCT
dpc-1099	148	23	does	do	AUX
dpc-1099	148	24	not	not	PART
dpc-1099	148	25	fix	fix	VERB
dpc-1099	148	26	complement	complement	NOUN
dpc-1099	148	27	.	.	PUNCT
dpc-1099	149	1	bullous	bullous	ADJ
dpc-1099	149	2	pemphigoid	pemphigoid	NOUN
dpc-1099	149	3	it	it	PRON
dpc-1099	149	4	is	be	AUX
dpc-1099	149	5	best	good	ADJ
dpc-1099	149	6	to	to	PART
dpc-1099	149	7	biopsy	biopsy	VERB
dpc-1099	149	8	perilesional	perilesional	ADJ
dpc-1099	149	9	skin	skin	NOUN
dpc-1099	149	10	from	from	ADP
dpc-1099	149	11	a	a	DET
dpc-1099	149	12	recent	recent	ADJ
dpc-1099	149	13	blister	blister	NOUN
dpc-1099	149	14	.	.	PUNCT
dpc-1099	150	1	the	the	DET
dpc-1099	150	2	diagnostic	diagnostic	ADJ
dpc-1099	150	3	hallmark	hallmark	NOUN
dpc-1099	150	4	consists	consist	NOUN
dpc-1099	150	5	of	of	ADP
dpc-1099	150	6	fine	fine	ADJ
dpc-1099	150	7	,	,	PUNCT
dpc-1099	150	8	linear	linear	ADJ
dpc-1099	150	9	,	,	PUNCT
dpc-1099	150	10	continuous	continuous	ADJ
dpc-1099	150	11	deposits	deposit	NOUN
dpc-1099	150	12	of	of	ADP
dpc-1099	150	13	igg	igg	PROPN
dpc-1099	150	14	and/or	and/or	CCONJ
dpc-1099	150	15	c3	c3	PROPN
dpc-1099	150	16	along	along	ADP
dpc-1099	150	17	the	the	DET
dpc-1099	150	18	dermal	dermal	NOUN
dpc-1099	150	19	-	-	PUNCT
dpc-1099	150	20	epidermal	epidermal	ADJ
dpc-1099	150	21	junction	junction	NOUN
dpc-1099	150	22	.	.	PUNCT
dpc-1099	151	1	occasionally	occasionally	ADV
dpc-1099	151	2	iga	iga	PROPN
dpc-1099	151	3	and	and	CCONJ
dpc-1099	151	4	ige	ige	PROPN
dpc-1099	151	5	may	may	AUX
dpc-1099	151	6	be	be	AUX
dpc-1099	151	7	observed	observe	VERB
dpc-1099	151	8	showing	show	VERB
dpc-1099	151	9	a	a	DET
dpc-1099	151	10	similar	similar	ADJ
dpc-1099	151	11	pattern	pattern	NOUN
dpc-1099	151	12	[	[	X
dpc-1099	151	13	33,38	33,38	NOUN
dpc-1099	151	14	]	]	PUNCT
dpc-1099	151	15	.	.	PUNCT
dpc-1099	152	1	salt	salt	NOUN
dpc-1099	152	2	-	-	PUNCT
dpc-1099	152	3	split	split	NOUN
dpc-1099	152	4	technique	technique	NOUN
dpc-1099	152	5	is	be	AUX
dpc-1099	152	6	a	a	DET
dpc-1099	152	7	useful	useful	ADJ
dpc-1099	152	8	tool	tool	NOUN
dpc-1099	152	9	in	in	ADP
dpc-1099	152	10	the	the	DET
dpc-1099	152	11	differential	differential	ADJ
dpc-1099	152	12	diagnosis	diagnosis	NOUN
dpc-1099	152	13	of	of	ADP
dpc-1099	152	14	other	other	ADJ
dpc-1099	152	15	abds	abds	NOUN
dpc-1099	152	16	,	,	PUNCT
dpc-1099	152	17	such	such	ADJ
dpc-1099	152	18	as	as	ADP
dpc-1099	152	19	epidermolysis	epidermolysis	NOUN
dpc-1099	152	20	bullosa	bullosa	PROPN
dpc-1099	152	21	acquisita	acquisita	PROPN
dpc-1099	152	22	,	,	PUNCT
dpc-1099	152	23	which	which	PRON
dpc-1099	152	24	shows	show	VERB
dpc-1099	152	25	a	a	DET
dpc-1099	152	26	similar	similar	ADJ
dpc-1099	152	27	dif	dif	NOUN
dpc-1099	152	28	pattern	pattern	NOUN
dpc-1099	152	29	.	.	PUNCT
dpc-1099	153	1	in	in	ADP
dpc-1099	153	2	bp	bp	PROPN
dpc-1099	153	3	,	,	PUNCT
dpc-1099	153	4	immune	immune	ADJ
dpc-1099	153	5	deposits	deposit	NOUN
dpc-1099	153	6	are	be	AUX
dpc-1099	153	7	found	find	VERB
dpc-1099	153	8	in	in	ADP
dpc-1099	153	9	the	the	DET
dpc-1099	153	10	epidermal	epidermal	ADJ
dpc-1099	153	11	side	side	NOUN
dpc-1099	153	12	or	or	CCONJ
dpc-1099	153	13	mixed	mixed	ADJ
dpc-1099	153	14	at	at	ADP
dpc-1099	153	15	both	both	CCONJ
dpc-1099	153	16	the	the	DET
dpc-1099	153	17	epidermal	epidermal	ADJ
dpc-1099	153	18	and	and	CCONJ
dpc-1099	153	19	dermal	dermal	ADJ
dpc-1099	153	20	sites	site	NOUN
dpc-1099	153	21	of	of	ADP
dpc-1099	153	22	the	the	DET
dpc-1099	153	23	split	split	NOUN
dpc-1099	153	24	(	(	PUNCT
dpc-1099	153	25	n	n	CCONJ
dpc-1099	153	26	-	-	PUNCT
dpc-1099	153	27	serration	serration	NOUN
dpc-1099	153	28	pattern	pattern	NOUN
dpc-1099	153	29	)	)	PUNCT
dpc-1099	153	30	,	,	PUNCT
dpc-1099	153	31	while	while	SCONJ
dpc-1099	153	32	in	in	ADP
dpc-1099	153	33	epidermolysis	epidermolysis	NOUN
dpc-1099	153	34	bullosa	bullosa	PROPN
dpc-1099	153	35	acquisita	acquisita	PROPN
dpc-1099	153	36	,	,	PUNCT
dpc-1099	153	37	deposits	deposit	NOUN
dpc-1099	153	38	are	be	AUX
dpc-1099	153	39	typically	typically	ADV
dpc-1099	153	40	localized	localize	VERB
dpc-1099	153	41	on	on	ADP
dpc-1099	153	42	the	the	DET
dpc-1099	153	43	dermal	dermal	ADJ
dpc-1099	153	44	side	side	NOUN
dpc-1099	153	45	of	of	ADP
dpc-1099	153	46	the	the	DET
dpc-1099	153	47	cleavage	cleavage	NOUN
dpc-1099	153	48	(	(	PUNCT
dpc-1099	153	49	u	u	NOUN
dpc-1099	153	50	-	-	NOUN
dpc-1099	153	51	serration	serration	NOUN
dpc-1099	153	52	pattern	pattern	NOUN
dpc-1099	153	53	)	)	PUNCT
dpc-1099	153	54	.	.	PUNCT
dpc-1099	154	1	serological	serological	ADJ
dpc-1099	154	2	studies	study	NOUN
dpc-1099	154	3	the	the	DET
dpc-1099	154	4	method	method	NOUN
dpc-1099	154	5	of	of	ADP
dpc-1099	154	6	serological	serological	ADJ
dpc-1099	154	7	detection	detection	NOUN
dpc-1099	154	8	of	of	ADP
dpc-1099	154	9	the	the	DET
dpc-1099	154	10	autoantibodies	autoantibody	NOUN
dpc-1099	154	11	largely	largely	ADV
dpc-1099	154	12	relies	rely	VERB
dpc-1099	154	13	on	on	ADP
dpc-1099	154	14	indirect	indirect	ADJ
dpc-1099	154	15	immunofluorescence	immunofluorescence	NOUN
dpc-1099	154	16	(	(	PUNCT
dpc-1099	154	17	iif	iif	PROPN
dpc-1099	154	18	)	)	PUNCT
dpc-1099	154	19	and	and	CCONJ
dpc-1099	154	20	enzyme‐linked	enzyme‐linke	VERB
dpc-1099	154	21	immunosorbent	immunosorbent	VERB
dpc-1099	154	22	assay	assay	PROPN
dpc-1099	154	23	(	(	PUNCT
dpc-1099	154	24	elisa	elisa	NOUN
dpc-1099	154	25	)	)	PUNCT
dpc-1099	154	26	tests	test	NOUN
dpc-1099	154	27	.	.	PUNCT
dpc-1099	155	1	recently	recently	ADV
dpc-1099	155	2	,	,	PUNCT
dpc-1099	155	3	novel	novel	ADJ
dpc-1099	155	4	diagnostic	diagnostic	ADJ
dpc-1099	155	5	multivariant	multivariant	NOUN
dpc-1099	155	6	assays	assay	NOUN
dpc-1099	155	7	were	be	AUX
dpc-1099	155	8	developed	develop	VERB
dpc-1099	155	9	as	as	ADP
dpc-1099	155	10	practical	practical	ADJ
dpc-1099	155	11	screening	screening	NOUN
dpc-1099	155	12	tools	tool	NOUN
dpc-1099	155	13	for	for	ADP
dpc-1099	155	14	patients	patient	NOUN
dpc-1099	155	15	with	with	ADP
dpc-1099	155	16	suspected	suspect	VERB
dpc-1099	155	17	abd	abd	NOUN
dpc-1099	155	18	with	with	ADP
dpc-1099	155	19	the	the	DET
dpc-1099	155	20	aim	aim	NOUN
dpc-1099	155	21	of	of	ADP
dpc-1099	155	22	processing	process	VERB
dpc-1099	155	23	the	the	DET
dpc-1099	155	24	most	most	ADV
dpc-1099	155	25	common	common	ADJ
dpc-1099	155	26	autoantibodies	autoantibody	NOUN
dpc-1099	155	27	simultaneously	simultaneously	ADV
dpc-1099	155	28	[	[	X
dpc-1099	155	29	39,40	39,40	NUM
dpc-1099	155	30	]	]	PUNCT
dpc-1099	155	31	.	.	PUNCT
dpc-1099	156	1	pemphigus	pemphigus	PROPN
dpc-1099	156	2	vulgaris	vulgaris	PROPN
dpc-1099	156	3	iif	iif	PROPN
dpc-1099	156	4	allows	allow	VERB
dpc-1099	156	5	for	for	ADP
dpc-1099	156	6	the	the	DET
dpc-1099	156	7	detection	detection	NOUN
dpc-1099	156	8	of	of	ADP
dpc-1099	156	9	circulating	circulate	VERB
dpc-1099	156	10	autoantibodies	autoantibody	NOUN
dpc-1099	156	11	against	against	ADP
dpc-1099	156	12	proteins	protein	NOUN
dpc-1099	156	13	or	or	CCONJ
dpc-1099	156	14	epithelial	epithelial	ADJ
dpc-1099	156	15	keratinocytes	keratinocyte	NOUN
dpc-1099	156	16	by	by	ADP
dpc-1099	156	17	incubating	incubate	VERB
dpc-1099	156	18	patient	patient	ADJ
dpc-1099	156	19	serum	serum	NOUN
dpc-1099	156	20	with	with	ADP
dpc-1099	156	21	appropriate	appropriate	ADJ
dpc-1099	156	22	commercially	commercially	ADV
dpc-1099	156	23	available	available	ADJ
dpc-1099	156	24	substrates	substrate	NOUN
dpc-1099	156	25	containing	contain	VERB
dpc-1099	156	26	the	the	DET
dpc-1099	156	27	target	target	NOUN
dpc-1099	156	28	antigen	antigen	ADV
dpc-1099	156	29	.	.	PUNCT
dpc-1099	157	1	the	the	DET
dpc-1099	157	2	testing	testing	NOUN
dpc-1099	157	3	study	study	NOUN
dpc-1099	157	4	is	be	AUX
dpc-1099	157	5	conducted	conduct	VERB
dpc-1099	157	6	on	on	ADP
dpc-1099	157	7	monkey	monkey	NOUN
dpc-1099	157	8	esophagus	esophagus	NOUN
dpc-1099	157	9	or	or	CCONJ
dpc-1099	157	10	epithelial	epithelial	ADJ
dpc-1099	157	11	substrates	substrate	NOUN
dpc-1099	157	12	.	.	PUNCT
dpc-1099	158	1	pv	pv	NOUN
dpc-1099	158	2	sera	sera	NOUN
dpc-1099	158	3	produces	produce	VERB
dpc-1099	158	4	a	a	DET
dpc-1099	158	5	characteristic	characteristic	ADJ
dpc-1099	158	6	smooth	smooth	ADJ
dpc-1099	158	7	and	and	CCONJ
dpc-1099	158	8	reticular	reticular	ADJ
dpc-1099	158	9	pattern	pattern	NOUN
dpc-1099	158	10	on	on	ADP
dpc-1099	158	11	most	most	ADJ
dpc-1099	158	12	epithelial	epithelial	ADJ
dpc-1099	158	13	layer	layer	NOUN
dpc-1099	158	14	,	,	PUNCT
dpc-1099	158	15	referred	refer	VERB
dpc-1099	158	16	as	as	ADP
dpc-1099	158	17	“	"	PUNCT
dpc-1099	158	18	fishnet	fishnet	NOUN
dpc-1099	158	19	-	-	PUNCT
dpc-1099	158	20	like	like	ADJ
dpc-1099	158	21	,	,	PUNCT
dpc-1099	158	22	”	"	PUNCT
dpc-1099	158	23	“	"	PUNCT
dpc-1099	158	24	chicken	chicken	NOUN
dpc-1099	158	25	wire	wire	NOUN
dpc-1099	158	26	,	,	PUNCT
dpc-1099	158	27	”	"	PUNCT
dpc-1099	158	28	or	or	CCONJ
dpc-1099	158	29	“	"	PUNCT
dpc-1099	158	30	honeycomb	honeycomb	NOUN
dpc-1099	158	31	”	"	PUNCT
dpc-1099	158	32	pattern	pattern	NOUN
dpc-1099	158	33	[	[	X
dpc-1099	158	34	37,38	37,38	NOUN
dpc-1099	158	35	]	]	PUNCT
dpc-1099	158	36	.	.	PUNCT
dpc-1099	159	1	cloning	cloning	NOUN
dpc-1099	159	2	of	of	ADP
dpc-1099	159	3	the	the	DET
dpc-1099	159	4	gene	gene	NOUN
dpc-1099	159	5	coding	code	VERB
dpc-1099	159	6	for	for	ADP
dpc-1099	159	7	the	the	DET
dpc-1099	159	8	major	major	ADJ
dpc-1099	159	9	pemphigus	pemphigus	NOUN
dpc-1099	159	10	antigens	antigen	NOUN
dpc-1099	159	11	,	,	PUNCT
dpc-1099	159	12	dsg1	dsg1	NOUN
dpc-1099	159	13	and	and	CCONJ
dpc-1099	159	14	dsg3	dsg3	PROPN
dpc-1099	159	15	,	,	PUNCT
dpc-1099	159	16	has	have	AUX
dpc-1099	159	17	enabled	enable	VERB
dpc-1099	159	18	the	the	DET
dpc-1099	159	19	production	production	NOUN
dpc-1099	159	20	of	of	ADP
dpc-1099	159	21	recombinant	recombinant	ADJ
dpc-1099	159	22	proteins	protein	NOUN
dpc-1099	159	23	,	,	PUNCT
dpc-1099	159	24	which	which	PRON
dpc-1099	159	25	are	be	AUX
dpc-1099	159	26	used	use	VERB
dpc-1099	159	27	to	to	PART
dpc-1099	159	28	detect	detect	VERB
dpc-1099	159	29	igg	igg	NOUN
dpc-1099	159	30	autoantibodies	autoantibody	NOUN
dpc-1099	159	31	by	by	ADP
dpc-1099	159	32	elisa	elisa	NOUN
dpc-1099	159	33	[	[	X
dpc-1099	159	34	41	41	NUM
dpc-1099	159	35	]	]	PUNCT
dpc-1099	159	36	.	.	PUNCT
dpc-1099	160	1	the	the	DET
dpc-1099	160	2	dsg3	dsg3	PROPN
dpc-1099	160	3	/	/	SYM
dpc-1099	160	4	dsg1	dsg1	NOUN
dpc-1099	160	5	autoantibody	autoantibody	VERB
dpc-1099	160	6	profile	profile	NOUN
dpc-1099	160	7	defines	define	VERB
dpc-1099	160	8	the	the	DET
dpc-1099	160	9	clinical	clinical	ADJ
dpc-1099	160	10	outcome	outcome	NOUN
dpc-1099	160	11	,	,	PUNCT
dpc-1099	160	12	since	since	SCONJ
dpc-1099	160	13	pv	pv	VERB
dpc-1099	160	14	with	with	ADP
dpc-1099	160	15	exclusive	exclusive	ADJ
dpc-1099	160	16	involvement	involvement	NOUN
dpc-1099	160	17	of	of	ADP
dpc-1099	160	18	the	the	DET
dpc-1099	160	19	mucous	mucous	ADJ
dpc-1099	160	20	membranes	membrane	NOUN
dpc-1099	160	21	is	be	AUX
dpc-1099	160	22	associated	associate	VERB
dpc-1099	160	23	with	with	ADP
dpc-1099	160	24	igg	igg	PROPN
dpc-1099	160	25	against	against	ADP
dpc-1099	160	26	dsg3	dsg3	PROPN
dpc-1099	160	27	,	,	PUNCT
dpc-1099	160	28	while	while	SCONJ
dpc-1099	160	29	the	the	DET
dpc-1099	160	30	mucocutaneous	mucocutaneous	ADJ
dpc-1099	160	31	variant	variant	NOUN
dpc-1099	160	32	of	of	ADP
dpc-1099	160	33	pv	pv	PROPN
dpc-1099	160	34	is	be	AUX
dpc-1099	160	35	associated	associate	VERB
dpc-1099	160	36	with	with	ADP
dpc-1099	160	37	both	both	CCONJ
dpc-1099	160	38	anti	anti	ADJ
dpc-1099	160	39	-	-	ADJ
dpc-1099	160	40	dsg1	dsg1	NOUN
dpc-1099	160	41	and	and	CCONJ
dpc-1099	160	42	anti	anti	ADJ
dpc-1099	160	43	-	-	ADJ
dpc-1099	160	44	dsg3	dsg3	ADJ
dpc-1099	160	45	igg	igg	PROPN
dpc-1099	160	46	.	.	PUNCT
dpc-1099	161	1	the	the	DET
dpc-1099	161	2	detection	detection	NOUN
dpc-1099	161	3	of	of	ADP
dpc-1099	161	4	igg	igg	NOUN
dpc-1099	161	5	autoantibodies	autoantibody	NOUN
dpc-1099	161	6	by	by	ADP
dpc-1099	161	7	elisa	elisa	NOUN
dpc-1099	161	8	is	be	AUX
dpc-1099	161	9	positive	positive	ADJ
dpc-1099	161	10	in	in	ADP
dpc-1099	161	11	more	more	ADJ
dpc-1099	161	12	than	than	ADP
dpc-1099	161	13	90	90	NUM
dpc-1099	161	14	%	%	NOUN
dpc-1099	161	15	of	of	ADP
dpc-1099	161	16	cases	case	NOUN
dpc-1099	161	17	[	[	X
dpc-1099	161	18	37	37	NUM
dpc-1099	161	19	]	]	PUNCT
dpc-1099	161	20	.	.	PUNCT
dpc-1099	162	1	the	the	DET
dpc-1099	162	2	titers	titer	NOUN
dpc-1099	162	3	of	of	ADP
dpc-1099	162	4	serum	serum	NOUN
dpc-1099	162	5	igg	igg	PROPN
dpc-1099	162	6	autoantibodies	autoantibody	NOUN
dpc-1099	162	7	against	against	ADP
dpc-1099	162	8	review	review	NOUN
dpc-1099	162	9	|	|	ADV
dpc-1099	162	10	dermatol	dermatol	ADJ
dpc-1099	162	11	pract	pract	NOUN
dpc-1099	162	12	concept	concept	NOUN
dpc-1099	162	13	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	162	14	7	7	NUM
dpc-1099	162	15	nosuppressive	nosuppressive	ADJ
dpc-1099	162	16	adjuvant	adjuvant	ADJ
dpc-1099	162	17	drug	drug	NOUN
dpc-1099	162	18	is	be	AUX
dpc-1099	162	19	continued	continue	VERB
dpc-1099	162	20	,	,	PUNCT
dpc-1099	162	21	while	while	SCONJ
dpc-1099	162	22	the	the	DET
dpc-1099	162	23	prednisone	prednisone	NOUN
dpc-1099	162	24	is	be	AUX
dpc-1099	162	25	gradually	gradually	ADV
dpc-1099	162	26	tapered	taper	VERB
dpc-1099	162	27	.	.	PUNCT
dpc-1099	163	1	no	no	DET
dpc-1099	163	2	particular	particular	ADJ
dpc-1099	163	3	advantage	advantage	NOUN
dpc-1099	163	4	has	have	AUX
dpc-1099	163	5	been	be	AUX
dpc-1099	163	6	found	find	VERB
dpc-1099	163	7	with	with	ADP
dpc-1099	163	8	intravenous	intravenous	ADJ
dpc-1099	163	9	corticosteroid	corticosteroid	ADJ
dpc-1099	163	10	pulse	pulse	NOUN
dpc-1099	163	11	treatment	treatment	NOUN
dpc-1099	163	12	over	over	ADP
dpc-1099	163	13	treatment	treatment	NOUN
dpc-1099	163	14	with	with	ADP
dpc-1099	163	15	oral	oral	ADJ
dpc-1099	163	16	corticosteroids	corticosteroid	NOUN
dpc-1099	163	17	[	[	X
dpc-1099	163	18	46	46	NUM
dpc-1099	163	19	]	]	PUNCT
dpc-1099	163	20	.	.	PUNCT
dpc-1099	164	1	rituximab	rituximab	NOUN
dpc-1099	164	2	,	,	PUNCT
dpc-1099	164	3	a	a	DET
dpc-1099	164	4	chimeric	chimeric	ADJ
dpc-1099	164	5	monoclonal	monoclonal	NOUN
dpc-1099	164	6	antibody	antibody	NOUN
dpc-1099	164	7	targeting	target	VERB
dpc-1099	164	8	the	the	DET
dpc-1099	164	9	cd20	cd20	PROPN
dpc-1099	164	10	antigen	antigen	NOUN
dpc-1099	164	11	of	of	ADP
dpc-1099	164	12	b	b	NOUN
dpc-1099	164	13	lymphocytes	lymphocyte	NOUN
dpc-1099	164	14	,	,	PUNCT
dpc-1099	164	15	has	have	AUX
dpc-1099	164	16	recently	recently	ADV
dpc-1099	164	17	emerged	emerge	VERB
dpc-1099	164	18	as	as	ADP
dpc-1099	164	19	a	a	DET
dpc-1099	164	20	highly	highly	ADV
dpc-1099	164	21	promising	promising	ADJ
dpc-1099	164	22	therapeutic	therapeutic	ADJ
dpc-1099	164	23	option	option	NOUN
dpc-1099	164	24	for	for	ADP
dpc-1099	164	25	pv	pv	NOUN
dpc-1099	164	26	.	.	PUNCT
dpc-1099	165	1	rituximab	rituximab	NOUN
dpc-1099	165	2	causes	cause	VERB
dpc-1099	165	3	b	b	NOUN
dpc-1099	165	4	-	-	PUNCT
dpc-1099	165	5	cell	cell	NOUN
dpc-1099	165	6	depletion	depletion	NOUN
dpc-1099	165	7	and	and	CCONJ
dpc-1099	165	8	a	a	DET
dpc-1099	165	9	subsequent	subsequent	ADJ
dpc-1099	165	10	reduction	reduction	NOUN
dpc-1099	165	11	in	in	ADP
dpc-1099	165	12	pathogenic	pathogenic	ADJ
dpc-1099	165	13	autoantibodies	autoantibody	NOUN
dpc-1099	165	14	.	.	PUNCT
dpc-1099	166	1	pretreatment	pretreatment	NOUN
dpc-1099	166	2	investigations	investigation	NOUN
dpc-1099	166	3	,	,	PUNCT
dpc-1099	166	4	contraindications	contraindication	NOUN
dpc-1099	166	5	,	,	PUNCT
dpc-1099	166	6	and	and	CCONJ
dpc-1099	166	7	treatment	treatment	NOUN
dpc-1099	166	8	schedules	schedule	NOUN
dpc-1099	166	9	are	be	AUX
dpc-1099	166	10	summarized	summarize	VERB
dpc-1099	166	11	in	in	ADP
dpc-1099	166	12	table	table	NOUN
dpc-1099	166	13	4	4	NUM
dpc-1099	166	14	.	.	PUNCT
dpc-1099	167	1	rituximab	rituximab	NOUN
dpc-1099	167	2	is	be	AUX
dpc-1099	167	3	one	one	NUM
dpc-1099	167	4	of	of	ADP
dpc-1099	167	5	the	the	DET
dpc-1099	167	6	only	only	ADJ
dpc-1099	167	7	drugs	drug	NOUN
dpc-1099	167	8	to	to	PART
dpc-1099	167	9	gain	gain	VERB
dpc-1099	167	10	european	european	ADJ
dpc-1099	167	11	medicine	medicine	PROPN
dpc-1099	167	12	agency	agency	NOUN
dpc-1099	167	13	and	and	CCONJ
dpc-1099	167	14	us	we	PRON
dpc-1099	167	15	food	food	NOUN
dpc-1099	167	16	and	and	CCONJ
dpc-1099	167	17	drug	drug	PROPN
dpc-1099	167	18	administration	administration	NOUN
dpc-1099	167	19	approval	approval	NOUN
dpc-1099	167	20	for	for	ADP
dpc-1099	167	21	the	the	DET
dpc-1099	167	22	treatment	treatment	NOUN
dpc-1099	167	23	of	of	ADP
dpc-1099	167	24	pv	pv	NOUN
dpc-1099	167	25	.	.	PUNCT
dpc-1099	168	1	previous	previous	ADJ
dpc-1099	168	2	clinical	clinical	ADJ
dpc-1099	168	3	experiences	experience	NOUN
dpc-1099	168	4	showed	show	VERB
dpc-1099	168	5	its	its	PRON
dpc-1099	168	6	dramatic	dramatic	ADJ
dpc-1099	168	7	efficacy	efficacy	NOUN
dpc-1099	168	8	as	as	ADP
dpc-1099	168	9	secondor	secondor	NOUN
dpc-1099	168	10	third	third	ADJ
dpc-1099	168	11	-	-	PUNCT
dpc-1099	168	12	line	line	NOUN
dpc-1099	168	13	treatment	treatment	NOUN
dpc-1099	168	14	in	in	ADP
dpc-1099	168	15	severe	severe	ADJ
dpc-1099	168	16	recalcitrant	recalcitrant	ADJ
dpc-1099	168	17	or	or	CCONJ
dpc-1099	168	18	relapsing	relapse	VERB
dpc-1099	168	19	cases	case	NOUN
dpc-1099	168	20	of	of	ADP
dpc-1099	168	21	pv	pv	NOUN
dpc-1099	169	1	[	[	X
dpc-1099	169	2	47,48	47,48	NOUN
dpc-1099	169	3	]	]	PUNCT
dpc-1099	169	4	.	.	PUNCT
dpc-1099	170	1	in	in	ADP
dpc-1099	170	2	particular	particular	ADJ
dpc-1099	170	3	,	,	PUNCT
dpc-1099	170	4	a	a	DET
dpc-1099	170	5	meta	meta	NOUN
dpc-1099	170	6	-	-	PUNCT
dpc-1099	170	7	analysis	analysis	NOUN
dpc-1099	170	8	including	include	VERB
dpc-1099	170	9	578	578	NUM
dpc-1099	170	10	patients	patient	NOUN
dpc-1099	170	11	with	with	ADP
dpc-1099	170	12	pemphigus	pemphigus	PROPN
dpc-1099	170	13	showed	show	VERB
dpc-1099	170	14	a	a	DET
dpc-1099	170	15	remission	remission	NOUN
dpc-1099	170	16	rate	rate	NOUN
dpc-1099	170	17	of	of	ADP
dpc-1099	170	18	76	76	NUM
dpc-1099	170	19	%	%	NOUN
dpc-1099	170	20	following	follow	VERB
dpc-1099	170	21	a	a	DET
dpc-1099	170	22	single	single	ADJ
dpc-1099	170	23	cycle	cycle	NOUN
dpc-1099	170	24	of	of	ADP
dpc-1099	170	25	rituximab	rituximab	NOUN
dpc-1099	170	26	,	,	PUNCT
dpc-1099	170	27	with	with	ADP
dpc-1099	170	28	a	a	DET
dpc-1099	170	29	relapse	relapse	NOUN
dpc-1099	170	30	rate	rate	NOUN
dpc-1099	170	31	of	of	ADP
dpc-1099	170	32	20	20	NUM
dpc-1099	170	33	%	%	NOUN
dpc-1099	170	34	(	(	PUNCT
dpc-1099	170	35	2	2	NUM
dpc-1099	170	36	years	year	NOUN
dpc-1099	170	37	)	)	PUNCT
dpc-1099	170	38	to	to	ADP
dpc-1099	170	39	60	60	NUM
dpc-1099	170	40	%	%	NOUN
dpc-1099	170	41	(	(	PUNCT
dpc-1099	170	42	5	5	NUM
dpc-1099	170	43	years	year	NOUN
dpc-1099	170	44	)	)	PUNCT
dpc-1099	171	1	[	[	X
dpc-1099	171	2	49	49	NUM
dpc-1099	171	3	]	]	PUNCT
dpc-1099	171	4	.	.	PUNCT
dpc-1099	172	1	more	more	ADV
dpc-1099	172	2	robust	robust	ADJ
dpc-1099	172	3	evidence	evidence	NOUN
dpc-1099	172	4	showed	show	VERB
dpc-1099	172	5	a	a	DET
dpc-1099	172	6	higher	high	ADJ
dpc-1099	172	7	efficacy	efficacy	NOUN
dpc-1099	172	8	when	when	SCONJ
dpc-1099	172	9	it	it	PRON
dpc-1099	172	10	was	be	AUX
dpc-1099	172	11	administered	administer	VERB
dpc-1099	172	12	early	early	ADV
dpc-1099	172	13	in	in	ADP
dpc-1099	172	14	the	the	DET
dpc-1099	172	15	course	course	NOUN
dpc-1099	172	16	of	of	ADP
dpc-1099	172	17	the	the	DET
dpc-1099	172	18	disease	disease	NOUN
dpc-1099	172	19	[	[	X
dpc-1099	172	20	50	50	NUM
dpc-1099	172	21	]	]	PUNCT
dpc-1099	172	22	.	.	PUNCT
dpc-1099	173	1	ritux	ritux	PROPN
dpc-1099	173	2	3	3	NUM
dpc-1099	173	3	,	,	PUNCT
dpc-1099	173	4	a	a	DET
dpc-1099	173	5	prospective	prospective	ADJ
dpc-1099	173	6	,	,	PUNCT
dpc-1099	173	7	open	open	ADJ
dpc-1099	173	8	-	-	PUNCT
dpc-1099	173	9	label	label	NOUN
dpc-1099	173	10	,	,	PUNCT
dpc-1099	173	11	randomized	randomize	VERB
dpc-1099	173	12	clinical	clinical	ADJ
dpc-1099	173	13	trial	trial	NOUN
dpc-1099	173	14	investigated	investigate	VERB
dpc-1099	173	15	rituximab	rituximab	NOUN
dpc-1099	173	16	as	as	ADP
dpc-1099	173	17	first	first	ADJ
dpc-1099	173	18	-	-	PUNCT
dpc-1099	173	19	line	line	NOUN
dpc-1099	173	20	treatment	treatment	NOUN
dpc-1099	173	21	in	in	ADP
dpc-1099	173	22	combination	combination	NOUN
dpc-1099	173	23	with	with	ADP
dpc-1099	173	24	short	short	ADJ
dpc-1099	173	25	-	-	PUNCT
dpc-1099	173	26	term	term	NOUN
dpc-1099	173	27	prednisone	prednisone	NOUN
dpc-1099	173	28	vs	vs	ADP
dpc-1099	173	29	prednisone	prednisone	NOUN
dpc-1099	173	30	alone	alone	ADV
dpc-1099	173	31	for	for	ADP
dpc-1099	173	32	the	the	DET
dpc-1099	173	33	treatment	treatment	NOUN
dpc-1099	173	34	of	of	ADP
dpc-1099	173	35	pemphigus	pemphigus	PROPN
dpc-1099	173	36	.	.	PUNCT
dpc-1099	174	1	results	result	NOUN
dpc-1099	174	2	showed	show	VERB
dpc-1099	174	3	that	that	SCONJ
dpc-1099	174	4	first	first	ADJ
dpc-1099	174	5	-	-	PUNCT
dpc-1099	174	6	line	line	NOUN
dpc-1099	174	7	use	use	NOUN
dpc-1099	174	8	of	of	ADP
dpc-1099	174	9	rituximab	rituximab	NOUN
dpc-1099	174	10	plus	plus	CCONJ
dpc-1099	174	11	short	short	ADJ
dpc-1099	174	12	-	-	PUNCT
dpc-1099	174	13	term	term	NOUN
dpc-1099	174	14	prednisone	prednisone	NOUN
dpc-1099	174	15	for	for	ADP
dpc-1099	174	16	patients	patient	NOUN
dpc-1099	174	17	with	with	ADP
dpc-1099	174	18	pemphigus	pemphigus	NOUN
dpc-1099	174	19	is	be	AUX
dpc-1099	174	20	more	more	ADV
dpc-1099	174	21	effective	effective	ADJ
dpc-1099	174	22	than	than	ADP
dpc-1099	174	23	using	use	VERB
dpc-1099	174	24	prednisone	prednisone	NOUN
dpc-1099	174	25	alone	alone	ADV
dpc-1099	174	26	,	,	PUNCT
dpc-1099	174	27	with	with	ADP
dpc-1099	174	28	fewer	few	ADJ
dpc-1099	174	29	adverse	adverse	ADJ
dpc-1099	174	30	events	event	NOUN
dpc-1099	174	31	[	[	X
dpc-1099	174	32	50	50	NUM
dpc-1099	174	33	]	]	PUNCT
dpc-1099	174	34	.	.	PUNCT
dpc-1099	175	1	at	at	ADP
dpc-1099	175	2	month	month	NOUN
dpc-1099	175	3	24	24	NUM
dpc-1099	175	4	,	,	PUNCT
dpc-1099	175	5	89	89	NUM
dpc-1099	175	6	%	%	NOUN
dpc-1099	175	7	of	of	ADP
dpc-1099	175	8	46	46	NUM
dpc-1099	175	9	patients	patient	NOUN
dpc-1099	175	10	assigned	assign	VERB
dpc-1099	175	11	to	to	AUX
dpc-1099	175	12	rituximab	rituximab	VERB
dpc-1099	175	13	plus	plus	CCONJ
dpc-1099	175	14	short	short	ADJ
dpc-1099	175	15	-	-	PUNCT
dpc-1099	175	16	term	term	NOUN
dpc-1099	175	17	prednisone	prednisone	NOUN
dpc-1099	175	18	were	be	AUX
dpc-1099	175	19	in	in	ADP
dpc-1099	175	20	complete	complete	ADJ
dpc-1099	175	21	remission	remission	NOUN
dpc-1099	175	22	off	off	ADP
dpc-1099	175	23	therapy	therapy	NOUN
dpc-1099	175	24	vs	vs	ADP
dpc-1099	175	25	34	34	NUM
dpc-1099	175	26	%	%	NOUN
dpc-1099	175	27	of	of	ADP
dpc-1099	175	28	44	44	NUM
dpc-1099	175	29	assigned	assign	VERB
dpc-1099	175	30	to	to	ADP
dpc-1099	175	31	prednisone	prednisone	NOUN
dpc-1099	175	32	alone	alone	ADV
dpc-1099	175	33	.	.	PUNCT
dpc-1099	176	1	a	a	DET
dpc-1099	176	2	post	post	X
dpc-1099	176	3	hoc	hoc	X
dpc-1099	176	4	analysis	analysis	NOUN
dpc-1099	176	5	of	of	ADP
dpc-1099	176	6	the	the	DET
dpc-1099	176	7	enrolled	enrol	VERB
dpc-1099	176	8	patients	patient	NOUN
dpc-1099	176	9	in	in	ADP
dpc-1099	176	10	the	the	DET
dpc-1099	176	11	ritux	ritux	NOUN
dpc-1099	176	12	3	3	NUM
dpc-1099	176	13	study	study	NOUN
dpc-1099	176	14	showed	show	VERB
dpc-1099	176	15	a	a	DET
dpc-1099	176	16	steroid	steroid	NOUN
dpc-1099	176	17	-	-	PUNCT
dpc-1099	176	18	sparing	spare	VERB
dpc-1099	176	19	effect	effect	NOUN
dpc-1099	176	20	of	of	ADP
dpc-1099	176	21	rituximab	rituximab	NOUN
dpc-1099	176	22	,	,	PUNCT
dpc-1099	176	23	with	with	ADP
dpc-1099	176	24	rituximab	rituximab	NOUN
dpc-1099	176	25	-	-	PUNCT
dpc-1099	176	26	treated	treat	VERB
dpc-1099	176	27	patients	patient	NOUN
dpc-1099	176	28	having	have	VERB
dpc-1099	176	29	lower	low	ADJ
dpc-1099	176	30	cumulative	cumulative	ADJ
dpc-1099	176	31	and	and	CCONJ
dpc-1099	176	32	cardiovascular	cardiovascular	ADJ
dpc-1099	176	33	disease	disease	NOUN
dpc-1099	176	34	.	.	PUNCT
dpc-1099	177	1	therefore	therefore	ADV
dpc-1099	177	2	,	,	PUNCT
dpc-1099	177	3	correct	correct	ADJ
dpc-1099	177	4	management	management	NOUN
dpc-1099	177	5	of	of	ADP
dpc-1099	177	6	the	the	DET
dpc-1099	177	7	comorbidities	comorbiditie	NOUN
dpc-1099	177	8	of	of	ADP
dpc-1099	177	9	pemphigus	pemphigus	NOUN
dpc-1099	177	10	is	be	AUX
dpc-1099	177	11	crucial	crucial	ADJ
dpc-1099	177	12	to	to	PART
dpc-1099	177	13	decrease	decrease	VERB
dpc-1099	177	14	disease‐associated	disease‐associate	VERB
dpc-1099	177	15	morbidity	morbidity	NOUN
dpc-1099	177	16	and	and	CCONJ
dpc-1099	177	17	mortality	mortality	NOUN
dpc-1099	177	18	.	.	PUNCT
dpc-1099	178	1	the	the	DET
dpc-1099	178	2	traditional	traditional	ADJ
dpc-1099	178	3	treatment	treatment	NOUN
dpc-1099	178	4	paradigm	paradigm	NOUN
dpc-1099	178	5	of	of	ADP
dpc-1099	178	6	pv	pv	NOUN
dpc-1099	178	7	relies	relie	NOUN
dpc-1099	178	8	on	on	ADP
dpc-1099	178	9	systemic	systemic	ADJ
dpc-1099	178	10	corticosteroid	corticosteroid	ADJ
dpc-1099	178	11	immunosuppression	immunosuppression	NOUN
dpc-1099	178	12	.	.	PUNCT
dpc-1099	179	1	prednisone	prednisone	PROPN
dpc-1099	179	2	is	be	AUX
dpc-1099	179	3	usually	usually	ADV
dpc-1099	179	4	given	give	VERB
dpc-1099	179	5	at	at	ADP
dpc-1099	179	6	0.5	0.5	NUM
dpc-1099	179	7	-	-	SYM
dpc-1099	179	8	1.5	1.5	NUM
dpc-1099	179	9	mg	mg	PROPN
dpc-1099	179	10	/	/	SYM
dpc-1099	179	11	kg	kg	NOUN
dpc-1099	179	12	/	/	SYM
dpc-1099	179	13	day	day	NOUN
dpc-1099	179	14	as	as	ADP
dpc-1099	179	15	a	a	DET
dpc-1099	179	16	typical	typical	ADJ
dpc-1099	179	17	initial	initial	ADJ
dpc-1099	179	18	dosage	dosage	NOUN
dpc-1099	179	19	.	.	PUNCT
dpc-1099	180	1	the	the	DET
dpc-1099	180	2	therapeutic	therapeutic	ADJ
dpc-1099	180	3	effect	effect	NOUN
dpc-1099	180	4	is	be	AUX
dpc-1099	180	5	evaluated	evaluate	VERB
dpc-1099	180	6	by	by	ADP
dpc-1099	180	7	the	the	DET
dpc-1099	180	8	number	number	NOUN
dpc-1099	180	9	of	of	ADP
dpc-1099	180	10	new	new	ADJ
dpc-1099	180	11	blisters	blister	NOUN
dpc-1099	180	12	per	per	ADP
dpc-1099	180	13	day	day	NOUN
dpc-1099	180	14	and	and	CCONJ
dpc-1099	180	15	the	the	DET
dpc-1099	180	16	ability	ability	NOUN
dpc-1099	180	17	to	to	PART
dpc-1099	180	18	stop	stop	VERB
dpc-1099	180	19	the	the	DET
dpc-1099	180	20	blistering	blister	VERB
dpc-1099	180	21	eruption	eruption	NOUN
dpc-1099	180	22	.	.	PUNCT
dpc-1099	181	1	in	in	ADP
dpc-1099	181	2	refractory	refractory	NOUN
dpc-1099	181	3	cases	case	NOUN
dpc-1099	181	4	,	,	PUNCT
dpc-1099	181	5	the	the	DET
dpc-1099	181	6	initial	initial	ADJ
dpc-1099	181	7	dose	dose	NOUN
dpc-1099	181	8	may	may	AUX
dpc-1099	181	9	be	be	AUX
dpc-1099	181	10	increased	increase	VERB
dpc-1099	181	11	to	to	ADP
dpc-1099	181	12	2	2	NUM
dpc-1099	181	13	mg	mg	PROPN
dpc-1099	181	14	/	/	SYM
dpc-1099	181	15	kg	kg	PROPN
dpc-1099	181	16	/	/	SYM
dpc-1099	181	17	day	day	NOUN
dpc-1099	181	18	.	.	PUNCT
dpc-1099	182	1	on	on	ADP
dpc-1099	182	2	the	the	DET
dpc-1099	182	3	other	other	ADJ
dpc-1099	182	4	hand	hand	NOUN
dpc-1099	182	5	,	,	PUNCT
dpc-1099	182	6	if	if	SCONJ
dpc-1099	182	7	clinical	clinical	ADJ
dpc-1099	182	8	remission	remission	NOUN
dpc-1099	182	9	is	be	AUX
dpc-1099	182	10	obtained	obtain	VERB
dpc-1099	182	11	and	and	CCONJ
dpc-1099	182	12	no	no	DET
dpc-1099	182	13	new	new	ADJ
dpc-1099	182	14	blisters	blister	NOUN
dpc-1099	182	15	occur	occur	VERB
dpc-1099	182	16	,	,	PUNCT
dpc-1099	182	17	glucocorticoids	glucocorticoid	NOUN
dpc-1099	182	18	may	may	AUX
dpc-1099	182	19	be	be	AUX
dpc-1099	182	20	gradually	gradually	ADV
dpc-1099	182	21	tapered	taper	VERB
dpc-1099	182	22	.	.	PUNCT
dpc-1099	183	1	appropriate	appropriate	ADJ
dpc-1099	183	2	steroid‐tapering	steroid‐tapere	VERB
dpc-1099	183	3	strategies	strategy	NOUN
dpc-1099	183	4	may	may	AUX
dpc-1099	183	5	prevent	prevent	VERB
dpc-1099	183	6	relapses	relapse	NOUN
dpc-1099	183	7	,	,	PUNCT
dpc-1099	183	8	although	although	SCONJ
dpc-1099	183	9	an	an	DET
dpc-1099	183	10	optimal	optimal	ADJ
dpc-1099	183	11	treatment	treatment	NOUN
dpc-1099	183	12	regimen	regimen	NOUN
dpc-1099	183	13	remains	remain	VERB
dpc-1099	183	14	indeterminable	indeterminable	ADJ
dpc-1099	183	15	because	because	SCONJ
dpc-1099	183	16	of	of	ADP
dpc-1099	183	17	the	the	DET
dpc-1099	183	18	lack	lack	NOUN
dpc-1099	183	19	of	of	ADP
dpc-1099	183	20	evidence	evidence	NOUN
dpc-1099	183	21	.	.	PUNCT
dpc-1099	184	1	a	a	DET
dpc-1099	184	2	decrease	decrease	NOUN
dpc-1099	184	3	in	in	ADP
dpc-1099	184	4	the	the	DET
dpc-1099	184	5	titers	titer	NOUN
dpc-1099	184	6	of	of	ADP
dpc-1099	184	7	circulating	circulate	VERB
dpc-1099	184	8	autoantibodies	autoantibody	NOUN
dpc-1099	184	9	may	may	AUX
dpc-1099	184	10	drive	drive	VERB
dpc-1099	184	11	tapering	tapering	NOUN
dpc-1099	184	12	decisions	decision	NOUN
dpc-1099	184	13	.	.	PUNCT
dpc-1099	185	1	recommendations	recommendation	NOUN
dpc-1099	185	2	by	by	ADP
dpc-1099	185	3	an	an	DET
dpc-1099	185	4	international	international	ADJ
dpc-1099	185	5	expert	expert	NOUN
dpc-1099	185	6	panel	panel	NOUN
dpc-1099	185	7	are	be	AUX
dpc-1099	185	8	to	to	PART
dpc-1099	185	9	check	check	VERB
dpc-1099	185	10	serum	serum	NOUN
dpc-1099	185	11	autoantibodies	autoantibody	NOUN
dpc-1099	185	12	at	at	ADP
dpc-1099	185	13	the	the	DET
dpc-1099	185	14	initiation	initiation	NOUN
dpc-1099	185	15	of	of	ADP
dpc-1099	185	16	treatment	treatment	NOUN
dpc-1099	185	17	,	,	PUNCT
dpc-1099	185	18	after	after	ADP
dpc-1099	185	19	3	3	NUM
dpc-1099	185	20	months	month	NOUN
dpc-1099	185	21	and	and	CCONJ
dpc-1099	185	22	every	every	DET
dpc-1099	185	23	3	3	NUM
dpc-1099	185	24	-	-	SYM
dpc-1099	185	25	6	6	NUM
dpc-1099	185	26	months	month	NOUN
dpc-1099	185	27	,	,	PUNCT
dpc-1099	185	28	or	or	CCONJ
dpc-1099	185	29	in	in	ADP
dpc-1099	185	30	case	case	NOUN
dpc-1099	185	31	of	of	ADP
dpc-1099	185	32	relapse	relapse	NOUN
dpc-1099	185	33	[	[	X
dpc-1099	185	34	44	44	NUM
dpc-1099	185	35	]	]	PUNCT
dpc-1099	185	36	.	.	PUNCT
dpc-1099	186	1	control	control	NOUN
dpc-1099	186	2	of	of	ADP
dpc-1099	186	3	disease	disease	NOUN
dpc-1099	186	4	activity	activity	NOUN
dpc-1099	186	5	is	be	AUX
dpc-1099	186	6	usually	usually	ADV
dpc-1099	186	7	achieved	achieve	VERB
dpc-1099	186	8	within	within	ADP
dpc-1099	186	9	several	several	ADJ
dpc-1099	186	10	weeks	week	NOUN
dpc-1099	186	11	,	,	PUNCT
dpc-1099	186	12	whereas	whereas	SCONJ
dpc-1099	186	13	complete	complete	ADJ
dpc-1099	186	14	remission	remission	NOUN
dpc-1099	186	15	of	of	ADP
dpc-1099	186	16	quiescent	quiescent	ADJ
dpc-1099	186	17	disease	disease	NOUN
dpc-1099	186	18	on	on	ADP
dpc-1099	186	19	minimal	minimal	ADJ
dpc-1099	186	20	treatment	treatment	NOUN
dpc-1099	186	21	(	(	PUNCT
dpc-1099	186	22	≤10	≤10	ADJ
dpc-1099	186	23	mg	mg	PROPN
dpc-1099	186	24	/	/	SYM
dpc-1099	186	25	day	day	NOUN
dpc-1099	186	26	prednisone	prednisone	NOUN
dpc-1099	186	27	)	)	PUNCT
dpc-1099	186	28	more	more	ADV
dpc-1099	186	29	often	often	ADV
dpc-1099	186	30	requires	require	VERB
dpc-1099	186	31	several	several	ADJ
dpc-1099	186	32	months	month	NOUN
dpc-1099	186	33	.	.	PUNCT
dpc-1099	187	1	long	long	ADJ
dpc-1099	187	2	-	-	PUNCT
dpc-1099	187	3	term	term	NOUN
dpc-1099	187	4	,	,	PUNCT
dpc-1099	187	5	complete	complete	ADJ
dpc-1099	187	6	remission	remission	NOUN
dpc-1099	187	7	off	off	ADP
dpc-1099	187	8	treatment	treatment	NOUN
dpc-1099	187	9	may	may	AUX
dpc-1099	187	10	require	require	VERB
dpc-1099	187	11	years	year	NOUN
dpc-1099	187	12	of	of	ADP
dpc-1099	187	13	therapy	therapy	NOUN
dpc-1099	187	14	[	[	X
dpc-1099	187	15	45	45	NUM
dpc-1099	187	16	]	]	PUNCT
dpc-1099	187	17	.	.	PUNCT
dpc-1099	188	1	additional	additional	ADJ
dpc-1099	188	2	immunosuppressive	immunosuppressive	ADJ
dpc-1099	188	3	adjuvants	adjuvant	NOUN
dpc-1099	188	4	,	,	PUNCT
dpc-1099	188	5	such	such	ADJ
dpc-1099	188	6	as	as	ADP
dpc-1099	188	7	azathioprine	azathioprine	NOUN
dpc-1099	188	8	(	(	PUNCT
dpc-1099	188	9	1	1	NUM
dpc-1099	188	10	-	-	SYM
dpc-1099	188	11	3	3	NUM
dpc-1099	188	12	mg	mg	PROPN
dpc-1099	188	13	/	/	SYM
dpc-1099	188	14	kg	kg	PROPN
dpc-1099	188	15	/	/	SYM
dpc-1099	188	16	day	day	NOUN
dpc-1099	188	17	)	)	PUNCT
dpc-1099	188	18	or	or	CCONJ
dpc-1099	188	19	mycophenolate	mycophenolate	PROPN
dpc-1099	188	20	mofetil	mofetil	NOUN
dpc-1099	188	21	(	(	PUNCT
dpc-1099	188	22	2	2	NUM
dpc-1099	188	23	g/	g/	NOUN
dpc-1099	188	24	day	day	NOUN
dpc-1099	188	25	)	)	PUNCT
dpc-1099	188	26	,	,	PUNCT
dpc-1099	188	27	are	be	AUX
dpc-1099	188	28	often	often	ADV
dpc-1099	188	29	administered	administer	VERB
dpc-1099	188	30	at	at	ADP
dpc-1099	188	31	initiation	initiation	NOUN
dpc-1099	188	32	of	of	ADP
dpc-1099	188	33	treatment	treatment	NOUN
dpc-1099	188	34	or	or	CCONJ
dpc-1099	188	35	in	in	ADP
dpc-1099	188	36	refractory	refractory	NOUN
dpc-1099	188	37	cases	case	NOUN
dpc-1099	188	38	in	in	ADP
dpc-1099	188	39	order	order	NOUN
dpc-1099	188	40	to	to	PART
dpc-1099	188	41	achieve	achieve	VERB
dpc-1099	188	42	faster	fast	ADV
dpc-1099	188	43	or	or	CCONJ
dpc-1099	188	44	better	well	ADJ
dpc-1099	188	45	control	control	NOUN
dpc-1099	188	46	of	of	ADP
dpc-1099	188	47	the	the	DET
dpc-1099	188	48	disease	disease	NOUN
dpc-1099	188	49	and	and	CCONJ
dpc-1099	188	50	spare	spare	ADJ
dpc-1099	188	51	corticosteroids	corticosteroid	NOUN
dpc-1099	188	52	,	,	PUNCT
dpc-1099	188	53	respectively	respectively	ADV
dpc-1099	188	54	.	.	PUNCT
dpc-1099	189	1	second	second	ADJ
dpc-1099	189	2	-	-	PUNCT
dpc-1099	189	3	line	line	NOUN
dpc-1099	189	4	adjuvants	adjuvant	NOUN
dpc-1099	189	5	include	include	VERB
dpc-1099	189	6	cyclophosphamide	cyclophosphamide	NOUN
dpc-1099	189	7	,	,	PUNCT
dpc-1099	189	8	methotrexate	methotrexate	NOUN
dpc-1099	189	9	,	,	PUNCT
dpc-1099	189	10	intravenous	intravenous	ADJ
dpc-1099	189	11	immunoglobulins	immunoglobulin	NOUN
dpc-1099	189	12	,	,	PUNCT
dpc-1099	189	13	and	and	CCONJ
dpc-1099	189	14	immunoadsorption	immunoadsorption	NOUN
dpc-1099	189	15	.	.	PUNCT
dpc-1099	190	1	the	the	DET
dpc-1099	190	2	latter	latter	ADJ
dpc-1099	190	3	treatment	treatment	NOUN
dpc-1099	190	4	consists	consist	VERB
dpc-1099	190	5	of	of	ADP
dpc-1099	190	6	the	the	DET
dpc-1099	190	7	passive	passive	ADJ
dpc-1099	190	8	removal	removal	NOUN
dpc-1099	190	9	of	of	ADP
dpc-1099	190	10	igg	igg	PROPN
dpc-1099	190	11	from	from	ADP
dpc-1099	190	12	the	the	DET
dpc-1099	190	13	patient	patient	NOUN
dpc-1099	190	14	’s	’s	PART
dpc-1099	190	15	systemic	systemic	ADJ
dpc-1099	190	16	circulation	circulation	NOUN
dpc-1099	190	17	.	.	PUNCT
dpc-1099	191	1	when	when	SCONJ
dpc-1099	191	2	complete	complete	ADJ
dpc-1099	191	3	remission	remission	NOUN
dpc-1099	191	4	is	be	AUX
dpc-1099	191	5	obtained	obtain	VERB
dpc-1099	191	6	with	with	ADP
dpc-1099	191	7	combined	combined	ADJ
dpc-1099	191	8	therapy	therapy	NOUN
dpc-1099	191	9	,	,	PUNCT
dpc-1099	191	10	the	the	DET
dpc-1099	191	11	dosage	dosage	NOUN
dpc-1099	191	12	of	of	ADP
dpc-1099	191	13	the	the	DET
dpc-1099	191	14	immutable	immutable	ADJ
dpc-1099	191	15	4	4	NUM
dpc-1099	191	16	.	.	PUNCT
dpc-1099	191	17	dosage	dosage	NOUN
dpc-1099	191	18	and	and	CCONJ
dpc-1099	191	19	pretreatment	pretreatment	NOUN
dpc-1099	191	20	investigations	investigation	NOUN
dpc-1099	191	21	for	for	ADP
dpc-1099	191	22	rituximab	rituximab	NOUN
dpc-1099	191	23	in	in	ADP
dpc-1099	191	24	pemphigus	pemphigus	NOUN
dpc-1099	191	25	vulgaris	vulgaris	NOUN
dpc-1099	191	26	rituximab	rituximab	NOUN
dpc-1099	191	27	dosage	dosage	NOUN
dpc-1099	191	28	pretreatment	pretreatment	NOUN
dpc-1099	191	29	investigations	investigation	NOUN
dpc-1099	191	30	contraindications	contraindication	NOUN
dpc-1099	191	31	adverse	adverse	ADJ
dpc-1099	191	32	events	event	NOUN
dpc-1099	191	33	two	two	NUM
dpc-1099	191	34	1,000	1,000	NUM
dpc-1099	191	35	-	-	PUNCT
dpc-1099	191	36	mg	mg	NOUN
dpc-1099	191	37	intravenous	intravenous	ADJ
dpc-1099	191	38	infusions	infusion	NOUN
dpc-1099	191	39	separated	separate	VERB
dpc-1099	191	40	by	by	ADP
dpc-1099	191	41	2	2	NUM
dpc-1099	191	42	weeks	week	NOUN
dpc-1099	192	1	[	[	X
dpc-1099	192	2	1	1	NUM
dpc-1099	192	3	]	]	PUNCT
dpc-1099	192	4	;	;	PUNCT
dpc-1099	192	5	lower	low	ADJ
dpc-1099	192	6	doses	dose	NOUN
dpc-1099	192	7	(	(	PUNCT
dpc-1099	192	8	500	500	NUM
dpc-1099	192	9	mg	mg	NOUN
dpc-1099	192	10	)	)	PUNCT
dpc-1099	192	11	may	may	AUX
dpc-1099	192	12	be	be	AUX
dpc-1099	192	13	used	use	VERB
dpc-1099	192	14	for	for	ADP
dpc-1099	192	15	retreatment	retreatment	NOUN
dpc-1099	192	16	(	(	PUNCT
dpc-1099	192	17	at	at	ADP
dpc-1099	192	18	month	month	NOUN
dpc-1099	192	19	12	12	NUM
dpc-1099	192	20	and	and	CCONJ
dpc-1099	192	21	every	every	DET
dpc-1099	192	22	6	6	NUM
dpc-1099	192	23	months	month	NOUN
dpc-1099	192	24	thereafter	thereafter	ADV
dpc-1099	192	25	)	)	PUNCT
dpc-1099	192	26	;	;	PUNCT
dpc-1099	192	27	methylprednisolone	methylprednisolone	NOUN
dpc-1099	192	28	100	100	NUM
dpc-1099	192	29	mg	mg	ADP
dpc-1099	192	30	intravenous	intravenous	ADJ
dpc-1099	192	31	or	or	CCONJ
dpc-1099	192	32	equivalent	equivalent	ADJ
dpc-1099	192	33	glucocorticoid	glucocorticoid	NOUN
dpc-1099	192	34	is	be	AUX
dpc-1099	192	35	recommended	recommend	VERB
dpc-1099	192	36	30	30	NUM
dpc-1099	192	37	minutes	minute	NOUN
dpc-1099	192	38	prior	prior	ADV
dpc-1099	192	39	to	to	ADP
dpc-1099	192	40	each	each	DET
dpc-1099	192	41	infusion	infusion	NOUN
dpc-1099	192	42	complete	complete	ADJ
dpc-1099	192	43	blood	blood	NOUN
dpc-1099	192	44	cell	cell	NOUN
dpc-1099	192	45	count	count	NOUN
dpc-1099	192	46	,	,	PUNCT
dpc-1099	192	47	liver	liver	NOUN
dpc-1099	192	48	and	and	CCONJ
dpc-1099	192	49	renal	renal	ADJ
dpc-1099	192	50	function	function	NOUN
dpc-1099	192	51	tests	test	NOUN
dpc-1099	192	52	,	,	PUNCT
dpc-1099	192	53	creatinine	creatinine	NOUN
dpc-1099	192	54	,	,	PUNCT
dpc-1099	192	55	interferon	interferon	ADJ
dpc-1099	192	56	gamma	gamma	NOUN
dpc-1099	192	57	release	release	PROPN
dpc-1099	192	58	assay	assay	PROPN
dpc-1099	192	59	,	,	PUNCT
dpc-1099	192	60	hepatitis	hepatitis	PROPN
dpc-1099	192	61	b	b	PROPN
dpc-1099	192	62	and	and	CCONJ
dpc-1099	192	63	hepatitis	hepatitis	PROPN
dpc-1099	192	64	c	c	PROPN
dpc-1099	192	65	markers	marker	NOUN
dpc-1099	192	66	,	,	PUNCT
dpc-1099	192	67	hiv	hiv	PROPN
dpc-1099	192	68	antibodies	antibodie	VERB
dpc-1099	192	69	,	,	PUNCT
dpc-1099	192	70	chest	chest	NOUN
dpc-1099	192	71	x	x	NOUN
dpc-1099	192	72	-	-	NOUN
dpc-1099	192	73	ray	ray	NOUN
dpc-1099	192	74	,	,	PUNCT
dpc-1099	192	75	ecg	ecg	PROPN
dpc-1099	192	76	,	,	PUNCT
dpc-1099	192	77	cardiological	cardiological	ADJ
dpc-1099	192	78	examination	examination	NOUN
dpc-1099	192	79	active	active	ADJ
dpc-1099	192	80	,	,	PUNCT
dpc-1099	192	81	severe	severe	ADJ
dpc-1099	192	82	infections	infection	NOUN
dpc-1099	192	83	,	,	PUNCT
dpc-1099	192	84	severely	severely	ADV
dpc-1099	192	85	immunocompromised	immunocompromise	VERB
dpc-1099	192	86	state	state	NOUN
dpc-1099	192	87	,	,	PUNCT
dpc-1099	192	88	severe	severe	ADJ
dpc-1099	192	89	heart	heart	NOUN
dpc-1099	192	90	failure	failure	NOUN
dpc-1099	192	91	(	(	PUNCT
dpc-1099	192	92	new	new	PROPN
dpc-1099	192	93	york	york	PROPN
dpc-1099	192	94	heart	heart	PROPN
dpc-1099	192	95	association	association	PROPN
dpc-1099	192	96	class	class	PROPN
dpc-1099	192	97	iv	iv	NOUN
dpc-1099	192	98	)	)	PUNCT
dpc-1099	192	99	or	or	CCONJ
dpc-1099	192	100	severe	severe	ADJ
dpc-1099	192	101	,	,	PUNCT
dpc-1099	192	102	uncontrolled	uncontrolled	ADJ
dpc-1099	192	103	cardiac	cardiac	ADJ
dpc-1099	192	104	disease	disease	NOUN
dpc-1099	192	105	,	,	PUNCT
dpc-1099	192	106	cardiomyopathy	cardiomyopathy	ADJ
dpc-1099	192	107	,	,	PUNCT
dpc-1099	192	108	ischemic	ischemic	ADJ
dpc-1099	192	109	heart	heart	NOUN
dpc-1099	192	110	disease	disease	NOUN
dpc-1099	192	111	,	,	PUNCT
dpc-1099	192	112	severe	severe	ADJ
dpc-1099	192	113	arrhythmias	arrhythmia	NOUN
dpc-1099	192	114	such	such	ADJ
dpc-1099	192	115	as	as	ADP
dpc-1099	192	116	rapid	rapid	ADJ
dpc-1099	192	117	atrial	atrial	ADJ
dpc-1099	192	118	fibrillation	fibrillation	NOUN
dpc-1099	192	119	,	,	PUNCT
dpc-1099	192	120	frequent	frequent	ADJ
dpc-1099	192	121	premature	premature	ADJ
dpc-1099	192	122	ventricular	ventricular	ADJ
dpc-1099	192	123	contractions	contraction	NOUN
dpc-1099	192	124	infusion	infusion	NOUN
dpc-1099	192	125	reactions	reaction	NOUN
dpc-1099	192	126	,	,	PUNCT
dpc-1099	192	127	depression	depression	NOUN
dpc-1099	192	128	,	,	PUNCT
dpc-1099	192	129	infections	infection	NOUN
dpc-1099	192	130	,	,	PUNCT
dpc-1099	192	131	cardiac	cardiac	ADJ
dpc-1099	192	132	disorders	disorder	NOUN
dpc-1099	192	133	,	,	PUNCT
dpc-1099	192	134	rare	rare	ADJ
dpc-1099	192	135	cases	case	NOUN
dpc-1099	192	136	of	of	ADP
dpc-1099	192	137	fatal	fatal	ADJ
dpc-1099	192	138	progressive	progressive	ADJ
dpc-1099	192	139	multifocal	multifocal	ADJ
dpc-1099	192	140	leukoencephalopathy	leukoencephalopathy	NOUN
dpc-1099	192	141	the	the	DET
dpc-1099	192	142	dosing	dose	VERB
dpc-1099	192	143	protocol	protocol	NOUN
dpc-1099	192	144	corresponds	correspond	VERB
dpc-1099	192	145	to	to	ADP
dpc-1099	192	146	that	that	PRON
dpc-1099	192	147	of	of	ADP
dpc-1099	192	148	the	the	DET
dpc-1099	192	149	european	european	PROPN
dpc-1099	192	150	medicine	medicine	PROPN
dpc-1099	192	151	agency	agency	NOUN
dpc-1099	192	152	’s	’s	PART
dpc-1099	192	153	“	"	PUNCT
dpc-1099	192	154	summary	summary	NOUN
dpc-1099	192	155	of	of	ADP
dpc-1099	192	156	product	product	NOUN
dpc-1099	192	157	characteristics	characteristic	NOUN
dpc-1099	192	158	”	"	PUNCT
dpc-1099	192	159	and	and	CCONJ
dpc-1099	192	160	us	we	PRON
dpc-1099	192	161	food	food	NOUN
dpc-1099	192	162	and	and	CCONJ
dpc-1099	192	163	drug	drug	PROPN
dpc-1099	192	164	administration	administration	NOUN
dpc-1099	192	165	’s	’s	PART
dpc-1099	192	166	highlights	highlight	NOUN
dpc-1099	192	167	of	of	ADP
dpc-1099	192	168	prescribing	prescribe	VERB
dpc-1099	192	169	information	information	NOUN
dpc-1099	192	170	.	.	PUNCT
dpc-1099	193	1	different	different	ADJ
dpc-1099	193	2	dosing	dose	VERB
dpc-1099	193	3	protocols	protocol	NOUN
dpc-1099	193	4	are	be	AUX
dpc-1099	193	5	reported	report	VERB
dpc-1099	193	6	in	in	ADP
dpc-1099	193	7	expert	expert	ADJ
dpc-1099	193	8	recommendations	recommendation	NOUN
dpc-1099	193	9	and	and	CCONJ
dpc-1099	193	10	therapeutic	therapeutic	ADJ
dpc-1099	193	11	guidelines	guideline	NOUN
dpc-1099	193	12	[	[	X
dpc-1099	193	13	42,50	42,50	X
dpc-1099	193	14	]	]	X
dpc-1099	193	15	.	.	PUNCT
dpc-1099	194	1	8	8	NUM
dpc-1099	194	2	review	review	NOUN
dpc-1099	194	3	|	|	ADV
dpc-1099	194	4	dermatol	dermatol	ADJ
dpc-1099	194	5	pract	pract	NOUN
dpc-1099	194	6	concept	concept	NOUN
dpc-1099	194	7	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	194	8	bullous	bullous	ADJ
dpc-1099	194	9	pemphigoid	pemphigoid	ADV
dpc-1099	194	10	although	although	SCONJ
dpc-1099	194	11	there	there	PRON
dpc-1099	194	12	is	be	VERB
dpc-1099	194	13	no	no	DET
dpc-1099	194	14	generally	generally	ADV
dpc-1099	194	15	accepted	accept	VERB
dpc-1099	194	16	classification	classification	NOUN
dpc-1099	194	17	of	of	ADP
dpc-1099	194	18	disease	disease	NOUN
dpc-1099	194	19	severity	severity	NOUN
dpc-1099	194	20	,	,	PUNCT
dpc-1099	194	21	a	a	DET
dpc-1099	194	22	classification	classification	NOUN
dpc-1099	194	23	of	of	ADP
dpc-1099	194	24	bp	bp	PROPN
dpc-1099	194	25	into	into	ADP
dpc-1099	194	26	mild	mild	ADJ
dpc-1099	194	27	(	(	PUNCT
dpc-1099	194	28	<	<	X
dpc-1099	194	29	10	10	NUM
dpc-1099	194	30	%	%	NOUN
dpc-1099	194	31	affected	affected	ADJ
dpc-1099	194	32	body	body	NOUN
dpc-1099	194	33	surface	surface	NOUN
dpc-1099	194	34	area	area	NOUN
dpc-1099	194	35	)	)	PUNCT
dpc-1099	194	36	,	,	PUNCT
dpc-1099	194	37	moderate	moderate	ADJ
dpc-1099	194	38	,	,	PUNCT
dpc-1099	194	39	and	and	CCONJ
dpc-1099	194	40	severe	severe	ADJ
dpc-1099	194	41	forms	form	NOUN
dpc-1099	194	42	has	have	AUX
dpc-1099	194	43	been	be	AUX
dpc-1099	194	44	suggested	suggest	VERB
dpc-1099	194	45	[	[	X
dpc-1099	194	46	57	57	NUM
dpc-1099	194	47	]	]	PUNCT
dpc-1099	194	48	.	.	PUNCT
dpc-1099	195	1	the	the	DET
dpc-1099	195	2	effectiveness	effectiveness	NOUN
dpc-1099	195	3	of	of	ADP
dpc-1099	195	4	topical	topical	ADJ
dpc-1099	195	5	therapy	therapy	NOUN
dpc-1099	195	6	with	with	ADP
dpc-1099	195	7	superpotent	superpotent	NOUN
dpc-1099	195	8	topical	topical	ADJ
dpc-1099	195	9	corticosteroids	corticosteroid	NOUN
dpc-1099	195	10	in	in	ADP
dpc-1099	195	11	localized	localized	ADJ
dpc-1099	195	12	and	and	CCONJ
dpc-1099	195	13	moderate	moderate	ADJ
dpc-1099	195	14	forms	form	NOUN
dpc-1099	195	15	of	of	ADP
dpc-1099	195	16	bp	bp	PROPN
dpc-1099	195	17	is	be	AUX
dpc-1099	195	18	supported	support	VERB
dpc-1099	195	19	by	by	ADP
dpc-1099	195	20	a	a	DET
dpc-1099	195	21	cochrane	cochrane	NOUN
dpc-1099	195	22	review	review	NOUN
dpc-1099	195	23	[	[	X
dpc-1099	195	24	38,58	38,58	NUM
dpc-1099	195	25	]	]	PUNCT
dpc-1099	195	26	.	.	PUNCT
dpc-1099	196	1	be	be	AUX
dpc-1099	196	2	aware	aware	ADJ
dpc-1099	196	3	that	that	SCONJ
dpc-1099	196	4	the	the	DET
dpc-1099	196	5	dose	dose	NOUN
dpc-1099	196	6	of	of	ADP
dpc-1099	196	7	40	40	NUM
dpc-1099	196	8	g	g	NOUN
dpc-1099	196	9	every	every	DET
dpc-1099	196	10	day	day	NOUN
dpc-1099	196	11	or	or	CCONJ
dpc-1099	196	12	10	10	NUM
dpc-1099	196	13	to	to	PART
dpc-1099	196	14	30	30	NUM
dpc-1099	196	15	g	g	NOUN
dpc-1099	196	16	every	every	DET
dpc-1099	196	17	day	day	NOUN
dpc-1099	196	18	[	[	X
dpc-1099	196	19	59,60	59,60	NUM
dpc-1099	196	20	]	]	PUNCT
dpc-1099	196	21	,	,	PUNCT
dpc-1099	196	22	which	which	PRON
dpc-1099	196	23	has	have	AUX
dpc-1099	196	24	proven	prove	VERB
dpc-1099	196	25	equally	equally	ADV
dpc-1099	196	26	effective	effective	ADJ
dpc-1099	196	27	as	as	ADP
dpc-1099	196	28	systemic	systemic	ADJ
dpc-1099	196	29	prednisolone	prednisolone	PROPN
dpc-1099	196	30	,	,	PUNCT
dpc-1099	196	31	is	be	AUX
dpc-1099	196	32	equivalent	equivalent	ADJ
dpc-1099	196	33	to	to	ADP
dpc-1099	196	34	about	about	ADP
dpc-1099	196	35	a	a	DET
dpc-1099	196	36	tube	tube	NOUN
dpc-1099	196	37	per	per	ADP
dpc-1099	196	38	day	day	NOUN
dpc-1099	196	39	.	.	PUNCT
dpc-1099	197	1	practicability	practicability	NOUN
dpc-1099	197	2	and	and	CCONJ
dpc-1099	197	3	limitations	limitation	NOUN
dpc-1099	197	4	of	of	ADP
dpc-1099	197	5	this	this	DET
dpc-1099	197	6	drug	drug	NOUN
dpc-1099	197	7	regimen	regiman	NOUN
dpc-1099	197	8	are	be	AUX
dpc-1099	197	9	that	that	SCONJ
dpc-1099	197	10	for	for	ADP
dpc-1099	197	11	some	some	DET
dpc-1099	197	12	patients	patient	NOUN
dpc-1099	197	13	with	with	ADP
dpc-1099	197	14	bp	bp	PROPN
dpc-1099	197	15	,	,	PUNCT
dpc-1099	197	16	a	a	DET
dpc-1099	197	17	twice	twice	ADV
dpc-1099	197	18	-	-	PUNCT
dpc-1099	197	19	daily	daily	ADJ
dpc-1099	197	20	topical	topical	ADJ
dpc-1099	197	21	application	application	NOUN
dpc-1099	197	22	[	[	X
dpc-1099	197	23	57	57	NUM
dpc-1099	197	24	]	]	PUNCT
dpc-1099	197	25	on	on	ADP
dpc-1099	197	26	widespread	widespread	ADJ
dpc-1099	197	27	areas	area	NOUN
dpc-1099	197	28	or	or	CCONJ
dpc-1099	197	29	the	the	DET
dpc-1099	197	30	daily	daily	ADJ
dpc-1099	197	31	purchase	purchase	NOUN
dpc-1099	197	32	of	of	ADP
dpc-1099	197	33	an	an	DET
dpc-1099	197	34	ointment	ointment	NOUN
dpc-1099	197	35	tube	tube	NOUN
dpc-1099	197	36	may	may	AUX
dpc-1099	197	37	not	not	PART
dpc-1099	197	38	be	be	AUX
dpc-1099	197	39	manageable	manageable	ADJ
dpc-1099	197	40	.	.	PUNCT
dpc-1099	198	1	in	in	ADP
dpc-1099	198	2	the	the	DET
dpc-1099	198	3	localized	localize	VERB
dpc-1099	198	4	,	,	PUNCT
dpc-1099	198	5	nonsevere	nonsevere	ADJ
dpc-1099	198	6	forms	form	NOUN
dpc-1099	198	7	,	,	PUNCT
dpc-1099	198	8	immunomodulatory	immunomodulatory	ADJ
dpc-1099	198	9	,	,	PUNCT
dpc-1099	198	10	nonimmunosuppressant	nonimmunosuppressant	ADJ
dpc-1099	198	11	drugs	drug	NOUN
dpc-1099	198	12	such	such	ADJ
dpc-1099	198	13	as	as	ADP
dpc-1099	198	14	doxycycline	doxycycline	NOUN
dpc-1099	198	15	may	may	AUX
dpc-1099	198	16	be	be	AUX
dpc-1099	198	17	considered	consider	VERB
dpc-1099	198	18	a	a	DET
dpc-1099	198	19	viable	viable	ADJ
dpc-1099	198	20	option	option	NOUN
dpc-1099	198	21	[	[	X
dpc-1099	198	22	61	61	NUM
dpc-1099	198	23	]	]	PUNCT
dpc-1099	198	24	.	.	PUNCT
dpc-1099	199	1	although	although	SCONJ
dpc-1099	199	2	its	its	PRON
dpc-1099	199	3	exact	exact	ADJ
dpc-1099	199	4	mechanism	mechanism	NOUN
dpc-1099	199	5	of	of	ADP
dpc-1099	199	6	action	action	NOUN
dpc-1099	199	7	is	be	AUX
dpc-1099	199	8	not	not	PART
dpc-1099	199	9	well	well	ADV
dpc-1099	199	10	understood	understand	VERB
dpc-1099	199	11	,	,	PUNCT
dpc-1099	199	12	doxycycline	doxycycline	PROPN
dpc-1099	199	13	proved	prove	VERB
dpc-1099	199	14	to	to	PART
dpc-1099	199	15	be	be	AUX
dpc-1099	199	16	not	not	PART
dpc-1099	199	17	inferior	inferior	ADJ
dpc-1099	199	18	to	to	PART
dpc-1099	199	19	oral	oral	VERB
dpc-1099	199	20	prednisolone	prednisolone	PROPN
dpc-1099	199	21	for	for	ADP
dpc-1099	199	22	short	short	ADJ
dpc-1099	199	23	-	-	PUNCT
dpc-1099	199	24	term	term	NOUN
dpc-1099	199	25	blister	blister	NOUN
dpc-1099	199	26	control	control	NOUN
dpc-1099	199	27	and	and	CCONJ
dpc-1099	199	28	is	be	AUX
dpc-1099	199	29	safer	safe	ADJ
dpc-1099	199	30	in	in	ADP
dpc-1099	199	31	the	the	DET
dpc-1099	199	32	long	long	ADJ
dpc-1099	199	33	term	term	NOUN
dpc-1099	200	1	[	[	X
dpc-1099	200	2	61,62	61,62	NOUN
dpc-1099	200	3	]	]	PUNCT
dpc-1099	200	4	.	.	PUNCT
dpc-1099	201	1	systemic	systemic	ADJ
dpc-1099	201	2	corticosteroid	corticosteroid	ADJ
dpc-1099	201	3	therapy	therapy	NOUN
dpc-1099	201	4	(	(	PUNCT
dpc-1099	201	5	prednisone	prednisone	NOUN
dpc-1099	201	6	0.5	0.5	NUM
dpc-1099	201	7	mg	mg	PROPN
dpc-1099	201	8	/	/	SYM
dpc-1099	201	9	kg	kg	PROPN
dpc-1099	201	10	/	/	SYM
dpc-1099	201	11	day	day	NOUN
dpc-1099	201	12	)	)	PUNCT
dpc-1099	201	13	represents	represent	VERB
dpc-1099	201	14	the	the	DET
dpc-1099	201	15	treatment	treatment	NOUN
dpc-1099	201	16	of	of	ADP
dpc-1099	201	17	choice	choice	NOUN
dpc-1099	201	18	for	for	ADP
dpc-1099	201	19	severe	severe	ADJ
dpc-1099	201	20	forms	form	NOUN
dpc-1099	201	21	[	[	X
dpc-1099	201	22	38	38	NUM
dpc-1099	201	23	]	]	PUNCT
dpc-1099	201	24	.	.	PUNCT
dpc-1099	202	1	for	for	ADP
dpc-1099	202	2	maintenance	maintenance	NOUN
dpc-1099	202	3	treatment	treatment	NOUN
dpc-1099	202	4	,	,	PUNCT
dpc-1099	202	5	doses	dose	NOUN
dpc-1099	202	6	may	may	AUX
dpc-1099	202	7	be	be	AUX
dpc-1099	202	8	tapered	taper	VERB
dpc-1099	202	9	gradually	gradually	ADV
dpc-1099	202	10	within	within	ADP
dpc-1099	202	11	4	4	NUM
dpc-1099	202	12	to	to	PART
dpc-1099	202	13	6	6	NUM
dpc-1099	202	14	months	month	NOUN
dpc-1099	202	15	of	of	ADP
dpc-1099	202	16	initiation	initiation	NOUN
dpc-1099	202	17	of	of	ADP
dpc-1099	202	18	treatment	treatment	NOUN
dpc-1099	202	19	.	.	PUNCT
dpc-1099	203	1	adjunctive	adjunctive	ADJ
dpc-1099	203	2	therapy	therapy	NOUN
dpc-1099	203	3	includes	include	VERB
dpc-1099	203	4	combination	combination	NOUN
dpc-1099	203	5	with	with	ADP
dpc-1099	203	6	azathioprine	azathioprine	NOUN
dpc-1099	203	7	,	,	PUNCT
dpc-1099	203	8	mycophenolate	mycophenolate	PROPN
dpc-1099	203	9	mofetil	mofetil	PROPN
dpc-1099	203	10	,	,	PUNCT
dpc-1099	203	11	tetracyclines	tetracycline	NOUN
dpc-1099	203	12	plus	plus	CCONJ
dpc-1099	203	13	nicotinamide	nicotinamide	NOUN
dpc-1099	203	14	,	,	PUNCT
dpc-1099	203	15	methotrexate	methotrexate	NOUN
dpc-1099	203	16	,	,	PUNCT
dpc-1099	203	17	and	and	CCONJ
dpc-1099	203	18	dapsone	dapsone	NOUN
dpc-1099	204	1	[	[	X
dpc-1099	204	2	63	63	NUM
dpc-1099	204	3	]	]	PUNCT
dpc-1099	204	4	(	(	PUNCT
dpc-1099	204	5	figure	figure	NOUN
dpc-1099	204	6	7	7	NUM
dpc-1099	204	7	)	)	PUNCT
dpc-1099	204	8	.	.	PUNCT
dpc-1099	205	1	bacterial	bacterial	ADJ
dpc-1099	205	2	superinfection	superinfection	NOUN
dpc-1099	205	3	of	of	ADP
dpc-1099	205	4	erosions	erosion	NOUN
dpc-1099	205	5	should	should	AUX
dpc-1099	205	6	be	be	AUX
dpc-1099	205	7	treated	treat	VERB
dpc-1099	205	8	with	with	ADP
dpc-1099	205	9	local	local	ADJ
dpc-1099	205	10	antiseptics	antiseptic	NOUN
dpc-1099	205	11	.	.	PUNCT
dpc-1099	206	1	wound	wound	ADJ
dpc-1099	206	2	dressings	dressing	NOUN
dpc-1099	206	3	should	should	AUX
dpc-1099	206	4	be	be	AUX
dpc-1099	206	5	considered	consider	VERB
dpc-1099	206	6	for	for	ADP
dpc-1099	206	7	large	large	ADJ
dpc-1099	206	8	wounds	wound	NOUN
dpc-1099	206	9	.	.	PUNCT
dpc-1099	207	1	sterile	sterile	ADJ
dpc-1099	207	2	puncture	puncture	NOUN
dpc-1099	207	3	of	of	ADP
dpc-1099	207	4	large	large	ADJ
dpc-1099	207	5	blisters	blister	NOUN
dpc-1099	207	6	is	be	AUX
dpc-1099	207	7	recommended	recommend	VERB
dpc-1099	207	8	[	[	PUNCT
dpc-1099	207	9	57	57	NUM
dpc-1099	207	10	]	]	PUNCT
dpc-1099	207	11	.	.	PUNCT
dpc-1099	208	1	available	available	ADJ
dpc-1099	208	2	data	datum	NOUN
dpc-1099	208	3	suggest	suggest	VERB
dpc-1099	208	4	that	that	SCONJ
dpc-1099	208	5	rituximab	rituximab	NOUN
dpc-1099	208	6	may	may	AUX
dpc-1099	208	7	provide	provide	VERB
dpc-1099	208	8	clinical	clinical	ADJ
dpc-1099	208	9	benefits	benefit	NOUN
dpc-1099	208	10	for	for	ADP
dpc-1099	208	11	patients	patient	NOUN
dpc-1099	208	12	with	with	ADP
dpc-1099	208	13	refractory	refractory	NOUN
dpc-1099	208	14	bp	bp	PROPN
dpc-1099	209	1	[	[	X
dpc-1099	209	2	64	64	NUM
dpc-1099	209	3	]	]	PUNCT
dpc-1099	209	4	,	,	PUNCT
dpc-1099	209	5	although	although	SCONJ
dpc-1099	209	6	with	with	ADP
dpc-1099	209	7	less	less	ADJ
dpc-1099	209	8	effectiveness	effectiveness	NOUN
dpc-1099	209	9	.	.	PUNCT
dpc-1099	210	1	a	a	DET
dpc-1099	210	2	complex	complex	ADJ
dpc-1099	210	3	interplay	interplay	NOUN
dpc-1099	210	4	of	of	ADP
dpc-1099	210	5	complement	complement	NOUN
dpc-1099	210	6	activation	activation	NOUN
dpc-1099	210	7	of	of	ADP
dpc-1099	210	8	igg	igg	NOUN
dpc-1099	210	9	autoantibodies	autoantibody	NOUN
dpc-1099	210	10	deposited	deposit	VERB
dpc-1099	210	11	doses	dose	NOUN
dpc-1099	210	12	of	of	ADP
dpc-1099	210	13	corticosteroids	corticosteroid	NOUN
dpc-1099	210	14	and	and	CCONJ
dpc-1099	210	15	experiencing	experience	VERB
dpc-1099	210	16	less	less	ADV
dpc-1099	210	17	severe	severe	ADJ
dpc-1099	210	18	or	or	CCONJ
dpc-1099	210	19	life	life	NOUN
dpc-1099	210	20	-	-	PUNCT
dpc-1099	210	21	threatening	threaten	VERB
dpc-1099	210	22	corticosteroid	corticosteroid	NOUN
dpc-1099	210	23	-	-	PUNCT
dpc-1099	210	24	related	relate	VERB
dpc-1099	210	25	adverse	adverse	ADJ
dpc-1099	210	26	events	event	NOUN
dpc-1099	210	27	[	[	X
dpc-1099	210	28	51	51	NUM
dpc-1099	210	29	]	]	PUNCT
dpc-1099	210	30	.	.	PUNCT
dpc-1099	211	1	therefore	therefore	ADV
dpc-1099	211	2	,	,	PUNCT
dpc-1099	211	3	intravenous	intravenous	ADJ
dpc-1099	211	4	rituximab	rituximab	NOUN
dpc-1099	211	5	is	be	AUX
dpc-1099	211	6	now	now	ADV
dpc-1099	211	7	recommended	recommend	VERB
dpc-1099	211	8	as	as	ADP
dpc-1099	211	9	first	first	ADJ
dpc-1099	211	10	-	-	PUNCT
dpc-1099	211	11	line	line	NOUN
dpc-1099	211	12	option	option	NOUN
dpc-1099	211	13	for	for	ADP
dpc-1099	211	14	new	new	ADJ
dpc-1099	211	15	-	-	PUNCT
dpc-1099	211	16	onset	onset	NOUN
dpc-1099	211	17	moderate	moderate	ADJ
dpc-1099	211	18	to	to	ADP
dpc-1099	211	19	severe	severe	ADJ
dpc-1099	211	20	pemphigus	pemphigus	NOUN
dpc-1099	211	21	,	,	PUNCT
dpc-1099	211	22	but	but	CCONJ
dpc-1099	211	23	also	also	ADV
dpc-1099	211	24	for	for	ADP
dpc-1099	211	25	previously	previously	ADV
dpc-1099	211	26	treated	treat	VERB
dpc-1099	211	27	patients	patient	NOUN
dpc-1099	211	28	who	who	PRON
dpc-1099	211	29	do	do	AUX
dpc-1099	211	30	not	not	PART
dpc-1099	211	31	achieve	achieve	VERB
dpc-1099	211	32	clinical	clinical	ADJ
dpc-1099	211	33	remission	remission	NOUN
dpc-1099	211	34	with	with	ADP
dpc-1099	211	35	systemic	systemic	ADJ
dpc-1099	211	36	corticosteroids	corticosteroid	NOUN
dpc-1099	211	37	and/	and/	PROPN
dpc-1099	211	38	or	or	CCONJ
dpc-1099	211	39	immunosuppressive	immunosuppressive	ADJ
dpc-1099	211	40	adjuvants	adjuvant	NOUN
dpc-1099	211	41	[	[	X
dpc-1099	211	42	44,52	44,52	NUM
dpc-1099	211	43	]	]	PUNCT
dpc-1099	211	44	.	.	PUNCT
dpc-1099	212	1	the	the	DET
dpc-1099	212	2	introduction	introduction	NOUN
dpc-1099	212	3	of	of	ADP
dpc-1099	212	4	rituximab	rituximab	NOUN
dpc-1099	212	5	presents	present	VERB
dpc-1099	212	6	an	an	DET
dpc-1099	212	7	opportunity	opportunity	NOUN
dpc-1099	212	8	to	to	PART
dpc-1099	212	9	change	change	VERB
dpc-1099	212	10	the	the	DET
dpc-1099	212	11	traditional	traditional	ADJ
dpc-1099	212	12	therapeutic	therapeutic	ADJ
dpc-1099	212	13	approach	approach	NOUN
dpc-1099	212	14	to	to	ADP
dpc-1099	212	15	pv	pv	VERB
dpc-1099	212	16	.	.	PUNCT
dpc-1099	213	1	a	a	DET
dpc-1099	213	2	complete	complete	ADJ
dpc-1099	213	3	remission	remission	NOUN
dpc-1099	213	4	off	off	ADP
dpc-1099	213	5	therapy	therapy	NOUN
dpc-1099	213	6	may	may	AUX
dpc-1099	213	7	represent	represent	VERB
dpc-1099	213	8	a	a	DET
dpc-1099	213	9	realistic	realistic	ADJ
dpc-1099	213	10	expectation	expectation	NOUN
dpc-1099	213	11	for	for	ADP
dpc-1099	213	12	many	many	ADJ
dpc-1099	213	13	patients	patient	NOUN
dpc-1099	213	14	.	.	PUNCT
dpc-1099	214	1	many	many	ADJ
dpc-1099	214	2	aspects	aspect	NOUN
dpc-1099	214	3	remain	remain	VERB
dpc-1099	214	4	to	to	PART
dpc-1099	214	5	be	be	AUX
dpc-1099	214	6	deepened	deepen	VERB
dpc-1099	214	7	.	.	PUNCT
dpc-1099	215	1	b	b	X
dpc-1099	215	2	-	-	PUNCT
dpc-1099	215	3	cell	cell	NOUN
dpc-1099	215	4	repopulation	repopulation	NOUN
dpc-1099	215	5	,	,	PUNCT
dpc-1099	215	6	low	low	ADJ
dpc-1099	215	7	cd41	cd41	PROPN
dpc-1099	215	8	t	t	PROPN
dpc-1099	215	9	-	-	PUNCT
dpc-1099	215	10	cell	cell	NOUN
dpc-1099	215	11	count	count	NOUN
dpc-1099	215	12	,	,	PUNCT
dpc-1099	215	13	persistence	persistence	NOUN
dpc-1099	215	14	of	of	ADP
dpc-1099	215	15	anti	anti	NOUN
dpc-1099	215	16	-	-	NOUN
dpc-1099	215	17	dsg1	dsg1	ADJ
dpc-1099	215	18	(	(	PUNCT
dpc-1099	215	19	>	>	SYM
dpc-1099	215	20	20	20	NUM
dpc-1099	215	21	iu	iu	NOUN
dpc-1099	215	22	)	)	PUNCT
dpc-1099	215	23	and	and	CCONJ
dpc-1099	215	24	dsg3	dsg3	PROPN
dpc-1099	215	25	(	(	PUNCT
dpc-1099	215	26	>	>	X
dpc-1099	215	27	120	120	NUM
dpc-1099	215	28	iu	iu	NOUN
dpc-1099	215	29	)	)	PUNCT
dpc-1099	215	30	at	at	ADP
dpc-1099	215	31	month	month	NOUN
dpc-1099	215	32	3	3	NUM
dpc-1099	215	33	,	,	PUNCT
dpc-1099	215	34	and	and	CCONJ
dpc-1099	215	35	severe	severe	ADJ
dpc-1099	215	36	pemphigus	pemphigus	NOUN
dpc-1099	215	37	disease	disease	NOUN
dpc-1099	215	38	area	area	NOUN
dpc-1099	215	39	index	index	NOUN
dpc-1099	215	40	score	score	NOUN
dpc-1099	215	41	at	at	ADP
dpc-1099	215	42	baseline	baseline	PROPN
dpc-1099	215	43	(	(	PUNCT
dpc-1099	215	44	>	>	X
dpc-1099	215	45	45	45	NUM
dpc-1099	215	46	)	)	PUNCT
dpc-1099	215	47	were	be	AUX
dpc-1099	215	48	identified	identify	VERB
dpc-1099	215	49	as	as	ADP
dpc-1099	215	50	predictors	predictor	NOUN
dpc-1099	215	51	of	of	ADP
dpc-1099	215	52	relapse	relapse	NOUN
dpc-1099	215	53	in	in	ADP
dpc-1099	215	54	patients	patient	NOUN
dpc-1099	215	55	treated	treat	VERB
dpc-1099	215	56	with	with	ADP
dpc-1099	215	57	rituximab	rituximab	NOUN
dpc-1099	215	58	[	[	X
dpc-1099	215	59	53,54	53,54	NUM
dpc-1099	215	60	]	]	PUNCT
dpc-1099	215	61	.	.	PUNCT
dpc-1099	216	1	additional	additional	ADJ
dpc-1099	216	2	areas	area	NOUN
dpc-1099	216	3	that	that	PRON
dpc-1099	216	4	deserve	deserve	VERB
dpc-1099	216	5	further	further	ADJ
dpc-1099	216	6	studies	study	NOUN
dpc-1099	216	7	are	be	AUX
dpc-1099	216	8	the	the	DET
dpc-1099	216	9	combination	combination	NOUN
dpc-1099	216	10	protocols	protocol	NOUN
dpc-1099	216	11	with	with	ADP
dpc-1099	216	12	corticosteroids	corticosteroid	NOUN
dpc-1099	216	13	,	,	PUNCT
dpc-1099	216	14	the	the	DET
dpc-1099	216	15	possibility	possibility	NOUN
dpc-1099	216	16	of	of	ADP
dpc-1099	216	17	using	use	VERB
dpc-1099	216	18	cd20	cd20	PROPN
dpc-1099	216	19	inhibitors	inhibitor	NOUN
dpc-1099	216	20	alone	alone	ADV
dpc-1099	216	21	,	,	PUNCT
dpc-1099	216	22	prevention	prevention	NOUN
dpc-1099	216	23	of	of	ADP
dpc-1099	216	24	relapses	relapse	NOUN
dpc-1099	216	25	,	,	PUNCT
dpc-1099	216	26	the	the	DET
dpc-1099	216	27	role	role	NOUN
dpc-1099	216	28	of	of	ADP
dpc-1099	216	29	anti	anti	ADJ
dpc-1099	216	30	-	-	ADJ
dpc-1099	216	31	dsg	dsg	ADJ
dpc-1099	216	32	elisa	elisa	NOUN
dpc-1099	216	33	values	value	NOUN
dpc-1099	216	34	as	as	ADP
dpc-1099	216	35	biomarkers	biomarker	NOUN
dpc-1099	216	36	to	to	PART
dpc-1099	216	37	drive	drive	VERB
dpc-1099	216	38	further	further	ADJ
dpc-1099	216	39	infusions	infusion	NOUN
dpc-1099	216	40	,	,	PUNCT
dpc-1099	216	41	and	and	CCONJ
dpc-1099	216	42	the	the	DET
dpc-1099	216	43	benefit	benefit	NOUN
dpc-1099	216	44	from	from	ADP
dpc-1099	216	45	combining	combine	VERB
dpc-1099	216	46	other	other	ADJ
dpc-1099	216	47	adjuvants	adjuvant	NOUN
dpc-1099	216	48	in	in	ADP
dpc-1099	216	49	patient	patient	ADJ
dpc-1099	216	50	management	management	NOUN
dpc-1099	216	51	.	.	PUNCT
dpc-1099	217	1	consequently	consequently	ADV
dpc-1099	217	2	,	,	PUNCT
dpc-1099	217	3	the	the	DET
dpc-1099	217	4	therapeutic	therapeutic	ADJ
dpc-1099	217	5	algorithm	algorithm	NOUN
dpc-1099	217	6	of	of	ADP
dpc-1099	217	7	pv	pv	NOUN
dpc-1099	217	8	could	could	AUX
dpc-1099	217	9	be	be	AUX
dpc-1099	217	10	redefined	redefine	VERB
dpc-1099	217	11	in	in	ADP
dpc-1099	217	12	the	the	DET
dpc-1099	217	13	future	future	NOUN
dpc-1099	217	14	(	(	PUNCT
dpc-1099	217	15	figure	figure	NOUN
dpc-1099	217	16	6	6	NUM
dpc-1099	217	17	)	)	PUNCT
dpc-1099	217	18	.	.	PUNCT
dpc-1099	218	1	topical	topical	ADJ
dpc-1099	218	2	therapy	therapy	NOUN
dpc-1099	218	3	of	of	ADP
dpc-1099	218	4	pv	pv	PROPN
dpc-1099	218	5	is	be	AUX
dpc-1099	218	6	essentially	essentially	ADV
dpc-1099	218	7	symptomatic	symptomatic	ADJ
dpc-1099	218	8	and	and	CCONJ
dpc-1099	218	9	is	be	AUX
dpc-1099	218	10	practiced	practice	VERB
dpc-1099	218	11	to	to	PART
dpc-1099	218	12	alleviate	alleviate	VERB
dpc-1099	218	13	inflammation	inflammation	NOUN
dpc-1099	218	14	and	and	CCONJ
dpc-1099	218	15	prevent	prevent	VERB
dpc-1099	218	16	secondary	secondary	ADJ
dpc-1099	218	17	infections	infection	NOUN
dpc-1099	218	18	.	.	PUNCT
dpc-1099	219	1	usually	usually	ADV
dpc-1099	219	2	corticosteroids	corticosteroid	NOUN
dpc-1099	219	3	,	,	PUNCT
dpc-1099	219	4	calcineurin	calcineurin	ADJ
dpc-1099	219	5	inhibitors	inhibitor	NOUN
dpc-1099	219	6	or	or	CCONJ
dpc-1099	219	7	corticosteroids	corticosteroid	NOUN
dpc-1099	219	8	and	and	CCONJ
dpc-1099	219	9	antibiotics	antibiotic	NOUN
dpc-1099	219	10	in	in	ADP
dpc-1099	219	11	combination	combination	NOUN
dpc-1099	219	12	are	be	AUX
dpc-1099	219	13	administered	administer	VERB
dpc-1099	219	14	on	on	ADP
dpc-1099	219	15	the	the	DET
dpc-1099	219	16	cutaneous	cutaneous	ADJ
dpc-1099	219	17	and	and	CCONJ
dpc-1099	219	18	mucous	mucous	ADJ
dpc-1099	219	19	lesions	lesion	NOUN
dpc-1099	219	20	.	.	PUNCT
dpc-1099	220	1	cutaneous	cutaneous	ADJ
dpc-1099	220	2	erosive	erosive	ADJ
dpc-1099	220	3	lesions	lesion	NOUN
dpc-1099	220	4	should	should	AUX
dpc-1099	220	5	be	be	AUX
dpc-1099	220	6	covered	cover	VERB
dpc-1099	220	7	using	use	VERB
dpc-1099	220	8	low	low	ADJ
dpc-1099	220	9	-	-	PUNCT
dpc-1099	220	10	adhesive	adhesive	ADJ
dpc-1099	220	11	wound	wound	NOUN
dpc-1099	220	12	dressings	dressing	NOUN
dpc-1099	220	13	.	.	PUNCT
dpc-1099	221	1	supportive	supportive	ADJ
dpc-1099	221	2	care	care	NOUN
dpc-1099	221	3	for	for	ADP
dpc-1099	221	4	oral	oral	ADJ
dpc-1099	221	5	lesions	lesion	NOUN
dpc-1099	221	6	includes	include	VERB
dpc-1099	221	7	gel	gel	NOUN
dpc-1099	221	8	-	-	PUNCT
dpc-1099	221	9	containing	contain	VERB
dpc-1099	221	10	local	local	ADJ
dpc-1099	221	11	anesthetics	anesthetic	NOUN
dpc-1099	221	12	and	and	CCONJ
dpc-1099	221	13	proper	proper	ADJ
dpc-1099	221	14	dental	dental	ADJ
dpc-1099	221	15	care	care	NOUN
dpc-1099	221	16	.	.	PUNCT
dpc-1099	222	1	limited	limited	ADJ
dpc-1099	222	2	experience	experience	NOUN
dpc-1099	222	3	proved	prove	VERB
dpc-1099	222	4	rituximab	rituximab	NOUN
dpc-1099	222	5	useful	useful	ADJ
dpc-1099	222	6	in	in	ADP
dpc-1099	222	7	refractory	refractory	NOUN
dpc-1099	222	8	pf	pf	PROPN
dpc-1099	222	9	as	as	ADV
dpc-1099	222	10	well	well	ADV
dpc-1099	222	11	[	[	X
dpc-1099	222	12	55,56	55,56	NOUN
dpc-1099	222	13	]	]	PUNCT
dpc-1099	222	14	.	.	PUNCT
dpc-1099	223	1	figure	figure	NOUN
dpc-1099	223	2	6	6	NUM
dpc-1099	223	3	.	.	PUNCT
dpc-1099	223	4	treatment	treatment	NOUN
dpc-1099	223	5	options	option	NOUN
dpc-1099	223	6	for	for	ADP
dpc-1099	223	7	pemphigus	pemphigus	PROPN
dpc-1099	223	8	.	.	PUNCT
dpc-1099	224	1	review	review	VERB
dpc-1099	224	2	|	|	ADV
dpc-1099	225	1	dermatol	dermatol	ADJ
dpc-1099	225	2	pract	pract	NOUN
dpc-1099	225	3	concept	concept	NOUN
dpc-1099	225	4	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	225	5	9	9	NUM
dpc-1099	225	6	immune	immune	ADJ
dpc-1099	225	7	suppression	suppression	NOUN
dpc-1099	225	8	in	in	ADP
dpc-1099	225	9	pv	pv	NOUN
dpc-1099	225	10	by	by	ADP
dpc-1099	225	11	therapeutic	therapeutic	ADJ
dpc-1099	225	12	immunoadsorption	immunoadsorption	NOUN
dpc-1099	225	13	of	of	ADP
dpc-1099	225	14	pathogenic	pathogenic	ADJ
dpc-1099	225	15	autoantibodies	autoantibody	NOUN
dpc-1099	225	16	[	[	X
dpc-1099	225	17	68,69	68,69	VERB
dpc-1099	225	18	]	]	PUNCT
dpc-1099	225	19	.	.	PUNCT
dpc-1099	226	1	a	a	DET
dpc-1099	226	2	promising	promising	ADJ
dpc-1099	226	3	approach	approach	NOUN
dpc-1099	226	4	is	be	AUX
dpc-1099	226	5	the	the	DET
dpc-1099	226	6	use	use	NOUN
dpc-1099	226	7	of	of	ADP
dpc-1099	226	8	reengineering	reengineere	VERB
dpc-1099	226	9	chimeric	chimeric	ADJ
dpc-1099	226	10	autoantibody	autoantibody	ADJ
dpc-1099	226	11	receptor	receptor	NOUN
dpc-1099	226	12	t	t	NOUN
dpc-1099	226	13	cells	cell	NOUN
dpc-1099	226	14	.	.	PUNCT
dpc-1099	227	1	patient	patient	NOUN
dpc-1099	227	2	-	-	PUNCT
dpc-1099	227	3	derived	derive	VERB
dpc-1099	227	4	t	t	NOUN
dpc-1099	227	5	cells	cell	NOUN
dpc-1099	227	6	are	be	AUX
dpc-1099	227	7	modified	modify	VERB
dpc-1099	227	8	ex	ex	PRON
dpc-1099	227	9	vivo	vivo	NOUN
dpc-1099	227	10	to	to	PART
dpc-1099	227	11	express	express	VERB
dpc-1099	227	12	a	a	DET
dpc-1099	227	13	chimeric	chimeric	ADJ
dpc-1099	227	14	antibody	antibody	NOUN
dpc-1099	227	15	receptor	receptor	NOUN
dpc-1099	227	16	,	,	PUNCT
dpc-1099	227	17	which	which	PRON
dpc-1099	227	18	allows	allow	VERB
dpc-1099	227	19	selective	selective	ADJ
dpc-1099	227	20	recognition	recognition	NOUN
dpc-1099	227	21	and	and	CCONJ
dpc-1099	227	22	consequent	consequent	ADJ
dpc-1099	227	23	killing	killing	NOUN
dpc-1099	227	24	of	of	ADP
dpc-1099	227	25	anti	anti	ADJ
dpc-1099	227	26	-	-	ADJ
dpc-1099	227	27	dsg3	dsg3	ADJ
dpc-1099	227	28	autoreactive	autoreactive	ADJ
dpc-1099	227	29	b	b	PROPN
dpc-1099	227	30	lymphocytes	lymphocyte	VERB
dpc-1099	227	31	[	[	X
dpc-1099	227	32	70,71	70,71	NUM
dpc-1099	227	33	]	]	X
dpc-1099	227	34	.	.	PUNCT
dpc-1099	228	1	also	also	ADV
dpc-1099	228	2	in	in	ADP
dpc-1099	228	3	bp	bp	PROPN
dpc-1099	228	4	,	,	PUNCT
dpc-1099	228	5	new	new	ADJ
dpc-1099	228	6	therapeutic	therapeutic	ADJ
dpc-1099	228	7	targets	target	NOUN
dpc-1099	228	8	aim	aim	VERB
dpc-1099	228	9	to	to	PART
dpc-1099	228	10	provide	provide	VERB
dpc-1099	228	11	new	new	ADJ
dpc-1099	228	12	treatment	treatment	NOUN
dpc-1099	228	13	strategies	strategy	NOUN
dpc-1099	228	14	that	that	PRON
dpc-1099	228	15	may	may	AUX
dpc-1099	228	16	go	go	VERB
dpc-1099	228	17	beyond	beyond	ADP
dpc-1099	228	18	nonspecific	nonspecific	ADJ
dpc-1099	228	19	immunosuppression	immunosuppression	NOUN
dpc-1099	228	20	.	.	PUNCT
dpc-1099	229	1	in	in	ADP
dpc-1099	229	2	addition	addition	NOUN
dpc-1099	229	3	to	to	ADP
dpc-1099	229	4	omalizumab	omalizumab	NOUN
dpc-1099	229	5	,	,	PUNCT
dpc-1099	229	6	monoclonal	monoclonal	NOUN
dpc-1099	229	7	antibodies	antibody	NOUN
dpc-1099	229	8	to	to	ADP
dpc-1099	229	9	il-5	il-5	PRON
dpc-1099	229	10	such	such	ADJ
dpc-1099	229	11	as	as	ADP
dpc-1099	229	12	mepolizumab	mepolizumab	NOUN
dpc-1099	229	13	and	and	CCONJ
dpc-1099	229	14	bertilimumab	bertilimumab	NOUN
dpc-1099	229	15	,	,	PUNCT
dpc-1099	229	16	an	an	DET
dpc-1099	229	17	anti	anti	ADJ
dpc-1099	229	18	-	-	ADJ
dpc-1099	229	19	eotaxin-1	eotaxin-1	ADJ
dpc-1099	229	20	antibody	antibody	NOUN
dpc-1099	229	21	,	,	PUNCT
dpc-1099	229	22	are	be	AUX
dpc-1099	229	23	currently	currently	ADV
dpc-1099	229	24	being	be	AUX
dpc-1099	229	25	investigated	investigate	VERB
dpc-1099	229	26	in	in	ADP
dpc-1099	229	27	bp	bp	PROPN
dpc-1099	230	1	[	[	X
dpc-1099	230	2	65	65	NUM
dpc-1099	230	3	]	]	PUNCT
dpc-1099	230	4	.	.	PUNCT
dpc-1099	231	1	in	in	ADP
dpc-1099	231	2	the	the	DET
dpc-1099	231	3	context	context	NOUN
dpc-1099	231	4	of	of	ADP
dpc-1099	231	5	immunomodulatory	immunomodulatory	ADJ
dpc-1099	231	6	drugs	drug	NOUN
dpc-1099	231	7	,	,	PUNCT
dpc-1099	231	8	dimethyl	dimethyl	NOUN
dpc-1099	231	9	fumarate	fumarate	NOUN
dpc-1099	231	10	,	,	PUNCT
dpc-1099	231	11	which	which	PRON
dpc-1099	231	12	is	be	AUX
dpc-1099	231	13	a	a	DET
dpc-1099	231	14	prodrug	prodrug	NOUN
dpc-1099	231	15	utilized	utilize	VERB
dpc-1099	231	16	in	in	ADP
dpc-1099	231	17	psoriasis	psoriasis	NOUN
dpc-1099	231	18	and	and	CCONJ
dpc-1099	231	19	multiple	multiple	ADJ
dpc-1099	231	20	sclerosis	sclerosis	NOUN
dpc-1099	231	21	,	,	PUNCT
dpc-1099	231	22	is	be	AUX
dpc-1099	231	23	also	also	ADV
dpc-1099	231	24	under	under	ADP
dpc-1099	231	25	investigation	investigation	NOUN
dpc-1099	231	26	for	for	ADP
dpc-1099	231	27	bp	bp	PROPN
dpc-1099	231	28	because	because	SCONJ
dpc-1099	231	29	of	of	ADP
dpc-1099	231	30	its	its	PRON
dpc-1099	231	31	pleotropic	pleotropic	ADJ
dpc-1099	231	32	anti	anti	ADJ
dpc-1099	231	33	-	-	ADJ
dpc-1099	231	34	inflammatory	inflammatory	ADJ
dpc-1099	231	35	effects	effect	NOUN
dpc-1099	231	36	[	[	X
dpc-1099	231	37	72	72	NUM
dpc-1099	231	38	]	]	PUNCT
dpc-1099	231	39	.	.	PUNCT
dpc-1099	232	1	references	reference	NOUN
dpc-1099	232	2	1	1	X
dpc-1099	232	3	.	.	PUNCT
dpc-1099	233	1	kridin	kridin	VERB
dpc-1099	233	2	k.	k.	PROPN
dpc-1099	233	3	pemphigus	pemphigus	PROPN
dpc-1099	233	4	group	group	PROPN
dpc-1099	233	5	:	:	PUNCT
dpc-1099	233	6	overview	overview	NOUN
dpc-1099	233	7	,	,	PUNCT
dpc-1099	233	8	epidemiology	epidemiology	NOUN
dpc-1099	233	9	,	,	PUNCT
dpc-1099	233	10	mortality	mortality	NOUN
dpc-1099	233	11	,	,	PUNCT
dpc-1099	233	12	and	and	CCONJ
dpc-1099	233	13	comorbidities	comorbiditie	NOUN
dpc-1099	233	14	.	.	PUNCT
dpc-1099	234	1	immunol	immunol	NOUN
dpc-1099	234	2	res	re	NOUN
dpc-1099	234	3	.	.	PUNCT
dpc-1099	235	1	2018;66(2):255	2018;66(2):255	NUM
dpc-1099	235	2	-	-	SYM
dpc-1099	235	3	270	270	NUM
dpc-1099	235	4	.	.	PUNCT
dpc-1099	236	1	https://	https://	PROPN
dpc-1099	236	2	doi.org/10.1007/s12026-018-8986-7	doi.org/10.1007/s12026-018-8986-7	PROPN
dpc-1099	236	3	2	2	PROPN
dpc-1099	236	4	.	.	PUNCT
dpc-1099	237	1	daniel	daniel	PROPN
dpc-1099	237	2	bs	bs	PROPN
dpc-1099	237	3	,	,	PUNCT
dpc-1099	237	4	murrell	murrell	PROPN
dpc-1099	237	5	df	df	PROPN
dpc-1099	237	6	.	.	PUNCT
dpc-1099	238	1	review	review	NOUN
dpc-1099	238	2	of	of	ADP
dpc-1099	238	3	autoimmune	autoimmune	ADJ
dpc-1099	238	4	blistering	blister	VERB
dpc-1099	238	5	diseases	disease	NOUN
dpc-1099	238	6	:	:	PUNCT
dpc-1099	238	7	the	the	DET
dpc-1099	238	8	pemphigoid	pemphigoid	ADJ
dpc-1099	238	9	diseases	disease	NOUN
dpc-1099	238	10	.	.	PUNCT
dpc-1099	239	1	j	j	PROPN
dpc-1099	239	2	eur	eur	PROPN
dpc-1099	239	3	acad	acad	PROPN
dpc-1099	239	4	dermatol	dermatol	NOUN
dpc-1099	239	5	venereol	venereol	NOUN
dpc-1099	239	6	.	.	PUNCT
dpc-1099	240	1	2019;33(9):1685	2019;33(9):1685	NUM
dpc-1099	240	2	-	-	SYM
dpc-1099	240	3	1694	1694	NUM
dpc-1099	240	4	.	.	PUNCT
dpc-1099	241	1	https://doi.org/10.1111/jdv.15679	https://doi.org/10.1111/jdv.15679	PROPN
dpc-1099	241	2	3	3	NUM
dpc-1099	241	3	.	.	PUNCT
dpc-1099	241	4	alpsoy	alpsoy	PROPN
dpc-1099	241	5	e	e	PROPN
dpc-1099	241	6	,	,	PUNCT
dpc-1099	241	7	akman	akman	NOUN
dpc-1099	241	8	-	-	PUNCT
dpc-1099	241	9	karakas	karakas	PROPN
dpc-1099	241	10	a	a	PRON
dpc-1099	241	11	,	,	PUNCT
dpc-1099	241	12	uzun	uzun	PROPN
dpc-1099	241	13	s.	s.	PROPN
dpc-1099	241	14	geographic	geographic	ADJ
dpc-1099	241	15	variations	variation	NOUN
dpc-1099	241	16	in	in	ADP
dpc-1099	241	17	epidemiology	epidemiology	NOUN
dpc-1099	241	18	of	of	ADP
dpc-1099	241	19	two	two	NUM
dpc-1099	241	20	autoimmune	autoimmune	ADJ
dpc-1099	241	21	bullous	bullous	ADJ
dpc-1099	241	22	diseases	disease	NOUN
dpc-1099	241	23	:	:	PUNCT
dpc-1099	241	24	pemphigus	pemphigus	NOUN
dpc-1099	241	25	at	at	ADP
dpc-1099	241	26	the	the	DET
dpc-1099	241	27	dermal	dermal	NOUN
dpc-1099	241	28	-	-	PUNCT
dpc-1099	241	29	epidermal	epidermal	ADJ
dpc-1099	241	30	basement	basement	NOUN
dpc-1099	241	31	membrane	membrane	NOUN
dpc-1099	241	32	zone	zone	NOUN
dpc-1099	241	33	and	and	CCONJ
dpc-1099	241	34	inflammatory	inflammatory	ADJ
dpc-1099	241	35	response	response	NOUN
dpc-1099	241	36	might	might	AUX
dpc-1099	241	37	be	be	AUX
dpc-1099	241	38	not	not	PART
dpc-1099	241	39	fully	fully	ADV
dpc-1099	241	40	ruled	rule	VERB
dpc-1099	241	41	by	by	ADP
dpc-1099	241	42	a	a	DET
dpc-1099	241	43	b	b	NOUN
dpc-1099	241	44	-	-	PUNCT
dpc-1099	241	45	cell	cell	NOUN
dpc-1099	241	46	downregulation	downregulation	NOUN
dpc-1099	241	47	and	and	CCONJ
dpc-1099	241	48	a	a	DET
dpc-1099	241	49	decrease	decrease	NOUN
dpc-1099	241	50	in	in	ADP
dpc-1099	241	51	autoantibody	autoantibody	ADJ
dpc-1099	241	52	titers	titer	NOUN
dpc-1099	241	53	[	[	X
dpc-1099	241	54	65	65	NUM
dpc-1099	241	55	]	]	PUNCT
dpc-1099	241	56	.	.	PUNCT
dpc-1099	242	1	recent	recent	ADJ
dpc-1099	242	2	studies	study	NOUN
dpc-1099	242	3	support	support	VERB
dpc-1099	242	4	a	a	DET
dpc-1099	242	5	pathogenic	pathogenic	ADJ
dpc-1099	242	6	role	role	NOUN
dpc-1099	242	7	of	of	ADP
dpc-1099	242	8	ige	ige	PROPN
dpc-1099	242	9	in	in	ADP
dpc-1099	242	10	the	the	DET
dpc-1099	242	11	development	development	NOUN
dpc-1099	242	12	of	of	ADP
dpc-1099	242	13	bp	bp	PROPN
dpc-1099	242	14	.	.	PUNCT
dpc-1099	243	1	this	this	DET
dpc-1099	243	2	hypothesis	hypothesis	NOUN
dpc-1099	243	3	is	be	AUX
dpc-1099	243	4	endorsed	endorse	VERB
dpc-1099	243	5	by	by	ADP
dpc-1099	243	6	the	the	DET
dpc-1099	243	7	finding	finding	NOUN
dpc-1099	243	8	of	of	ADP
dpc-1099	243	9	ige	ige	PROPN
dpc-1099	243	10	deposition	deposition	NOUN
dpc-1099	243	11	in	in	ADP
dpc-1099	243	12	the	the	DET
dpc-1099	243	13	basement	basement	NOUN
dpc-1099	243	14	membrane	membrane	NOUN
dpc-1099	243	15	zone	zone	NOUN
dpc-1099	243	16	in	in	ADP
dpc-1099	243	17	patients	patient	NOUN
dpc-1099	243	18	with	with	ADP
dpc-1099	243	19	bp	bp	PROPN
dpc-1099	243	20	.	.	PUNCT
dpc-1099	244	1	in	in	ADP
dpc-1099	244	2	addition	addition	NOUN
dpc-1099	244	3	,	,	PUNCT
dpc-1099	244	4	there	there	PRON
dpc-1099	244	5	is	be	VERB
dpc-1099	244	6	correlation	correlation	NOUN
dpc-1099	244	7	between	between	ADP
dpc-1099	244	8	serum	serum	NOUN
dpc-1099	244	9	levels	level	NOUN
dpc-1099	244	10	of	of	ADP
dpc-1099	244	11	ige	ige	NOUN
dpc-1099	244	12	autoantibodies	autoantibody	NOUN
dpc-1099	244	13	against	against	ADP
dpc-1099	244	14	bp180	bp180	PROPN
dpc-1099	244	15	and	and	CCONJ
dpc-1099	244	16	bp	bp	PROPN
dpc-1099	244	17	disease	disease	NOUN
dpc-1099	244	18	activity	activity	NOUN
dpc-1099	244	19	[	[	X
dpc-1099	244	20	62	62	NUM
dpc-1099	244	21	]	]	PUNCT
dpc-1099	244	22	.	.	PUNCT
dpc-1099	245	1	use	use	NOUN
dpc-1099	245	2	of	of	ADP
dpc-1099	245	3	ige	ige	PROPN
dpc-1099	245	4	targeted	target	VERB
dpc-1099	245	5	therapies	therapy	NOUN
dpc-1099	245	6	,	,	PUNCT
dpc-1099	245	7	such	such	ADJ
dpc-1099	245	8	as	as	ADP
dpc-1099	245	9	omalizumab	omalizumab	NOUN
dpc-1099	245	10	,	,	PUNCT
dpc-1099	245	11	has	have	AUX
dpc-1099	245	12	been	be	AUX
dpc-1099	245	13	shown	show	VERB
dpc-1099	245	14	as	as	ADP
dpc-1099	245	15	promising	promise	VERB
dpc-1099	245	16	in	in	ADP
dpc-1099	245	17	recent	recent	ADJ
dpc-1099	245	18	studies	study	NOUN
dpc-1099	245	19	[	[	X
dpc-1099	245	20	66	66	NUM
dpc-1099	245	21	]	]	PUNCT
dpc-1099	245	22	,	,	PUNCT
dpc-1099	245	23	with	with	ADP
dpc-1099	245	24	80	80	NUM
dpc-1099	245	25	%	%	NOUN
dpc-1099	245	26	complete	complete	ADJ
dpc-1099	245	27	response	response	NOUN
dpc-1099	245	28	rates	rate	NOUN
dpc-1099	245	29	and	and	CCONJ
dpc-1099	245	30	mean	mean	VERB
dpc-1099	245	31	time	time	NOUN
dpc-1099	245	32	to	to	PART
dpc-1099	245	33	recurrence	recurrence	NOUN
dpc-1099	245	34	of	of	ADP
dpc-1099	245	35	3.4	3.4	NUM
dpc-1099	245	36	months	month	NOUN
dpc-1099	245	37	[	[	X
dpc-1099	245	38	64	64	NUM
dpc-1099	245	39	]	]	PUNCT
dpc-1099	245	40	.	.	PUNCT
dpc-1099	246	1	conclusions	conclusion	NOUN
dpc-1099	246	2	current	current	ADJ
dpc-1099	246	3	treatment	treatment	NOUN
dpc-1099	246	4	paradigms	paradigm	NOUN
dpc-1099	246	5	in	in	ADP
dpc-1099	246	6	abd	abd	PROPN
dpc-1099	246	7	are	be	AUX
dpc-1099	246	8	traditionally	traditionally	ADV
dpc-1099	246	9	based	base	VERB
dpc-1099	246	10	on	on	ADP
dpc-1099	246	11	the	the	DET
dpc-1099	246	12	administration	administration	NOUN
dpc-1099	246	13	of	of	ADP
dpc-1099	246	14	immunosuppressive	immunosuppressive	ADJ
dpc-1099	246	15	drugs	drug	NOUN
dpc-1099	246	16	,	,	PUNCT
dpc-1099	246	17	often	often	ADV
dpc-1099	246	18	in	in	ADP
dpc-1099	246	19	combination	combination	NOUN
dpc-1099	246	20	.	.	PUNCT
dpc-1099	247	1	the	the	DET
dpc-1099	247	2	advent	advent	NOUN
dpc-1099	247	3	of	of	ADP
dpc-1099	247	4	rituximab	rituximab	NOUN
dpc-1099	247	5	,	,	PUNCT
dpc-1099	247	6	the	the	DET
dpc-1099	247	7	monoclonal	monoclonal	NOUN
dpc-1099	247	8	igg	igg	NOUN
dpc-1099	247	9	antibody	antibody	NOUN
dpc-1099	247	10	against	against	ADP
dpc-1099	247	11	cd20	cd20	PROPN
dpc-1099	247	12	,	,	PUNCT
dpc-1099	247	13	has	have	AUX
dpc-1099	247	14	revolutionized	revolutionize	VERB
dpc-1099	247	15	the	the	DET
dpc-1099	247	16	treatment	treatment	NOUN
dpc-1099	247	17	of	of	ADP
dpc-1099	247	18	pemphigus	pemphigus	NOUN
dpc-1099	247	19	,	,	PUNCT
dpc-1099	247	20	indicating	indicate	VERB
dpc-1099	247	21	that	that	SCONJ
dpc-1099	247	22	a	a	DET
dpc-1099	247	23	complete	complete	ADJ
dpc-1099	247	24	remission	remission	NOUN
dpc-1099	247	25	off	off	ADP
dpc-1099	247	26	therapy	therapy	NOUN
dpc-1099	247	27	is	be	AUX
dpc-1099	247	28	now	now	ADV
dpc-1099	247	29	possible	possible	ADJ
dpc-1099	247	30	.	.	PUNCT
dpc-1099	248	1	therefore	therefore	ADV
dpc-1099	248	2	,	,	PUNCT
dpc-1099	248	3	additional	additional	ADJ
dpc-1099	248	4	studies	study	NOUN
dpc-1099	248	5	are	be	AUX
dpc-1099	248	6	investigating	investigate	VERB
dpc-1099	248	7	other	other	ADJ
dpc-1099	248	8	anti	anti	ADJ
dpc-1099	248	9	-	-	ADJ
dpc-1099	248	10	cd20	cd20	ADJ
dpc-1099	248	11	monoclonal	monoclonal	NOUN
dpc-1099	248	12	antibodies	antibodie	VERB
dpc-1099	249	1	[	[	X
dpc-1099	249	2	67	67	NUM
dpc-1099	249	3	]	]	PUNCT
dpc-1099	249	4	.	.	PUNCT
dpc-1099	250	1	ideally	ideally	ADV
dpc-1099	250	2	,	,	PUNCT
dpc-1099	250	3	therapy	therapy	NOUN
dpc-1099	250	4	for	for	ADP
dpc-1099	250	5	autoimmune	autoimmune	ADJ
dpc-1099	250	6	diseases	disease	NOUN
dpc-1099	250	7	should	should	AUX
dpc-1099	250	8	eliminate	eliminate	VERB
dpc-1099	250	9	pathogenic	pathogenic	ADJ
dpc-1099	250	10	autoimmune	autoimmune	ADJ
dpc-1099	250	11	cells	cell	NOUN
dpc-1099	250	12	without	without	ADP
dpc-1099	250	13	affecting	affect	VERB
dpc-1099	250	14	protective	protective	ADJ
dpc-1099	250	15	immunity	immunity	NOUN
dpc-1099	250	16	.	.	PUNCT
dpc-1099	251	1	innovative	innovative	ADJ
dpc-1099	251	2	approaches	approach	NOUN
dpc-1099	251	3	include	include	VERB
dpc-1099	251	4	antigen	antigen	NOUN
dpc-1099	251	5	-	-	PUNCT
dpc-1099	251	6	specific	specific	ADJ
dpc-1099	251	7	figure	figure	NOUN
dpc-1099	251	8	7	7	NUM
dpc-1099	251	9	.	.	PUNCT
dpc-1099	251	10	treatment	treatment	NOUN
dpc-1099	251	11	options	option	NOUN
dpc-1099	251	12	for	for	ADP
dpc-1099	251	13	bullous	bullous	ADJ
dpc-1099	251	14	pemphigoid	pemphigoid	NOUN
dpc-1099	251	15	.	.	PUNCT
dpc-1099	252	1	https://doi.org/10.1007/s12026-018-8986-7	https://doi.org/10.1007/s12026-018-8986-7	PROPN
dpc-1099	252	2	https://doi.org/10.1007/s12026-018-8986-7	https://doi.org/10.1007/s12026-018-8986-7	PROPN
dpc-1099	253	1	https://doi.org/10.1111/jdv.15679	https://doi.org/10.1111/jdv.15679	PROPN
dpc-1099	253	2	10	10	NUM
dpc-1099	253	3	review	review	NOUN
dpc-1099	253	4	|	|	ADV
dpc-1099	253	5	dermatol	dermatol	ADJ
dpc-1099	253	6	pract	pract	NOUN
dpc-1099	253	7	concept	concept	NOUN
dpc-1099	253	8	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	253	9	18	18	NUM
dpc-1099	253	10	.	.	PUNCT
dpc-1099	254	1	takahashi	takahashi	PROPN
dpc-1099	254	2	h	h	PROPN
dpc-1099	254	3	,	,	PUNCT
dpc-1099	254	4	iriki	iriki	ADJ
dpc-1099	254	5	h	h	NOUN
dpc-1099	254	6	,	,	PUNCT
dpc-1099	254	7	mukai	mukai	PROPN
dpc-1099	254	8	m	m	PROPN
dpc-1099	254	9	,	,	PUNCT
dpc-1099	254	10	et	et	PROPN
dpc-1099	254	11	al	al	PROPN
dpc-1099	254	12	.	.	PROPN
dpc-1099	254	13	autoimmunity	autoimmunity	NOUN
dpc-1099	254	14	and	and	CCONJ
dpc-1099	254	15	immunological	immunological	ADJ
dpc-1099	254	16	tolerance	tolerance	NOUN
dpc-1099	254	17	in	in	ADP
dpc-1099	254	18	autoimmune	autoimmune	ADJ
dpc-1099	254	19	bullous	bullous	ADJ
dpc-1099	254	20	diseases	disease	NOUN
dpc-1099	254	21	.	.	PUNCT
dpc-1099	255	1	int	int	NOUN
dpc-1099	255	2	immunol	immunol	NOUN
dpc-1099	255	3	.	.	PUNCT
dpc-1099	256	1	2019;31(7):431	2019;31(7):431	NUM
dpc-1099	256	2	-	-	PUNCT
dpc-1099	256	3	437	437	NUM
dpc-1099	256	4	.	.	PUNCT
dpc-1099	257	1	https://doi.org/10.1093/intimm/dxz030	https://doi.org/10.1093/intimm/dxz030	NOUN
dpc-1099	257	2	19	19	NUM
dpc-1099	257	3	.	.	PUNCT
dpc-1099	258	1	cho	cho	PROPN
dpc-1099	258	2	mj	mj	PROPN
dpc-1099	258	3	,	,	PUNCT
dpc-1099	258	4	ellebrecht	ellebrecht	PROPN
dpc-1099	258	5	ct	ct	PROPN
dpc-1099	258	6	,	,	PUNCT
dpc-1099	258	7	hammers	hammer	NOUN
dpc-1099	258	8	cm	cm	PROPN
dpc-1099	258	9	,	,	PUNCT
dpc-1099	258	10	et	et	PROPN
dpc-1099	258	11	al	al	PROPN
dpc-1099	258	12	.	.	PUNCT
dpc-1099	259	1	determinants	determinant	NOUN
dpc-1099	259	2	of	of	ADP
dpc-1099	259	3	vh146	vh146	PROPN
dpc-1099	259	4	cross	cross	NOUN
dpc-1099	259	5	-	-	NOUN
dpc-1099	259	6	reactivity	reactivity	NOUN
dpc-1099	259	7	to	to	ADP
dpc-1099	259	8	pemphigus	pemphigus	PROPN
dpc-1099	259	9	vulgaris	vulgaris	PROPN
dpc-1099	259	10	autoantigen	autoantigen	PROPN
dpc-1099	259	11	desmoglein	desmoglein	PROPN
dpc-1099	259	12	3	3	NUM
dpc-1099	259	13	and	and	CCONJ
dpc-1099	259	14	rotavirus	rotavirus	NOUN
dpc-1099	259	15	antigen	antigen	ADP
dpc-1099	259	16	vp6	vp6	PROPN
dpc-1099	259	17	.	.	PUNCT
dpc-1099	260	1	j	j	PROPN
dpc-1099	260	2	immunol	immunol	NOUN
dpc-1099	260	3	.	.	PUNCT
dpc-1099	261	1	2016;197(4):1065	2016;197(4):1065	NUM
dpc-1099	261	2	-	-	PUNCT
dpc-1099	261	3	1073	1073	NUM
dpc-1099	261	4	.	.	PUNCT
dpc-1099	262	1	https://doi.org/10.4049/jimmunol.1600567	https://doi.org/10.4049/jimmunol.1600567	ADJ
dpc-1099	262	2	20	20	NUM
dpc-1099	262	3	.	.	PUNCT
dpc-1099	263	1	qian	qian	PROPN
dpc-1099	263	2	y	y	PROPN
dpc-1099	263	3	,	,	PUNCT
dpc-1099	263	4	jeong	jeong	PROPN
dpc-1099	263	5	js	js	PROPN
dpc-1099	263	6	,	,	PUNCT
dpc-1099	263	7	ye	ye	PROPN
dpc-1099	263	8	j	j	PROPN
dpc-1099	263	9	,	,	PUNCT
dpc-1099	263	10	et	et	PROPN
dpc-1099	263	11	al	al	PROPN
dpc-1099	263	12	.	.	PROPN
dpc-1099	264	1	overlapping	overlap	VERB
dpc-1099	264	2	igg4	igg4	PROPN
dpc-1099	264	3	responses	response	NOUN
dpc-1099	264	4	to	to	ADP
dpc-1099	264	5	self	self	NOUN
dpc-1099	264	6	and	and	CCONJ
dpc-1099	264	7	environmental	environmental	ADJ
dpc-1099	264	8	antigens	antigen	NOUN
dpc-1099	264	9	in	in	ADP
dpc-1099	264	10	endemic	endemic	ADJ
dpc-1099	264	11	pemphigus	pemphigus	NOUN
dpc-1099	264	12	foliaceus	foliaceus	NOUN
dpc-1099	264	13	.	.	PUNCT
dpc-1099	265	1	j	j	PROPN
dpc-1099	265	2	immunol	immunol	NOUN
dpc-1099	265	3	.	.	PUNCT
dpc-1099	266	1	2016;196(5):2041	2016;196(5):2041	NUM
dpc-1099	266	2	-	-	SYM
dpc-1099	266	3	2050	2050	NUM
dpc-1099	266	4	.	.	PUNCT
dpc-1099	267	1	https://doi.org/10.4049/	https://doi.org/10.4049/	PROPN
dpc-1099	267	2	jimmunol.1502233	jimmunol.1502233	PROPN
dpc-1099	267	3	21	21	NUM
dpc-1099	267	4	.	.	PUNCT
dpc-1099	268	1	schmidt	schmidt	PROPN
dpc-1099	268	2	e	e	PROPN
dpc-1099	268	3	,	,	PUNCT
dpc-1099	268	4	kasperkiewicz	kasperkiewicz	PROPN
dpc-1099	268	5	m	m	PROPN
dpc-1099	268	6	,	,	PUNCT
dpc-1099	268	7	joly	joly	PROPN
dpc-1099	268	8	p.	p.	PROPN
dpc-1099	268	9	pemphigus	pemphigus	PROPN
dpc-1099	268	10	.	.	PUNCT
dpc-1099	269	1	lancet	lancet	PROPN
dpc-1099	269	2	.	.	PUNCT
dpc-1099	270	1	2019;394(10201):882	2019;394(10201):882	NUM
dpc-1099	270	2	-	-	SYM
dpc-1099	270	3	894	894	NUM
dpc-1099	270	4	.	.	PUNCT
dpc-1099	271	1	https://doi.org/10.1016/s0140-6736	https://doi.org/10.1016/s0140-6736	PROPN
dpc-1099	271	2	(	(	PUNCT
dpc-1099	271	3	19)31778	19)31778	PROPN
dpc-1099	271	4	-	-	SYM
dpc-1099	271	5	7	7	NUM
dpc-1099	271	6	22	22	NUM
dpc-1099	271	7	.	.	PUNCT
dpc-1099	272	1	pollmann	pollmann	PROPN
dpc-1099	272	2	r	r	NOUN
dpc-1099	272	3	,	,	PUNCT
dpc-1099	272	4	schmidt	schmidt	PROPN
dpc-1099	272	5	t	t	PROPN
dpc-1099	272	6	,	,	PUNCT
dpc-1099	272	7	eming	eme	VERB
dpc-1099	272	8	r	r	NOUN
dpc-1099	272	9	,	,	PUNCT
dpc-1099	272	10	hertl	hertl	NOUN
dpc-1099	272	11	m.	m.	NOUN
dpc-1099	272	12	pemphigus	pemphigus	PROPN
dpc-1099	272	13	:	:	PUNCT
dpc-1099	272	14	a	a	DET
dpc-1099	272	15	comprehensive	comprehensive	ADJ
dpc-1099	272	16	review	review	NOUN
dpc-1099	272	17	on	on	ADP
dpc-1099	272	18	pathogenesis	pathogenesis	NOUN
dpc-1099	272	19	,	,	PUNCT
dpc-1099	272	20	clinical	clinical	ADJ
dpc-1099	272	21	presentation	presentation	NOUN
dpc-1099	272	22	and	and	CCONJ
dpc-1099	272	23	novel	novel	ADJ
dpc-1099	272	24	therapeutic	therapeutic	ADJ
dpc-1099	272	25	approaches	approach	NOUN
dpc-1099	272	26	.	.	PUNCT
dpc-1099	273	1	clin	clin	PROPN
dpc-1099	273	2	rev	rev	PROPN
dpc-1099	273	3	allergy	allergy	PROPN
dpc-1099	273	4	immunol	immunol	NOUN
dpc-1099	273	5	.	.	PUNCT
dpc-1099	274	1	2018;54(1):125	2018;54(1):125	NOUN
dpc-1099	274	2	.	.	PUNCT
dpc-1099	275	1	https://doi.org/10.1007/s12016-017-8662-z	https://doi.org/10.1007/s12016-017-8662-z	PROPN
dpc-1099	275	2	23	23	NUM
dpc-1099	275	3	.	.	PUNCT
dpc-1099	276	1	lo	lo	PROPN
dpc-1099	276	2	schiavo	schiavo	PROPN
dpc-1099	276	3	a	a	PROPN
dpc-1099	276	4	,	,	PUNCT
dpc-1099	276	5	ruocco	ruocco	PROPN
dpc-1099	276	6	e	e	NOUN
dpc-1099	276	7	,	,	PUNCT
dpc-1099	276	8	brancaccio	brancaccio	VERB
dpc-1099	276	9	g	g	PROPN
dpc-1099	276	10	,	,	PUNCT
dpc-1099	276	11	caccavale	caccavale	PROPN
dpc-1099	276	12	s	s	PROPN
dpc-1099	276	13	,	,	PUNCT
dpc-1099	276	14	ruocco	ruocco	PROPN
dpc-1099	276	15	v	v	NOUN
dpc-1099	276	16	,	,	PUNCT
dpc-1099	276	17	wolf	wolf	PROPN
dpc-1099	276	18	r.	r.	PROPN
dpc-1099	276	19	bullous	bullous	ADJ
dpc-1099	276	20	pemphigoid	pemphigoid	ADV
dpc-1099	276	21	:	:	PUNCT
dpc-1099	276	22	etiology	etiology	NOUN
dpc-1099	276	23	,	,	PUNCT
dpc-1099	276	24	pathogenesis	pathogenesis	NOUN
dpc-1099	276	25	,	,	PUNCT
dpc-1099	276	26	and	and	CCONJ
dpc-1099	276	27	inducing	induce	VERB
dpc-1099	276	28	factors	factor	NOUN
dpc-1099	276	29	:	:	PUNCT
dpc-1099	276	30	facts	fact	NOUN
dpc-1099	276	31	and	and	CCONJ
dpc-1099	276	32	controversies	controversy	NOUN
dpc-1099	276	33	.	.	PUNCT
dpc-1099	277	1	clin	clin	PROPN
dpc-1099	277	2	dermatol	dermatol	NOUN
dpc-1099	277	3	.	.	PUNCT
dpc-1099	278	1	2013;31(4):391399	2013;31(4):391399	NUM
dpc-1099	278	2	.	.	PUNCT
dpc-1099	279	1	https://doi.org/10.1016/j.clindermatol.2013.01.006	https://doi.org/10.1016/j.clindermatol.2013.01.006	NOUN
dpc-1099	279	2	24	24	NUM
dpc-1099	279	3	.	.	PUNCT
dpc-1099	280	1	genovese	genovese	NOUN
dpc-1099	280	2	g	g	PROPN
dpc-1099	280	3	,	,	PUNCT
dpc-1099	280	4	di	di	NOUN
dpc-1099	280	5	zenzo	zenzo	NOUN
dpc-1099	280	6	g	g	NOUN
dpc-1099	280	7	,	,	PUNCT
dpc-1099	280	8	cozzani	cozzani	NOUN
dpc-1099	280	9	e	e	PROPN
dpc-1099	280	10	,	,	PUNCT
dpc-1099	280	11	berti	berti	PROPN
dpc-1099	280	12	e	e	PROPN
dpc-1099	280	13	,	,	PUNCT
dpc-1099	280	14	cugno	cugno	PROPN
dpc-1099	280	15	m	m	PROPN
dpc-1099	280	16	,	,	PUNCT
dpc-1099	280	17	marzano	marzano	PROPN
dpc-1099	280	18	av	av	PROPN
dpc-1099	280	19	.	.	PUNCT
dpc-1099	281	1	new	new	ADJ
dpc-1099	281	2	insights	insight	NOUN
dpc-1099	281	3	into	into	ADP
dpc-1099	281	4	the	the	DET
dpc-1099	281	5	pathogenesis	pathogenesis	NOUN
dpc-1099	281	6	of	of	ADP
dpc-1099	281	7	bullous	bullous	ADJ
dpc-1099	281	8	pemphigoid	pemphigoid	NOUN
dpc-1099	281	9	:	:	PUNCT
dpc-1099	281	10	2019	2019	NUM
dpc-1099	281	11	update	update	NOUN
dpc-1099	281	12	.	.	PUNCT
dpc-1099	282	1	front	front	ADJ
dpc-1099	282	2	immunol	immunol	NOUN
dpc-1099	282	3	.	.	PUNCT
dpc-1099	283	1	2019;10:1506	2019;10:1506	NUM
dpc-1099	283	2	.	.	PUNCT
dpc-1099	284	1	https://doi	https://doi	PROPN
dpc-1099	284	2	.	.	PUNCT
dpc-1099	284	3	org/10.3389	org/10.3389	PROPN
dpc-1099	284	4	/	/	SYM
dpc-1099	284	5	fimmu.2019.01506	fimmu.2019.01506	PROPN
dpc-1099	284	6	25	25	NUM
dpc-1099	284	7	.	.	PUNCT
dpc-1099	284	8	plaquevent	plaquevent	PROPN
dpc-1099	284	9	m	m	PROPN
dpc-1099	284	10	,	,	PUNCT
dpc-1099	284	11	tétart	tétart	NOUN
dpc-1099	284	12	f	f	NOUN
dpc-1099	284	13	,	,	PUNCT
dpc-1099	284	14	fardet	fardet	NOUN
dpc-1099	284	15	l	l	PROPN
dpc-1099	284	16	,	,	PUNCT
dpc-1099	284	17	et	et	PROPN
dpc-1099	284	18	al	al	PROPN
dpc-1099	284	19	.	.	PROPN
dpc-1099	284	20	higher	high	ADJ
dpc-1099	284	21	frequency	frequency	NOUN
dpc-1099	284	22	of	of	ADP
dpc-1099	284	23	dipeptidyl	dipeptidyl	NOUN
dpc-1099	284	24	peptidase-4	peptidase-4	NOUN
dpc-1099	284	25	inhibitor	inhibitor	NOUN
dpc-1099	284	26	intake	intake	NOUN
dpc-1099	284	27	in	in	ADP
dpc-1099	284	28	bullous	bullous	ADJ
dpc-1099	284	29	pemphigoid	pemphigoid	ADJ
dpc-1099	284	30	patients	patient	NOUN
dpc-1099	284	31	than	than	ADP
dpc-1099	284	32	in	in	ADP
dpc-1099	284	33	the	the	DET
dpc-1099	284	34	french	french	ADJ
dpc-1099	284	35	general	general	ADJ
dpc-1099	284	36	population	population	NOUN
dpc-1099	284	37	.	.	PUNCT
dpc-1099	285	1	j	j	PROPN
dpc-1099	285	2	invest	invest	VERB
dpc-1099	285	3	dermatol	dermatol	NOUN
dpc-1099	285	4	.	.	PUNCT
dpc-1099	286	1	2019;139(4):835	2019;139(4):835	NUM
dpc-1099	286	2	-	-	SYM
dpc-1099	286	3	841	841	NUM
dpc-1099	286	4	.	.	PUNCT
dpc-1099	287	1	https://doi.org/10.1016/j.jid.2018.10.045	https://doi.org/10.1016/j.jid.2018.10.045	ADJ
dpc-1099	287	2	26	26	NUM
dpc-1099	287	3	.	.	PUNCT
dpc-1099	288	1	muramatsu	muramatsu	PROPN
dpc-1099	288	2	k	k	PROPN
dpc-1099	288	3	,	,	PUNCT
dpc-1099	288	4	ujiie	ujiie	ADJ
dpc-1099	288	5	h	h	NOUN
dpc-1099	288	6	,	,	PUNCT
dpc-1099	288	7	kobayashi	kobayashi	PROPN
dpc-1099	288	8	i	i	PROPN
dpc-1099	288	9	,	,	PUNCT
dpc-1099	288	10	et	et	PROPN
dpc-1099	288	11	al	al	PROPN
dpc-1099	288	12	.	.	PUNCT
dpc-1099	289	1	regulatory	regulatory	PROPN
dpc-1099	289	2	t	t	PROPN
dpc-1099	289	3	-	-	PUNCT
dpc-1099	289	4	cell	cell	NOUN
dpc-1099	289	5	dysfunction	dysfunction	NOUN
dpc-1099	289	6	induces	induce	VERB
dpc-1099	289	7	autoantibodies	autoantibody	NOUN
dpc-1099	289	8	to	to	ADP
dpc-1099	289	9	bullous	bullous	ADJ
dpc-1099	289	10	pemphigoid	pemphigoid	ADJ
dpc-1099	289	11	antigens	antigen	NOUN
dpc-1099	289	12	in	in	ADP
dpc-1099	289	13	mice	mouse	NOUN
dpc-1099	289	14	and	and	CCONJ
dpc-1099	289	15	human	human	ADJ
dpc-1099	289	16	subjects	subject	NOUN
dpc-1099	289	17	.	.	PUNCT
dpc-1099	290	1	j	j	PROPN
dpc-1099	290	2	allergy	allergy	PROPN
dpc-1099	290	3	clin	clin	PROPN
dpc-1099	290	4	immunol	immunol	NOUN
dpc-1099	290	5	.	.	PUNCT
dpc-1099	291	1	2018;142(6):1818	2018;142(6):1818	NUM
dpc-1099	291	2	-	-	SYM
dpc-1099	291	3	1830	1830	NUM
dpc-1099	291	4	.	.	PUNCT
dpc-1099	292	1	https://doi.org/10.1016/j.jaci.2018	https://doi.org/10.1016/j.jaci.2018	NOUN
dpc-1099	292	2	.	.	PUNCT
dpc-1099	293	1	03.014	03.014	NUM
dpc-1099	293	2	27	27	NUM
dpc-1099	293	3	.	.	PUNCT
dpc-1099	294	1	hébert	hébert	NOUN
dpc-1099	294	2	v	v	PROPN
dpc-1099	294	3	,	,	PUNCT
dpc-1099	294	4	boulard	boulard	ADJ
dpc-1099	294	5	c	c	NOUN
dpc-1099	294	6	,	,	PUNCT
dpc-1099	294	7	houivet	houivet	NOUN
dpc-1099	294	8	e	e	NOUN
dpc-1099	294	9	,	,	PUNCT
dpc-1099	294	10	et	et	PROPN
dpc-1099	294	11	al	al	PROPN
dpc-1099	294	12	.	.	PUNCT
dpc-1099	295	1	large	large	ADJ
dpc-1099	295	2	international	international	ADJ
dpc-1099	295	3	validation	validation	NOUN
dpc-1099	295	4	of	of	ADP
dpc-1099	295	5	absis	absis	NOUN
dpc-1099	295	6	and	and	CCONJ
dpc-1099	295	7	pdai	pdai	PROPN
dpc-1099	295	8	pemphigus	pemphigus	PROPN
dpc-1099	295	9	severity	severity	PROPN
dpc-1099	295	10	scores	score	NOUN
dpc-1099	295	11	.	.	PUNCT
dpc-1099	296	1	j	j	PROPN
dpc-1099	296	2	invest	invest	VERB
dpc-1099	296	3	dermatol	dermatol	NOUN
dpc-1099	296	4	.	.	PUNCT
dpc-1099	297	1	2019;139(1):31	2019;139(1):31	NUM
dpc-1099	297	2	-	-	SYM
dpc-1099	297	3	37	37	NUM
dpc-1099	297	4	.	.	PUNCT
dpc-1099	298	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
dpc-1099	298	2	j.jid.2018.04.042	j.jid.2018.04.042	ADP
dpc-1099	298	3	28	28	NUM
dpc-1099	298	4	.	.	PUNCT
dpc-1099	299	1	cozzani	cozzani	PROPN
dpc-1099	299	2	e	e	NOUN
dpc-1099	299	3	,	,	PUNCT
dpc-1099	299	4	gasparini	gasparini	VERB
dpc-1099	299	5	g	g	NOUN
dpc-1099	299	6	,	,	PUNCT
dpc-1099	299	7	burlando	burlando	PROPN
dpc-1099	299	8	m	m	PROPN
dpc-1099	299	9	,	,	PUNCT
dpc-1099	299	10	drago	drago	PROPN
dpc-1099	299	11	f	f	NUM
dpc-1099	299	12	,	,	PUNCT
dpc-1099	299	13	parodi	parodi	PROPN
dpc-1099	299	14	a.	a.	NOUN
dpc-1099	299	15	atypical	atypical	ADJ
dpc-1099	299	16	presentations	presentation	NOUN
dpc-1099	299	17	of	of	ADP
dpc-1099	299	18	bullous	bullous	ADJ
dpc-1099	299	19	pemphigoid	pemphigoid	NOUN
dpc-1099	299	20	:	:	PUNCT
dpc-1099	299	21	clinical	clinical	ADJ
dpc-1099	299	22	and	and	CCONJ
dpc-1099	299	23	immunopathological	immunopathological	ADJ
dpc-1099	299	24	aspects	aspect	NOUN
dpc-1099	299	25	.	.	PUNCT
dpc-1099	300	1	autoimmun	autoimmun	PROPN
dpc-1099	300	2	rev	rev	PROPN
dpc-1099	300	3	.	.	PUNCT
dpc-1099	301	1	2015;14(5):438	2015;14(5):438	NUM
dpc-1099	301	2	-	-	SYM
dpc-1099	301	3	445	445	NUM
dpc-1099	301	4	.	.	PUNCT
dpc-1099	302	1	https://doi	https://doi	X
dpc-1099	302	2	.	.	PUNCT
dpc-1099	303	1	org/10.1016	org/10.1016	PROPN
dpc-1099	303	2	/	/	SYM
dpc-1099	303	3	j.autrev.2015.01.006	j.autrev.2015.01.006	ADJ
dpc-1099	303	4	29	29	NUM
dpc-1099	303	5	.	.	PUNCT
dpc-1099	304	1	murrell	murrell	PROPN
dpc-1099	304	2	df	df	PROPN
dpc-1099	304	3	,	,	PUNCT
dpc-1099	304	4	daniel	daniel	PROPN
dpc-1099	304	5	bs	bs	PROPN
dpc-1099	304	6	,	,	PUNCT
dpc-1099	304	7	joly	joly	PROPN
dpc-1099	304	8	p	p	PROPN
dpc-1099	304	9	,	,	PUNCT
dpc-1099	304	10	et	et	PROPN
dpc-1099	304	11	al	al	PROPN
dpc-1099	304	12	.	.	PUNCT
dpc-1099	305	1	definitions	definition	NOUN
dpc-1099	305	2	and	and	CCONJ
dpc-1099	305	3	outcome	outcome	VERB
dpc-1099	305	4	measures	measure	NOUN
dpc-1099	305	5	for	for	ADP
dpc-1099	305	6	bullous	bullous	ADJ
dpc-1099	305	7	pemphigoid	pemphigoid	NOUN
dpc-1099	305	8	:	:	PUNCT
dpc-1099	305	9	recommendations	recommendation	NOUN
dpc-1099	305	10	by	by	ADP
dpc-1099	305	11	an	an	DET
dpc-1099	305	12	international	international	ADJ
dpc-1099	305	13	panel	panel	NOUN
dpc-1099	305	14	of	of	ADP
dpc-1099	305	15	experts	expert	NOUN
dpc-1099	305	16	.	.	PUNCT
dpc-1099	306	1	j	j	PROPN
dpc-1099	306	2	am	be	AUX
dpc-1099	306	3	acad	acad	ADJ
dpc-1099	306	4	dermatol	dermatol	NOUN
dpc-1099	306	5	.	.	PUNCT
dpc-1099	307	1	2012;66(3):479485	2012;66(3):479485	NUM
dpc-1099	307	2	.	.	PUNCT
dpc-1099	308	1	https://doi.org/10.1016/j.jaad.2011.06.032	https://doi.org/10.1016/j.jaad.2011.06.032	PROPN
dpc-1099	308	2	30	30	NUM
dpc-1099	308	3	.	.	PUNCT
dpc-1099	309	1	pfütze	pfütze	PROPN
dpc-1099	309	2	m	m	PROPN
dpc-1099	309	3	,	,	PUNCT
dpc-1099	309	4	niedermeier	niedermeier	PROPN
dpc-1099	309	5	a	a	PRON
dpc-1099	309	6	,	,	PUNCT
dpc-1099	309	7	hertl	hertl	NOUN
dpc-1099	309	8	m	m	PROPN
dpc-1099	309	9	,	,	PUNCT
dpc-1099	309	10	eming	eme	VERB
dpc-1099	309	11	r.	r.	NOUN
dpc-1099	309	12	introducing	introduce	VERB
dpc-1099	309	13	a	a	DET
dpc-1099	309	14	novel	novel	ADJ
dpc-1099	309	15	autoimmune	autoimmune	ADJ
dpc-1099	309	16	bullous	bullous	ADJ
dpc-1099	309	17	skin	skin	NOUN
dpc-1099	309	18	disorder	disorder	NOUN
dpc-1099	309	19	intensity	intensity	NOUN
dpc-1099	309	20	score	score	NOUN
dpc-1099	309	21	(	(	PUNCT
dpc-1099	309	22	absis	absis	NOUN
dpc-1099	309	23	)	)	PUNCT
dpc-1099	309	24	in	in	ADP
dpc-1099	309	25	pemphigus	pemphigus	PROPN
dpc-1099	309	26	.	.	PUNCT
dpc-1099	310	1	eur	eur	PROPN
dpc-1099	310	2	j	j	PROPN
dpc-1099	310	3	dermatol	dermatol	NOUN
dpc-1099	310	4	.	.	PUNCT
dpc-1099	311	1	2007;17(1):4	2007;17(1):4	NUM
dpc-1099	311	2	-	-	SYM
dpc-1099	311	3	11	11	NUM
dpc-1099	311	4	.	.	PUNCT
dpc-1099	312	1	31	31	NUM
dpc-1099	312	2	.	.	PUNCT
dpc-1099	313	1	wijayanti	wijayanti	VERB
dpc-1099	313	2	a	a	PRON
dpc-1099	313	3	,	,	PUNCT
dpc-1099	313	4	zhao	zhao	PROPN
dpc-1099	313	5	cy	cy	PROPN
dpc-1099	313	6	,	,	PUNCT
dpc-1099	313	7	boettiger	boettiger	NOUN
dpc-1099	313	8	d	d	PROPN
dpc-1099	313	9	,	,	PUNCT
dpc-1099	313	10	et	et	PROPN
dpc-1099	313	11	al	al	PROPN
dpc-1099	313	12	.	.	PUNCT
dpc-1099	314	1	the	the	DET
dpc-1099	314	2	reliability	reliability	NOUN
dpc-1099	314	3	,	,	PUNCT
dpc-1099	314	4	validity	validity	NOUN
dpc-1099	314	5	and	and	CCONJ
dpc-1099	314	6	responsiveness	responsiveness	NOUN
dpc-1099	314	7	of	of	ADP
dpc-1099	314	8	two	two	NUM
dpc-1099	314	9	disease	disease	NOUN
dpc-1099	314	10	scores	score	NOUN
dpc-1099	314	11	(	(	PUNCT
dpc-1099	314	12	bpdai	bpdai	NOUN
dpc-1099	314	13	and	and	CCONJ
dpc-1099	314	14	absis	absis	NOUN
dpc-1099	314	15	)	)	PUNCT
dpc-1099	314	16	for	for	ADP
dpc-1099	314	17	bullous	bullous	ADJ
dpc-1099	314	18	pemphigoid	pemphigoid	NOUN
dpc-1099	314	19	:	:	PUNCT
dpc-1099	314	20	which	which	DET
dpc-1099	314	21	one	one	NOUN
dpc-1099	314	22	to	to	PART
dpc-1099	314	23	use	use	VERB
dpc-1099	314	24	?	?	PUNCT
dpc-1099	315	1	acta	acta	PROPN
dpc-1099	315	2	derm	derm	PROPN
dpc-1099	315	3	venereol	venereol	NOUN
dpc-1099	315	4	.	.	PUNCT
dpc-1099	316	1	2017;97(1):24	2017;97(1):24	NUM
dpc-1099	316	2	-	-	SYM
dpc-1099	316	3	31	31	NUM
dpc-1099	316	4	.	.	PUNCT
dpc-1099	317	1	https://doi.org/10.2340/00015555-2473	https://doi.org/10.2340/00015555-2473	PROPN
dpc-1099	317	2	32	32	NUM
dpc-1099	317	3	.	.	PUNCT
dpc-1099	318	1	miyamoto	miyamoto	PROPN
dpc-1099	318	2	d	d	PROPN
dpc-1099	318	3	,	,	PUNCT
dpc-1099	318	4	santi	santi	PROPN
dpc-1099	318	5	cg	cg	PROPN
dpc-1099	318	6	,	,	PUNCT
dpc-1099	318	7	aoki	aoki	PROPN
dpc-1099	318	8	v	v	PROPN
dpc-1099	318	9	,	,	PUNCT
dpc-1099	318	10	maruta	maruta	PROPN
dpc-1099	318	11	cw	cw	PROPN
dpc-1099	318	12	.	.	PUNCT
dpc-1099	318	13	bullous	bullous	ADJ
dpc-1099	318	14	pemphigoid	pemphigoid	NOUN
dpc-1099	318	15	.	.	PUNCT
dpc-1099	319	1	an	an	DET
dpc-1099	319	2	bras	bras	NOUN
dpc-1099	319	3	dermatol	dermatol	NOUN
dpc-1099	319	4	.	.	PUNCT
dpc-1099	320	1	2019;94(2):133	2019;94(2):133	PROPN
dpc-1099	320	2	-	-	SYM
dpc-1099	320	3	146	146	NUM
dpc-1099	320	4	.	.	PUNCT
dpc-1099	321	1	https://doi.org/10.1590/	https://doi.org/10.1590/	X
dpc-1099	321	2	abd1806	abd1806	ADV
dpc-1099	321	3	-	-	ADJ
dpc-1099	321	4	4841.20199007	4841.20199007	ADJ
dpc-1099	321	5	33	33	NUM
dpc-1099	321	6	.	.	PUNCT
dpc-1099	322	1	cozzani	cozzani	PROPN
dpc-1099	322	2	e	e	X
dpc-1099	322	3	,	,	PUNCT
dpc-1099	322	4	marzano	marzano	PROPN
dpc-1099	322	5	av	av	PROPN
dpc-1099	322	6	,	,	PUNCT
dpc-1099	322	7	caproni	caproni	PROPN
dpc-1099	322	8	m	m	PROPN
dpc-1099	322	9	,	,	PUNCT
dpc-1099	322	10	feliciani	feliciani	PROPN
dpc-1099	322	11	c	c	NOUN
dpc-1099	322	12	,	,	PUNCT
dpc-1099	322	13	calzavara	calzavara	NOUN
dpc-1099	322	14	-	-	PUNCT
dpc-1099	322	15	pinton	pinton	NOUN
dpc-1099	322	16	p	p	NOUN
dpc-1099	322	17	;	;	PUNCT
dpc-1099	322	18	cutaneous	cutaneous	ADJ
dpc-1099	322	19	immunology	immunology	NOUN
dpc-1099	322	20	group	group	NOUN
dpc-1099	322	21	of	of	ADP
dpc-1099	322	22	sidemast	sidemast	NOUN
dpc-1099	322	23	.	.	PUNCT
dpc-1099	323	1	bullous	bullous	ADJ
dpc-1099	323	2	and	and	CCONJ
dpc-1099	323	3	bullous	bullous	ADJ
dpc-1099	323	4	pemphigoid	pemphigoid	NOUN
dpc-1099	323	5	.	.	PUNCT
dpc-1099	324	1	arch	arch	ADJ
dpc-1099	324	2	dermatol	dermatol	NOUN
dpc-1099	324	3	res	re	NOUN
dpc-1099	324	4	.	.	PUNCT
dpc-1099	325	1	2015;307(4):291298	2015;307(4):291298	NUM
dpc-1099	325	2	.	.	PUNCT
dpc-1099	326	1	https://doi.org/10.1007/s00403-014-1531-1	https://doi.org/10.1007/s00403-014-1531-1	NUM
dpc-1099	326	2	4	4	NUM
dpc-1099	326	3	.	.	PUNCT
dpc-1099	326	4	marazza	marazza	NOUN
dpc-1099	326	5	g	g	PROPN
dpc-1099	326	6	,	,	PUNCT
dpc-1099	326	7	pham	pham	PROPN
dpc-1099	326	8	hc	hc	PROPN
dpc-1099	326	9	,	,	PUNCT
dpc-1099	326	10	schärer	schärer	NOUN
dpc-1099	326	11	l	l	NOUN
dpc-1099	326	12	,	,	PUNCT
dpc-1099	326	13	et	et	PROPN
dpc-1099	326	14	al	al	PROPN
dpc-1099	326	15	.	.	PROPN
dpc-1099	326	16	incidence	incidence	NOUN
dpc-1099	326	17	of	of	ADP
dpc-1099	326	18	bullous	bullous	ADJ
dpc-1099	326	19	pemphigoid	pemphigoid	NOUN
dpc-1099	326	20	and	and	CCONJ
dpc-1099	326	21	pemphigus	pemphigus	PROPN
dpc-1099	326	22	in	in	ADP
dpc-1099	326	23	switzerland	switzerland	PROPN
dpc-1099	326	24	:	:	PUNCT
dpc-1099	326	25	a	a	DET
dpc-1099	326	26	2	2	NUM
dpc-1099	326	27	-	-	PUNCT
dpc-1099	326	28	year	year	NOUN
dpc-1099	326	29	prospective	prospective	ADJ
dpc-1099	326	30	study	study	NOUN
dpc-1099	326	31	.	.	PUNCT
dpc-1099	327	1	br	br	PROPN
dpc-1099	327	2	j	j	PROPN
dpc-1099	327	3	dermatol	dermatol	NOUN
dpc-1099	327	4	.	.	PUNCT
dpc-1099	328	1	2009;161(4):861	2009;161(4):861	NUM
dpc-1099	328	2	-	-	SYM
dpc-1099	328	3	868	868	NUM
dpc-1099	328	4	.	.	PUNCT
dpc-1099	329	1	https://doi	https://doi	NOUN
dpc-1099	329	2	.	.	PUNCT
dpc-1099	329	3	org/10.1111	org/10.1111	PROPN
dpc-1099	329	4	/	/	SYM
dpc-1099	329	5	j.1365	j.1365	NOUN
dpc-1099	329	6	-	-	PUNCT
dpc-1099	329	7	2133.2009.09300.x	2133.2009.09300.x	NUM
dpc-1099	329	8	5	5	NUM
dpc-1099	329	9	.	.	PUNCT
dpc-1099	329	10	bertram	bertram	PROPN
dpc-1099	329	11	f	f	PROPN
dpc-1099	329	12	,	,	PUNCT
dpc-1099	329	13	bröcker	bröcker	PROPN
dpc-1099	329	14	eb	eb	PROPN
dpc-1099	329	15	,	,	PUNCT
dpc-1099	329	16	zillikens	zillikens	PROPN
dpc-1099	329	17	d	d	PROPN
dpc-1099	329	18	,	,	PUNCT
dpc-1099	329	19	et	et	PROPN
dpc-1099	329	20	al	al	PROPN
dpc-1099	329	21	.	.	PROPN
dpc-1099	329	22	prospective	prospective	ADJ
dpc-1099	329	23	analysis	analysis	NOUN
dpc-1099	329	24	of	of	ADP
dpc-1099	329	25	the	the	DET
dpc-1099	329	26	incidence	incidence	NOUN
dpc-1099	329	27	of	of	ADP
dpc-1099	329	28	autoimmune	autoimmune	ADJ
dpc-1099	329	29	bullous	bullous	ADJ
dpc-1099	329	30	disorders	disorder	NOUN
dpc-1099	329	31	in	in	ADP
dpc-1099	329	32	lower	low	ADJ
dpc-1099	329	33	franconia	franconia	PROPN
dpc-1099	329	34	,	,	PUNCT
dpc-1099	329	35	germany	germany	PROPN
dpc-1099	329	36	.	.	PUNCT
dpc-1099	330	1	j	j	PROPN
dpc-1099	330	2	dtsch	dtsch	PROPN
dpc-1099	330	3	dermatol	dermatol	NOUN
dpc-1099	330	4	ges	ge	NOUN
dpc-1099	330	5	.	.	PROPN
dpc-1099	330	6	2009;7(5):434	2009;7(5):434	NUM
dpc-1099	330	7	-	-	SYM
dpc-1099	330	8	440	440	NUM
dpc-1099	330	9	.	.	PUNCT
dpc-1099	331	1	https://	https://	NOUN
dpc-1099	331	2	doi.org/10.1111/j.1610-0387.2008.06976.x	doi.org/10.1111/j.1610-0387.2008.06976.x	NOUN
dpc-1099	331	3	6	6	NUM
dpc-1099	331	4	.	.	PUNCT
dpc-1099	332	1	baican	baican	PROPN
dpc-1099	332	2	a	a	PRON
dpc-1099	332	3	,	,	PUNCT
dpc-1099	332	4	baican	baican	NOUN
dpc-1099	332	5	c	c	NOUN
dpc-1099	332	6	,	,	PUNCT
dpc-1099	332	7	chiriac	chiriac	PROPN
dpc-1099	332	8	g	g	PROPN
dpc-1099	332	9	,	,	PUNCT
dpc-1099	332	10	et	et	PROPN
dpc-1099	332	11	al	al	PROPN
dpc-1099	332	12	.	.	PUNCT
dpc-1099	333	1	pemphigus	pemphigus	PROPN
dpc-1099	333	2	vulgaris	vulgaris	PROPN
dpc-1099	333	3	is	be	AUX
dpc-1099	333	4	the	the	DET
dpc-1099	333	5	most	most	ADV
dpc-1099	333	6	common	common	ADJ
dpc-1099	333	7	autoimmune	autoimmune	ADJ
dpc-1099	333	8	bullous	bullous	ADJ
dpc-1099	333	9	disease	disease	NOUN
dpc-1099	333	10	in	in	ADP
dpc-1099	333	11	northwestern	northwestern	ADJ
dpc-1099	333	12	romania	romania	PROPN
dpc-1099	333	13	.	.	PUNCT
dpc-1099	334	1	int	int	PROPN
dpc-1099	334	2	j	j	PROPN
dpc-1099	334	3	dermatol	dermatol	NOUN
dpc-1099	334	4	.	.	PUNCT
dpc-1099	335	1	2010;49(7):768	2010;49(7):768	NOUN
dpc-1099	335	2	-	-	PUNCT
dpc-1099	335	3	774	774	NUM
dpc-1099	335	4	.	.	PUNCT
dpc-1099	336	1	https://doi	https://doi	PROPN
dpc-1099	336	2	.	.	PUNCT
dpc-1099	336	3	org/10.1111	org/10.1111	PROPN
dpc-1099	336	4	/	/	SYM
dpc-1099	336	5	j.1365	j.1365	NOUN
dpc-1099	336	6	-	-	PUNCT
dpc-1099	336	7	4632.2009.04345.x	4632.2009.04345.x	NUM
dpc-1099	336	8	7	7	NUM
dpc-1099	336	9	.	.	PUNCT
dpc-1099	337	1	pisanti	pisanti	PROPN
dpc-1099	337	2	s	s	PROPN
dpc-1099	337	3	,	,	PUNCT
dpc-1099	337	4	sharav	sharav	VERB
dpc-1099	337	5	y	y	PROPN
dpc-1099	337	6	,	,	PUNCT
dpc-1099	337	7	kaufman	kaufman	PROPN
dpc-1099	337	8	e	e	PROPN
dpc-1099	337	9	,	,	PUNCT
dpc-1099	337	10	posner	posner	NOUN
dpc-1099	337	11	ln	ln	ADJ
dpc-1099	337	12	.	.	PUNCT
dpc-1099	338	1	pemphigus	pemphigus	PROPN
dpc-1099	338	2	vulgaris	vulgaris	PROPN
dpc-1099	338	3	:	:	PUNCT
dpc-1099	338	4	incidence	incidence	NOUN
dpc-1099	338	5	in	in	ADP
dpc-1099	338	6	jews	jews	PROPN
dpc-1099	338	7	of	of	ADP
dpc-1099	338	8	different	different	ADJ
dpc-1099	338	9	ethnic	ethnic	ADJ
dpc-1099	338	10	groups	group	NOUN
dpc-1099	338	11	,	,	PUNCT
dpc-1099	338	12	according	accord	VERB
dpc-1099	338	13	to	to	ADP
dpc-1099	338	14	age	age	NOUN
dpc-1099	338	15	,	,	PUNCT
dpc-1099	338	16	sex	sex	NOUN
dpc-1099	338	17	,	,	PUNCT
dpc-1099	338	18	and	and	CCONJ
dpc-1099	338	19	initial	initial	ADJ
dpc-1099	338	20	lesion	lesion	NOUN
dpc-1099	338	21	.	.	PUNCT
dpc-1099	339	1	oral	oral	ADJ
dpc-1099	339	2	surg	surg	NOUN
dpc-1099	339	3	oral	oral	ADJ
dpc-1099	339	4	med	med	ADJ
dpc-1099	339	5	oral	oral	ADJ
dpc-1099	339	6	pathol	pathol	NOUN
dpc-1099	339	7	.	.	PUNCT
dpc-1099	340	1	1974;38(3):382	1974;38(3):382	NUM
dpc-1099	340	2	-	-	SYM
dpc-1099	340	3	387	387	NUM
dpc-1099	340	4	.	.	PUNCT
dpc-1099	340	5	https://doi.org/10.1016/00304220(74)90365-x	https://doi.org/10.1016/00304220(74)90365-x	PROPN
dpc-1099	340	6	8	8	NUM
dpc-1099	340	7	.	.	PUNCT
dpc-1099	340	8	chams	cham	NOUN
dpc-1099	340	9	-	-	PUNCT
dpc-1099	340	10	davatchi	davatchi	PROPN
dpc-1099	340	11	c	c	PROPN
dpc-1099	340	12	,	,	PUNCT
dpc-1099	340	13	valikhani	valikhani	PROPN
dpc-1099	340	14	m	m	PROPN
dpc-1099	340	15	,	,	PUNCT
dpc-1099	340	16	daneshpazhooh	daneshpazhooh	VERB
dpc-1099	340	17	m	m	PROPN
dpc-1099	340	18	,	,	PUNCT
dpc-1099	340	19	et	et	PROPN
dpc-1099	340	20	al	al	PROPN
dpc-1099	340	21	.	.	PUNCT
dpc-1099	341	1	pemphigus	pemphigus	PROPN
dpc-1099	341	2	:	:	PUNCT
dpc-1099	341	3	analysis	analysis	NOUN
dpc-1099	341	4	of	of	ADP
dpc-1099	341	5	1209	1209	NUM
dpc-1099	341	6	cases	case	NOUN
dpc-1099	341	7	.	.	PUNCT
dpc-1099	342	1	int	int	NOUN
dpc-1099	342	2	j	j	PROPN
dpc-1099	342	3	dermatol	dermatol	NOUN
dpc-1099	342	4	.	.	PUNCT
dpc-1099	343	1	2005;44:470	2005;44:470	PROPN
dpc-1099	343	2	-	-	PUNCT
dpc-1099	343	3	476	476	NUM
dpc-1099	343	4	.	.	PUNCT
dpc-1099	344	1	https://doi.org/10.1111/j.1365-4632.2004.02501.x	https://doi.org/10.1111/j.1365-4632.2004.02501.x	NOUN
dpc-1099	344	2	9	9	NUM
dpc-1099	344	3	.	.	PUNCT
dpc-1099	345	1	simon	simon	PROPN
dpc-1099	345	2	dg	dg	PROPN
dpc-1099	345	3	,	,	PUNCT
dpc-1099	345	4	krutchkoff	krutchkoff	PROPN
dpc-1099	345	5	d	d	PROPN
dpc-1099	345	6	,	,	PUNCT
dpc-1099	345	7	kaslow	kaslow	PROPN
dpc-1099	345	8	ra	ra	PROPN
dpc-1099	345	9	,	,	PUNCT
dpc-1099	345	10	zarbo	zarbo	PROPN
dpc-1099	345	11	r.	r.	PROPN
dpc-1099	345	12	pemphigus	pemphigus	PROPN
dpc-1099	345	13	in	in	ADP
dpc-1099	345	14	hartford	hartford	PROPN
dpc-1099	345	15	county	county	PROPN
dpc-1099	345	16	,	,	PUNCT
dpc-1099	345	17	connecticut	connecticut	PROPN
dpc-1099	345	18	,	,	PUNCT
dpc-1099	345	19	from	from	ADP
dpc-1099	345	20	1972	1972	NUM
dpc-1099	345	21	to	to	ADP
dpc-1099	345	22	1977	1977	NUM
dpc-1099	345	23	.	.	PUNCT
dpc-1099	346	1	arch	arch	ADJ
dpc-1099	346	2	dermatol	dermatol	NOUN
dpc-1099	346	3	.	.	PUNCT
dpc-1099	347	1	1980;116(9):1035	1980;116(9):1035	NUM
dpc-1099	347	2	-	-	SYM
dpc-1099	347	3	1037	1037	NUM
dpc-1099	347	4	.	.	PUNCT
dpc-1099	348	1	https://doi.org/10.1001/	https://doi.org/10.1001/	PROPN
dpc-1099	348	2	archderm.1980.01640330073017	archderm.1980.01640330073017	PROPN
dpc-1099	348	3	10	10	NUM
dpc-1099	348	4	.	.	PUNCT
dpc-1099	349	1	langan	langan	PROPN
dpc-1099	349	2	sm	sm	PROPN
dpc-1099	349	3	,	,	PUNCT
dpc-1099	349	4	smeeth	smeeth	PROPN
dpc-1099	349	5	l	l	PROPN
dpc-1099	349	6	,	,	PUNCT
dpc-1099	349	7	hubbard	hubbard	PROPN
dpc-1099	349	8	r	r	PROPN
dpc-1099	349	9	,	,	PUNCT
dpc-1099	349	10	fleming	fleming	NOUN
dpc-1099	349	11	km	km	PROPN
dpc-1099	349	12	,	,	PUNCT
dpc-1099	349	13	smith	smith	PROPN
dpc-1099	349	14	cj	cj	PROPN
dpc-1099	349	15	,	,	PUNCT
dpc-1099	349	16	west	west	PROPN
dpc-1099	349	17	j.	j.	PROPN
dpc-1099	349	18	bullous	bullous	PROPN
dpc-1099	349	19	pemphigoid	pemphigoid	NOUN
dpc-1099	349	20	and	and	CCONJ
dpc-1099	349	21	pemphigus	pemphigus	NOUN
dpc-1099	349	22	vulgaris	vulgaris	NOUN
dpc-1099	349	23	—	—	PUNCT
dpc-1099	349	24	incidence	incidence	NOUN
dpc-1099	349	25	and	and	CCONJ
dpc-1099	349	26	mortality	mortality	NOUN
dpc-1099	349	27	in	in	ADP
dpc-1099	349	28	the	the	DET
dpc-1099	349	29	uk	uk	PROPN
dpc-1099	349	30	:	:	PUNCT
dpc-1099	349	31	population	population	NOUN
dpc-1099	349	32	based	base	VERB
dpc-1099	349	33	cohort	cohort	NOUN
dpc-1099	349	34	study	study	NOUN
dpc-1099	349	35	.	.	PUNCT
dpc-1099	350	1	bmj	bmj	PROPN
dpc-1099	350	2	.	.	PUNCT
dpc-1099	350	3	2008;337(7662):a180	2008;337(7662):a180	PROPN
dpc-1099	350	4	.	.	PUNCT
dpc-1099	351	1	https://doi.org/10.1136/bmj.a180	https://doi.org/10.1136/bmj.a180	NOUN
dpc-1099	351	2	11	11	NUM
dpc-1099	351	3	.	.	PUNCT
dpc-1099	352	1	bastuji	bastuji	PROPN
dpc-1099	352	2	-	-	PUNCT
dpc-1099	352	3	garin	garin	PROPN
dpc-1099	352	4	s	s	PROPN
dpc-1099	352	5	,	,	PUNCT
dpc-1099	352	6	joly	joly	PROPN
dpc-1099	352	7	p	p	PROPN
dpc-1099	352	8	,	,	PUNCT
dpc-1099	352	9	lemordant	lemordant	PROPN
dpc-1099	352	10	p	p	X
dpc-1099	352	11	,	,	PUNCT
dpc-1099	352	12	et	et	PROPN
dpc-1099	352	13	al	al	PROPN
dpc-1099	352	14	.	.	PUNCT
dpc-1099	353	1	risk	risk	NOUN
dpc-1099	353	2	factors	factor	NOUN
dpc-1099	353	3	for	for	ADP
dpc-1099	353	4	bullous	bullous	ADJ
dpc-1099	353	5	pemphigoid	pemphigoid	NOUN
dpc-1099	353	6	in	in	ADP
dpc-1099	353	7	the	the	DET
dpc-1099	353	8	elderly	elderly	ADJ
dpc-1099	353	9	:	:	PUNCT
dpc-1099	353	10	a	a	DET
dpc-1099	353	11	prospective	prospective	ADJ
dpc-1099	353	12	case	case	NOUN
dpc-1099	353	13	-	-	PUNCT
dpc-1099	353	14	control	control	NOUN
dpc-1099	353	15	study	study	NOUN
dpc-1099	353	16	.	.	PUNCT
dpc-1099	354	1	j	j	PROPN
dpc-1099	354	2	invest	invest	VERB
dpc-1099	354	3	dermatol	dermatol	NOUN
dpc-1099	354	4	.	.	PUNCT
dpc-1099	355	1	2011;131(3):637	2011;131(3):637	NUM
dpc-1099	355	2	-	-	SYM
dpc-1099	355	3	643	643	NUM
dpc-1099	355	4	.	.	PUNCT
dpc-1099	356	1	https://doi.org/10.1038/	https://doi.org/10.1038/	NOUN
dpc-1099	356	2	jid.2010.301	jid.2010.301	PROPN
dpc-1099	356	3	12	12	NUM
dpc-1099	356	4	.	.	PUNCT
dpc-1099	357	1	ahmed	ahmed	PROPN
dpc-1099	357	2	ar	ar	PROPN
dpc-1099	357	3	,	,	PUNCT
dpc-1099	357	4	yunis	yunis	PROPN
dpc-1099	357	5	ej	ej	PROPN
dpc-1099	357	6	,	,	PUNCT
dpc-1099	357	7	khatri	khatri	PROPN
dpc-1099	357	8	k	k	PROPN
dpc-1099	357	9	,	,	PUNCT
dpc-1099	357	10	et	et	PROPN
dpc-1099	357	11	al	al	PROPN
dpc-1099	357	12	.	.	PUNCT
dpc-1099	358	1	major	major	ADJ
dpc-1099	358	2	histocompatibility	histocompatibility	ADJ
dpc-1099	358	3	complex	complex	ADJ
dpc-1099	358	4	haplotype	haplotype	NOUN
dpc-1099	358	5	studies	study	NOUN
dpc-1099	358	6	in	in	ADP
dpc-1099	358	7	ashkenazi	ashkenazi	ADJ
dpc-1099	358	8	jewish	jewish	ADJ
dpc-1099	358	9	patients	patient	NOUN
dpc-1099	358	10	with	with	ADP
dpc-1099	358	11	pemphigus	pemphigus	NOUN
dpc-1099	358	12	vulgaris	vulgaris	NOUN
dpc-1099	358	13	.	.	PUNCT
dpc-1099	359	1	proc	proc	PROPN
dpc-1099	359	2	natl	natl	PROPN
dpc-1099	359	3	acad	acad	PROPN
dpc-1099	359	4	sci	sci	PROPN
dpc-1099	359	5	u	u	PROPN
dpc-1099	359	6	s	s	PROPN
dpc-1099	359	7	a.	a.	NOUN
dpc-1099	359	8	1990;87(19):76587662	1990;87(19):76587662	NUM
dpc-1099	359	9	.	.	PUNCT
dpc-1099	360	1	https://doi.org/10.1073/pnas.87.19.7658	https://doi.org/10.1073/pnas.87.19.7658	NUM
dpc-1099	360	2	13	13	NUM
dpc-1099	360	3	.	.	PUNCT
dpc-1099	361	1	ahmed	ahmed	PROPN
dpc-1099	361	2	ar	ar	PROPN
dpc-1099	361	3	,	,	PUNCT
dpc-1099	361	4	wagner	wagner	PROPN
dpc-1099	361	5	r	r	PROPN
dpc-1099	361	6	,	,	PUNCT
dpc-1099	361	7	khatri	khatri	PROPN
dpc-1099	361	8	k	k	PROPN
dpc-1099	361	9	,	,	PUNCT
dpc-1099	361	10	et	et	PROPN
dpc-1099	361	11	al	al	PROPN
dpc-1099	361	12	.	.	PUNCT
dpc-1099	362	1	major	major	ADJ
dpc-1099	362	2	histocompatibility	histocompatibility	ADJ
dpc-1099	362	3	complex	complex	ADJ
dpc-1099	362	4	haplotypes	haplotype	NOUN
dpc-1099	362	5	and	and	CCONJ
dpc-1099	362	6	class	class	NOUN
dpc-1099	362	7	ii	ii	NOUN
dpc-1099	362	8	genes	gene	NOUN
dpc-1099	362	9	in	in	ADP
dpc-1099	362	10	non	non	ADJ
dpc-1099	362	11	-	-	ADJ
dpc-1099	362	12	jewish	jewish	ADJ
dpc-1099	362	13	patients	patient	NOUN
dpc-1099	362	14	with	with	ADP
dpc-1099	362	15	pemphigus	pemphigus	NOUN
dpc-1099	362	16	vulgaris	vulgaris	NOUN
dpc-1099	362	17	.	.	PUNCT
dpc-1099	363	1	proc	proc	PROPN
dpc-1099	363	2	natl	natl	PROPN
dpc-1099	363	3	acad	acad	PROPN
dpc-1099	363	4	sci	sci	PROPN
dpc-1099	363	5	u	u	PROPN
dpc-1099	363	6	s	s	PROPN
dpc-1099	363	7	a.	a.	NOUN
dpc-1099	363	8	1991;88(11):50565060	1991;88(11):50565060	NUM
dpc-1099	363	9	.	.	PUNCT
dpc-1099	363	10	https://doi.org/10.1073/pnas.88.11.5056	https://doi.org/10.1073/pnas.88.11.5056	PROPN
dpc-1099	363	11	14	14	NUM
dpc-1099	363	12	.	.	PUNCT
dpc-1099	364	1	sun	sun	PROPN
dpc-1099	364	2	y	y	PROPN
dpc-1099	364	3	,	,	PUNCT
dpc-1099	364	4	liu	liu	PROPN
dpc-1099	364	5	h	h	PROPN
dpc-1099	364	6	,	,	PUNCT
dpc-1099	364	7	yang	yang	PROPN
dpc-1099	364	8	b	b	PROPN
dpc-1099	364	9	,	,	PUNCT
dpc-1099	364	10	et	et	PROPN
dpc-1099	364	11	al	al	PROPN
dpc-1099	364	12	.	.	PROPN
dpc-1099	365	1	investigation	investigation	NOUN
dpc-1099	365	2	of	of	ADP
dpc-1099	365	3	the	the	DET
dpc-1099	365	4	predisposing	predispose	VERB
dpc-1099	365	5	factor	factor	NOUN
dpc-1099	365	6	of	of	ADP
dpc-1099	365	7	pemphigus	pemphigus	NOUN
dpc-1099	365	8	and	and	CCONJ
dpc-1099	365	9	its	its	PRON
dpc-1099	365	10	clinical	clinical	ADJ
dpc-1099	365	11	subtype	subtype	NOUN
dpc-1099	365	12	through	through	ADP
dpc-1099	365	13	a	a	DET
dpc-1099	365	14	genome	genome	NOUN
dpc-1099	365	15	-	-	PUNCT
dpc-1099	365	16	wide	wide	ADJ
dpc-1099	365	17	association	association	NOUN
dpc-1099	365	18	and	and	CCONJ
dpc-1099	365	19	next	next	ADJ
dpc-1099	365	20	generation	generation	NOUN
dpc-1099	365	21	sequence	sequence	NOUN
dpc-1099	365	22	analysis	analysis	NOUN
dpc-1099	365	23	.	.	PUNCT
dpc-1099	366	1	j	j	PROPN
dpc-1099	366	2	eur	eur	PROPN
dpc-1099	366	3	acad	acad	PROPN
dpc-1099	366	4	dermatol	dermatol	NOUN
dpc-1099	366	5	venereol	venereol	NOUN
dpc-1099	366	6	.	.	PUNCT
dpc-1099	367	1	2019;33(2):410	2019;33(2):410	NUM
dpc-1099	367	2	-	-	SYM
dpc-1099	367	3	415	415	NUM
dpc-1099	367	4	.	.	PUNCT
dpc-1099	368	1	https://doi.org/10.1111/	https://doi.org/10.1111/	PROPN
dpc-1099	368	2	jdv.15227	jdv.15227	PROPN
dpc-1099	368	3	15	15	NUM
dpc-1099	368	4	.	.	PUNCT
dpc-1099	369	1	mahmoudi	mahmoudi	PROPN
dpc-1099	369	2	h	h	PROPN
dpc-1099	369	3	,	,	PUNCT
dpc-1099	369	4	ebrahimi	ebrahimi	PROPN
dpc-1099	369	5	e	e	PROPN
dpc-1099	369	6	,	,	PUNCT
dpc-1099	369	7	daneshpazhooh	daneshpazhooh	VERB
dpc-1099	369	8	m	m	PROPN
dpc-1099	369	9	,	,	PUNCT
dpc-1099	369	10	et	et	PROPN
dpc-1099	369	11	al	al	PROPN
dpc-1099	369	12	.	.	PUNCT
dpc-1099	370	1	single	single	ADJ
dpc-1099	370	2	-	-	PUNCT
dpc-1099	370	3	nucleotide	nucleotide	NOUN
dpc-1099	370	4	polymorphisms	polymorphism	NOUN
dpc-1099	370	5	associated	associate	VERB
dpc-1099	370	6	with	with	ADP
dpc-1099	370	7	pemphigus	pemphigus	NOUN
dpc-1099	370	8	vulgaris	vulgaris	NOUN
dpc-1099	370	9	:	:	PUNCT
dpc-1099	370	10	potent	potent	ADJ
dpc-1099	370	11	markers	marker	NOUN
dpc-1099	370	12	for	for	ADP
dpc-1099	370	13	better	well	ADJ
dpc-1099	370	14	treatment	treatment	NOUN
dpc-1099	370	15	and	and	CCONJ
dpc-1099	370	16	personalized	personalized	ADJ
dpc-1099	370	17	medicine	medicine	NOUN
dpc-1099	370	18	.	.	PUNCT
dpc-1099	371	1	int	int	NOUN
dpc-1099	371	2	j	j	PROPN
dpc-1099	371	3	immunogenet	immunogenet	PROPN
dpc-1099	371	4	.	.	PUNCT
dpc-1099	372	1	2020;47(1):41	2020;47(1):41	NUM
dpc-1099	372	2	-	-	SYM
dpc-1099	372	3	49	49	NUM
dpc-1099	372	4	.	.	PUNCT
dpc-1099	373	1	https://doi.org/10.1111/iji.12451	https://doi.org/10.1111/iji.12451	PROPN
dpc-1099	373	2	16	16	PROPN
dpc-1099	373	3	.	.	PUNCT
dpc-1099	374	1	delgado	delgado	PROPN
dpc-1099	374	2	jc	jc	PROPN
dpc-1099	374	3	,	,	PUNCT
dpc-1099	374	4	turbay	turbay	VERB
dpc-1099	374	5	d	d	PROPN
dpc-1099	374	6	,	,	PUNCT
dpc-1099	374	7	yunis	yunis	PROPN
dpc-1099	374	8	ej	ej	PROPN
dpc-1099	374	9	,	,	PUNCT
dpc-1099	374	10	et	et	PROPN
dpc-1099	374	11	al	al	PROPN
dpc-1099	374	12	.	.	PUNCT
dpc-1099	375	1	a	a	DET
dpc-1099	375	2	common	common	ADJ
dpc-1099	375	3	major	major	ADJ
dpc-1099	375	4	histocompatibility	histocompatibility	NOUN
dpc-1099	375	5	complex	complex	ADJ
dpc-1099	375	6	class	class	NOUN
dpc-1099	375	7	ii	ii	PROPN
dpc-1099	375	8	allele	allele	PROPN
dpc-1099	375	9	hla	hla	PROPN
dpc-1099	375	10	-	-	PUNCT
dpc-1099	375	11	dqb1	dqb1	PROPN
dpc-1099	375	12	*	*	SYM
dpc-1099	375	13	0301	0301	NUM
dpc-1099	375	14	is	be	AUX
dpc-1099	375	15	present	present	ADJ
dpc-1099	375	16	in	in	ADP
dpc-1099	375	17	clinical	clinical	ADJ
dpc-1099	375	18	variants	variant	NOUN
dpc-1099	375	19	of	of	ADP
dpc-1099	375	20	pemphigoid	pemphigoid	ADJ
dpc-1099	375	21	.	.	PUNCT
dpc-1099	376	1	proc	proc	PROPN
dpc-1099	376	2	natl	natl	PROPN
dpc-1099	376	3	acad	acad	PROPN
dpc-1099	376	4	sci	sci	PROPN
dpc-1099	376	5	u	u	PROPN
dpc-1099	376	6	s	s	PROPN
dpc-1099	376	7	a.	a.	NOUN
dpc-1099	376	8	1996;93(16):8569	1996;93(16):8569	NUM
dpc-1099	376	9	-	-	NOUN
dpc-1099	376	10	8571	8571	NUM
dpc-1099	376	11	.	.	PUNCT
dpc-1099	377	1	https://doi.org/10.1073/	https://doi.org/10.1073/	PROPN
dpc-1099	377	2	pnas.93.16.8569	pnas.93.16.8569	PROPN
dpc-1099	377	3	17	17	NUM
dpc-1099	377	4	.	.	PUNCT
dpc-1099	377	5	di	di	NOUN
dpc-1099	377	6	zenzo	zenzo	NOUN
dpc-1099	377	7	g	g	PROPN
dpc-1099	377	8	,	,	PUNCT
dpc-1099	377	9	amber	amber	PROPN
dpc-1099	377	10	kt	kt	PROPN
dpc-1099	377	11	,	,	PUNCT
dpc-1099	377	12	sayar	sayar	NOUN
dpc-1099	377	13	bs	bs	PROPN
dpc-1099	377	14	,	,	PUNCT
dpc-1099	377	15	müller	müller	PROPN
dpc-1099	377	16	ej	ej	PROPN
dpc-1099	377	17	,	,	PUNCT
dpc-1099	377	18	borradori	borradori	PROPN
dpc-1099	377	19	l.	l.	PROPN
dpc-1099	377	20	immune	immune	PROPN
dpc-1099	377	21	response	response	NOUN
dpc-1099	377	22	in	in	ADP
dpc-1099	377	23	pemphigus	pemphigus	NOUN
dpc-1099	377	24	and	and	CCONJ
dpc-1099	377	25	beyond	beyond	ADP
dpc-1099	377	26	:	:	PUNCT
dpc-1099	377	27	progresses	progress	NOUN
dpc-1099	377	28	and	and	CCONJ
dpc-1099	377	29	emerging	emerge	VERB
dpc-1099	377	30	concepts	concept	NOUN
dpc-1099	377	31	.	.	PUNCT
dpc-1099	378	1	semin	semin	PROPN
dpc-1099	378	2	immunopathol	immunopathol	PROPN
dpc-1099	378	3	.	.	PUNCT
dpc-1099	379	1	2016;38(1):57	2016;38(1):57	NUM
dpc-1099	379	2	-	-	SYM
dpc-1099	379	3	74	74	NUM
dpc-1099	379	4	.	.	PUNCT
dpc-1099	380	1	https://doi	https://doi	X
dpc-1099	380	2	.	.	PUNCT
dpc-1099	380	3	org/10.1007	org/10.1007	PROPN
dpc-1099	380	4	/	/	SYM
dpc-1099	380	5	s00281	s00281	PROPN
dpc-1099	380	6	-	-	PUNCT
dpc-1099	380	7	015	015	NUM
dpc-1099	380	8	-	-	PUNCT
dpc-1099	380	9	0541	0541	NUM
dpc-1099	380	10	-	-	PUNCT
dpc-1099	380	11	1	1	NUM
dpc-1099	380	12	https://doi.org/10.1093/intimm/dxz030	https://doi.org/10.1093/intimm/dxz030	NOUN
dpc-1099	380	13	https://doi.org/10.4049/jimmunol.1600567	https://doi.org/10.4049/jimmunol.1600567	ADJ
dpc-1099	380	14	https://doi.org/10.4049/jimmunol.1502233	https://doi.org/10.4049/jimmunol.1502233	NOUN
dpc-1099	380	15	https://doi.org/10.4049/jimmunol.1502233	https://doi.org/10.4049/jimmunol.1502233	VERB
dpc-1099	380	16	https://doi.org/10.1016/s0140-6736(19)31778-7	https://doi.org/10.1016/s0140-6736(19)31778-7	PROPN
dpc-1099	380	17	https://doi.org/10.1016/s0140-6736(19)31778-7	https://doi.org/10.1016/s0140-6736(19)31778-7	PROPN
dpc-1099	380	18	https://doi.org/10.1007/s12016-017-8662-z	https://doi.org/10.1007/s12016-017-8662-z	PROPN
dpc-1099	380	19	https://doi.org/10.1016/j.clindermatol.2013.01.006	https://doi.org/10.1016/j.clindermatol.2013.01.006	PROPN
dpc-1099	380	20	https://doi.org/10.3389/fimmu.2019.01506	https://doi.org/10.3389/fimmu.2019.01506	PROPN
dpc-1099	380	21	https://doi.org/10.3389/fimmu.2019.01506	https://doi.org/10.3389/fimmu.2019.01506	PROPN
dpc-1099	380	22	https://doi.org/10.1016/j.jid.2018.10.045	https://doi.org/10.1016/j.jid.2018.10.045	ADJ
dpc-1099	380	23	https://doi.org/10.1016/j.jaci.2018.03.014	https://doi.org/10.1016/j.jaci.2018.03.014	NOUN
dpc-1099	380	24	https://doi.org/10.1016/j.jaci.2018.03.014	https://doi.org/10.1016/j.jaci.2018.03.014	NOUN
dpc-1099	380	25	https://doi.org/10.1016/j.jid.2018.04.042	https://doi.org/10.1016/j.jid.2018.04.042	NOUN
dpc-1099	380	26	https://doi.org/10.1016/j.jid.2018.04.042	https://doi.org/10.1016/j.jid.2018.04.042	VERB
dpc-1099	380	27	https://doi.org/10.1016/j.autrev.2015.01.006	https://doi.org/10.1016/j.autrev.2015.01.006	ADJ
dpc-1099	380	28	https://doi.org/10.1016/j.autrev.2015.01.006	https://doi.org/10.1016/j.autrev.2015.01.006	ADJ
dpc-1099	380	29	https://doi.org/10.1016/j.jaad.2011.06.032	https://doi.org/10.1016/j.jaad.2011.06.032	VERB
dpc-1099	380	30	https://doi.org/10.2340/00015555-2473	https://doi.org/10.2340/00015555-2473	NOUN
dpc-1099	380	31	https://doi.org/10.1590/abd1806-4841.20199007	https://doi.org/10.1590/abd1806-4841.20199007	NOUN
dpc-1099	380	32	https://doi.org/10.1590/abd1806-4841.20199007	https://doi.org/10.1590/abd1806-4841.20199007	NOUN
dpc-1099	380	33	https://doi.org/10.1007/s00403-014-1531-1	https://doi.org/10.1007/s00403-014-1531-1	NOUN
dpc-1099	380	34	https://doi.org/10.1111/j.1365-2133.2009.09300.x	https://doi.org/10.1111/j.1365-2133.2009.09300.x	ADJ
dpc-1099	380	35	https://doi.org/10.1111/j.1365-2133.2009.09300.x	https://doi.org/10.1111/j.1365-2133.2009.09300.x	NOUN
dpc-1099	380	36	https://doi.org/10.1111/j.1610-0387.2008.06976.x	https://doi.org/10.1111/j.1610-0387.2008.06976.x	NOUN
dpc-1099	380	37	https://doi.org/10.1111/j.1610-0387.2008.06976.x	https://doi.org/10.1111/j.1610-0387.2008.06976.x	VERB
dpc-1099	380	38	https://doi.org/10.1111/j.1365-4632.2009.04345.x	https://doi.org/10.1111/j.1365-4632.2009.04345.x	PROPN
dpc-1099	380	39	https://doi.org/10.1111/j.1365-4632.2009.04345.x	https://doi.org/10.1111/j.1365-4632.2009.04345.x	ADJ
dpc-1099	380	40	https://doi.org/10.1016/0030-4220(74)90365-x	https://doi.org/10.1016/0030-4220(74)90365-x	ADJ
dpc-1099	380	41	https://doi.org/10.1016/0030-4220(74)90365-x	https://doi.org/10.1016/0030-4220(74)90365-x	PROPN
dpc-1099	380	42	https://doi.org/10.1111/j.1365-4632.2004.02501.x	https://doi.org/10.1111/j.1365-4632.2004.02501.x	NOUN
dpc-1099	380	43	https://doi.org/10.1001/archderm.1980.01640330073017	https://doi.org/10.1001/archderm.1980.01640330073017	PROPN
dpc-1099	380	44	https://doi.org/10.1001/archderm.1980.01640330073017	https://doi.org/10.1001/archderm.1980.01640330073017	PROPN
dpc-1099	380	45	https://doi.org/10.1136/bmj.a180	https://doi.org/10.1136/bmj.a180	NOUN
dpc-1099	380	46	https://doi.org/10.1038/jid.2010.301	https://doi.org/10.1038/jid.2010.301	PROPN
dpc-1099	381	1	https://doi.org/10.1038/jid.2010.301	https://doi.org/10.1038/jid.2010.301	PROPN
dpc-1099	381	2	https://doi.org/10.1073/pnas.87.19.7658	https://doi.org/10.1073/pnas.87.19.7658	NOUN
dpc-1099	381	3	https://doi.org/10.1073/pnas.88.11.5056	https://doi.org/10.1073/pnas.88.11.5056	NOUN
dpc-1099	382	1	https://doi.org/10.1111/jdv.15227	https://doi.org/10.1111/jdv.15227	PROPN
dpc-1099	382	2	https://doi.org/10.1111/jdv.15227	https://doi.org/10.1111/jdv.15227	PROPN
dpc-1099	382	3	https://doi.org/10.1111/iji.12451	https://doi.org/10.1111/iji.12451	PROPN
dpc-1099	382	4	https://doi.org/10.1073/pnas.93.16.8569	https://doi.org/10.1073/pnas.93.16.8569	PROPN
dpc-1099	382	5	https://doi.org/10.1073/pnas.93.16.8569	https://doi.org/10.1073/pnas.93.16.8569	PROPN
dpc-1099	382	6	https://doi.org/10.1007/s00281-015-0541-1	https://doi.org/10.1007/s00281-015-0541-1	PROPN
dpc-1099	382	7	https://doi.org/10.1007/s00281-015-0541-1	https://doi.org/10.1007/s00281-015-0541-1	PROPN
dpc-1099	382	8	review	review	NOUN
dpc-1099	382	9	|	|	ADV
dpc-1099	382	10	dermatol	dermatol	ADJ
dpc-1099	382	11	pract	pract	NOUN
dpc-1099	382	12	concept	concept	NOUN
dpc-1099	382	13	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	382	14	11	11	NUM
dpc-1099	382	15	47	47	NUM
dpc-1099	382	16	.	.	PUNCT
dpc-1099	383	1	sharma	sharma	PROPN
dpc-1099	383	2	vk	vk	PROPN
dpc-1099	383	3	,	,	PUNCT
dpc-1099	383	4	gupta	gupta	PROPN
dpc-1099	383	5	v	v	NOUN
dpc-1099	383	6	,	,	PUNCT
dpc-1099	383	7	bhari	bhari	PROPN
dpc-1099	383	8	n	n	CCONJ
dpc-1099	383	9	,	,	PUNCT
dpc-1099	383	10	singh	singh	PROPN
dpc-1099	383	11	v.	v.	ADP
dpc-1099	383	12	rituximab	rituximab	NOUN
dpc-1099	383	13	as	as	ADP
dpc-1099	383	14	an	an	DET
dpc-1099	383	15	adjuvant	adjuvant	ADJ
dpc-1099	383	16	therapy	therapy	NOUN
dpc-1099	383	17	for	for	ADP
dpc-1099	383	18	pemphigus	pemphigus	PROPN
dpc-1099	383	19	:	:	PUNCT
dpc-1099	383	20	experience	experience	NOUN
dpc-1099	383	21	in	in	ADP
dpc-1099	383	22	61	61	NUM
dpc-1099	383	23	patients	patient	NOUN
dpc-1099	383	24	from	from	ADP
dpc-1099	383	25	a	a	DET
dpc-1099	383	26	single	single	ADJ
dpc-1099	383	27	center	center	NOUN
dpc-1099	383	28	with	with	ADP
dpc-1099	383	29	long	long	ADJ
dpc-1099	383	30	-	-	PUNCT
dpc-1099	383	31	term	term	NOUN
dpc-1099	383	32	follow	follow	NOUN
dpc-1099	383	33	-	-	PUNCT
dpc-1099	383	34	up	up	NOUN
dpc-1099	383	35	.	.	PUNCT
dpc-1099	384	1	int	int	NOUN
dpc-1099	384	2	j	j	PROPN
dpc-1099	384	3	dermatol	dermatol	NOUN
dpc-1099	384	4	.	.	PUNCT
dpc-1099	385	1	2020;59(1):7681	2020;59(1):7681	NUM
dpc-1099	385	2	.	.	PUNCT
dpc-1099	386	1	https://doi.org/10.1111/ijd.14546	https://doi.org/10.1111/ijd.14546	PROPN
dpc-1099	386	2	48	48	NUM
dpc-1099	386	3	.	.	PUNCT
dpc-1099	387	1	de	de	PROPN
dpc-1099	387	2	d	d	PROPN
dpc-1099	387	3	,	,	PUNCT
dpc-1099	387	4	bishnoi	bishnoi	PROPN
dpc-1099	387	5	a	a	X
dpc-1099	387	6	,	,	PUNCT
dpc-1099	387	7	handa	handa	PROPN
dpc-1099	387	8	s	s	PROPN
dpc-1099	387	9	,	,	PUNCT
dpc-1099	387	10	mahapatra	mahapatra	PROPN
dpc-1099	387	11	t	t	PROPN
dpc-1099	387	12	,	,	PUNCT
dpc-1099	387	13	mahajan	mahajan	PROPN
dpc-1099	387	14	r.	r.	PROPN
dpc-1099	387	15	effectiveness	effectiveness	PROPN
dpc-1099	387	16	and	and	CCONJ
dpc-1099	387	17	safety	safety	NOUN
dpc-1099	387	18	analysis	analysis	NOUN
dpc-1099	387	19	of	of	ADP
dpc-1099	387	20	rituximab	rituximab	NOUN
dpc-1099	387	21	in	in	ADP
dpc-1099	387	22	146	146	NUM
dpc-1099	387	23	indian	indian	ADJ
dpc-1099	387	24	pemphigus	pemphigus	NOUN
dpc-1099	387	25	patients	patient	NOUN
dpc-1099	387	26	:	:	PUNCT
dpc-1099	387	27	a	a	DET
dpc-1099	387	28	retrospective	retrospective	ADJ
dpc-1099	387	29	single	single	ADJ
dpc-1099	387	30	-	-	PUNCT
dpc-1099	387	31	center	center	NOUN
dpc-1099	387	32	review	review	NOUN
dpc-1099	387	33	of	of	ADP
dpc-1099	387	34	up	up	ADP
dpc-1099	387	35	to	to	PART
dpc-1099	387	36	68	68	NUM
dpc-1099	387	37	months	month	NOUN
dpc-1099	387	38	follow	follow	VERB
dpc-1099	387	39	-	-	PUNCT
dpc-1099	387	40	up	up	NOUN
dpc-1099	387	41	.	.	PUNCT
dpc-1099	388	1	indian	indian	PROPN
dpc-1099	388	2	j	j	PROPN
dpc-1099	388	3	dermatol	dermatol	PROPN
dpc-1099	388	4	venereol	venereol	ADJ
dpc-1099	388	5	leprol	leprol	NOUN
dpc-1099	388	6	.	.	PUNCT
dpc-1099	389	1	2020;86(1):39	2020;86(1):39	NUM
dpc-1099	389	2	-	-	SYM
dpc-1099	389	3	44	44	NUM
dpc-1099	389	4	.	.	PUNCT
dpc-1099	390	1	https://doi.org/10.4103/ijdvl.ijdvl_848_17	https://doi.org/10.4103/ijdvl.ijdvl_848_17	PROPN
dpc-1099	390	2	49	49	NUM
dpc-1099	390	3	.	.	PUNCT
dpc-1099	391	1	wang	wang	PROPN
dpc-1099	391	2	hh	hh	PROPN
dpc-1099	391	3	,	,	PUNCT
dpc-1099	391	4	liu	liu	PROPN
dpc-1099	391	5	cw	cw	PROPN
dpc-1099	391	6	,	,	PUNCT
dpc-1099	391	7	li	li	PROPN
dpc-1099	391	8	yc	yc	PROPN
dpc-1099	391	9	,	,	PUNCT
dpc-1099	391	10	huang	huang	PROPN
dpc-1099	391	11	yc	yc	PROPN
dpc-1099	391	12	.	.	PUNCT
dpc-1099	391	13	efficacy	efficacy	NOUN
dpc-1099	391	14	of	of	ADP
dpc-1099	391	15	rituximab	rituximab	NOUN
dpc-1099	391	16	for	for	ADP
dpc-1099	391	17	pemphigus	pemphigus	NOUN
dpc-1099	391	18	:	:	PUNCT
dpc-1099	391	19	a	a	DET
dpc-1099	391	20	systematic	systematic	ADJ
dpc-1099	391	21	review	review	NOUN
dpc-1099	391	22	and	and	CCONJ
dpc-1099	391	23	meta	meta	ADJ
dpc-1099	391	24	-	-	PUNCT
dpc-1099	391	25	analysis	analysis	NOUN
dpc-1099	391	26	of	of	ADP
dpc-1099	391	27	different	different	ADJ
dpc-1099	391	28	regimens	regimen	NOUN
dpc-1099	391	29	.	.	PUNCT
dpc-1099	392	1	acta	acta	PROPN
dpc-1099	392	2	derm	derm	PROPN
dpc-1099	392	3	venereol	venereol	NOUN
dpc-1099	392	4	.	.	PUNCT
dpc-1099	393	1	2015;95(8):928	2015;95(8):928	NOUN
dpc-1099	393	2	-	-	SYM
dpc-1099	393	3	932	932	NUM
dpc-1099	393	4	.	.	PUNCT
dpc-1099	394	1	https://doi	https://doi	NOUN
dpc-1099	394	2	.	.	PUNCT
dpc-1099	394	3	org/10.2340/00015555	org/10.2340/00015555	PROPN
dpc-1099	394	4	-	-	PUNCT
dpc-1099	394	5	2116	2116	NUM
dpc-1099	394	6	50	50	NUM
dpc-1099	394	7	.	.	PUNCT
dpc-1099	395	1	joly	joly	PROPN
dpc-1099	395	2	p	p	PROPN
dpc-1099	395	3	,	,	PUNCT
dpc-1099	395	4	maho	maho	PROPN
dpc-1099	395	5	-	-	PUNCT
dpc-1099	395	6	vaillant	vaillant	PROPN
dpc-1099	395	7	m	m	PROPN
dpc-1099	395	8	,	,	PUNCT
dpc-1099	395	9	prost	prost	PROPN
dpc-1099	395	10	-	-	NOUN
dpc-1099	395	11	squarcioni	squarcioni	PROPN
dpc-1099	395	12	c	c	PROPN
dpc-1099	395	13	,	,	PUNCT
dpc-1099	395	14	et	et	PROPN
dpc-1099	395	15	al	al	PROPN
dpc-1099	395	16	.	.	PUNCT
dpc-1099	396	1	first	first	ADJ
dpc-1099	396	2	-	-	PUNCT
dpc-1099	396	3	line	line	NOUN
dpc-1099	396	4	rituximab	rituximab	NOUN
dpc-1099	396	5	combined	combine	VERB
dpc-1099	396	6	with	with	ADP
dpc-1099	396	7	short	short	ADJ
dpc-1099	396	8	-	-	PUNCT
dpc-1099	396	9	term	term	NOUN
dpc-1099	396	10	prednisone	prednisone	NOUN
dpc-1099	396	11	versus	versus	ADP
dpc-1099	396	12	prednisone	prednisone	NOUN
dpc-1099	396	13	alone	alone	ADV
dpc-1099	396	14	for	for	ADP
dpc-1099	396	15	the	the	DET
dpc-1099	396	16	treatment	treatment	NOUN
dpc-1099	396	17	of	of	ADP
dpc-1099	396	18	pemphigus	pemphigus	NOUN
dpc-1099	396	19	(	(	PUNCT
dpc-1099	396	20	ritux	ritux	NOUN
dpc-1099	396	21	3	3	NUM
dpc-1099	396	22	):	):	PUNCT
dpc-1099	396	23	a	a	DET
dpc-1099	396	24	prospective	prospective	ADJ
dpc-1099	396	25	,	,	PUNCT
dpc-1099	396	26	multicentre	multicentre	NOUN
dpc-1099	396	27	,	,	PUNCT
dpc-1099	396	28	parallel	parallel	NOUN
dpc-1099	396	29	-	-	PUNCT
dpc-1099	396	30	group	group	NOUN
dpc-1099	396	31	,	,	PUNCT
dpc-1099	396	32	open	open	ADJ
dpc-1099	396	33	-	-	PUNCT
dpc-1099	396	34	label	label	NOUN
dpc-1099	396	35	randomised	randomised	ADJ
dpc-1099	396	36	trial	trial	NOUN
dpc-1099	396	37	.	.	PUNCT
dpc-1099	397	1	lancet	lancet	PROPN
dpc-1099	397	2	.	.	PUNCT
dpc-1099	398	1	2017;389(10083):2031	2017;389(10083):2031	NUM
dpc-1099	398	2	-	-	SYM
dpc-1099	398	3	2040	2040	NUM
dpc-1099	398	4	.	.	PUNCT
dpc-1099	399	1	https://doi.org/10.1016/s01406736(17)30070-3	https://doi.org/10.1016/s01406736(17)30070-3	ADJ
dpc-1099	399	2	51	51	NUM
dpc-1099	399	3	.	.	PUNCT
dpc-1099	400	1	chen	chen	PROPN
dpc-1099	400	2	dm	dm	PROPN
dpc-1099	400	3	,	,	PUNCT
dpc-1099	400	4	odueyungbo	odueyungbo	NOUN
dpc-1099	400	5	a	a	PRON
dpc-1099	400	6	,	,	PUNCT
dpc-1099	400	7	csinady	csinady	NOUN
dpc-1099	400	8	e	e	NOUN
dpc-1099	400	9	,	,	PUNCT
dpc-1099	400	10	et	et	PROPN
dpc-1099	400	11	al	al	PROPN
dpc-1099	400	12	.	.	PROPN
dpc-1099	400	13	rituximab	rituximab	NOUN
dpc-1099	400	14	is	be	AUX
dpc-1099	400	15	an	an	DET
dpc-1099	400	16	effective	effective	ADJ
dpc-1099	400	17	treatment	treatment	NOUN
dpc-1099	400	18	in	in	ADP
dpc-1099	400	19	patients	patient	NOUN
dpc-1099	400	20	with	with	ADP
dpc-1099	400	21	pemphigus	pemphigus	NOUN
dpc-1099	400	22	vulgaris	vulgaris	NOUN
dpc-1099	400	23	and	and	CCONJ
dpc-1099	400	24	demonstrates	demonstrate	VERB
dpc-1099	400	25	a	a	DET
dpc-1099	400	26	steroid	steroid	NOUN
dpc-1099	400	27	-	-	PUNCT
dpc-1099	400	28	sparing	spare	VERB
dpc-1099	400	29	effect	effect	NOUN
dpc-1099	400	30	.	.	PUNCT
dpc-1099	401	1	br	br	PROPN
dpc-1099	401	2	j	j	PROPN
dpc-1099	401	3	dermatol	dermatol	NOUN
dpc-1099	401	4	.	.	PUNCT
dpc-1099	402	1	2020;182(5):11111119	2020;182(5):11111119	NUM
dpc-1099	402	2	.	.	PUNCT
dpc-1099	403	1	https://doi.org/10.1111/bjd.18482	https://doi.org/10.1111/bjd.18482	PROPN
dpc-1099	403	2	52	52	NUM
dpc-1099	403	3	.	.	PUNCT
dpc-1099	404	1	daneshpazhooh	daneshpazhooh	PROPN
dpc-1099	404	2	m	m	PROPN
dpc-1099	404	3	,	,	PUNCT
dpc-1099	404	4	balighi	balighi	PROPN
dpc-1099	404	5	k	k	PROPN
dpc-1099	404	6	,	,	PUNCT
dpc-1099	404	7	mahmoudi	mahmoudi	ADJ
dpc-1099	404	8	h	h	NOUN
dpc-1099	404	9	,	,	PUNCT
dpc-1099	404	10	et	et	PROPN
dpc-1099	404	11	al	al	PROPN
dpc-1099	404	12	.	.	PROPN
dpc-1099	405	1	iranian	iranian	PROPN
dpc-1099	405	2	guideline	guideline	NOUN
dpc-1099	405	3	for	for	ADP
dpc-1099	405	4	rituximab	rituximab	NOUN
dpc-1099	405	5	therapy	therapy	NOUN
dpc-1099	405	6	in	in	ADP
dpc-1099	405	7	pemphigus	pemphigus	NOUN
dpc-1099	405	8	patients	patient	NOUN
dpc-1099	405	9	.	.	PUNCT
dpc-1099	406	1	dermatol	dermatol	NOUN
dpc-1099	406	2	ther	ther	ADV
dpc-1099	406	3	.	.	PUNCT
dpc-1099	407	1	2019;32(5):e13016	2019;32(5):e13016	NUM
dpc-1099	407	2	.	.	PUNCT
dpc-1099	408	1	https://doi.org/10.1111/dth.13016	https://doi.org/10.1111/dth.13016	PROPN
dpc-1099	408	2	53	53	NUM
dpc-1099	408	3	.	.	PUNCT
dpc-1099	409	1	albers	albers	PROPN
dpc-1099	409	2	ln	ln	PROPN
dpc-1099	409	3	,	,	PUNCT
dpc-1099	409	4	liu	liu	PROPN
dpc-1099	409	5	y	y	PROPN
dpc-1099	409	6	,	,	PUNCT
dpc-1099	409	7	bo	bo	PROPN
dpc-1099	409	8	n	n	PRON
dpc-1099	409	9	,	,	PUNCT
dpc-1099	409	10	swerlick	swerlick	PROPN
dpc-1099	409	11	ra	ra	PROPN
dpc-1099	409	12	,	,	PUNCT
dpc-1099	409	13	feldman	feldman	PROPN
dpc-1099	409	14	rj	rj	PROPN
dpc-1099	409	15	.	.	PUNCT
dpc-1099	410	1	developing	develop	VERB
dpc-1099	410	2	biomarkers	biomarker	NOUN
dpc-1099	410	3	for	for	ADP
dpc-1099	410	4	predicting	predict	VERB
dpc-1099	410	5	clinical	clinical	ADJ
dpc-1099	410	6	relapse	relapse	NOUN
dpc-1099	410	7	in	in	ADP
dpc-1099	410	8	pemphigus	pemphigus	NOUN
dpc-1099	410	9	patients	patient	NOUN
dpc-1099	410	10	treated	treat	VERB
dpc-1099	410	11	with	with	ADP
dpc-1099	410	12	rituximab	rituximab	NOUN
dpc-1099	410	13	.	.	PUNCT
dpc-1099	411	1	j	j	PROPN
dpc-1099	411	2	am	be	AUX
dpc-1099	411	3	acad	acad	ADJ
dpc-1099	411	4	dermatol	dermatol	NOUN
dpc-1099	411	5	.	.	PUNCT
dpc-1099	412	1	2017;77(6):10741082	2017;77(6):10741082	NUM
dpc-1099	412	2	.	.	PUNCT
dpc-1099	413	1	https://doi.org/10.1016/j.jaad.2017.07.012	https://doi.org/10.1016/j.jaad.2017.07.012	PROPN
dpc-1099	413	2	54	54	NUM
dpc-1099	413	3	.	.	PUNCT
dpc-1099	414	1	saleh	saleh	PROPN
dpc-1099	414	2	ma	ma	PROPN
dpc-1099	414	3	.	.	PROPN
dpc-1099	415	1	a	a	DET
dpc-1099	415	2	prospective	prospective	ADJ
dpc-1099	415	3	study	study	NOUN
dpc-1099	415	4	comparing	compare	VERB
dpc-1099	415	5	patients	patient	NOUN
dpc-1099	415	6	with	with	ADP
dpc-1099	415	7	early	early	ADJ
dpc-1099	415	8	and	and	CCONJ
dpc-1099	415	9	late	late	ADV
dpc-1099	415	10	relapsing	relapse	VERB
dpc-1099	415	11	pemphigus	pemphigus	PROPN
dpc-1099	415	12	treated	treat	VERB
dpc-1099	415	13	with	with	ADP
dpc-1099	415	14	rituximab	rituximab	NOUN
dpc-1099	415	15	.	.	PUNCT
dpc-1099	416	1	j	j	PROPN
dpc-1099	416	2	am	be	AUX
dpc-1099	416	3	acad	acad	ADJ
dpc-1099	416	4	dermatol	dermatol	NOUN
dpc-1099	416	5	.	.	PUNCT
dpc-1099	417	1	2018;79(1):97	2018;79(1):97	NUM
dpc-1099	417	2	-	-	SYM
dpc-1099	417	3	103	103	NUM
dpc-1099	417	4	.	.	PUNCT
dpc-1099	418	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
dpc-1099	418	2	j.jaad.2018.01.029	j.jaad.2018.01.029	NOUN
dpc-1099	418	3	55	55	NUM
dpc-1099	418	4	.	.	PUNCT
dpc-1099	419	1	sharma	sharma	PROPN
dpc-1099	419	2	vk	vk	PROPN
dpc-1099	419	3	,	,	PUNCT
dpc-1099	419	4	bhari	bhari	PROPN
dpc-1099	419	5	n	n	CCONJ
dpc-1099	419	6	,	,	PUNCT
dpc-1099	419	7	gupta	gupta	PROPN
dpc-1099	419	8	s	s	PART
dpc-1099	419	9	,	,	PUNCT
dpc-1099	419	10	et	et	PROPN
dpc-1099	419	11	al	al	PROPN
dpc-1099	419	12	.	.	PROPN
dpc-1099	420	1	clinical	clinical	ADJ
dpc-1099	420	2	efficacy	efficacy	NOUN
dpc-1099	420	3	of	of	ADP
dpc-1099	420	4	rituximab	rituximab	NOUN
dpc-1099	420	5	in	in	ADP
dpc-1099	420	6	the	the	DET
dpc-1099	420	7	treatment	treatment	NOUN
dpc-1099	420	8	of	of	ADP
dpc-1099	420	9	pemphigus	pemphigus	NOUN
dpc-1099	420	10	:	:	PUNCT
dpc-1099	420	11	a	a	DET
dpc-1099	420	12	retrospective	retrospective	ADJ
dpc-1099	420	13	study	study	NOUN
dpc-1099	420	14	.	.	PUNCT
dpc-1099	421	1	indian	indian	PROPN
dpc-1099	421	2	j	j	PROPN
dpc-1099	421	3	dermatol	dermatol	PROPN
dpc-1099	421	4	venereol	venereol	ADJ
dpc-1099	421	5	leprol	leprol	NOUN
dpc-1099	421	6	.	.	PUNCT
dpc-1099	422	1	2016;82(4):389	2016;82(4):389	NUM
dpc-1099	422	2	-	-	PUNCT
dpc-1099	422	3	394	394	NUM
dpc-1099	422	4	.	.	PUNCT
dpc-1099	423	1	https://doi	https://doi	NOUN
dpc-1099	423	2	.	.	PUNCT
dpc-1099	424	1	org/10.4103/0378	org/10.4103/0378	PROPN
dpc-1099	424	2	-	-	PUNCT
dpc-1099	424	3	6323.174379	6323.174379	NUM
dpc-1099	424	4	56	56	NUM
dpc-1099	424	5	.	.	PUNCT
dpc-1099	425	1	de	de	PROPN
dpc-1099	425	2	sena	sena	PROPN
dpc-1099	425	3	nogueira	nogueira	PROPN
dpc-1099	425	4	maehara	maehara	PROPN
dpc-1099	425	5	l	l	PROPN
dpc-1099	425	6	,	,	PUNCT
dpc-1099	425	7	huizinga	huizinga	ADV
dpc-1099	425	8	j	j	PROPN
dpc-1099	425	9	,	,	PUNCT
dpc-1099	425	10	jonkman	jonkman	NOUN
dpc-1099	425	11	mf	mf	PROPN
dpc-1099	425	12	.	.	PROPN
dpc-1099	425	13	rituximab	rituximab	NOUN
dpc-1099	425	14	therapy	therapy	NOUN
dpc-1099	425	15	in	in	ADP
dpc-1099	425	16	pemphigus	pemphigus	PROPN
dpc-1099	425	17	foliaceus	foliaceus	NOUN
dpc-1099	425	18	:	:	PUNCT
dpc-1099	425	19	report	report	NOUN
dpc-1099	425	20	of	of	ADP
dpc-1099	425	21	12	12	NUM
dpc-1099	425	22	cases	case	NOUN
dpc-1099	425	23	and	and	CCONJ
dpc-1099	425	24	review	review	NOUN
dpc-1099	425	25	of	of	ADP
dpc-1099	425	26	recent	recent	ADJ
dpc-1099	425	27	literature	literature	NOUN
dpc-1099	425	28	.	.	PUNCT
dpc-1099	426	1	br	br	PROPN
dpc-1099	426	2	j	j	PROPN
dpc-1099	426	3	dermatol	dermatol	NOUN
dpc-1099	426	4	.	.	PUNCT
dpc-1099	427	1	2015;172(5):1420	2015;172(5):1420	NUM
dpc-1099	427	2	-	-	SYM
dpc-1099	427	3	1423	1423	NUM
dpc-1099	427	4	.	.	PUNCT
dpc-1099	428	1	https://doi.org/10.1111/bjd.13586	https://doi.org/10.1111/bjd.13586	PROPN
dpc-1099	428	2	57	57	NUM
dpc-1099	428	3	.	.	PUNCT
dpc-1099	429	1	eming	eme	VERB
dpc-1099	429	2	r	r	NOUN
dpc-1099	429	3	,	,	PUNCT
dpc-1099	429	4	sticherling	sticherle	VERB
dpc-1099	429	5	m	m	PROPN
dpc-1099	429	6	,	,	PUNCT
dpc-1099	429	7	hofmann	hofmann	PROPN
dpc-1099	429	8	sc	sc	PROPN
dpc-1099	429	9	,	,	PUNCT
dpc-1099	429	10	et	et	PROPN
dpc-1099	429	11	al	al	PROPN
dpc-1099	429	12	.	.	PUNCT
dpc-1099	430	1	s2k	s2k	PROPN
dpc-1099	430	2	guidelines	guideline	NOUN
dpc-1099	430	3	for	for	ADP
dpc-1099	430	4	the	the	DET
dpc-1099	430	5	treatment	treatment	NOUN
dpc-1099	430	6	of	of	ADP
dpc-1099	430	7	pemphigus	pemphigus	NOUN
dpc-1099	430	8	vulgaris	vulgaris	NOUN
dpc-1099	430	9	/	/	SYM
dpc-1099	430	10	foliaceus	foliaceus	NOUN
dpc-1099	430	11	and	and	CCONJ
dpc-1099	430	12	bullous	bullous	ADJ
dpc-1099	430	13	pemphigoid	pemphigoid	NOUN
dpc-1099	430	14	.	.	PUNCT
dpc-1099	431	1	j	j	PROPN
dpc-1099	431	2	dtsch	dtsch	PROPN
dpc-1099	431	3	dermatol	dermatol	NOUN
dpc-1099	431	4	ges	ge	NOUN
dpc-1099	431	5	.	.	PROPN
dpc-1099	431	6	2015;13(8):833	2015;13(8):833	NUM
dpc-1099	431	7	-	-	PUNCT
dpc-1099	431	8	844	844	NUM
dpc-1099	431	9	.	.	PUNCT
dpc-1099	432	1	https://doi	https://doi	NOUN
dpc-1099	432	2	.	.	PUNCT
dpc-1099	432	3	org/10.1111	org/10.1111	PROPN
dpc-1099	432	4	/	/	SYM
dpc-1099	432	5	ddg.12606	ddg.12606	PROPN
dpc-1099	432	6	58	58	NUM
dpc-1099	432	7	.	.	PUNCT
dpc-1099	433	1	kirtschig	kirtschig	PROPN
dpc-1099	433	2	g	g	PROPN
dpc-1099	433	3	,	,	PUNCT
dpc-1099	433	4	middleton	middleton	PROPN
dpc-1099	433	5	p	p	PROPN
dpc-1099	433	6	,	,	PUNCT
dpc-1099	433	7	bennett	bennett	PROPN
dpc-1099	433	8	c	c	PROPN
dpc-1099	433	9	,	,	PUNCT
dpc-1099	433	10	murrell	murrell	PROPN
dpc-1099	433	11	df	df	PROPN
dpc-1099	433	12	,	,	PUNCT
dpc-1099	433	13	wojnarowska	wojnarowska	PROPN
dpc-1099	433	14	f	f	NUM
dpc-1099	433	15	,	,	PUNCT
dpc-1099	433	16	khumalo	khumalo	PROPN
dpc-1099	433	17	np	np	PROPN
dpc-1099	433	18	.	.	PUNCT
dpc-1099	433	19	interventions	intervention	NOUN
dpc-1099	433	20	for	for	ADP
dpc-1099	433	21	bullous	bullous	ADJ
dpc-1099	433	22	pemphigoid	pemphigoid	NOUN
dpc-1099	433	23	:	:	PUNCT
dpc-1099	433	24	a	a	DET
dpc-1099	433	25	summarised	summarise	VERB
dpc-1099	433	26	cochrane	cochrane	NOUN
dpc-1099	433	27	review	review	PROPN
dpc-1099	433	28	.	.	PUNCT
dpc-1099	434	1	clin	clin	PROPN
dpc-1099	434	2	exp	exp	NOUN
dpc-1099	434	3	dermatol	dermatol	NOUN
dpc-1099	434	4	.	.	PUNCT
dpc-1099	435	1	2011;36(4):449450	2011;36(4):449450	NUM
dpc-1099	435	2	.	.	PUNCT
dpc-1099	436	1	https://doi.org/10.1111/j.1365-2230.2011.04104.x	https://doi.org/10.1111/j.1365-2230.2011.04104.x	PROPN
dpc-1099	436	2	59	59	NUM
dpc-1099	436	3	.	.	PUNCT
dpc-1099	437	1	joly	joly	PROPN
dpc-1099	437	2	p	p	PROPN
dpc-1099	437	3	,	,	PUNCT
dpc-1099	437	4	roujeau	roujeau	PROPN
dpc-1099	437	5	jc	jc	PROPN
dpc-1099	437	6	,	,	PUNCT
dpc-1099	437	7	benichou	benichou	PROPN
dpc-1099	437	8	j	j	PROPN
dpc-1099	437	9	,	,	PUNCT
dpc-1099	437	10	et	et	PROPN
dpc-1099	437	11	al	al	PROPN
dpc-1099	437	12	.	.	PUNCT
dpc-1099	438	1	a	a	DET
dpc-1099	438	2	comparison	comparison	NOUN
dpc-1099	438	3	of	of	ADP
dpc-1099	438	4	oral	oral	ADJ
dpc-1099	438	5	and	and	CCONJ
dpc-1099	438	6	topical	topical	ADJ
dpc-1099	438	7	corticosteroids	corticosteroid	NOUN
dpc-1099	438	8	in	in	ADP
dpc-1099	438	9	patients	patient	NOUN
dpc-1099	438	10	with	with	ADP
dpc-1099	438	11	bullous	bullous	ADJ
dpc-1099	438	12	pemphigoid	pemphigoid	NOUN
dpc-1099	438	13	.	.	PUNCT
dpc-1099	439	1	n	n	PROPN
dpc-1099	439	2	engl	engl	PROPN
dpc-1099	439	3	j	j	PROPN
dpc-1099	439	4	med	med	PROPN
dpc-1099	439	5	.	.	PUNCT
dpc-1099	440	1	2002;346(5):321	2002;346(5):321	NUM
dpc-1099	440	2	-	-	SYM
dpc-1099	440	3	327	327	NUM
dpc-1099	440	4	.	.	PUNCT
dpc-1099	441	1	https://doi.org/10.1056/	https://doi.org/10.1056/	PROPN
dpc-1099	441	2	nejmoa011592	nejmoa011592	PROPN
dpc-1099	441	3	60	60	NUM
dpc-1099	441	4	.	.	PUNCT
dpc-1099	442	1	joly	joly	PROPN
dpc-1099	442	2	p	p	PROPN
dpc-1099	442	3	,	,	PUNCT
dpc-1099	442	4	roujeau	roujeau	PROPN
dpc-1099	442	5	jc	jc	PROPN
dpc-1099	442	6	,	,	PUNCT
dpc-1099	442	7	benichou	benichou	PROPN
dpc-1099	442	8	j	j	PROPN
dpc-1099	442	9	,	,	PUNCT
dpc-1099	442	10	et	et	PROPN
dpc-1099	442	11	al	al	PROPN
dpc-1099	442	12	.	.	PUNCT
dpc-1099	443	1	a	a	DET
dpc-1099	443	2	comparison	comparison	NOUN
dpc-1099	443	3	of	of	ADP
dpc-1099	443	4	two	two	NUM
dpc-1099	443	5	regimens	regimen	NOUN
dpc-1099	443	6	of	of	ADP
dpc-1099	443	7	topical	topical	ADJ
dpc-1099	443	8	corticosteroids	corticosteroid	NOUN
dpc-1099	443	9	in	in	ADP
dpc-1099	443	10	the	the	DET
dpc-1099	443	11	treatment	treatment	NOUN
dpc-1099	443	12	of	of	ADP
dpc-1099	443	13	patients	patient	NOUN
dpc-1099	443	14	with	with	ADP
dpc-1099	443	15	bullous	bullous	ADJ
dpc-1099	443	16	pemphigoid	pemphigoid	NOUN
dpc-1099	443	17	:	:	PUNCT
dpc-1099	443	18	a	a	DET
dpc-1099	443	19	multicenter	multicenter	ADJ
dpc-1099	443	20	randomized	randomized	ADJ
dpc-1099	443	21	study	study	NOUN
dpc-1099	443	22	.	.	PUNCT
dpc-1099	444	1	j	j	PROPN
dpc-1099	444	2	invest	invest	VERB
dpc-1099	444	3	dermatol	dermatol	NOUN
dpc-1099	444	4	.	.	PUNCT
dpc-1099	445	1	2009;129(1):1681	2009;129(1):1681	NUM
dpc-1099	445	2	-	-	SYM
dpc-1099	445	3	1687	1687	NUM
dpc-1099	445	4	.	.	PUNCT
dpc-1099	446	1	https://doi.org/10.1038/	https://doi.org/10.1038/	NOUN
dpc-1099	446	2	jid.2008.412	jid.2008.412	VERB
dpc-1099	446	3	pemphigoid	pemphigoid	ADJ
dpc-1099	446	4	:	:	PUNCT
dpc-1099	446	5	italian	italian	ADJ
dpc-1099	446	6	guidelines	guideline	NOUN
dpc-1099	446	7	adapted	adapt	VERB
dpc-1099	446	8	from	from	ADP
dpc-1099	446	9	the	the	DET
dpc-1099	446	10	edf	edf	PROPN
dpc-1099	446	11	/	/	SYM
dpc-1099	446	12	eadv	eadv	ADJ
dpc-1099	446	13	guidelines	guideline	NOUN
dpc-1099	446	14	.	.	PUNCT
dpc-1099	447	1	g	g	ADP
dpc-1099	447	2	ital	ital	ADJ
dpc-1099	447	3	dermatol	dermatol	NOUN
dpc-1099	447	4	venereol	venereol	NOUN
dpc-1099	447	5	.	.	PUNCT
dpc-1099	448	1	2018;153(3):305	2018;153(3):305	NUM
dpc-1099	448	2	-	-	SYM
dpc-1099	448	3	315	315	NUM
dpc-1099	448	4	.	.	PUNCT
dpc-1099	449	1	34	34	NUM
dpc-1099	449	2	.	.	PUNCT
dpc-1099	450	1	machado	machado	PROPN
dpc-1099	450	2	-	-	PUNCT
dpc-1099	450	3	pinto	pinto	PROPN
dpc-1099	450	4	j	j	PROPN
dpc-1099	450	5	,	,	PUNCT
dpc-1099	450	6	mccalmont	mccalmont	NOUN
dpc-1099	450	7	th	th	NOUN
dpc-1099	450	8	,	,	PUNCT
dpc-1099	450	9	golitz	golitz	PROPN
dpc-1099	450	10	le	le	X
dpc-1099	450	11	.	.	PROPN
dpc-1099	451	1	eosinophilic	eosinophilic	PROPN
dpc-1099	451	2	and	and	CCONJ
dpc-1099	451	3	neutrophilic	neutrophilic	ADJ
dpc-1099	451	4	spongiosis	spongiosis	NOUN
dpc-1099	451	5	:	:	PUNCT
dpc-1099	451	6	clues	clue	NOUN
dpc-1099	451	7	to	to	ADP
dpc-1099	451	8	the	the	DET
dpc-1099	451	9	diagnosis	diagnosis	NOUN
dpc-1099	451	10	of	of	ADP
dpc-1099	451	11	immunobullous	immunobullous	ADJ
dpc-1099	451	12	diseases	disease	NOUN
dpc-1099	451	13	and	and	CCONJ
dpc-1099	451	14	other	other	ADJ
dpc-1099	451	15	inflammatory	inflammatory	ADJ
dpc-1099	451	16	disorders	disorder	NOUN
dpc-1099	451	17	.	.	PUNCT
dpc-1099	452	1	semin	semin	PROPN
dpc-1099	452	2	cutan	cutan	PROPN
dpc-1099	452	3	med	med	PROPN
dpc-1099	452	4	surg	surg	NOUN
dpc-1099	452	5	.	.	PUNCT
dpc-1099	453	1	1996;15(4):308	1996;15(4):308	NUM
dpc-1099	453	2	-	-	PUNCT
dpc-1099	453	3	316	316	NUM
dpc-1099	453	4	.	.	PUNCT
dpc-1099	453	5	https://doi.org/10.1016/s10855629(96)80044-7	https://doi.org/10.1016/s10855629(96)80044-7	PROPN
dpc-1099	453	6	35	35	NUM
dpc-1099	453	7	.	.	PUNCT
dpc-1099	454	1	schmidt	schmidt	PROPN
dpc-1099	454	2	e	e	PROPN
dpc-1099	454	3	,	,	PUNCT
dpc-1099	454	4	goebeler	goebeler	PROPN
dpc-1099	454	5	m	m	PROPN
dpc-1099	454	6	,	,	PUNCT
dpc-1099	454	7	hertl	hertl	NOUN
dpc-1099	454	8	m	m	PROPN
dpc-1099	454	9	,	,	PUNCT
dpc-1099	454	10	et	et	PROPN
dpc-1099	454	11	al	al	PROPN
dpc-1099	454	12	.	.	PUNCT
dpc-1099	455	1	s2k	s2k	PROPN
dpc-1099	455	2	guideline	guideline	PROPN
dpc-1099	455	3	for	for	ADP
dpc-1099	455	4	the	the	DET
dpc-1099	455	5	diagnosis	diagnosis	NOUN
dpc-1099	455	6	of	of	ADP
dpc-1099	455	7	pemphigus	pemphigus	NOUN
dpc-1099	455	8	vulgaris	vulgaris	NOUN
dpc-1099	455	9	/	/	SYM
dpc-1099	455	10	foliaceus	foliaceus	NOUN
dpc-1099	455	11	and	and	CCONJ
dpc-1099	455	12	bullous	bullous	ADJ
dpc-1099	455	13	pemphigoid	pemphigoid	NOUN
dpc-1099	455	14	.	.	PUNCT
dpc-1099	456	1	j	j	PROPN
dpc-1099	456	2	dtsch	dtsch	PROPN
dpc-1099	456	3	dermatol	dermatol	NOUN
dpc-1099	456	4	ges	ge	NOUN
dpc-1099	456	5	.	.	PUNCT
dpc-1099	457	1	2015;13(7):713	2015;13(7):713	NUM
dpc-1099	457	2	-	-	PUNCT
dpc-1099	457	3	727	727	NUM
dpc-1099	457	4	.	.	PUNCT
dpc-1099	458	1	https://doi	https://doi	PROPN
dpc-1099	458	2	.	.	PUNCT
dpc-1099	458	3	org/10.1111	org/10.1111	PROPN
dpc-1099	458	4	/	/	SYM
dpc-1099	458	5	ddg.12612	ddg.12612	PROPN
dpc-1099	458	6	36	36	NUM
dpc-1099	458	7	.	.	PUNCT
dpc-1099	459	1	miller	miller	PROPN
dpc-1099	459	2	dd	dd	PROPN
dpc-1099	459	3	,	,	PUNCT
dpc-1099	459	4	bhawan	bhawan	PROPN
dpc-1099	459	5	j.	j.	PROPN
dpc-1099	459	6	bullous	bullous	PROPN
dpc-1099	459	7	tinea	tinea	PROPN
dpc-1099	459	8	pedis	pedi	VERB
dpc-1099	459	9	with	with	ADP
dpc-1099	459	10	direct	direct	ADJ
dpc-1099	459	11	immunofluorescence	immunofluorescence	NOUN
dpc-1099	459	12	positivity	positivity	NOUN
dpc-1099	459	13	:	:	PUNCT
dpc-1099	459	14	when	when	SCONJ
dpc-1099	459	15	is	be	AUX
dpc-1099	459	16	a	a	DET
dpc-1099	459	17	positive	positive	ADJ
dpc-1099	459	18	result	result	NOUN
dpc-1099	459	19	not	not	PART
dpc-1099	459	20	autoimmune	autoimmune	ADJ
dpc-1099	459	21	bullous	bullous	ADJ
dpc-1099	459	22	disease	disease	NOUN
dpc-1099	459	23	?	?	PUNCT
dpc-1099	460	1	am	be	AUX
dpc-1099	460	2	j	j	PROPN
dpc-1099	460	3	dermatopathol	dermatopathol	NOUN
dpc-1099	460	4	.	.	PUNCT
dpc-1099	461	1	2013;35(5):587	2013;35(5):587	NUM
dpc-1099	461	2	-	-	SYM
dpc-1099	461	3	594	594	NUM
dpc-1099	461	4	.	.	PUNCT
dpc-1099	462	1	https://doi.org/10.1097/dad.0b013e3182604854	https://doi.org/10.1097/dad.0b013e3182604854	PROPN
dpc-1099	462	2	37	37	NUM
dpc-1099	462	3	.	.	PUNCT
dpc-1099	463	1	feliciani	feliciani	PROPN
dpc-1099	463	2	c	c	PROPN
dpc-1099	463	3	,	,	PUNCT
dpc-1099	463	4	cozzani	cozzani	PROPN
dpc-1099	463	5	e	e	NOUN
dpc-1099	463	6	,	,	PUNCT
dpc-1099	463	7	marzano	marzano	PROPN
dpc-1099	463	8	av	av	PROPN
dpc-1099	463	9	,	,	PUNCT
dpc-1099	463	10	et	et	PROPN
dpc-1099	463	11	al	al	PROPN
dpc-1099	463	12	.	.	PUNCT
dpc-1099	464	1	italian	italian	ADJ
dpc-1099	464	2	guidelines	guideline	NOUN
dpc-1099	464	3	in	in	ADP
dpc-1099	464	4	pemphigus	pemphigus	PROPN
dpc-1099	464	5	—	—	PUNCT
dpc-1099	464	6	adapted	adapt	VERB
dpc-1099	464	7	from	from	ADP
dpc-1099	464	8	the	the	DET
dpc-1099	464	9	european	european	PROPN
dpc-1099	464	10	dermatology	dermatology	PROPN
dpc-1099	464	11	forum	forum	PROPN
dpc-1099	464	12	(	(	PUNCT
dpc-1099	464	13	edf	edf	PROPN
dpc-1099	464	14	)	)	PUNCT
dpc-1099	464	15	and	and	CCONJ
dpc-1099	464	16	european	european	PROPN
dpc-1099	464	17	academy	academy	PROPN
dpc-1099	464	18	of	of	ADP
dpc-1099	464	19	dermatology	dermatology	NOUN
dpc-1099	464	20	and	and	CCONJ
dpc-1099	464	21	venerology	venerology	NOUN
dpc-1099	464	22	(	(	PUNCT
dpc-1099	464	23	eadv	eadv	ADJ
dpc-1099	464	24	)	)	PUNCT
dpc-1099	464	25	.	.	PUNCT
dpc-1099	465	1	g	g	PROPN
dpc-1099	465	2	ital	ital	ADJ
dpc-1099	465	3	dermatol	dermatol	NOUN
dpc-1099	465	4	venereol	venereol	NOUN
dpc-1099	465	5	.	.	PUNCT
dpc-1099	466	1	2018;153(5):599	2018;153(5):599	NUM
dpc-1099	466	2	-	-	SYM
dpc-1099	466	3	608	608	NUM
dpc-1099	466	4	.	.	PUNCT
dpc-1099	467	1	https://	https://	PROPN
dpc-1099	467	2	doi.org/10.23736/s0392-0488.18.06073-x	doi.org/10.23736/s0392-0488.18.06073-x	PROPN
dpc-1099	467	3	38	38	NUM
dpc-1099	467	4	.	.	PUNCT
dpc-1099	468	1	feliciani	feliciani	PROPN
dpc-1099	468	2	c	c	X
dpc-1099	468	3	,	,	PUNCT
dpc-1099	468	4	joly	joly	PROPN
dpc-1099	468	5	p	p	PROPN
dpc-1099	468	6	,	,	PUNCT
dpc-1099	468	7	jonkman	jonkman	NOUN
dpc-1099	468	8	mf	mf	NOUN
dpc-1099	468	9	,	,	PUNCT
dpc-1099	468	10	et	et	PROPN
dpc-1099	468	11	al	al	PROPN
dpc-1099	468	12	.	.	PUNCT
dpc-1099	468	13	management	management	NOUN
dpc-1099	468	14	of	of	ADP
dpc-1099	468	15	bullous	bullous	ADJ
dpc-1099	468	16	pemphigoid	pemphigoid	NOUN
dpc-1099	468	17	:	:	PUNCT
dpc-1099	468	18	the	the	DET
dpc-1099	468	19	european	european	PROPN
dpc-1099	468	20	dermatology	dermatology	PROPN
dpc-1099	468	21	forum	forum	PROPN
dpc-1099	468	22	consensus	consensus	NOUN
dpc-1099	468	23	in	in	ADP
dpc-1099	468	24	collaboration	collaboration	NOUN
dpc-1099	468	25	with	with	ADP
dpc-1099	468	26	the	the	DET
dpc-1099	468	27	european	european	PROPN
dpc-1099	468	28	academy	academy	PROPN
dpc-1099	468	29	of	of	ADP
dpc-1099	468	30	dermatology	dermatology	NOUN
dpc-1099	468	31	and	and	CCONJ
dpc-1099	468	32	venereology	venereology	NOUN
dpc-1099	468	33	.	.	PUNCT
dpc-1099	469	1	br	br	PROPN
dpc-1099	469	2	j	j	PROPN
dpc-1099	469	3	dermatol	dermatol	NOUN
dpc-1099	469	4	.	.	PUNCT
dpc-1099	470	1	2015;172(4):867	2015;172(4):867	NUM
dpc-1099	470	2	-	-	SYM
dpc-1099	470	3	877	877	NUM
dpc-1099	470	4	.	.	PUNCT
dpc-1099	471	1	https://doi	https://doi	X
dpc-1099	471	2	.	.	PUNCT
dpc-1099	471	3	org/10.1111	org/10.1111	PROPN
dpc-1099	471	4	/	/	SYM
dpc-1099	471	5	bjd.13717	bjd.13717	X
dpc-1099	471	6	39	39	NUM
dpc-1099	471	7	.	.	PUNCT
dpc-1099	472	1	van	van	PROPN
dpc-1099	472	2	beek	beek	PROPN
dpc-1099	472	3	n	n	CCONJ
dpc-1099	472	4	,	,	PUNCT
dpc-1099	472	5	dähnrich	dähnrich	PROPN
dpc-1099	472	6	c	c	X
dpc-1099	472	7	,	,	PUNCT
dpc-1099	472	8	johannsen	johannsen	PROPN
dpc-1099	472	9	n	n	CCONJ
dpc-1099	472	10	,	,	PUNCT
dpc-1099	472	11	et	et	PROPN
dpc-1099	472	12	al	al	PROPN
dpc-1099	472	13	.	.	PROPN
dpc-1099	472	14	prospective	prospective	ADJ
dpc-1099	472	15	studies	study	NOUN
dpc-1099	472	16	on	on	ADP
dpc-1099	472	17	the	the	DET
dpc-1099	472	18	routine	routine	ADJ
dpc-1099	472	19	use	use	NOUN
dpc-1099	472	20	of	of	ADP
dpc-1099	472	21	a	a	DET
dpc-1099	472	22	novel	novel	ADJ
dpc-1099	472	23	multivariant	multivariant	NOUN
dpc-1099	472	24	enzyme	enzyme	NOUN
dpc-1099	472	25	-	-	PUNCT
dpc-1099	472	26	linked	link	VERB
dpc-1099	472	27	immunosorbent	immunosorbent	NOUN
dpc-1099	472	28	assay	assay	NOUN
dpc-1099	472	29	for	for	ADP
dpc-1099	472	30	the	the	DET
dpc-1099	472	31	diagnosis	diagnosis	NOUN
dpc-1099	472	32	of	of	ADP
dpc-1099	472	33	autoimmune	autoimmune	ADJ
dpc-1099	472	34	bullous	bullous	ADJ
dpc-1099	472	35	diseases	disease	NOUN
dpc-1099	472	36	.	.	PUNCT
dpc-1099	473	1	j	j	PROPN
dpc-1099	473	2	am	be	AUX
dpc-1099	473	3	acad	acad	ADJ
dpc-1099	473	4	dermatol	dermatol	NOUN
dpc-1099	473	5	.	.	PUNCT
dpc-1099	474	1	2017;76(5):889	2017;76(5):889	PROPN
dpc-1099	474	2	-	-	PUNCT
dpc-1099	474	3	894	894	NUM
dpc-1099	474	4	.	.	PUNCT
dpc-1099	475	1	https://doi	https://doi	PROPN
dpc-1099	475	2	.	.	PUNCT
dpc-1099	476	1	org/10.1016	org/10.1016	PROPN
dpc-1099	476	2	/	/	SYM
dpc-1099	476	3	j.jaad.2016.11.002	j.jaad.2016.11.002	NOUN
dpc-1099	476	4	40	40	NUM
dpc-1099	476	5	.	.	PUNCT
dpc-1099	477	1	yang	yang	PROPN
dpc-1099	477	2	a	a	PROPN
dpc-1099	477	3	,	,	PUNCT
dpc-1099	477	4	xuan	xuan	PROPN
dpc-1099	477	5	r	r	PROPN
dpc-1099	477	6	,	,	PUNCT
dpc-1099	477	7	melbourne	melbourne	PROPN
dpc-1099	477	8	w	w	PROPN
dpc-1099	477	9	,	,	PUNCT
dpc-1099	477	10	tran	tran	PROPN
dpc-1099	477	11	k	k	PROPN
dpc-1099	477	12	,	,	PUNCT
dpc-1099	477	13	murrell	murrell	PROPN
dpc-1099	477	14	df	df	PROPN
dpc-1099	477	15	.	.	PUNCT
dpc-1099	478	1	validation	validation	NOUN
dpc-1099	478	2	of	of	ADP
dpc-1099	478	3	the	the	DET
dpc-1099	478	4	biochip	biochip	NOUN
dpc-1099	478	5	test	test	NOUN
dpc-1099	478	6	for	for	ADP
dpc-1099	478	7	the	the	DET
dpc-1099	478	8	diagnosis	diagnosis	NOUN
dpc-1099	478	9	of	of	ADP
dpc-1099	478	10	bullous	bullous	ADJ
dpc-1099	478	11	pemphigoid	pemphigoid	NOUN
dpc-1099	478	12	,	,	PUNCT
dpc-1099	478	13	pemphigus	pemphigus	NOUN
dpc-1099	478	14	vulgaris	vulgaris	NOUN
dpc-1099	478	15	and	and	CCONJ
dpc-1099	478	16	pemphigus	pemphigus	PROPN
dpc-1099	478	17	foliaceus	foliaceus	NOUN
dpc-1099	478	18	.	.	PUNCT
dpc-1099	479	1	j	j	PROPN
dpc-1099	479	2	eur	eur	PROPN
dpc-1099	479	3	acad	acad	PROPN
dpc-1099	479	4	dermatol	dermatol	NOUN
dpc-1099	479	5	venereol	venereol	NOUN
dpc-1099	479	6	.	.	PUNCT
dpc-1099	480	1	2020;34(1):153	2020;34(1):153	NUM
dpc-1099	480	2	-	-	SYM
dpc-1099	480	3	160	160	NUM
dpc-1099	480	4	.	.	PUNCT
dpc-1099	481	1	https://doi.org/10.1111/jdv.15770	https://doi.org/10.1111/jdv.15770	PROPN
dpc-1099	481	2	41	41	NUM
dpc-1099	481	3	.	.	PUNCT
dpc-1099	482	1	amagai	amagai	PROPN
dpc-1099	482	2	m	m	PROPN
dpc-1099	482	3	,	,	PUNCT
dpc-1099	482	4	komai	komai	PROPN
dpc-1099	482	5	a	a	PRON
dpc-1099	482	6	,	,	PUNCT
dpc-1099	482	7	hashimoto	hashimoto	NOUN
dpc-1099	482	8	t	t	PROPN
dpc-1099	482	9	,	,	PUNCT
dpc-1099	482	10	et	et	PROPN
dpc-1099	482	11	al	al	PROPN
dpc-1099	482	12	.	.	PUNCT
dpc-1099	483	1	usefulness	usefulness	NOUN
dpc-1099	483	2	of	of	ADP
dpc-1099	483	3	enzyme‐linked	enzyme‐linke	VERB
dpc-1099	483	4	immunosorbent	immunosorbent	NOUN
dpc-1099	483	5	assay	assay	NOUN
dpc-1099	483	6	using	use	VERB
dpc-1099	483	7	recombinant	recombinant	ADJ
dpc-1099	483	8	desmogleins	desmoglein	NOUN
dpc-1099	483	9	1	1	NUM
dpc-1099	483	10	and	and	CCONJ
dpc-1099	483	11	3	3	NUM
dpc-1099	483	12	for	for	ADP
dpc-1099	483	13	serodiagnosis	serodiagnosis	NOUN
dpc-1099	483	14	of	of	ADP
dpc-1099	483	15	pemphigus	pemphigus	PROPN
dpc-1099	483	16	.	.	PUNCT
dpc-1099	484	1	br	br	PROPN
dpc-1099	484	2	j	j	PROPN
dpc-1099	484	3	dermatol	dermatol	NOUN
dpc-1099	484	4	.	.	PUNCT
dpc-1099	485	1	1999;140(2):351	1999;140(2):351	NOUN
dpc-1099	485	2	-	-	SYM
dpc-1099	485	3	357	357	NUM
dpc-1099	485	4	.	.	PUNCT
dpc-1099	486	1	https://doi.org/10.1046/j.13652133.1999.02752.x	https://doi.org/10.1046/j.13652133.1999.02752.x	NUM
dpc-1099	486	2	42	42	NUM
dpc-1099	486	3	.	.	PUNCT
dpc-1099	487	1	jamora	jamora	PROPN
dpc-1099	487	2	mj	mj	PROPN
dpc-1099	487	3	,	,	PUNCT
dpc-1099	487	4	jiao	jiao	PROPN
dpc-1099	487	5	d	d	PROPN
dpc-1099	487	6	,	,	PUNCT
dpc-1099	487	7	bystryn	bystryn	PROPN
dpc-1099	487	8	jc	jc	PROPN
dpc-1099	487	9	.	.	PROPN
dpc-1099	487	10	antibodies	antibodie	VERB
dpc-1099	487	11	to	to	PART
dpc-1099	487	12	desmoglein	desmoglein	VERB
dpc-1099	487	13	1	1	NUM
dpc-1099	487	14	and	and	CCONJ
dpc-1099	487	15	3	3	NUM
dpc-1099	487	16	,	,	PUNCT
dpc-1099	487	17	and	and	CCONJ
dpc-1099	487	18	the	the	DET
dpc-1099	487	19	clinical	clinical	ADJ
dpc-1099	487	20	phenotype	phenotype	NOUN
dpc-1099	487	21	of	of	ADP
dpc-1099	487	22	pemphigus	pemphigus	PROPN
dpc-1099	487	23	vulgaris	vulgaris	NOUN
dpc-1099	487	24	.	.	PUNCT
dpc-1099	488	1	j	j	PROPN
dpc-1099	488	2	am	be	AUX
dpc-1099	488	3	acad	acad	ADJ
dpc-1099	488	4	dermatol	dermatol	NOUN
dpc-1099	488	5	.	.	PUNCT
dpc-1099	489	1	2003;48(6):976	2003;48(6):976	NUM
dpc-1099	489	2	-	-	PUNCT
dpc-1099	489	3	977	977	NUM
dpc-1099	489	4	.	.	PUNCT
dpc-1099	490	1	https://doi.org/10.1067/	https://doi.org/10.1067/	ADJ
dpc-1099	490	2	mjd.2003.438	mjd.2003.438	NOUN
dpc-1099	490	3	43	43	NUM
dpc-1099	490	4	.	.	PUNCT
dpc-1099	491	1	bağcı	bağcı	PROPN
dpc-1099	491	2	is	be	AUX
dpc-1099	491	3	,	,	PUNCT
dpc-1099	491	4	horváth	horváth	ADV
dpc-1099	491	5	on	on	ADP
dpc-1099	491	6	,	,	PUNCT
dpc-1099	491	7	ruzicka	ruzicka	PROPN
dpc-1099	491	8	t	t	PROPN
dpc-1099	491	9	,	,	PUNCT
dpc-1099	491	10	sárdy	sárdy	VERB
dpc-1099	491	11	m.	m.	NOUN
dpc-1099	491	12	bullous	bullous	ADJ
dpc-1099	491	13	pemphigoid	pemphigoid	PROPN
dpc-1099	491	14	.	.	PUNCT
dpc-1099	492	1	autoimmun	autoimmun	PROPN
dpc-1099	492	2	rev	rev	PROPN
dpc-1099	492	3	.	.	PROPN
dpc-1099	493	1	2017;16(5):445	2017;16(5):445	PROPN
dpc-1099	493	2	-	-	PUNCT
dpc-1099	493	3	455	455	NUM
dpc-1099	493	4	.	.	PUNCT
dpc-1099	494	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
dpc-1099	494	2	j.autrev.2017.03.010	j.autrev.2017.03.010	NOUN
dpc-1099	494	3	44	44	NUM
dpc-1099	494	4	.	.	PUNCT
dpc-1099	495	1	murrell	murrell	PROPN
dpc-1099	495	2	df	df	PROPN
dpc-1099	495	3	,	,	PUNCT
dpc-1099	495	4	peña	peña	PROPN
dpc-1099	495	5	s	s	PROPN
dpc-1099	495	6	,	,	PUNCT
dpc-1099	495	7	joly	joly	PROPN
dpc-1099	495	8	p	p	PROPN
dpc-1099	495	9	,	,	PUNCT
dpc-1099	495	10	et	et	PROPN
dpc-1099	495	11	al	al	PROPN
dpc-1099	495	12	.	.	PUNCT
dpc-1099	495	13	diagnosis	diagnosis	NOUN
dpc-1099	495	14	and	and	CCONJ
dpc-1099	495	15	management	management	NOUN
dpc-1099	495	16	of	of	ADP
dpc-1099	495	17	pemphigus	pemphigus	NOUN
dpc-1099	495	18	:	:	PUNCT
dpc-1099	495	19	recommendations	recommendation	NOUN
dpc-1099	495	20	of	of	ADP
dpc-1099	495	21	an	an	DET
dpc-1099	495	22	international	international	ADJ
dpc-1099	495	23	panel	panel	NOUN
dpc-1099	495	24	of	of	ADP
dpc-1099	495	25	experts	expert	NOUN
dpc-1099	495	26	.	.	PUNCT
dpc-1099	496	1	j	j	PROPN
dpc-1099	496	2	am	be	AUX
dpc-1099	496	3	acad	acad	ADJ
dpc-1099	496	4	dermatol	dermatol	NOUN
dpc-1099	496	5	.	.	PUNCT
dpc-1099	497	1	2020;82(3):575	2020;82(3):575	NUM
dpc-1099	497	2	-	-	PUNCT
dpc-1099	497	3	585.e1	585.e1	NUM
dpc-1099	497	4	.	.	PUNCT
dpc-1099	498	1	https://doi	https://doi	X
dpc-1099	498	2	.	.	PUNCT
dpc-1099	499	1	org/10.1016	org/10.1016	PROPN
dpc-1099	499	2	/	/	SYM
dpc-1099	499	3	j.jaad.2018.02.021	j.jaad.2018.02.021	PROPN
dpc-1099	499	4	45	45	NUM
dpc-1099	499	5	.	.	PUNCT
dpc-1099	500	1	almugairen	almugairen	PROPN
dpc-1099	500	2	n	n	CCONJ
dpc-1099	500	3	,	,	PUNCT
dpc-1099	500	4	hospital	hospital	NOUN
dpc-1099	500	5	v	v	NOUN
dpc-1099	500	6	,	,	PUNCT
dpc-1099	500	7	bedane	bedane	PROPN
dpc-1099	500	8	c	c	NOUN
dpc-1099	500	9	,	,	PUNCT
dpc-1099	500	10	et	et	PROPN
dpc-1099	500	11	al	al	PROPN
dpc-1099	500	12	.	.	PROPN
dpc-1099	500	13	assessment	assessment	NOUN
dpc-1099	500	14	of	of	ADP
dpc-1099	500	15	the	the	DET
dpc-1099	500	16	rate	rate	NOUN
dpc-1099	500	17	of	of	ADP
dpc-1099	500	18	long	long	ADJ
dpc-1099	500	19	-	-	PUNCT
dpc-1099	500	20	term	term	NOUN
dpc-1099	500	21	complete	complete	ADJ
dpc-1099	500	22	remission	remission	NOUN
dpc-1099	500	23	off	off	ADP
dpc-1099	500	24	therapy	therapy	NOUN
dpc-1099	500	25	in	in	ADP
dpc-1099	500	26	patients	patient	NOUN
dpc-1099	500	27	with	with	ADP
dpc-1099	500	28	pemphigus	pemphigus	PROPN
dpc-1099	500	29	treated	treat	VERB
dpc-1099	500	30	with	with	ADP
dpc-1099	500	31	different	different	ADJ
dpc-1099	500	32	regimens	regimen	NOUN
dpc-1099	500	33	including	include	VERB
dpc-1099	500	34	mediumand	mediumand	NOUN
dpc-1099	500	35	high	high	ADV
dpc-1099	500	36	-	-	PUNCT
dpc-1099	500	37	dose	dose	NOUN
dpc-1099	500	38	corticosteroids	corticosteroid	NOUN
dpc-1099	500	39	.	.	PUNCT
dpc-1099	501	1	j	j	PROPN
dpc-1099	501	2	am	be	AUX
dpc-1099	501	3	acad	acad	ADJ
dpc-1099	501	4	dermatol	dermatol	NOUN
dpc-1099	501	5	.	.	PUNCT
dpc-1099	502	1	2013;69(4):583588	2013;69(4):583588	NUM
dpc-1099	502	2	.	.	PUNCT
dpc-1099	503	1	https://doi.org/10.1016/j.jaad.2013.05.016	https://doi.org/10.1016/j.jaad.2013.05.016	PROPN
dpc-1099	503	2	46	46	NUM
dpc-1099	503	3	.	.	PUNCT
dpc-1099	504	1	mentink	mentink	PROPN
dpc-1099	504	2	lf	lf	PROPN
dpc-1099	504	3	,	,	PUNCT
dpc-1099	504	4	mackenzie	mackenzie	PROPN
dpc-1099	504	5	mw	mw	PROPN
dpc-1099	504	6	,	,	PUNCT
dpc-1099	504	7	tóth	tóth	PROPN
dpc-1099	504	8	gg	gg	PROPN
dpc-1099	504	9	,	,	PUNCT
dpc-1099	504	10	et	et	PROPN
dpc-1099	504	11	al	al	PROPN
dpc-1099	504	12	.	.	PROPN
dpc-1099	504	13	randomized	randomize	VERB
dpc-1099	504	14	controlled	control	VERB
dpc-1099	504	15	trial	trial	NOUN
dpc-1099	504	16	of	of	ADP
dpc-1099	504	17	adjuvant	adjuvant	ADJ
dpc-1099	504	18	oral	oral	ADJ
dpc-1099	504	19	dexamethasone	dexamethasone	NOUN
dpc-1099	504	20	pulse	pulse	NOUN
dpc-1099	504	21	therapy	therapy	NOUN
dpc-1099	504	22	in	in	ADP
dpc-1099	504	23	pemphigus	pemphigus	PROPN
dpc-1099	504	24	vulgaris	vulgaris	NOUN
dpc-1099	504	25	:	:	PUNCT
dpc-1099	504	26	pempuls	pempuls	NOUN
dpc-1099	504	27	trial	trial	NOUN
dpc-1099	504	28	.	.	PUNCT
dpc-1099	505	1	arch	arch	ADJ
dpc-1099	505	2	dermatol	dermatol	NOUN
dpc-1099	505	3	.	.	PUNCT
dpc-1099	506	1	2006;142(5):570576	2006;142(5):570576	NUM
dpc-1099	506	2	.	.	PUNCT
dpc-1099	507	1	https://doi.org/10.1001/archderm.142.5.570	https://doi.org/10.1001/archderm.142.5.570	AUX
dpc-1099	507	2	https://doi.org/10.1111/ijd.14546	https://doi.org/10.1111/ijd.14546	PROPN
dpc-1099	507	3	https://doi.org/10.4103/ijdvl.ijdvl_848_17	https://doi.org/10.4103/ijdvl.ijdvl_848_17	PROPN
dpc-1099	507	4	https://doi.org/10.2340/00015555-2116	https://doi.org/10.2340/00015555-2116	PROPN
dpc-1099	507	5	https://doi.org/10.2340/00015555-2116	https://doi.org/10.2340/00015555-2116	PROPN
dpc-1099	507	6	https://doi.org/10.1016/s0140-6736(17)30070-3	https://doi.org/10.1016/s0140-6736(17)30070-3	NOUN
dpc-1099	507	7	https://doi.org/10.1016/s0140-6736(17)30070-3	https://doi.org/10.1016/s0140-6736(17)30070-3	NOUN
dpc-1099	507	8	https://doi.org/10.1111/bjd.18482	https://doi.org/10.1111/bjd.18482	PROPN
dpc-1099	507	9	https://doi.org/10.1111/dth.13016	https://doi.org/10.1111/dth.13016	PROPN
dpc-1099	507	10	https://doi.org/10.1016/j.jaad.2017.07.012	https://doi.org/10.1016/j.jaad.2017.07.012	PROPN
dpc-1099	507	11	https://doi.org/10.1016/j.jaad.2018.01.029	https://doi.org/10.1016/j.jaad.2018.01.029	NOUN
dpc-1099	507	12	https://doi.org/10.1016/j.jaad.2018.01.029	https://doi.org/10.1016/j.jaad.2018.01.029	NOUN
dpc-1099	507	13	https://doi.org/10.4103/0378-6323.174379	https://doi.org/10.4103/0378-6323.174379	PROPN
dpc-1099	507	14	https://doi.org/10.4103/0378-6323.174379	https://doi.org/10.4103/0378-6323.174379	PROPN
dpc-1099	507	15	https://doi.org/10.1111/bjd.13586	https://doi.org/10.1111/bjd.13586	PROPN
dpc-1099	507	16	https://doi.org/10.1111/ddg.12606	https://doi.org/10.1111/ddg.12606	NOUN
dpc-1099	507	17	https://doi.org/10.1111/ddg.12606	https://doi.org/10.1111/ddg.12606	ADJ
dpc-1099	507	18	https://doi.org/10.1111/j.1365-2230.2011.04104.x	https://doi.org/10.1111/j.1365-2230.2011.04104.x	ADJ
dpc-1099	507	19	https://doi.org/10.1056/nejmoa011592	https://doi.org/10.1056/nejmoa011592	NOUN
dpc-1099	507	20	https://doi.org/10.1056/nejmoa011592	https://doi.org/10.1056/nejmoa011592	NOUN
dpc-1099	508	1	https://doi.org/10.1038/jid.2008.412	https://doi.org/10.1038/jid.2008.412	PROPN
dpc-1099	508	2	https://doi.org/10.1038/jid.2008.412	https://doi.org/10.1038/jid.2008.412	PROPN
dpc-1099	508	3	https://doi.org/10.1016/s1085-5629(96)80044-7	https://doi.org/10.1016/s1085-5629(96)80044-7	PROPN
dpc-1099	508	4	https://doi.org/10.1016/s1085-5629(96)80044-7	https://doi.org/10.1016/s1085-5629(96)80044-7	PROPN
dpc-1099	508	5	https://doi.org/10.1111/ddg.12612	https://doi.org/10.1111/ddg.12612	PROPN
dpc-1099	508	6	https://doi.org/10.1111/ddg.12612	https://doi.org/10.1111/ddg.12612	PROPN
dpc-1099	508	7	https://doi.org/10.1097/dad.0b013e3182604854	https://doi.org/10.1097/dad.0b013e3182604854	PROPN
dpc-1099	508	8	https://doi.org/10.23736/s0392-0488.18.06073-x	https://doi.org/10.23736/s0392-0488.18.06073-x	NOUN
dpc-1099	508	9	https://doi.org/10.23736/s0392-0488.18.06073-x	https://doi.org/10.23736/s0392-0488.18.06073-x	NOUN
dpc-1099	508	10	https://doi.org/10.1111/bjd.13717	https://doi.org/10.1111/bjd.13717	PROPN
dpc-1099	508	11	https://doi.org/10.1111/bjd.13717	https://doi.org/10.1111/bjd.13717	PROPN
dpc-1099	508	12	https://doi.org/10.1016/j.jaad.2016.11.002	https://doi.org/10.1016/j.jaad.2016.11.002	AUX
dpc-1099	508	13	https://doi.org/10.1016/j.jaad.2016.11.002	https://doi.org/10.1016/j.jaad.2016.11.002	NOUN
dpc-1099	508	14	https://doi.org/10.1111/jdv.15770	https://doi.org/10.1111/jdv.15770	PROPN
dpc-1099	508	15	https://doi.org/10.1046/j.1365-2133.1999.02752.x	https://doi.org/10.1046/j.1365-2133.1999.02752.x	NOUN
dpc-1099	508	16	https://doi.org/10.1046/j.1365-2133.1999.02752.x	https://doi.org/10.1046/j.1365-2133.1999.02752.x	PROPN
dpc-1099	509	1	https://doi.org/10.1067/mjd.2003.438	https://doi.org/10.1067/mjd.2003.438	ADP
dpc-1099	509	2	https://doi.org/10.1067/mjd.2003.438	https://doi.org/10.1067/mjd.2003.438	PRON
dpc-1099	509	3	https://doi.org/10.1016/j.autrev.2017.03.010	https://doi.org/10.1016/j.autrev.2017.03.010	PROPN
dpc-1099	509	4	https://doi.org/10.1016/j.autrev.2017.03.010	https://doi.org/10.1016/j.autrev.2017.03.010	PROPN
dpc-1099	509	5	https://doi.org/10.1016/j.jaad.2018.02.021	https://doi.org/10.1016/j.jaad.2018.02.021	PROPN
dpc-1099	509	6	https://doi.org/10.1016/j.jaad.2018.02.021	https://doi.org/10.1016/j.jaad.2018.02.021	PROPN
dpc-1099	509	7	https://doi.org/10.1016/j.jaad.2013.05.016	https://doi.org/10.1016/j.jaad.2013.05.016	PROPN
dpc-1099	509	8	https://doi.org/10.1001/archderm.142.5.570	https://doi.org/10.1001/archderm.142.5.570	PROPN
dpc-1099	509	9	12	12	NUM
dpc-1099	509	10	review	review	NOUN
dpc-1099	510	1	|	|	ADV
dpc-1099	510	2	dermatol	dermatol	ADJ
dpc-1099	510	3	pract	pract	NOUN
dpc-1099	510	4	concept	concept	NOUN
dpc-1099	510	5	2020;10(3):e2020050	2020;10(3):e2020050	NUM
dpc-1099	510	6	pression	pression	NOUN
dpc-1099	510	7	in	in	ADP
dpc-1099	510	8	lesional	lesional	ADJ
dpc-1099	510	9	skin	skin	NOUN
dpc-1099	510	10	of	of	ADP
dpc-1099	510	11	bullous	bullous	ADJ
dpc-1099	510	12	pemphigoid	pemphigoid	NOUN
dpc-1099	510	13	.	.	PUNCT
dpc-1099	511	1	front	front	ADJ
dpc-1099	511	2	immunol	immunol	NOUN
dpc-1099	511	3	.	.	PUNCT
dpc-1099	512	1	2019;10:1919	2019;10:1919	X
dpc-1099	512	2	.	.	PUNCT
dpc-1099	513	1	https://doi.org/10.3389/fimmu.2019.01919	https://doi.org/10.3389/fimmu.2019.01919	PROPN
dpc-1099	513	2	67	67	NUM
dpc-1099	513	3	.	.	PUNCT
dpc-1099	514	1	bilgic	bilgic	ADV
dpc-1099	514	2	a	a	PRON
dpc-1099	514	3	,	,	PUNCT
dpc-1099	514	4	murrell	murrell	PROPN
dpc-1099	514	5	df	df	PROPN
dpc-1099	514	6	.	.	PUNCT
dpc-1099	515	1	what	what	PRON
dpc-1099	515	2	is	be	AUX
dpc-1099	515	3	novel	novel	ADJ
dpc-1099	515	4	in	in	ADP
dpc-1099	515	5	the	the	DET
dpc-1099	515	6	clinical	clinical	ADJ
dpc-1099	515	7	management	management	NOUN
dpc-1099	515	8	of	of	ADP
dpc-1099	515	9	pemphigus	pemphigus	PROPN
dpc-1099	515	10	.	.	PUNCT
dpc-1099	516	1	expert	expert	PROPN
dpc-1099	516	2	rev	rev	PROPN
dpc-1099	516	3	clin	clin	PROPN
dpc-1099	516	4	pharmacol	pharmacol	PROPN
dpc-1099	516	5	.	.	PUNCT
dpc-1099	517	1	2019;12(10):973	2019;12(10):973	NUM
dpc-1099	517	2	-	-	SYM
dpc-1099	517	3	980	980	NUM
dpc-1099	517	4	.	.	PUNCT
dpc-1099	518	1	https://doi.org/10.1080/17512433.2019.1670059	https://doi.org/10.1080/17512433.2019.1670059	PROPN
dpc-1099	519	1	68	68	NUM
dpc-1099	519	2	.	.	PUNCT
dpc-1099	519	3	langenhan	langenhan	PROPN
dpc-1099	519	4	j	j	PROPN
dpc-1099	519	5	,	,	PUNCT
dpc-1099	519	6	dworschak	dworschak	PROPN
dpc-1099	519	7	j	j	NOUN
dpc-1099	519	8	,	,	PUNCT
dpc-1099	519	9	saschenbrecker	saschenbrecker	NOUN
dpc-1099	519	10	s	s	PROPN
dpc-1099	519	11	,	,	PUNCT
dpc-1099	519	12	et	et	PROPN
dpc-1099	519	13	al	al	PROPN
dpc-1099	519	14	.	.	PROPN
dpc-1099	519	15	specific	specific	ADJ
dpc-1099	519	16	immunoadsorption	immunoadsorption	NOUN
dpc-1099	519	17	of	of	ADP
dpc-1099	519	18	pathogenic	pathogenic	ADJ
dpc-1099	519	19	autoantibodies	autoantibody	NOUN
dpc-1099	519	20	in	in	ADP
dpc-1099	519	21	pemphigus	pemphigus	PROPN
dpc-1099	519	22	requires	require	VERB
dpc-1099	519	23	the	the	DET
dpc-1099	519	24	entire	entire	ADJ
dpc-1099	519	25	ectodomains	ectodomain	NOUN
dpc-1099	519	26	of	of	ADP
dpc-1099	519	27	desmogleins	desmoglein	NOUN
dpc-1099	519	28	.	.	PUNCT
dpc-1099	520	1	exp	exp	NOUN
dpc-1099	520	2	dermatol	dermatol	NOUN
dpc-1099	520	3	.	.	PUNCT
dpc-1099	521	1	2014;23(4):253	2014;23(4):253	NUM
dpc-1099	521	2	-	-	SYM
dpc-1099	521	3	259	259	NUM
dpc-1099	521	4	.	.	PUNCT
dpc-1099	522	1	https://doi.org/10.1111/exd.12355	https://doi.org/10.1111/exd.12355	PROPN
dpc-1099	522	2	69	69	NUM
dpc-1099	522	3	.	.	PUNCT
dpc-1099	523	1	hofrichter	hofrichter	PROPN
dpc-1099	523	2	m	m	PROPN
dpc-1099	523	3	,	,	PUNCT
dpc-1099	523	4	dworschak	dworschak	PROPN
dpc-1099	523	5	j	j	NOUN
dpc-1099	523	6	,	,	PUNCT
dpc-1099	523	7	emtenani	emtenani	PROPN
dpc-1099	523	8	s	s	PROPN
dpc-1099	523	9	,	,	PUNCT
dpc-1099	523	10	et	et	PROPN
dpc-1099	523	11	al	al	PROPN
dpc-1099	523	12	.	.	PROPN
dpc-1099	523	13	immunoadsorption	immunoadsorption	NOUN
dpc-1099	523	14	of	of	ADP
dpc-1099	523	15	desmoglein-3	desmoglein-3	PROPN
dpc-1099	523	16	-	-	PUNCT
dpc-1099	523	17	specific	specific	ADJ
dpc-1099	523	18	igg	igg	NOUN
dpc-1099	523	19	abolishes	abolish	VERB
dpc-1099	523	20	the	the	DET
dpc-1099	523	21	blister	blister	NOUN
dpc-1099	523	22	-	-	PUNCT
dpc-1099	523	23	inducing	induce	VERB
dpc-1099	523	24	capacity	capacity	NOUN
dpc-1099	523	25	of	of	ADP
dpc-1099	523	26	pemphigus	pemphigus	PROPN
dpc-1099	523	27	vulgaris	vulgaris	NOUN
dpc-1099	523	28	igg	igg	PROPN
dpc-1099	523	29	in	in	ADP
dpc-1099	523	30	neonatal	neonatal	ADJ
dpc-1099	523	31	mice	mouse	NOUN
dpc-1099	523	32	.	.	PUNCT
dpc-1099	524	1	front	front	ADJ
dpc-1099	524	2	immunol	immunol	NOUN
dpc-1099	524	3	.	.	PUNCT
dpc-1099	525	1	2018;9:1935	2018;9:1935	NOUN
dpc-1099	525	2	.	.	PUNCT
dpc-1099	526	1	https://doi.org/10.3389/fimmu.2018.01935	https://doi.org/10.3389/fimmu.2018.01935	PROPN
dpc-1099	526	2	70	70	NUM
dpc-1099	526	3	.	.	PUNCT
dpc-1099	527	1	ellebrecht	ellebrecht	PROPN
dpc-1099	527	2	ct	ct	PROPN
dpc-1099	527	3	,	,	PUNCT
dpc-1099	527	4	bhoj	bhoj	NOUN
dpc-1099	527	5	vg	vg	NOUN
dpc-1099	527	6	,	,	PUNCT
dpc-1099	527	7	nace	nace	NOUN
dpc-1099	527	8	a	a	X
dpc-1099	527	9	,	,	PUNCT
dpc-1099	527	10	et	et	PROPN
dpc-1099	527	11	al	al	PROPN
dpc-1099	527	12	.	.	PUNCT
dpc-1099	528	1	reengineering	reengineere	VERB
dpc-1099	528	2	chimeric	chimeric	ADJ
dpc-1099	528	3	antigen	antigen	ADJ
dpc-1099	528	4	receptor	receptor	NOUN
dpc-1099	528	5	t	t	NOUN
dpc-1099	528	6	cells	cell	NOUN
dpc-1099	528	7	for	for	ADP
dpc-1099	528	8	targeted	target	VERB
dpc-1099	528	9	therapy	therapy	NOUN
dpc-1099	528	10	of	of	ADP
dpc-1099	528	11	autoimmune	autoimmune	ADJ
dpc-1099	528	12	disease	disease	NOUN
dpc-1099	528	13	.	.	PUNCT
dpc-1099	529	1	science	science	NOUN
dpc-1099	529	2	.	.	PUNCT
dpc-1099	530	1	2016;353(6295):179	2016;353(6295):179	NUM
dpc-1099	530	2	-	-	SYM
dpc-1099	530	3	184	184	NUM
dpc-1099	530	4	.	.	PUNCT
dpc-1099	531	1	https://doi.org/10.1126/	https://doi.org/10.1126/	PROPN
dpc-1099	531	2	science.aaf6756	science.aaf6756	NUM
dpc-1099	531	3	71	71	NUM
dpc-1099	531	4	.	.	PUNCT
dpc-1099	532	1	didona	didona	PROPN
dpc-1099	532	2	d	d	PROPN
dpc-1099	532	3	,	,	PUNCT
dpc-1099	532	4	maglie	maglie	PROPN
dpc-1099	532	5	r	r	NOUN
dpc-1099	532	6	,	,	PUNCT
dpc-1099	532	7	eming	eme	VERB
dpc-1099	532	8	r	r	NOUN
dpc-1099	532	9	,	,	PUNCT
dpc-1099	532	10	hertl	hertl	NOUN
dpc-1099	532	11	m.	m.	NOUN
dpc-1099	532	12	pemphigus	pemphigus	PROPN
dpc-1099	532	13	:	:	PUNCT
dpc-1099	532	14	current	current	ADJ
dpc-1099	532	15	and	and	CCONJ
dpc-1099	532	16	future	future	ADJ
dpc-1099	532	17	therapeutic	therapeutic	ADJ
dpc-1099	532	18	strategies	strategy	NOUN
dpc-1099	532	19	.	.	PUNCT
dpc-1099	533	1	front	front	ADJ
dpc-1099	533	2	immunol	immunol	NOUN
dpc-1099	533	3	.	.	PUNCT
dpc-1099	534	1	2019;10:1418	2019;10:1418	NUM
dpc-1099	534	2	.	.	PUNCT
dpc-1099	535	1	https://doi.org/10.3389/fimmu.2019.01418	https://doi.org/10.3389/fimmu.2019.01418	NOUN
dpc-1099	535	2	72	72	NUM
dpc-1099	535	3	.	.	PUNCT
dpc-1099	536	1	wannick	wannick	PROPN
dpc-1099	536	2	m	m	PROPN
dpc-1099	536	3	,	,	PUNCT
dpc-1099	536	4	assmann	assmann	PROPN
dpc-1099	536	5	jc	jc	PROPN
dpc-1099	536	6	,	,	PUNCT
dpc-1099	536	7	vielhauer	vielhauer	NOUN
dpc-1099	536	8	jf	jf	PROPN
dpc-1099	536	9	,	,	PUNCT
dpc-1099	536	10	et	et	PROPN
dpc-1099	536	11	al	al	PROPN
dpc-1099	536	12	.	.	PUNCT
dpc-1099	537	1	the	the	DET
dpc-1099	537	2	immunometabolomic	immunometabolomic	ADJ
dpc-1099	537	3	interface	interface	NOUN
dpc-1099	537	4	receptor	receptor	NOUN
dpc-1099	537	5	hydroxycarboxylic	hydroxycarboxylic	PROPN
dpc-1099	537	6	acid	acid	PROPN
dpc-1099	537	7	receptor	receptor	NOUN
dpc-1099	537	8	2	2	NUM
dpc-1099	537	9	mediates	mediate	VERB
dpc-1099	537	10	the	the	DET
dpc-1099	537	11	therapeutic	therapeutic	ADJ
dpc-1099	537	12	effects	effect	NOUN
dpc-1099	537	13	of	of	ADP
dpc-1099	537	14	dimethyl	dimethyl	NOUN
dpc-1099	537	15	fumarate	fumarate	NOUN
dpc-1099	537	16	in	in	ADP
dpc-1099	537	17	autoantibody	autoantibody	NOUN
dpc-1099	537	18	-	-	PUNCT
dpc-1099	537	19	induced	induce	VERB
dpc-1099	537	20	skin	skin	NOUN
dpc-1099	537	21	inflammation	inflammation	NOUN
dpc-1099	537	22	.	.	PUNCT
dpc-1099	538	1	front	front	ADJ
dpc-1099	538	2	immunol	immunol	NOUN
dpc-1099	538	3	.	.	PUNCT
dpc-1099	539	1	2018;9:1890	2018;9:1890	NOUN
dpc-1099	539	2	.	.	PUNCT
dpc-1099	540	1	https://doi.org/10.3389/fimmu.2018.01890	https://doi.org/10.3389/fimmu.2018.01890	PROPN
dpc-1099	540	2	61	61	NUM
dpc-1099	540	3	.	.	PUNCT
dpc-1099	541	1	williams	williams	PROPN
dpc-1099	541	2	hc	hc	PROPN
dpc-1099	541	3	,	,	PUNCT
dpc-1099	541	4	wojnarowska	wojnarowska	PROPN
dpc-1099	541	5	f	f	NOUN
dpc-1099	541	6	,	,	PUNCT
dpc-1099	541	7	kirtschig	kirtschig	NOUN
dpc-1099	541	8	g	g	PROPN
dpc-1099	541	9	,	,	PUNCT
dpc-1099	541	10	et	et	PROPN
dpc-1099	541	11	al	al	PROPN
dpc-1099	541	12	.	.	PROPN
dpc-1099	541	13	doxycycline	doxycycline	PROPN
dpc-1099	541	14	versus	versus	ADP
dpc-1099	541	15	prednisolone	prednisolone	PROPN
dpc-1099	541	16	as	as	ADP
dpc-1099	541	17	an	an	DET
dpc-1099	541	18	initial	initial	ADJ
dpc-1099	541	19	treatment	treatment	NOUN
dpc-1099	541	20	strategy	strategy	NOUN
dpc-1099	541	21	for	for	ADP
dpc-1099	541	22	bullous	bullous	ADJ
dpc-1099	541	23	pemphigoid	pemphigoid	NOUN
dpc-1099	541	24	:	:	PUNCT
dpc-1099	541	25	a	a	DET
dpc-1099	541	26	pragmatic	pragmatic	ADJ
dpc-1099	541	27	,	,	PUNCT
dpc-1099	541	28	non	non	ADJ
dpc-1099	541	29	-	-	NOUN
dpc-1099	541	30	inferiority	inferiority	NOUN
dpc-1099	541	31	,	,	PUNCT
dpc-1099	541	32	randomised	randomise	VERB
dpc-1099	541	33	controlled	control	VERB
dpc-1099	541	34	trial	trial	NOUN
dpc-1099	541	35	.	.	PUNCT
dpc-1099	542	1	lancet	lancet	NOUN
dpc-1099	542	2	.	.	PUNCT
dpc-1099	543	1	2017;389(10079):1630	2017;389(10079):1630	NUM
dpc-1099	543	2	-	-	PUNCT
dpc-1099	543	3	1638	1638	NUM
dpc-1099	543	4	.	.	PUNCT
dpc-1099	544	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
dpc-1099	544	2	s0140	s0140	PROPN
dpc-1099	544	3	-	-	PUNCT
dpc-1099	544	4	6736(17)30560	6736(17)30560	ADP
dpc-1099	544	5	-	-	PUNCT
dpc-1099	544	6	3	3	NUM
dpc-1099	544	7	62	62	NUM
dpc-1099	544	8	.	.	PUNCT
dpc-1099	545	1	yamagami	yamagami	PROPN
dpc-1099	545	2	j.	j.	PROPN
dpc-1099	545	3	recent	recent	ADJ
dpc-1099	545	4	advances	advance	NOUN
dpc-1099	545	5	in	in	ADP
dpc-1099	545	6	the	the	DET
dpc-1099	545	7	understanding	understanding	NOUN
dpc-1099	545	8	and	and	CCONJ
dpc-1099	545	9	treatment	treatment	NOUN
dpc-1099	545	10	of	of	ADP
dpc-1099	545	11	pemphigus	pemphigus	NOUN
dpc-1099	545	12	and	and	CCONJ
dpc-1099	545	13	pemphigoid	pemphigoid	ADJ
dpc-1099	545	14	.	.	PUNCT
dpc-1099	546	1	f1000res	f1000re	NOUN
dpc-1099	546	2	.	.	PUNCT
dpc-1099	547	1	2018;7	2018;7	NUM
dpc-1099	547	2	:	:	PUNCT
dpc-1099	547	3	f1000	f1000	PROPN
dpc-1099	547	4	faculty	faculty	NOUN
dpc-1099	547	5	rev-1360	rev-1360	NOUN
dpc-1099	547	6	.	.	PUNCT
dpc-1099	548	1	published	publish	VERB
dpc-1099	548	2	2018	2018	NUM
dpc-1099	548	3	aug	aug	PROPN
dpc-1099	548	4	30	30	NUM
dpc-1099	548	5	.	.	PUNCT
dpc-1099	549	1	https://doi.org/10.12688/	https://doi.org/10.12688/	NOUN
dpc-1099	549	2	f1000research.14474.1	f1000research.14474.1	NOUN
dpc-1099	549	3	63	63	NUM
dpc-1099	549	4	.	.	PUNCT
dpc-1099	549	5	sticherling	sticherle	VERB
dpc-1099	549	6	m	m	PROPN
dpc-1099	549	7	,	,	PUNCT
dpc-1099	549	8	franke	franke	PROPN
dpc-1099	549	9	a	a	PRON
dpc-1099	549	10	,	,	PUNCT
dpc-1099	549	11	aberer	aberer	NOUN
dpc-1099	549	12	e	e	NOUN
dpc-1099	549	13	,	,	PUNCT
dpc-1099	549	14	et	et	PROPN
dpc-1099	549	15	al	al	PROPN
dpc-1099	549	16	.	.	PUNCT
dpc-1099	550	1	an	an	DET
dpc-1099	550	2	open	open	ADJ
dpc-1099	550	3	,	,	PUNCT
dpc-1099	550	4	multicentre	multicentre	NOUN
dpc-1099	550	5	,	,	PUNCT
dpc-1099	550	6	randomized	randomize	VERB
dpc-1099	550	7	clinical	clinical	ADJ
dpc-1099	550	8	study	study	NOUN
dpc-1099	550	9	in	in	ADP
dpc-1099	550	10	patients	patient	NOUN
dpc-1099	550	11	with	with	ADP
dpc-1099	550	12	bullous	bullous	ADJ
dpc-1099	550	13	pemphigoid	pemphigoid	NOUN
dpc-1099	550	14	comparing	compare	VERB
dpc-1099	550	15	methylprednisolone	methylprednisolone	NOUN
dpc-1099	550	16	and	and	CCONJ
dpc-1099	550	17	azathioprine	azathioprine	VERB
dpc-1099	550	18	with	with	ADP
dpc-1099	550	19	methylprednisolone	methylprednisolone	PROPN
dpc-1099	550	20	and	and	CCONJ
dpc-1099	550	21	dapsone	dapsone	PROPN
dpc-1099	550	22	.	.	PUNCT
dpc-1099	551	1	br	br	PROPN
dpc-1099	551	2	j	j	PROPN
dpc-1099	551	3	dermatol	dermatol	NOUN
dpc-1099	551	4	.	.	PUNCT
dpc-1099	552	1	2017;177(5):12991305	2017;177(5):12991305	NUM
dpc-1099	552	2	.	.	PUNCT
dpc-1099	553	1	https://doi.org/10.1111/bjd.15649	https://doi.org/10.1111/bjd.15649	NOUN
dpc-1099	553	2	64	64	NUM
dpc-1099	553	3	.	.	PUNCT
dpc-1099	554	1	kremer	kremer	PROPN
dpc-1099	554	2	n	n	CCONJ
dpc-1099	554	3	,	,	PUNCT
dpc-1099	554	4	snast	snast	NOUN
dpc-1099	554	5	i	i	PROPN
dpc-1099	554	6	,	,	PUNCT
dpc-1099	554	7	cohen	cohen	PROPN
dpc-1099	554	8	es	es	PROPN
dpc-1099	554	9	,	,	PUNCT
dpc-1099	554	10	et	et	PROPN
dpc-1099	554	11	al	al	PROPN
dpc-1099	554	12	.	.	PROPN
dpc-1099	554	13	rituximab	rituximab	NOUN
dpc-1099	554	14	and	and	CCONJ
dpc-1099	554	15	omalizumab	omalizumab	NOUN
dpc-1099	554	16	for	for	ADP
dpc-1099	554	17	the	the	DET
dpc-1099	554	18	treatment	treatment	NOUN
dpc-1099	554	19	of	of	ADP
dpc-1099	554	20	bullous	bullous	ADJ
dpc-1099	554	21	pemphigoid	pemphigoid	NOUN
dpc-1099	554	22	:	:	PUNCT
dpc-1099	554	23	a	a	DET
dpc-1099	554	24	systematic	systematic	ADJ
dpc-1099	554	25	review	review	NOUN
dpc-1099	554	26	of	of	ADP
dpc-1099	554	27	the	the	DET
dpc-1099	554	28	literature	literature	NOUN
dpc-1099	554	29	.	.	PUNCT
dpc-1099	555	1	am	be	AUX
dpc-1099	555	2	j	j	PROPN
dpc-1099	555	3	clin	clin	PROPN
dpc-1099	555	4	dermatol	dermatol	NOUN
dpc-1099	555	5	.	.	PUNCT
dpc-1099	556	1	2019;20(2):209	2019;20(2):209	NUM
dpc-1099	556	2	-	-	PUNCT
dpc-1099	556	3	216	216	NUM
dpc-1099	556	4	.	.	PUNCT
dpc-1099	557	1	https://	https://	PROPN
dpc-1099	557	2	doi.org/10.1007/s40257-018-0401-6	doi.org/10.1007/s40257-018-0401-6	PROPN
dpc-1099	557	3	65	65	NUM
dpc-1099	557	4	.	.	PUNCT
dpc-1099	558	1	amber	amber	PROPN
dpc-1099	558	2	kt	kt	PROPN
dpc-1099	558	3	,	,	PUNCT
dpc-1099	558	4	maglie	maglie	PROPN
dpc-1099	558	5	r	r	PROPN
dpc-1099	558	6	,	,	PUNCT
dpc-1099	558	7	solimani	solimani	NOUN
dpc-1099	558	8	f	f	NOUN
dpc-1099	558	9	,	,	PUNCT
dpc-1099	558	10	eming	eme	VERB
dpc-1099	558	11	r	r	NOUN
dpc-1099	558	12	,	,	PUNCT
dpc-1099	558	13	hertl	hertl	ADJ
dpc-1099	558	14	m.	m.	NOUN
dpc-1099	558	15	targeted	target	VERB
dpc-1099	558	16	therapies	therapy	NOUN
dpc-1099	558	17	for	for	ADP
dpc-1099	558	18	autoimmune	autoimmune	ADJ
dpc-1099	558	19	bullous	bullous	ADJ
dpc-1099	558	20	diseases	disease	NOUN
dpc-1099	558	21	:	:	PUNCT
dpc-1099	558	22	current	current	ADJ
dpc-1099	558	23	status	status	NOUN
dpc-1099	558	24	.	.	PUNCT
dpc-1099	559	1	drugs	drug	NOUN
dpc-1099	559	2	.	.	PUNCT
dpc-1099	560	1	2018;78(15):1527	2018;78(15):1527	NUM
dpc-1099	560	2	-	-	SYM
dpc-1099	560	3	1548	1548	NUM
dpc-1099	560	4	.	.	PUNCT
dpc-1099	561	1	https://doi.org/10.1007/s40265-0180976-5	https://doi.org/10.1007/s40265-0180976-5	PROPN
dpc-1099	561	2	66	66	NUM
dpc-1099	561	3	.	.	PUNCT
dpc-1099	562	1	seyed	seyed	PROPN
dpc-1099	562	2	jafari	jafari	PROPN
dpc-1099	562	3	sm	sm	PROPN
dpc-1099	562	4	,	,	PUNCT
dpc-1099	562	5	gadaldi	gadaldi	PROPN
dpc-1099	562	6	k	k	PROPN
dpc-1099	562	7	,	,	PUNCT
dpc-1099	562	8	feldmeyer	feldmeyer	PROPN
dpc-1099	562	9	l	l	NOUN
dpc-1099	562	10	,	,	PUNCT
dpc-1099	562	11	yawalkar	yawalkar	NOUN
dpc-1099	562	12	n	n	CCONJ
dpc-1099	562	13	,	,	PUNCT
dpc-1099	562	14	borradori	borradori	PROPN
dpc-1099	562	15	l	l	NOUN
dpc-1099	562	16	,	,	PUNCT
dpc-1099	562	17	schlapbach	schlapbach	PRON
dpc-1099	562	18	c.	c.	NOUN
dpc-1099	562	19	effects	effect	NOUN
dpc-1099	562	20	of	of	ADP
dpc-1099	562	21	omalizumab	omalizumab	NOUN
dpc-1099	562	22	on	on	ADP
dpc-1099	562	23	fcεri	fcεri	ADJ
dpc-1099	562	24	and	and	CCONJ
dpc-1099	562	25	ige	ige	PROPN
dpc-1099	562	26	exhttps://doi.org/10.3389/fimmu.2019.01919	exhttps://doi.org/10.3389/fimmu.2019.01919	PROPN
dpc-1099	562	27	https://doi.org/10.1080/17512433.2019.1670059	https://doi.org/10.1080/17512433.2019.1670059	PROPN
dpc-1099	562	28	https://doi.org/10.1111/exd.12355	https://doi.org/10.1111/exd.12355	PROPN
dpc-1099	562	29	https://doi.org/10.3389/fimmu.2018.01935	https://doi.org/10.3389/fimmu.2018.01935	PROPN
dpc-1099	562	30	https://doi.org/10.1126/science.aaf6756	https://doi.org/10.1126/science.aaf6756	PROPN
dpc-1099	562	31	https://doi.org/10.1126/science.aaf6756	https://doi.org/10.1126/science.aaf6756	NOUN
dpc-1099	562	32	https://doi.org/10.3389/fimmu.2019.01418	https://doi.org/10.3389/fimmu.2019.01418	PROPN
dpc-1099	563	1	https://doi.org/10.3389/fimmu.2018.01890	https://doi.org/10.3389/fimmu.2018.01890	PROPN
dpc-1099	563	2	https://doi.org/10.1016/s0140-6736(17)30560-3	https://doi.org/10.1016/s0140-6736(17)30560-3	ADJ
dpc-1099	563	3	https://doi.org/10.1016/s0140-6736(17)30560-3	https://doi.org/10.1016/s0140-6736(17)30560-3	ADJ
dpc-1099	563	4	https://doi.org/10.12688/f1000research.14474.1	https://doi.org/10.12688/f1000research.14474.1	PROPN
dpc-1099	563	5	https://doi.org/10.12688/f1000research.14474.1	https://doi.org/10.12688/f1000research.14474.1	PROPN
dpc-1099	563	6	https://doi.org/10.1111/bjd.15649	https://doi.org/10.1111/bjd.15649	NOUN
dpc-1099	563	7	https://doi.org/10.1007/s40257-018-0401-6	https://doi.org/10.1007/s40257-018-0401-6	NUM
dpc-1099	563	8	https://doi.org/10.1007/s40257-018-0401-6	https://doi.org/10.1007/s40257-018-0401-6	NUM
dpc-1099	563	9	https://doi.org/10.1007/s40265-018-0976-5	https://doi.org/10.1007/s40265-018-0976-5	NUM
dpc-1099	563	10	https://doi.org/10.1007/s40265-018-0976-5	https://doi.org/10.1007/s40265-018-0976-5	VERB